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ABSTRACT 
 Despite many advances over the last two centuries, small molecule synthesis remains a 
relatively complex, unsystematized, and time-intensive process practiced almost exclusively by 
highly trained specialists. Collectively, these limitations represent a major bottleneck in the 
efforts to study, understand, and harness the vast functional capacity of small molecules. In an 
effort to shift the rate-limiting step of small molecule science from synthesis to function study, 
we have designed, constructed, and implemented a fully automated small molecule synthesizer.  
The synthesizer uses only one C-C bond forming reaction, the Suzuki-Miyaura cross-
coupling (SMC) reaction, to assemble off-the-shelf building blocks into many different types of 
small molecules including organic materials, pharmaceuticals, natural products, and natural 
product derivatives. Specifically, this automated synthesis platform utilizes the iterative cross-
coupling (ICC) strategy enabled by the capacity of N-methyliminodiacetic acid (MIDA) to 
reversibly attenuate the reactivity of a boronic acid. MIDA boronates are generally crystalline 
free-flowing solids and are stable to bench-top storage. Furthermore, it has been discovered that 
they are universally amenable to catch-and-release column chromatography and are universally 
susceptible to general mild deprotection conditions. Additionally, MIDA boronates can be 
prepared by a variety of synthetic methods on multi-gram scale and they demonstrate 
significantly improved reaction yields with slow-addition cross-coupling (SACC). It was 
understood that these strikingly general features of MIDA boronates made them highly amenable 
to an automated ICC platform. Fully automated modules for MIDA boronate purification, 
deprotection, and cross-coupling were developed and with thousands of applicable building 
blocks commercially available or easily accessible, this now simple, general, and fully automated 
synthesis platform stands to afford more efficient access to small molecule targets to specialists 
and non-specialists alike.  
iii 
 
 
 
 
 
 
 
 
 
To the two greatest loves of my life, 
Meghan Elisabeth Ballmer & Emerson Jeanne Beauregard Ballmer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
ACKNOWLEDGEMENTS 
I would first like to thank my advisor, Martin D. Burke. Marty’s unwavering commitment 
to rigorous science has been a constant source of inspiration over the last six years. He 
approaches big unsolved problems and unanswered questions fearlessly while understanding that 
all the minor problems and questions, whether predicted or not, that stand in the way will be 
solved in the process in their own time. This fundamental approach to science is by far the 
leading quality he, as a mentor, has instilled in me. His ability, too, to view science in the 
broadest scope by considering the impact of every experiment on the current project and the 
greater impact of the project on the world has changed the way I approach science. The method 
of forming global hypotheses and then testing them with the cleanest simplest experiments has 
become the model upon which I have developed my own scientific process.    
I would also like to acknowledge and thank my thesis committee members: Prof. Martin 
D. Burke, Prof. Scott E. Denmark, Prof. Jeffrey S. Moore, and Prof. Paul J. A. Kenis. Together 
they have held me to the highest standards of science and academics. The humbling experiences 
of prelim and ORP alone have had a profound effect on my maturation as a scientist, for which I 
am extraordinarily grateful. Their insistence that I, at the very least, be held accountable for both 
the science I do and the science I present has, I hope, helped to mold me into a better chemist and 
on overall well-rounded scientist.  
In the course of completing my thesis research I’ve had the distinct privilege of working 
closely with an incomparable set of colleagues: Eric Gillis, Seiko Fujii, Junqi Li, and Greg 
Morehouse. Each member of Team Machine brought their own set of unique skills to the project 
and played a significant role in its completion as well as my development as a scientist. Eric’s 
mastery of computer coding was essential to getting the first synthesizer up and running and his 
outside-the-box thinking transformed the way I approach problem solving. Seiko’s tenacious 
attitude toward science was crucial in bringing every difficult synthesis and mini-project to the 
finish line and taught me that when that final coupling just isn’t working, an unwavering 
commitment to making it happen, and maybe just one more ligand screen, are always a good 
idea. Junqi’s impeccable synthetic skills were an absolute luxury from the very beginning to the 
very end. I can’t even remember how many times the project needed a brand new building block 
v 
 
or an existing building block, but with an entirely new series of protecting groups or a final 
global deprotection done on sub-milligram quantities, but at every demand, Junqi delivered. Her 
golden hands helped bring the project to a close and became the gold standard in synthetic skill. 
Greg’s enviable command of the literature and physical organic chemistry shaped not only the 
way we designed and optimized experiments for the project, but also the way I approach new 
experiments myself.    
Many other members of the Burke group have played critical roles in my life over the 
past six years, all as colleagues many as friends. I was fortunate enough to have been lab partners 
with Brandon Wilcock for the majority of my graduate career. I credit Brandon as my official 
mentor during graduate school. Although our projects never had the opportunity to overlap, he 
taught me (whether he knows it or not) invaluable skills, including how to run giant silica gel 
columns two at a time, how to survive working 16-hour days in the dark, and how to persevere 
when the chemistry gets tough. I was also lucky enough to find a friend in my colleague, Kaitlyn 
Gray. Kaitlyn was as good a mentor in the fumehood as she was a friend outside of lab. I credit 
her, without a doubt, for my Dark Lab attitude. My colleagues Erin Davis, Matt Endo, Brice 
Uno, and Heath Timmons have been my four closest friends and confidants while I’ve been here. 
Erin has been my kindred Ohio State and state of Ohio buddy and I sincerely wish her the best of 
luck on her transition to nursing. Matt, Brice, and Heath have made these past six years bearable 
and as fun as possible, whether it was discussing science, drinking until dawn, or standing with 
me at my wedding. I will sorely miss them all should we ever lose contact. Lastly, Eric Woerly, 
Justin Struble, Dan Palacios, Jenna Klubnick, Dave Knapp, and Ian Dailey have all been equal 
parts mentors, colleagues, and high quality drinking partners.         
There are also a number of people beyond the walls of the Burke lab that made my 
graduate career possible, or perhaps easier. My undergraduate mentor, Ben Southerland, may be 
solely responsible for my decision to attend graduate school. His persistent nagging convinced 
me I had the skills to make it; I guess he was right. The entire staff of the SCS Machine Shop, 
Mike “Hodge” Harland and Brad Lutz, in particular, proved to be an invaluable asset in the 
construction of countless custom parts. Dr. Robert Elliot and his entire staff at J-KEM
®
 
Scientific, Inc. were instrumental in getting our first automated system together. I’d also like to 
thank the organic area administrative assistants past and present, but especially Stacy Olson, 
vi 
 
Becky Duffield, and Susan Lightly. There were times when it seemed that they ran the entire 
organic area all by themselves and they were always ready to lend a listening ear or an 
encouraging word when the stresses of graduate school became overwhelming. Also, their 
bottomless candy bowl was always a welcome distraction from the fumehood.    
As a general rule, money is never an easy thing to come by and scientific research and 
graduate school is no exception to that rule. I gratefully acknowledge the National Science 
Foundation, National Institutes of Health, Howard Hughes Medical Institute, University of 
Illinois at Urbana-Champaign Department of Chemistry, and Prof. Martin D. Burke for personal 
and/or research funding.   
Finally, I would like to thank my family for their endless support. My mother, Terri, and 
father, Bill have been there every step of the way with encouraging words, unconditional love, 
and an extra couple of dollars everytime I needed it and even sometimes when I didn’t. Whatever 
they did to raise a scientifically inclined son must have worked; I never would have made it to, 
and certainly not through graduate school without them. My big sister, Debba, whether she 
knows it or not, has been the inspiration for nearly every academic decision I’ve made in my life. 
I always wanted to do whatever she did; math, science, college. I consider earning my Ph.D. to 
be possibly the greatest accomplishment of my life to date. Even during the endless stress I 
endured to achieve this goal, though, I embarked on undoubtedly the two greatest journeys of my 
life. The first was marrying my beautiful wife, Meghan, and the second was having my 
wonderful daughter, Emerson. Meghan has been there for me like no one else has; she’s seen me 
at my best and worst and never gave up on me. She was there to comfort me during the lowest 
lows and darkest hours of my graduate career just like she was there to celebrate with me during 
the happy times, even though I think there were far more of the former than the latter. Emerson, 
too, though she’ll never remember it, has helped me immensely. Her innocent smiling face has 
given me daily inspiration to continue pursuing my passion for science in order to provide for 
her. Looking back, planning a wedding and preparing for a baby all while pursuing my Ph.D. 
may not have been the most practical decisions. Now that I have a loving and supportive wife by 
my side and a beautiful child to come home to, though, I wouldn’t have done it any other way. If 
nothing else, I hope that I’ve made my mother, father, big sister, wife, and daughter proud.    
 
vii 
 
ABBREVIATIONS 
 
1
st
 gen. SPhos palladacycle chloro(2-dicyclohexylphosphino-2’,6’- 
dimethoxy-1,1’-biphenyl)[2-(2-
aminoethylphenyl)]palladium(II)   
 
 
1
st
 gen. XPhos palladacycle chloro(2-dicyclohexylphosphino-2’,4’,6’-
triisopropyl-1,1’-biphenyl)[2-(2-
aminoethylphenyl)]palladium(II)   
 
 
2
nd
 gen. SPhos palladacycle chloro(2-dicyclohexylphosphino-2’,6’- 
dimethoxy-1,1’-biphenyl)[2-(2’-amino-1,1’-
biphenyl)]palladium(II)  
 
 
2
nd
 gen. XPhos palladacycle chloro(2-dicyclohexylphosphino-2’,4’,6’-
triisopropyl-1,1’-biphenyl)[2-(2’-amino-1,1’-
biphenyl)]palladium(II)  
 
 
Ac    acetate 
 
Boc    t-butoxycarbonyl 
 
BrettPhos 2-(dicyclohexylphosphino)-3,6-dimethoxy-
2’,4’,6’-triisopropyl-1,1’-biphenyl 
 
 
viii 
 
BrettPhos palladacycle chloro[2-(dicyclohexylphosphino)-3,6-
dimethoxy-2’,4’,6’-triisopropyl-1,1′-
biphenyl][2-(2-
aminoethyl)phenyl]palladium(II)   
 
Cy    cyclohexyl 
 
CyJohnPhos   (2-biphenyl)dicyclohexylphosphine 
 
DavePhos 2-dicyclohexylphosphino-2’-(N,N-
dimethylamino)biphenyl   
 
dba    dibenzylideneacetone 
 
DCM    dichloromethane 
 
DMF    N,N-dimethylformamide 
 
DMAP    4-(N,N-dimethylamino)-pyridine 
 
DMP    Dess-Martin periodinane 
 
DMSO    dimethyl sulfoxide 
 
dppf    1,1’-bis(diphenylphosphino)ferrocene 
 
GC    gas chromatography 
 
h    hour(s) 
 
ix 
 
HPLC    high-performance liquid chromatography 
 
ICC    iterative cross-coupling 
 
JohnPhos   (2-biphenyl)di-t-butylphosphine  
 
Mes    mesityl 
 
MePhos   2-dicyclohexylphosphino-2’- 
methylbiphenyl 
 
MIDA    N-methyliminodiacetic acid 
 
min     minute(s) 
 
MOM    methoxymethyl 
 
MPLC    medium-pressure liquid chromatography 
 
NMR    nuclear magnetic resonance 
 
pyr    pyridine 
 
rt    room temperature 
 
RuPhos 2-dicyclohexylphosphino-2’,6’-
diisopropoxybiphenyl 
 
SACC    slow-addition cross-coupling 
 
x 
 
SMC    Suzuki-Miyaura cross-coupling 
 
SPhos    2-dicyclohexylphosphino-2’,6’-dimethoxybiphenyl 
 
SRCC    slow-release cross-coupling 
 
TBAF    tetra-N-butylammonium fluoride 
 
TBDPS   t-butyldiphenylsilyl 
 
TBDPSE   2-(t-butyldiphenylsilyl)ethyl 
 
TBS    t-butyldimethylsilyl 
 
TES    triethylsilyl 
 
tBuBrettPhos   2-(di-t-butylphosphino)-2’,4’,6’- 
triisopropyl-3,6-dimethoxy-1,1’- 
biphenyl 
 
tBuDavePhos 2-di-t-butylphosphino-2’-(N,N-
dimethylamino)biphenyl 
 
tBuMePhos   2-di-t-butylphosphino-2’-methylbiphenyl 
 
tBuXPhos 2-di-t-butylphosphino-2’,4’,6’-
triisopropylbiphenyl 
 
TIPS    triisopropylsilyl 
 
xi 
 
TMSE    2-(trimethylsilyl)ethyl 
 
TLC    thin layer chromatography 
 
TMS    trimethylsilyl 
 
UV    ultraviolet 
 
XPhos 2-dicyclohexylphosphino-2’,4’,6’-
triisopropylbiphenyl 
xii 
 
TABLE OF CONTENTS 
 
CHAPTER 1: INTRODUCTION ....................................................................................1 
 
CHAPTER 2: DEVELOPMENT OF AN AUTOMATED PURIFICATION  
PLATFORM ...........................................................................................16 
  
 CHAPTER 2: EXPERIMENTAL SECTION .........................................34 
 
CHAPTER 3: DEVELOPMENT OF AN AUTOMATED DEPROTECTION 
PLATFORM ...........................................................................................45 
 
CHAPTER 4:  DEVELOPMENT OF AN AUTOMATED CROSS-COUPLING 
PLATFORM ...........................................................................................64 
 
 CHAPTER 4: EXPERIMENTAL SECTION .........................................78 
 
CHAPTER 5: A SMALL MOLECULE SYNTHESIZER ............................................89 
 
 CHAPTER 5: EXPERIMENTAL SECTION .......................................126 
 
APPENDIX A: SCRIPTING COMMANDS USED TO PROGRAM THE 
 SYNTHESIZER ....................................................................................246 
 
APPENDIX B: SAMPLE PROGRAM SCRIPT USED ON THE  
 SYNTHESIZER ....................................................................................261
1 
 
CHAPTER 1 
INTRODUCTION 
 
Steven G. Ballmer and Martin D. Burke 
 
Despite its advancements, small molecule synthesis remains a relatively complex, 
unsystematized, and time-intensive process practiced almost exclusively by highly-trained 
specialists which ultimately makes it the rate-limiting step in understanding small molecule 
function. In stark contrast, peptides, oligonucleotides, and oligosaccharides are synthesized, and 
subsequently studied, with relatively remarkable efficiency. This is largely because their 
synthesis platforms are now routinely automated, a process which is enabled by a general and 
modular iterative synthesis strategy for each class of macromolecule. Small molecules, though, 
are currently synthesized via customized routes and while advances have been made in the 
design, and even automation in some cases, of these routes, this approach has major limitations 
which includes the need for many different types of reactions and building blocks and a high 
degree of specialist expertise. This chapter discusses the pioneering development of automated 
synthesis platforms for peptides, oligonucleotides, oligosaccharides, and even organic polymers. 
It also describes the development of an analogous and general small molecule synthesis platform 
based on the iterative cross-coupling (ICC) strategy employing N-methyliminodiacetic acid 
(MIDA) boronates and how this general platform is amenable to automation which stands to 
make small molecule synthesis and study equally as efficient as that of macromolecules.   
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1-1 AUTOMATED ITERATIVE SYNTHESIS OF MACROMOLECULES 
Many peptides and oligonucleotides can now be readily prepared via general and 
automated synthesis platforms. In these systems common sets of building blocks, having all of 
the required functional groups and stereochemical features pre-installed, are assembled using a 
single reaction in an iterative fashion. Limitations still remain, including requirements for 
synthesis of some specialty building blocks that are not commercially available and optimization 
of reaction conditions for more challenging couplings. Nonetheless, these platforms have 
dramatically increased the efficiency with which these compounds can be prepared, and even 
extended this access to non-specialists. As a result, the rate-limiting step in these scientific areas 
has shifted from synthesis to function, which in turn has had a transformational impact on many 
areas of science, medicine, and technology. Progress in this direction has also been achieved 
with oligosaccharides and some organic polymers. This section highlights the development of 
automated iterative synthesis platforms for peptides, oligonucleotides, oligosaccharides, and 
outlines seminal work in the iterative synthesis of organic polymers.   
 
Automated peptide synthesis 
 The automated synthesis of peptides, oligonucleotides, and increasingly oligosaccharides 
via an iterative coupling platform is now ubiquitous. This automated iterative platform, however, 
is arguably most commonly associated with peptide synthesis. In particular, solid-phase peptide 
synthesis (SPPS), and specifically its automation, represents the classic paradigm for efficient 
and modular synthetic strategies.  
This strategy for modern peptide synthesis is represented schematically in Figure 1.1 
below. The paradigm relies wholly on the use of a bifunctional building block, an amino acid in 
this case, that is orthogonally protected at the nitrogen terminus (the classic 
fluorenylmethyloxycarbonyl, Fmoc
1
, group is shown in Figure 1.1) to avoid random 
oligomerization during the coupling event. Even though the first manually synthesized peptide, 
glycylglycine, was reported in 1901 by Emil Fischer,
2
 it was not until more than thirty years 
later, in 1932, that Max Bergmann reported the carboxybenzyl (Cbz) protecting group that first 
allowed for the reversible attenuation of reactivity of the nitrogen center by masking the nitrogen 
as the Cbz carbamate.
3
 With a properly protected nitrogen terminus, the peptide bond formation 
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can proceed with high selectivity. After each bond formation event, the protecting group can be 
removed, revealing the free reactive nitrogen terminus capable of undergoing another round of 
coupling. Because any amino acid can be introduced during the coupling reactions, this approach 
is inherently highly flexible and modular.  
 
 
Figure 1.1. Schematic representation of the modern paradigm for iterative synthesis of peptides via solid-phase 
peptide synthesis (SPPS) from amino acid building blocks, the automation of which has been pioneered by 
Merrifield and coworkers. Fmoc = fluorenylmethyloxycarbonyl. 
 
Enabled by this protecting group strategy, Merrifield first reported the concept of solid-
phase synthesis and its implementation in the synthesis of a tetrapeptide in 1963.
4
 In SPPS, the 
carboxy terminus of the peptide is immobilized via linkage to a solid resin. The enabling quality 
of this strategy is that it provides a highly efficient and, more importantly,  general method for 
purification; all impurities can be removed via simple filtration away from the immobilized 
growing peptide. Only two years after its initial report, the an instrument for automated SPPS 
was reported.
5
 The simplicity and generality of the SPPS strategy likely contributed heavily to its 
quick translation to an automated platform. As a striking example at the time, the system was 
used successfully in the automated synthesis of the nona-peptide, bradykinin, in only 32 hours.
6
 
By 1967, new designs for less expensive SPPS vessels were making the platform increasingly 
more efficient
7
 and less than 20 years later, fully automated peptide (and oligonucleotide) 
synthesizers were available as commercial units
8,9,10
 ultimately bringing the power of peptide 
synthesis to non-chemists. In a landmark implementation of automated SPPS, interleukin-3 (IL-
3), a 140-amino acid protein was synthesized in an automated fashion in 1986.
11
 The 
development of SPPS and the subsequent translation of it to an automated iterative synthesis 
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platform has had a dramatic effect on the synthesis and thereby the study of peptides and their 
functions in science.
12,13
  
 
Automated oligonucleotide synthesis 
Similar to SPPS, solid-phase methods for the iterative synthesis of oligonucleotides have 
also been developed.
14,15
 This process is represented schematically in Figure 1.2 below. Like 
peptide synthesis, this paradigm relies on the use of an appropriately protected bifunctional 
building block, an O-protected nucleotide in this case, to prevent random oligomerization during 
the coupling event. Figure 1.2 shows a generalized dimethoxytrityl-protected nucleotide where B 
represents the base, thymine, or appropriately protected bases adenine, cytosine, or guanine. This 
platform benefits from the same advantages that SPPS does; namely that facile purification can 
be performed by filtering away impurities.   
 
 
Figure 1.2. Schematic representation of the paradigm for the iterative synthesis of oligonucleotides from nucleotide 
building blocks, the automation of which has been pioneered by Ogilvie and coworkers as well as Caruthers and 
coworkers. B = thymine or appropriately protected adenine, cytosine, or guanine. DMT = dimethoxytrityl. DCL = 
dichloroacetic acid. 
 
Analogous to peptide synthesis, this simple and general strategy enabled the rapid 
development of a fully automated platform for oligonucleotide synthesis nearly concurrently by 
Ogilvie and coworkers in 1981
16
 and Caruthers and coworkers shortly after.
17
 In fact, this 
platform was so beneficial to the study of genes that in 1984, an entire facility was developed 
with a series of automated instruments for the analysis and synthesis of both genes and 
proteins.
18
 By 1985 an varied series of next-generation automated gene and deoxyribonucleic 
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acid (DNA) synthesizers were commercially available
19
 which, like automated peptides, 
ultimately brought the power of synthesis to the hands of non-specialists. Along with the 
technology capable of performing fully automated syntheses of oligonucleotides came the 
interest and development of separate automated platforms for DNA sequencing
20,21
 as well as 
DNA purification and isolation.
22
 Again, similar to automated SPPS, the development of an 
automated platform for oligonucleotide synthesis has had a dramatic effect on the field of gene 
and DNA function study. For example, these automated platforms continue to play a critical role 
in the efficient study of oligonucleotide functions as is evidenced by a recent report of the 
automated synthesis of oligodeoxynucleotides containing a 3’-S-phosphorothiolate linkages, 
which are important tools for probing enzyme-catalyzed cleave processes.
23
  
 
Automated oligosaccharide synthesis 
 Similar to the automated platforms that have been developed for peptide and 
oligonucleotide synthesis as discussed previously, a fully automated solid-phase synthesis 
platform for oligosaccharides has more recently been reported by Seeberger and coworkers in 
2001.
24
 This platform is represented schematically in Figure 1.3 below and analogous to the 
peptide and oligonucleotide platforms mentioned previously, this paradigm also relies on the use 
of an appropriately protected bifunctional building block, an O-protected saccharide in this case, 
to prevent random oligomerization during the coupling event. Figure 1.3 depicts a generalized 
case wherein the bifunctional saccharide building block is orthogonally protected as the 
levulinoyl ester in the presence of benzyl ethers and pivaloyl esters. The same facile purification 
process (simple filtration of the impurities away from the immobilized substrate) as solid-phase 
peptide and oligonucleotide synthesis is taken advantage of here. The development of an 
automated synthesis platform for oligosaccharides is relatively new science compared to the 
analogous platforms for peptides and oligonucleotides, and is actively being optimized. Like the 
other macromolecular synthesis platforms did for their respective research fields, though, this too 
will likely create a dramatic impact on the field of carbohydrate research by bringing the power 
of synthesis to the hands of non-specialists. That is, the study of carbohydrate structure-function 
relationships is currently of interest in the scientific community
25
 and implementing an 
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automated synthesis platform as a drug discovery engine can provide facile access, particularly 
by non-chemists, to varied carbohydrate structures to facilitate these studies.
26,27
 
 
 
Figure 1.3. Schematic representation of the paradigm for the iterative synthesis of oligosaccharides from saccharide 
building blocks, the automation of which has been pioneered by Seeberger and coworkers. Piv = pivaloyl. Lev = 
levulinoyl. Bn = benzyl. 
 
Iterative organic polymer synthesis 
 As discussed previously, the synthesis, and in turn the study, of macromolecules like 
peptides, oligonucleotides, and increasingly oligosaccharides has been dramatically simplified by 
the automation of a general and modular synthesis platform. Small molecule synthesis, however, 
is still limited by a lack of an analogous general, modular, and automated synthesis platform. 
Pioneering work by Moore and coworkers concerning the development of an iterative cross-
coupling (ICC) approach to organic polymer synthesis,
28,29
 however, represents a seminal 
advance, at least conceptually, in the modular synthesis of small molecules. Specifically, Moore 
and coworkers report the synthesis of phenylacetylene oligomers via iterative Pd-mediated cross-
couplings as, initially, a solution-phase process
28
 and two years later as a solid-supported 
synthesis strategy (Figure 1.4).
29
 Here a strategy of iterative Sonogashira cross-coupling 
reactions
30
 is employed with the terminal acetylene functionalities protected as the trimethylsilyl 
(SiMe3) acetylenes and the terminal aryl halides orthogonally masked as 1-aryl-3,3-
dialkyltriazene groups via an immobilized triazene linker. Although this work is not specifically 
reported as an automated process, it could theoretically be translated, especially as a solid-phase 
strategy, to known automated systems, thereby streamlining the synthetic process.       
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Figure 1.4. Iterative synthesis of polymers from arene building blocks via iterative Sonogashira cross-coupling 
pioneered by Moore and coworkers. 
 
Suginome and coworkers have pioneered a similar iterative strategy for the synthesis of 
oligoarenes in solution phase.
31
 This strategy employs 1,8-diaminonapthalene (dan) as a 
protecting ligand that attenuates the reactivity of boron in an iterative Suzuki-Miyaura cross-
coupling strategy. This platform represents a new strategy in iterative Suzuki-Miyaura 
transformations and is effective for the synthesis of a range of oligoarenes. Interestingly, while 
this particular strategy could also conceivably be employed in the synthesis small molecules, the 
harsh acidic conditions required to remove the dan ligand are not generally amenable to small 
molecule synthesis. While Suginome’s approach has not yet been reported as an automated 
platform, it is conceivable that the chemistry could be translated, either as a solid or solution 
phase process, to an automated system which would increase the efficiency of the synthesis of 
the oligoarene targets.       
 
1-2 A GENERAL PLATFORM FOR SMALL MOLECULE SYNTHESIS 
Small molecules perform an extraordinary range of important functions in science, 
medicine, and technology. However, the synthesis of such compounds still represents the rate-
limiting step in the effort to study and understand their vast functional capacity. This is largely 
because most small molecules are currently prepared via customized syntheses. While substantial 
advances have been made in the design, execution, and even in some cases, tailored automation 
of such pathways,
32,33
 this specialized approach has major limitations. These include the need for 
many different types of reactions and building blocks and a high degree of specialist expertise. 
8 
 
In stark contrast, as discussed previously, many peptides, oligonucleotides, 
oligosaccharides, and to a lesser extent, organic polymers, can now be readily prepared via 
general and automated synthesis platforms. As described, these systems utilize common sets of 
building blocks, having all of the required functional groups and stereochemical features pre-
installed, and assemble them using a single reaction in an iterative fashion. This strategy of 
assembling building blocks in a simple iterative fashion is enabled by the inherent modularity of 
these macromolecules (Figure 1.5, A). That is, even very large and complex peptides such as 
myoglobin
34
 (Figure 1.5, A, left), oligonucleotides such as a group II intron
35
 (Figure 1.5, A, 
middle), and oligosaccharides such as β-cyclodextrin36 (Figure 1.5, A, right) are composed 
simply of repeating units of amino acids, nucleotides, and saccharides, respectively. The exact 
identity of each repeating building block may be different, but each macromolecule is ultimately 
highly modular in nature.  
Unlike the macromolecular structures of peptides, oligonucleotides, and oligosaccharides, 
small molecules as a general class of molecules are not classically thought to be modular in 
nature, because their structures vary so dramatically. In fact, however, small molecules, 
including natural products, pharmaceuticals, and organic materials contain a high level of 
inherent modularity across the entire class (Figure 1.5, B). Specifically, organic materials like the 
quaterthiophene and pharmaceuticals like the B-Raf kinase inhibitor and glucagon receptor 
antagonist shown in Figure 1.5B are inherently modular due to the Csp
2
-Csp2 bond 
disconnections used in their syntheses. These types of aryl/heteroaryl-aryl/heteraryl connections 
are ubiquitous among many organic materials and active pharmaceuticals. Furthermore, natural 
products like amphotericin B, crocacin C, peridinin, ratanhine, β-parinaric acid, myxalamide A, 
and synechoxanthin also demonstrate a high degree of inherent modularity in their construction. 
Specifically, repeating olefin units forming a polyene are very common across many classes of 
natural products and similar to the materials and pharmaceuticals mentioned previously, many 
natural products, like ratanhine, also have repeating Csp
2
-Csp2 bond disconnections adding to 
their inherent modularity. This is not particularity surprising when one considers the similarities 
between the biosynthesis of many natural products and the biosynthesis of peptides, 
oligonucleotides, and oligosaccharides. As mentioned previously, peptides, oligonucleotides, and 
oligosaccharides are composed of repeating amino acid, nucleotide, and saccharides units, 
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respectively. Comparatively, the most common small molecule biosynthetic pathways, such as 
polyterpene, polyketide, and fatty acid synthesis, also consist of iterative modular strategies. For 
example, polyterpenes are composed of repeating isoprene units while polyketides are 
synthesized by repeating malonyl-CoA units and fatty acids are made from repeating acetyl-CoA 
units.         
 
 
Figure 1.5. Peptides, oligonucleotides, and oligosaccharides are inherently modular, A, which enables their efficient 
synthesis through automated iterative strategies. Small molecules, though not commonly considered to be modular, 
also contain inherent modularity based on their modular construction in nature or their modular C-C bond 
retrosynthesis, B, which can also enable their synthesis via automated iterative strategies.  
 
Collectively, the automated synthesis platforms for peptides, oligonucleotides, and 
oligosaccharides have dramatically increased the efficiency with which these macromolecules 
can be prepared, and even extended this access to non-specialists (see previous discussion). As a 
result, the rate-limiting step in these scientific areas has shifted from synthesis to function study. 
The same transformation in small molecule science would be enabled by a similarly general and 
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automated synthesis platform. In fact several fully automated synthesis platforms for small 
molecule discovery have been already been developed. Specifically, the development of fully-
automated synthesis systems for preparing various pharmaceutical compounds was reported in 
1994 by Okamoto and coworkers
37
 and commercial units for the automated solid-phase synthesis 
of small organic molecules were available shortly after.
38
 These automated platforms have been 
shown to be particularly effective for the synthesis of specific targets like radiolabeled imaging 
probes
39
 or targeted compound libraries.
40
 Recently, fully integrated and automated platforms for 
rapid drug discovery have even been reported.
41
 Collectively, these automated small molecule 
synthesis platforms are designed to automate either 1) very specific chemical transformations, 
which limits their generality in synthesis scope, or 2) many chemical transformations, which 
limits the efficiency of the synthesis platform. Ideally, a maximally general and efficient small 
molecule synthesis platform would be highly modular and iterative.  
As a step in this direction, a strategy for making small molecules has recently emerged 
that is analogous to peptide synthesis (Figure 1.6)
31,42,43
. As discussed previously, peptides are 
readily assembled via iterative N–C bond formation between amino acid building blocks (Figure 
1.6, A). Small molecules, many of which are alternatively comprised of building blocks 
connected by C–C bonds as detailed earlier, can now be similarly prepared via iterative cross-
coupling of haloboronic acids (Figure 1.6, B).
31,42,43,44,45,46,47,48,49 
The specifically employed 
Suzuki-Miyaura cross-coupling between a boronic acid and an organohalide
50
 is an increasingly 
general reaction for making certain types of C–C bonds, especially those that involve sp2-
hybridized carbon atoms. Importantly, as shown in Figure 1.5B previously, small molecules that 
contain such bonds include a wide range of materials, pharmaceuticals, and certain types of 
natural products. 
11 
 
 
Figure 1.6. Iterative C-C bond formation via iterative cross-coupling (ICC) of MIDA boronates, B, is analogous to 
iterative N-C bond formation via iterative peptide coupling, A. 
 
This iterative cross-coupling strategy is enabled by the capacity of N-methyliminodiacetic 
acid (MIDA) to reversibly attenuate the reactivity of a boronic acid (Figure 1.6, B), similar to the 
way an Fmoc group protects an amine and thereby avoids random oligomerization of amino 
acids (Figure 1.6, A).
42
 This switch in reactivity is fundamentally linked to a MIDA-induced 
change in the hybridization state of a boron atom from sp
2
 (reactive) to sp
3
 (unreactive).
43
 The 
resulting MIDA boronates are shelf-stable building blocks that can be readily accessed via many 
different methods,
42,43,44,45,46,47,48,49,51,52
 and more than 140 are now commercially available.
53
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These, combined with thousands of commercially available boronic acids and halides, constitute 
a formidable pool of off-the-shelf building blocks that are readily available for iterative cross-
coupling (ICC). Harnessing all of these features, several small molecule natural products,
42,43,44,45 
natural product derivatives,
46,49
 and pharmaceuticals
48,47
 have been manually prepared using this 
strategy. 
Transforming this platform into a fully automated process foremost required the 
development of a general strategy for purifying synthetic intermediates. Peptides, as well as 
oligonucleotides, and oligosaccharides, all contain common functional group handles for 
attachment to a solid support (Figure 1.7, A). This enables automated purification by solid-phase 
synthesis, in which excess reagents and byproducts are removed via simple filtration
5,17,24
. An 
important distinguishing feature of small molecules is that they do not contain such a universal 
functional group handle (Figure 1.7, B) and thus cannot be generally purified using this 
approach. Alternatively, we recognized that all of the intermediate coupling products in an ICC-
based synthesis contain a MIDA boronate (Figure 1.6, B). We thus sought a general and 
automatable strategy for purifying compounds that contain this functional group. 
 
 
Figure 1.7. Iterative synthesis (and its subsequent automation) of peptides, oligonucleotides, and oligosaccharides is 
enabled by the presence of a common function group handle in each class of molecules, A. A particular challenge in 
the iterative synthesis of small molecules including materials, pharmaceuticals, and natural products is the lack of a 
common functional group handle, B.  
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CHAPTER 2 
DEVELOPMENT OF AN AUTOMATED PURIFICATION PLATFORM 
 
Steven G. Ballmer, Eric P. Gillis, Gregory F. Morehouse, and Martin D. Burke 
 
 This chapter describes the development of an automated purification platform for MIDA 
boronates. Critical to the successful implementation of this automated platform was the 
discovery that MIDA boronates, while not amenable to solid-phase synthesis, exhibit binary 
silica gel elution properties that make them generally and universally amenable to catch-and-
release chromatographic purification. Furthermore, many MIDA boronates are not soluble in 
relatively non-polar solvents which makes them amenable to additional precipitation-based 
purification. For specific details on the hardware and software control of this automated 
purification platform please see Chapter 5. 
Eric P. Gillis contributed heavily to the design, construction, and development of the 
automated purification platform as well as some of the early solid-phase synthesis experiments. 
Gregory F. Morehouse performed the catch-and-release TLC experiments in Figure 2.4 and 
contributed heavily to the mock crude reaction purification experiments in Figure 2.9. 
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2-1 CATCH-AND-RELEASE PURIFICATION 
 This section describes the discovery and development of “catch-and-release” purification 
conditions for MIDA boronates that are amenable to automation and use in iterative cross-
coupling (ICC). Specifically, it details initial investigations of solid-phase synthesis with MIDA 
boronates and then discusses solution-phase chromatographic purification strategies. It is 
important to note that while the method discussed here represents a general and universal 
purification method for MIDA boronates, the concept of catch-and-release purification is not 
novel.
1
 In fact, this concept in general has been utilized for nearly four decades in the way of 
metal chelate affinity chromatography.
2
 It is also employed with the use of solid-supported 
reagents
3
 and organic synthesis.
4,5,6
 Phase-switch synthesis and purification methods, in 
particular, including fluorous tagging strategies
7
 have played a significant role in the continued 
development of the concept of catch-and-release purification.
8,9,10,11,12
 In general, catch-and-
release purification methods are a critical strategy in compound separation during 
synthesis.
13,14,15  
  
 
Attempts at solid-phase iterative cross-coupling (ICC) with MIDA boronates 
An important early decision concerning the development of the automated iterative cross-
coupling (ICC) platform was whether to develop it based on solid-phase or solution-phase 
methods. As a solution-phase based method, the platform would be able to take advantage of all 
of the MIDA boronate cross-coupling conditions previously developed in our laboratory.
16
 
However, it was unclear at the time how the general purification and isolation of MIDA 
boronate-containing products would be accomplished in a solution-phase based platform. A 
solid-phase based method, however, where MIDA boronates and their resulting cross-coupling 
products are immobilized on solid support would benefit from all of the purification and isolation 
advantages of solid-phase synthesis. That is, the immobilized MIDA boronates and cross-
coupling products could be purified and isolated by simple washing and filtration of the solid 
support. In this vein, then, we initially sought to develop the automated purification platform 
based on solid-phase chemistry. 
Specifically, we targeted the use of a carbamate linker with a traceless silyl chloride 
functionality to immobilize MIDA boronates (Figure 2.1).
17
 Attachment of p-nitrophenyl 
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carbonate linker 2.2 to aminomethyl resin 2.1 gave immobilized silane 2.3 to which bifunctional 
MIDA boronate ester 2.4 could be loaded as the silyl ether after formation of the silyl chloride 
with trichloroisocyanuric acid (TCICA), affording immobilized MIDA boronate 2.5. Despite 
extensive experimentation, however, evidence of a successfully loaded, resin-bound MIDA 
boronate ester could not be obtained. Subsequent efforts to directly load the MIDA boronate-
containing linker 2.6 were also attempted, but were similarly unproductive. We hypothesized 
that either the silyl linker motif or the reaction conditions being employed were surreptitiously 
affecting the successful loading of the MIDA boronate. Thus, we sought to develop a new, 
simplified, route to an immobilized MIDA boronate.  
 
 
Figure 2.1. Initial solid-phase experiments, using a silyl carbamate linker, in attempt at developing solid-supported 
MIDA boronates for solid-phase iterative cross-coupling (ICC).  
 
In this vein, we targeted a synthetic route to an immobilized MIDA boronate starting with 
an immobilized pinacol boronate ester (Figure 2.2). We first attempted to immobilize a boronic 
acid by condensing benzoic acid 2.7 onto 2.1 to afford resin-bound boronic acid 2.8. Subsequent 
attempts at performing a solid-supported Suzuki-Miyaura cross-coupling with bifunctional 
MIDA boronate 2.9 to give immobilized MIDA boronate 2.10 were ultimately unsuccessful. It is 
also known that the condensation of a benzoic acid 2.11 with 2.1 affords, after subsequent 
borylation, immobilized pinacol boronate ester 2.12.
18
 Surprisingly, however, efforts to 
immobilize 2.9 via a solid-phase Suzuki-Miyaura cross-coupling onto 2.12, again, gave no 
evidence of successful MIDA boronate loading (2.10).   
19 
 
 
 
Figure 2.2. Solid-phase experiments, using an immobilized boronic acid (2.8) or pinacol boronate ester (2.12), in 
attempt at developing solid-supported MIDA boronates for solid-phase iterative cross-coupling (ICC). 
 
It was at this point that we questioned whether the possible mismatched polarity of the 
MIDA boronate building blocks and the solid-phase resins was responsible for the lack of 
successful loading of MIDA boronates onto solid-support. We knew, for instance, that the MIDA 
boronate complex was highly polar and hypothesized that the inability to immobilize it onto a 
solid support may have been due to unfavorable interactions with the highly hydrophobic 
polystyrene core of the resins we were using. Commercially available solid-phase resins vary in 
polarity from relatively non-polar polystyrenes to relatively polar polyamides. Applying the 
conditions of both Figures 2.1 and 2.2 to a series of four resins of increasing polarity (Wang, 
TentaGel MB, PEGA gel, and polyamide lanterns) again gave no evidence of MIDA boronate 
immobilization. Having reached the polarity limit of available resins with the polyamide 
lanterns, we sought to address the possible polarity mismatch by decreasing the polarity of the 
MIDA boronate. We hypothesized that derivatizing the N-methyl group on the MIDA boronate 
with increasingly less-polar groups would provide an attenuation of substrate polarity and would 
furthermore enable a two-dimensional screening process to pinpoint effective combinations of 
ligands and resins. Inspired by the dual functionality of the fluorenylmethyloxycarbonyl (Fmoc) 
protecting group, widely used in solid-phase peptide synthesis, as both a protecting group and as 
a fluorescent tag we sought to create an analogous iminodiacetic acid derivative that was also 
less polar. Ideally, this derivative would possess the advantageous protecting properties of MIDA 
as well as a chromophore, which we realized could also provide the desired attenuation of 
polarity if designed correctly. Initially, N-(1-pyrenylmethyl)iminodiacetic acid was targeted, but 
20 
 
its synthetic route was severely limited by the drastically differing solubility of the two starting 
materials and was unable to be synthesized. We then targeted N-benzyliminodiacetic acid 
(BIDA) (Figure 2.3, 2.13). Treatment of benzylamine with aqueous base and chloroacetic acid 
afforded 2.13 after hydrolysis of its barium chelate.
19
 BIDA boronates 2.15 and 2.17 were 
obtained after condensation of 2.13 with boronic acids 2.7 and 2.16, respectively. While the 
ultraviolet signature of the unfunctionalized benzyl group was unlikely to provide sufficient 
photometric data for solid-phase methodology, 2.15 and 2.17 represented the first step toward a 
new hydrophobic chromophoric series of ligands for the attenuation of reactivity of boronic acids 
in ICC. However, under all of the conditions for solid-phase loading described above, these 
BIDA analogs did not demonstrate improved loading of the boron center onto solid support. 
  
 
Figure 2.3. Synthesis of benzyliminodiacetic acid (BIDA) boronates. 
  
It was clear that developing an automated ICC platform relying on solid-phase synthesis 
as the method for purification was going to continue to be met with significant limitations and 
challenges. Furthermore, we anticipated even more difficult challenges arising with the issue of 
properly mixing the heterogeneous cross-coupling reactions on solid phase. That is, MIDA 
boronate ICC reactions require anhydrous conditions, which necessitate the use of insoluble 
inorganic bases (e.g. K3PO4 and K2CO3). It is unlikely that insoluble bases would properly, if at 
all physically, penetrate the pores of the solid supports to mediate productive coupling. This 
limitation may have been observed with the results from Figure 2.2. During the course of these 
investigations, we began to question whether it would be possible to instead adapt our 
laboratory’s established, expanding, and highly versatile solution-phase methodology for MIDA 
boronate ICC directly to automation. As mentioned previously, at the time it was unclear how 
the purification and isolation of MIDA boronates would be accomplished in an automated 
solution-phase system. We understood that the primary advantage of solid-phase synthesis was 
the facile purification enabled by immobilizing substrates on resins. For solution-phase 
chemistry to become a tractable methodology for automation we required an equally facile 
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process for the purification of MIDA boronates in a solution-phase setting. Quite serendipitously, 
we realized that a general solution for the automated solution-phase purification of MIDA 
boronates was available in their unique and universal ability to undergo catch-and-release 
chromatography.  
  
Catch-and-release silica gel chromatography of MIDA boronates 
Silica gel chromatography is a standard method for purifying small molecules, but 
variable affinities of different compounds for this stationary phase often necessitate ad hoc 
optimization of eluent systems for each purification. In stark contrast, in the course of our 
laboratory’s investigations and development of the iterative cross-coupling (ICC) platform, we 
have discovered that MIDA boronates are not only generally and universally stable to silica gel 
column chromatography, but are also amenable to catch-and-release chromatographic 
purification.
20,21,22,23,24,25,26,27,28
 We found that MIDA boronates uniformly possess binary elution 
properties on silica gel with certain pairs of eluents. Specifically, in the presence of eluents such 
as diethyl ether or hexanes MIDA boronates display no mobility on silica gel regardless of their 
formula weight, polarity, or solubility in those eluents. These types of eluents allow MIDA 
boronates to be “caught” on the silica gel, and allow for indiscriminate elution of non-polar 
impurities with copious volumes of the eluent. However, the addition of as little as 10% of an 
eluent such as acetone or acetonitrile, allows for complete and rapid elution, or “release” of the 
purified MIDA boronate. We recognized that this phenomenon presents a direct parallel to solid-
phase synthesis, where substrates are now transiently immobilized on silica gel as opposed to 
covalently linked to a resin. Collectively, our laboratory has shown that this catch-and-release 
purification phenomenon is general and applies to every MIDA boronate that the Burke group 
has synthesized thus far.  
Interested in optimizing the catch-and-release eluent system for automation, we 
understood that it would be ideal to have the “release” solvent also be a solvent directly 
amenable to cross-coupling reactions. Fortuitously, we found that tetrahydrofuran (THF), a 
solvent commonly employed in cross-coupling reactions, is a competent “release” solvent. 
Additionally, we observed that in straight diethyl ether, many boronic acids elute inefficiently, 
likely due to hydrogen-bonding interactions with the silica gel. Experimentally, we found that a 
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mixture of methanol in diethyl ether efficiently eluted boronic acids as a single band, but still 
acted as a “catch” solvent for MIDA boronates. This pairing of methanolic ether and THF thus 
provided an eluent system amenable to both catch-and-release silica gel purification of MIDA 
boronates and its automation (Figure 2.4).  
 
 
Figure 2.4. TLC demonstration of the binary elution properties of the MIDA boronate functional group. This binary 
elution property enables catch-and-release chromatography purification of MIDA boronates.  
 
Specifically, when performing thin layer chromatography (TLC) with a 1.5% (v/v) 
solution of methanol (MeOH) and diethyl ether (Et2O), a polar eluent that causes rapid elution of 
most compounds and reagents, MIDA boronates 2.18a-t, representing a wide range of different 
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sizes, polarities, and functional group content, all show zero mobility (Figure 2.4, left). 
Furthermore, we also found that hexanes:THF (3:1) acts as a “catch” solvent where MIDA 
boronates shown no silica gel mobility. In contrast, all of the same MIDA boronates are rapidly 
eluted with THF a “release” solvent (Figure 2.4, right).  
Interestingly, while we had initially assumed that the “catch” and “release” requirements 
for an eluent followed a solvent polarity trend, it actually appears to not necessarily be 
correlated. For instance, we know that acetonitrile, acetone, ethyl acetate, and THF are all 
competent “release” solvents and that hexanes and diethyl ether are “catch” solvents. This seems 
to follow the expected polarity trend; the more polar solvents (acetonitrile, acetone, ethyl acetate, 
and THF) will elute the MIDA boronate whereas the less polar solvents (hexanes and diethyl 
ether) will not. However, we have also found that dichloromethane and chloroform are “catch” 
solvents. When examining these solvents’ polarities (Table 2.1)29 it can be seen that 
dichloromethane (Table 2.1, entry 5) and chloroform (Table 2.1, entry 6), specifically, are more 
polar than THF (Table 2.1, entry 8) and ethyl acetate (Table 2.1, entry 7), and should therefore 
be “release” solvents if this phenomenon is correlated to polarity. It is clear that the physical 
underpinnings of this MIDA boronate catch-and-release phenomenon are currently not well 
understood, but it has nonetheless shown itself to be general and universal for MIDA boronates 
and has in turn enabled our development of a general and readily automatable catch-and-release 
purification strategy.   
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Table 2.1. List of solvents arranged in order of decreasing EN
T
 value, as an empirical parameter of solvent polarity. 
These are normalized EN
T
 values derived from the transition energy at 25 °C of the long-wavelength visible 
absorption of a standard pyridinium N-phenolate betaine dye.     
Entry Solvent ET
N 
1 water (H2O) 1.000 
2 methanol (MeOH) 0.762 
3 acetonitrile (MeCN) 0.460 
4 acetone ((CH3)2CO) 0.355 
5 dichloromethane (CH2Cl2) 0.309 
6 chloroform (CHCl3) 0.259 
7 ethyl acetate (EtOAc) 0.228 
8 tetrahydrofuran (THF) 0.207 
9 diethyl ether (Et2O) 0.117 
10 n-hexane 0.009 
. 
2-2 DESIGN OF THE AUTOMATED PURIFICATION MODULE
30
 
Based on the catch-and-release purification platform for MIDA boronates discussed 
above, we have developed and constructed a fully automated purification module for MIDA 
boronates in an iterative cross-coupling (ICC) cycle (Figure 2.5, see Chapter 5 for specific details 
of the hardware and software control of this module). As can be seen, the platform consists of 
two major components, a silica gel plug for performing catch-and-release chromatography and a 
precipitation chamber that provides a secondary precipitation-based purification method. 
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Figure 2.5. Picture of the automated MIDA boronate purification platform showing both the precipitation chamber 
and the silica gel plug used for catch-and-release chromatography.  
 
In practice, we observed that many MIDA boronates are not soluble in the “catch” eluent 
hexanes:THF (3:1). This property means that these MIDA boronates can be precipitated from 
THF solution (the solution resulting from a cross-coupling reaction) by adding hexanes in the 
appropriate ratio. This phenomenon, then, allows for the implementation of a secondary 
precipitation-based purification strategy
31,32,33
 that is complementary to catch-and-release 
chromatography. Specifically, TLC experiments indicated that in most cases the impurities of 
cross-coupling reactions remained in the hexanes:THF (3:1) solution while the MIDA boronate 
was quantitatively precipitated. This precipitation-based purification strategy might be employed 
for MIDA boronate purification simply through selective precipitation of the boronate followed 
by filtration. However, not all MIDA boronates are insoluble in hexanes:THF (3:1), which makes 
this strategy considerably less general than catch-and-release chromatography. It is still, 
however, a beneficial secondary purification strategy to be implemented as a compliment to 
catch-and-release purification.   
Precipitation 
Chamber 
Silica Gel 
Plug 
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 The automated platform pictured in Figure 2.5 is represented schematically in Figure 2.6. 
The module is seated on a magnetic stir plate and it is connected to two automated syringe 
pumps through a series of automated valves and the entire module is controlled remotely by a 
computer. Collectively, the syringe pumps are connected to: 1) the cross-coupling reaction, 
which is the source of the crude MIDA boronate in THF, 2) a source of hexanes, which when 
combined with the reaction THF solution provides the precipitation solvent and a “catch” 
solvent, 3) a source of 1.5% (v/v) methanol in diethyl ether and straight diethyl ether, which are 
both “catch” solvents, 4) a source of THF, which is the “release” solvent, and 5) a waste 
container for disposing of unwanted eluents. The silica gel plug is approximately 1.5 cm X 1.5 
cm of standard unfunctionalized silica gel (SiO2) between two fiber frits (20 μm porosity) held in 
a custom-made Teflon
®
 tube. The precipitation chamber is a 25-mL polypropylene tube with a 
fiber frit (20 μm porosity), a small magnetic stir bar, Celite® filter aid, and 3-aminopropyl 
functionalized silica gel (3-AP SiO2). This functionalized silica gel acts as a palladium scavenger 
for the crude reaction mixtures. The bottom of the precipitation chamber is connected to the top 
of the silica gel plug through a tee connector. The bottom of the silica gel plug, in turn, is 
connected to one of the automated syringe pumps, while the other syringe pump is connected to 
the tee connector between the silica gel plug and precipitation chamber. This same syringe pump 
is also connected to the top of the precipitation chamber. Please see Chapter 2: Experimental 
Section for more details on the setup and of both the silica gel plug and the precipitation chamber 
in this automated purification module. Please see Chapter 5 for more details on the connectivity 
of the purification module.     
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Figure 2.6. Schematic representation of the automated MIDA boronate purification platform showing its 
connectivity to the automated syringe pump system.  
 
The intended process for fully automated MIDA boronate purification based on the 
platform and strategies described above is shown schematically in Figure 2.7. For a hypothetical 
cross-coupling of boronic acid 2.19 to bifunctional MIDA boronate 2.20 the resulting cross-
coupled product 2.21 is formed as part of a crude reaction mixture containing Pd, ligand, THF, 
and excess 2.19. Here it is assumed that the inorganic base used in the cross-coupling reaction 
has been previously removed via filtration (see Chapter 4 for details). This crude sample of 2.21 
is then submitted to the automated purification platform described here, affording purified 2.21. 
Specifically, the precipitation chamber is filled with hexanes. Then the crude reaction mixture, as 
a solution in THF and containing 2.19 and 2.21, is added to the hexanes. This effects the 
selective precipitation of MIDA boronate 2.21 (for MIDA boronates that are not soluble in 
hexanes:THF (3:1)). This “catch” eluent is then removed through the silica gel plug, eluting 
some of the impurities while leaving any soluble 2.21 caught on the silica gel plug. A subsequent 
elution with methanolic ether (a “catch” solvent) ensures the complete removal of the remaining 
impurities, particularly the boronic acid 2.19, leaving behind the now purified 2.21. Although 
2.21 is now purified and ready for release, the inclusion of any of the remaining residual 
methanol in the subsequent cross-coupling reaction would result in detrimental methanolysis of 
the MIDA boronate. In order to remove the methanol, the purification module is eluted with 
straight diethyl ether. This affords the purified 2.21, free of methanol, as a precipitated solid in 
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the precipitation chamber and/or an immobilized silica gel deposition. THF is then used as the 
“release” solvent to solubilize any 2.21 in the precipitation chamber and elute it from the silica 
gel plug. This entire sequence occurs in a fully automated fashion and the resulting THF solution 
of pure MIDA boronate is poised to undergo deprotection (see Chapter 3 for details) or isolation. 
Please see Chapter 2: Experimental Section and Chapter 5 for more details on the automated 
purification process specific to the automated operations. 
 
 
Figure 2.7. Schematic representation of the automated MIDA boronate purification process, including the 
precipitation-based purification and catch-and-release silica gel chromatography.  
 
 It should be noted that the actual elution method of the MIDA boronate off of the silica 
gel plug does not occur exactly as Figure 2.7 schematically indicates. An important criterion for 
the purification module is that the MIDA boronate be released as a THF solution at the highest 
possible molarity. In theory, the molarity of the product solution is limited by the solubility of 
the specific MIDA boronate in THF. In practice, this molarity is not possible to achieve without 
a step that concentrates the THF solution. Although we have developed an efficient process for 
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this concentration (see Chapter 3 for details) it is still beneficial to minimize the overall volume 
of THF used. Therefore, the molarity of the released MIDA boronate solution is directly related 
to the volume of solvent required to fully elute it from the silica gel plug. 
 The volume of THF required to elute the product from the silica gel plug is dependent on 
the Rf of the product multiplied by the volume of the silica gel the product must pass through in 
order to be fully eluted (the effective column volume). Based on the elution properties observed 
experimentally with MIDA boronates (and as demonstrated in Figure 2.4), Figure 2.8A 
schematically represents the most likely situation following the “catch” of a MIDA boronate 
onto the silica gel plug during automated purification. Because an Rf of zero is predicted for all 
MIDA boronates eluted with any “catch” solvent, the MIDA boronate will remain immobilized 
at the top of the silica gel plug. If, after purification, the MIDA boronate were “released” by THF 
in a normal (top to bottom) direction of flow, then the effective column volume would be at a 
maximum (Figure 2.8B), resulting in possible streaking of the MIDA boronate through the silica 
gel plug and necessitating a larger volume of THF to elute it. Further, the total volume of THF 
required to fully elute a MIDA boronate under this normal flow direction cannot be predicted for 
every MIDA boronate. Alternatively, if the silica gel plug were eluted in a reversed (bottom to 
top) direction of flow, then the effective column volume would be as small as theoretically 
possible (Figure 2.8C), resulting in elution of the MIDA boronate in a minimized solvent 
volume. Additionally, here the MIDA boronate should always be fully eluted from the silica gel 
plug as long as the volume of THF used for “release” is equal to or greater than the volume of 
solvent used in the “catch” step because the effective column volume is smaller in the “release” 
step than in the “catch” step and the product has a higher Rf value in THF than in any “catch” 
solvent. In fact, this reversed flow direction is the elution process used in the actual automated 
purification platform by utilizing a tee connector (shown in Figure 2.6) between the precipitation 
chamber and the silica gel plug. Impurities are eluted, using a “catch” solvent, through the silica 
gel plug in the normal flow direction, bypassing the side outlet of the tee connector, and then the 
purified MIDA boronate is released by reversing the flow direction of the “release” solvent. 
After elution of the MIDA boronate from the silica gel and dissolution of the MIDA boronate in 
the precipitation chamber, the THF solution is removed through the side outlet of the tee 
connector. Furthermore, the purity of the MIDA boronates obtained from this reversed flow 
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direction approach (Figure 2.8C) is the same as that obtained through the normal approach 
(Figure 2.8B), but the elution occurs with substantially greater efficiency. 
 
 
Figure 2.8. Schematic representation of the silica gel plug of the automated MIDA boronate purification platform 
during A. the “catch” of a MIDA boronate during catch-and-release chromatography B. the “release” of a MIDA 
boronate under normal eluent flow direction during catch-and-release chromatography C. the “release” of a MIDA 
boronate under reversed eluent flow direction during catch-and-release chromatography. 
 
With the fully automated MIDA boronate platform functioning, we sought to test its 
purification capability by having it purify a series of mock crude cross-coupling reactions 
(Figure 2.9, see Chapter 2: Experimental Section for operational details). Specifically, a series 
THF solutions of aryl (Figure 2.9, entries 2, 4, 9, 10, 12), heteroaryl (Figure 2.9, entries 1, 8, 11, 
13), vinyl (Figure 2.9, entries 6, 7, 16), alkyl (Figure 2.9, entries 3, 5, 14), and alkynyl (Figure 
2.9, entry 15) MIDA boronates (2.22a-p) was prepared as a mixture simulating a crude, 
completed cross-coupling reaction. These solutions contained 1 equivalent of p-tolyl boronic 
acid (2.23) to simulate unreacted excess boronic acid coupling partner and 2.5 mol% palladium 
as Pd(OAc)2 and 5 mol% ligand as SPhos to simulate the catalyst system. Each individual mock 
crude reaction mixture was subjected to the fully automated MIDA boronate purification 
procedure and the percent recovery of the MIDA boronate and its purity were determined. 
Encouragingly, in all 16 cases, MIDA boronate 2.22 was recovered in good yield (67-94% 
recovery) and a duplicate run of these experiments showed good reproducibility across the series. 
Furthermore, it was determined that the fully automated purification of the mock crude cross-
coupling reaction afforded all recovered MIDA boronates 2.22a-p in >90% purity. As expected, 
the only observable impurities by 
1
H NMR were small amounts of p-tolyl boronic acid and 
SPhos.   
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Figure 2.9. Mock crude reactions used to test the automated MIDA boronate purification platform. Each experiment 
was set up manually and then submitted to a fully automated purification cycle. Percent recoveries of the starting 
MIDA boronates were determined by mass and purities were determined by 
1
H NMR. All entries were recovered in 
>90 purity. Each experiment was run in duplicate and the percent recoveries are shown. 
 
2-3 SUMMARY 
 In summary, we have developed, constructed, and implemented a fully automated MIDA 
boronate purification platform. This platform utilizes a series of automated valves and syringe 
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pumps to purify MIDA boronates, taking advantage of their inherent physical properties. 
Specifically, the insolubility of most MIDA boronates in hexanes allows for a precipitation-
based purification while their general and universal stability to silica gel chromatography and 
their unique binary elution profile allows them to undergo catch-and-release silica gel 
chromatographic purification. Together, these properties have enabled a two-part 
(precipitation/catch-and-release) fully automated purification strategy capable of purifying 
MIDA boronates from a crude cross-coupling reaction.    
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CHAPTER 2: EXPERIMENTAL SECTION 
 
General materials and methods 
Commercial reagents were purchased from Sigma-Aldrich, EMD Millipore, Fisher 
Scientific, Alfa Aesar, Frontier Scientific, Inc., Oakwood Products, Inc., or Strem and were used 
without further purification unless otherwise noted. Many of the MIDA boronates used in 
purification studies are commercially available from Sigma-Aldrich
®
 [2.18a=2.22n (697311), 
2.18b=2.22o (700231), 2.18c (721573), 2.18d (710032), 2.18e (MIDA071), 2.18f (698229), 
2.18g (697494), 2.18h (698164), 2.18i=2.22d (698016), 2.18j (698148), 2.18k (704547), 2.18l 
(MIDA032), 2.18m (736600), 2.18n (748714), 2.18o (723711), 2.18p (738514), 2.18q=2.22b 
(699861), 2.18r (MIDA020), 2.18s (MIDA076), 2.18t (704873), 2.22a (701106), 2.22c 
(701580), 2.22e (699144), 2.22f (710024), 2.22g (699292), 2.22h (708828), 2.22i (698164), 
2.22j (698075), 2.22k (701084), 2.22l (699853), 2.22m (697443), 2.22p (707252)]. Manual 
syntheses were carried out in oven or flame-dried glassware and performed under a dry inert 
atmosphere unless otherwise noted. Unless otherwise noted, Celite™ refers to Celite™ 545 filter 
aid (not acid washed). Solvents were purified via passage through packed columns as described 
by Pangborn and coworkers
1
 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexanes, 
benzene, toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated molecular 
sieves. Water was deionized. Triethylamine, diisopropylamine, diethylamine, pyridine, and 2,6-
lutidine were freshly distilled under an atmosphere of dry nitrogen from CaH2. 
Thin layer chromatography (TLC) was performed using the indicated eluent on E. Merck 
silica gel 60 F254 plates (0.25 mm). Compounds were visualized by exposure to a UV lamp (λ = 
254 and/or 366 nm) and/or a basic solution of KMnO4 followed by brief heating with a 
Varitemp
®
 heat gun. Flash chromatography was performed as described by Still and coworkers
2
 
using EM Merck silica gel 60 (230-400 mesh). 
1
H NMR spectra were recorded at room 
temperature on one of the following instruments: Varian Unity 500, Varian VXR 500, or Varian 
Unity Inova 500NB. Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (CDCl3, δ = 7.26; 
(CD3)2CO, δ = 2.05, center line; CD2Cl2, δ = 5.32, center line; (CD3)2SO, δ = 2.50, center line). 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
35 
 
quartet, sept = septet, m = multiplet, br = broad, app = apparent, dd = doublet of doublets, dt = 
doublet of triplets, dq = doublet of quartets), coupling constant (J) in Hertz (Hz), and integration. 
13
C NMR spectra were recorded at room temperature on one of the following instruments: 
Varian Unity 500 or Varian VXR 500. Chemical shifts (δ) are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (CDCl3, δ = 77.16, 
center line; (CD3)2CO, δ = 29.84, center line; CD2Cl2, δ = 53.84; (CD3)2SO, δ = 39.52, center 
line). Carbons bearing boron substituents were not observed due to quadrupolar relaxation. Low 
resolution mass spectra (LRMS) and high resolution mass spectra (HRMS) were performed by 
Furong Sun, Steve Mullen, and Elizabeth Eves at the University of Illinois School of Chemical 
Sciences Mass Spectrometry Laboratory. 
 
 
 
4-iodobenzamide, resin bound (2.23). An oven-dried 40-mL glass I-Chem vial is 
charged with aminomethyl polystyrene resin (1.39 mmol/g, 1.014 g, 1.41 mmol, 1 equiv) 
followed by dry DMF (15.0 mL) for resin swelling. The vial is sealed with a PTFE-lined screw 
cap and allowed to stand at room temperature for 30 minutes with periodic manual agitation.   
During this time an oven-dried 4-mL glass I-Chem vial equipped with a magnetic stir bar 
is charged with 4-iodobenzoic acid (1050 mg, 4.23 mmol, 3.00 equiv), HOBt (572 mg, 4.23 
mmol, 3.00 equiv), and dry DMF (15.0 mL) giving a clear colorless solution. The vial is sealed 
with a PTFE-lined septum screw cap and then DIC (655 µL, 4.23 mmol, 3.00 equiv) is added via 
syringe with stirring. The solution is allowed to stir at room temperature for 10 minutes.   
During this time the vial containing the swelled resin is opened and the DMF is removed 
via syringe through a 25 G needle, being cautious not to extract any resin beads, leaving damp 
off-white resin. The benzoic acid solution is then transferred to the resin vial via syringe.  The 
vial is sealed with a PTFE-lined screw cap and allowed to stand at room temperature for 12 
hours with periodic manual agitation. At the end of 12 hours the reaction is transferred to a 
fritted polypropylene tube fitted with a stopcock and secured to a parallel vacuum manifold. The 
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reaction is filtered over vacuum and the resin is washed with dry DMF (5 x 10 mL x 5 min) and 
dry DCM (5 x 10 mL x 5 min). Residual solvent is then removed at reduced pressure (23 °C, 1 
Torr) over 2 hours to give free flowing off white resin. The resin gives a negative result in the 
ninhydrin (Kaiser) test.                    
 
 
 
4-(pinacolboronate)benzamide, resin bound (2.12). An oven-dried 40-mL I-Chem 
glass vial in a glovebox is charged with resin resin-bound 4-iodobenzamide (1.05 mmol/g, 200 
mg, 0.210 mmol, 1 equiv), bis(pinacolato)diboron (107 mg, 0.421 mmol, 2.00 equiv), potassium 
acetate (62 mg, 0.632 mmol, 3.01 equiv), PdCl2(dppf)-DCM (17 mg, 0.021 mmol, 10 mol%), 
and dry DMF (20.0 mL). The vial is sealed with a PTFE-lined screw cap and removed from the 
glovebox. The reaction is agitated at room temperature manually for 2 minutes. It is then placed 
in a preheated oil bath at 80 °C and allowed to stand for 15 hours with periodic manual agitation. 
Approximately 1 minute after exposure to heat the reaction turned black.   
At the end of 15 hours the reaction is allowed to cool to room temperature over 20 
minutes. It is then transferred to a fritted polypropylene tube fitted with a stopcock and secured 
to a parallel vacuum manifold. The reaction is filtered over vacuum and the resin is washed with 
dry DMF (5 x 10 mL x 5 min) and dry DCM (5 x 10 mL x 5 min). Residual solvent is then 
removed at reduced pressure (23 °C, 1 Torr) over 2 hours to give free flowing black resin.        
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N-benzyliminodiacetic acid (BIDA) (2.13). To a 250-mL single-necked round-bottom 
flask equipped with a PTFE-coated magnetic stir bar is added chloroacetic acid (9.45 g, 100 
mmol, 2 equiv) and water (20.0 mL) giving a clear colorless solution. This is allowed to cool in 
an ice bath with stirring for 10 minutes. Then an aqueous solution of sodium hydroxide (20 M, 
10 mL, 200 mmol, 4 equiv) is added slowly via syringe over 10 minutes with stirring. Upon 
completion of addition the reaction is allowed to stir at 0 °C for an additional 5 minutes. Then, 
benzylamine (5.45 mL, 50.0 mmol, 1 equiv) is added via syringe over 5 minutes with stirring. 
The flask is then removed from the ice bath, capped with a polypropylene cap, and allowed to 
stir at room temperature for 15 hours.   
At the end of 15 hours a hot solution of barium chloride dihydrate (12.849 g, 53 mmol, 
1.06 equiv) in water (20.0 mL) is poured slowly into the reaction with stirring, giving a white 
precipitate immediately. This is set to reflux in a heating mantle with stirring for 30 minutes. At 
the end of 30 minutes the reaction is allowed to cool to room temperature with stirring and is 
then filtered through a 120-mL medium porosity glass frit. The barium chelate is hydrolyzed 
with sulfuric acid to obtain the title compound as a white flaky solid.                 
 
 
 
1
H NMR (500 MHz, D2O) 
δ 7.52 (s, 5H), 4.52 (s, 2H), 3.99 (s, 4H). 
 
HRMS (ESI+) 
 Calculated for C11H14NO4 [M+H
+
]: 224.0923 
Found:     224.0919 
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4-carboxyphenylboronic acid BIDA ester (2.15). The glassware for this reaction was 
not dried and the procedure was performed under ambient atmosphere. A 100-mL, single-
necked, round-bottom flask, equipped with a magnetic stir bar is charged with 4-
carboxyphenylboronic acid (1.684 g, 10.15 mmol, 1 equiv) and N-benzyliminodiacetic acid 
(2.13) (2.547 g, 11.41 mmol, 1.12 equiv). To the flask with stirring is then added 50 mL of a 
freshly prepared mixture of DMSO:benzene 1:1. The flask is then fitted with a benzene-filled 
Dean-Stark trap topped with a water-cooled Graham condenser. All ground glass joints are 
sealed with Apiezon H high temperature vacuum grease and secured with Keck clips. The arm of 
the Dean-Stark trap is wrapped with aluminum foil to facilitate heat transfer.   
The stirred reaction mixture is brought to reflux using a heating mantle. The reaction 
mixture is allowed to reflux for 12 hours. The heating mantle is removed, and the reaction is 
allowed to cool to 23 °C with stirring for 1 hour. The Dean-Stark trap and magnetic stir bar are 
removed and the reaction mixture is concentrated in vacuo (40 °C, 15 Torr) to afford the crude 
product in solution with DMSO. This residue is dissolved in ethyl acetate (250 mL) and 
transferred to a 500-mL separatory funnel. This organic layer is washed with water (10 x 75 mL) 
(These successive water washes are crucial for the quantitative removal of DMSO. If not 
effectively removed, DMSO may result in difficulties with purification), brine (75 mL), dried 
over anhydrous MgSO4, filtered through Celite™, and concentrated in vacuo (40 °C, 50 Torr) 
giving the crude product as a brown solid. 
The crude solid is then dissolved in acetone and precipitated as a white solid with diethyl 
ether which is isolated by vacuum filtration to give 2.15 as a white solid (3.176 g, 89% yield).   
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1
H NMR (500 MHz, CD3CN) 
δ 8.04 (d, J = 8 Hz, 2H), 7.73 (d, J = 8 Hz, 2H), 7.42 (m, 5H), 4.20 (2, J = 17 Hz, 2H), 
3.72 (s, 2H), 3.68 (d, J = 17 Hz, 2H). 
 
 
 
4-bromophenylboronic acid BIDA ester 2.17. The glassware for this reaction was not 
dried and the procedure was performed under ambient atmosphere. A 100-mL, single-necked, 
round-bottom flask, equipped with a magnetic stir bar is charged with 4-bromophenylboronic 
acid (3) (2.015 g, 10.03 mmol, 1 equiv) and N-benzyliminodiacetic acid (2.13) (2.465 g, 11.04 
mmol, 1.10 equiv). To the flask with stirring is then added 50 mL of a freshly prepared mixture 
of DMSO:benzene 1:1. The flask is then fitted with a benzene-filled Dean-Stark trap topped with 
a water-cooled Graham condenser. All ground glass joints are sealed with Apiezon H high 
temperature vacuum grease and secured with Keck clips. The arm of the Dean-Stark trap is 
wrapped with aluminum foil to facilitate heat transfer.   
The stirred reaction mixture is brought to reflux using a heating mantle. The reaction 
mixture is allowed to reflux for 12 hours. The heating mantle is removed, and the reaction is 
allowed to cool to 23 °C with stirring for 1 hour. The Dean-Stark trap and magnetic stir bar are 
removed and the reaction mixture is concentrated in vacuo (40 °C, 15 Torr) to afford the crude 
product in solution with DMSO. This residue is dissolved in ethyl acetate (250 mL) and 
transferred to a 500-mL separatory funnel. This organic layer is washed with water (10 x 75 mL) 
(These successive water washes are crucial for the quantitative removal of DMSO. If not 
40 
 
effectively removed, DMSO may result in difficulties with purification), brine (75 mL), dried 
over anhydrous MgSO4, filtered through Celite™, and concentrated in vacuo (40 °C, 50 Torr) 
giving the crude product as a brown solid. 
The crude solid is then dissolved in acetone and precipitated as a white solid with diethyl 
ether which is isolated by vacuum filtration to give 2.17 as a white solid (3.275 g, 84% yield).   
     
 
 
1
H NMR (500 MHz, CD3CN) 
δ 7.60 (d, J = 8 Hz, 2H), 7.54 (d, J = 8 Hz, 2H), 7.43 (m, 5H), 4.17 (2, J = 17 Hz, 2H), 
3.72 (s, 2H), 3.65 (d, J = 17 Hz, 2H). 
 
Setup of mock crude reactions. The following is the procedure for setting up, running, and 
analyzing the mock crude reaction experiments as shown in Figure 2.9.  
Preparation and installation of the precipitation chamber: A new, fritted, 12-g Luknova 
polypropylene cartridge containing a PTFE-coated magnetic stir bar was charged with Celite (ca. 
150mg) and 3-aminopropyl functionalized silica gel (ca. 250 mg) and capped. This cartridge will 
serve as the precipitation chamber during the purification process. This mixture was suspended 
in hexanes (ca. 5 mL) and vigorously swirled to mix the solids. The mixed suspension was 
allowed to settle for ca. 5 seconds, then the liquid was drained by forcing a plug of ambient air 
through the top of the cartridge by syringe. The stir bar was now firmly embedded in the solids 
to prevent stirring before the precipitation chamber was filled with the simulated reaction 
mixture. It has been observed that stirring in the dry chamber causes damage to the frit resulting 
in increased clogging. The precipitation chamber was now installed into the luer fittings on the 
purification carousel. 
Preparation and installation of the silica gel plug: A silica gel plug chromatography 
cartridge was freshly prepared from custom PTFE fittings using unfunctionalized silica gel. The 
cartridge was similar to the Luknova cartridges except that the significantly smaller bottom 
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fritted fitting containing the silica was fashioned of PTFE rather than polypropylene. The 
cartridge was charged with silica gel by addition of silica gel during vacuum aspiration at the 
bottom luer fitting. This process ensures that fewer gaps are introduced in the silica gel plug. 
Excess silica gel was removed by spatula, and a frit was placed on top of the silica plug to ensure 
retention of all solids in the cartridge during operations where solvent flows from the bottom of 
the cartridge to the top. This doubly-fritted cartridge was secured with a cap from a 4-g Luknova 
polypropylene cartridge and placed into the luer fittings on the purification carousel on the 
automated synthesizer. 
Pre-activation of the catalyst solution: Palladium(II) acetate (0.001875 mmol, 2.5 mol%) 
and SPhos (0.00375 mmol, 5mol%) per purification to be run were combined in an 8-mL 
scintillation vial equipped with a PTFE-coated magnetic stir bar and placed under an argon 
atmosphere. THF was added to generate a 0.01 M catalyst stock solution (with respect to 
palladium(II) acetate), and it was stirred vigorously for 30 min at room temperature to generate 
an orange, yellow, or clear solution. After this activation process, 1 mL of catalyst stock solution 
was added to the solution in the polypropylene cartridge containing the mock reaction mixture. 
Preparation and installation of the mock reaction chamber: A new fritted 12-g Luknova 
polypropylene cartridge was charged with MIDA boronate (0.075 mmol, 1equiv), 4-
methylbenzene boronic acid (0.075 mmol, 1equiv), and THF (10 mL). After addition of the pre-
activated catalyst solution, the cartridge was installed into the luer fittings in the reaction block 
of the automated synthesizer. Once all cartridges were in place, the automated purification 
routine was run using the computer interface. The samples were collected as THF solutions into 
tared 40-mL scintillation vials.   
Concentration, azeotropic drying, and analysis of recovered materials from 
purifications: The THF solutions were concentrated under reduced pressure on a rotary 
evaporator, then the residue was azeotroped with dichloromethane (3x5 mL) to remove residual 
solvents. These residues were then placed under vacuum for 12-36 hours, after which the yield 
and purity were determined by comparison of 
1
H NMR in acetone-d6 with a standard sample of 
the desired MIDA boronate and with a sample taken of a simulated reaction mixture. 
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Automated purification summary. The following is a detailed list of the operations carried out, 
in order, by the automated MIDA boronate purification platform for the mock crude reaction 
experiments shown in Figure 2.9 (see Chapter 5 for more details).  
1. In the background, the Auxiliary Pump aspirates 6 mL of hexanes and delivers it to the 
bottom of the precipitation chamber, through the silica gel column. This is repeated once 
for a total of 12 mL of hexanes. 
2. The Primary Pump aspirates 9 mL of reaction mixture from reaction chamber bottom and 
returns 6 mL, through the bottom, to ensure no more than 3 mL will be delivered to the 
precipitation chamber.  
3. The Primary Pump delivers 3 mL of reaction mixture to the top of the precipitation 
chamber containing 12 mL of hexanes. This induces MIDA boronate precipitation from 
the THF solution. The Primary Pump then delivers two 10-mL plugs of dry nitrogen to 
bottom of precipitation chamber (bypassing the silica gel column) to dislodge the stir bar.   
4. The suspension in the precipitation chamber is aspirated from the bottom and through 
silica gel column by the Auxiliary Pump. The eluent is sent to waste. 
5. Steps 1-4 are repeated three additional times to send all of the reaction mixture to the 
precipitation chamber. 
6. The Primary Pump aspirates 1.5 mL of THF and delivers it to the top of the reaction 
chamber as a rinse. Steps 1-3 are repeated. 
7. The Primary Pump aspirates 1.5 mL of THF and delivers it to the top of the reaction 
chamber as a rinse. Steps 2-3 are repeated. 
8. Step 4 is repeated. 
9. Steps 1-4 are repeated.   
10. Step 4 is repeated. 
11. The Primary Pump aspirates 6.5 mL of 1.5% (v/v) MeOH in Et2O and delivers it to the 
top of the precipitation chamber. This is repeated once for a total delivery of 13 mL of 
solvent. 
12. The Primary Pump delivers two 10-mL plugs of dry nitrogen to the bottom of the 
precipitation chamber (bypassing the silica gel column) to dislodge the stir bar.   
13. Step 4 is repeated. 
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14. Steps 11-13 are repeated. Step 4 is repeated again.  
15. Steps 11-13 are repeated twice with Et2O instead of 1.5% (v/v) MeOH in Et2O. Step  4 is 
repeated twice more to dry out the silica gel column.  
16. The Auxiliary Pump is rinsed with 2 x 1 mL of THF to wash away any residual MeOH. 
The wash THF is sent to waste. 
17. The Auxiliary Pump aspirates 6 mL of THF and delivers it slowly to the bottom of the 
precipitation chamber through the silica gel column. This is repeated once for a total of 
12 mL of THF.  
18. The Primary Pump aspirates 5 mL of dry nitrogen and delivers it to the bottom of the 
precipitation chamber (bypassing the silica gel column) to agitate the suspension, thus 
promoting mixing and MIDA boronate dissolution. This is done 40 times.   
19. The THF solution of MIDA boronate is aspirated by the Primary Pump out of the bottom 
of the precipitation chamber (bypassing the silica gel column). The solution is delivered 
to the collection tube. This aspiration/delivery is repeated an additional 5 times to ensure 
full transfer.     
20. The Auxiliary Pump pushes residual THF in the silica gel column into the bottom of the 
precipitation chamber as a rinse.   
21. The Primary Pump aspirates 5 mL of dry nitrogen and delivers it to the bottom of the 
precipitation chamber (bypassing the silica gel column) to agitate the suspension, thus 
promoting mixing and MIDA boronate dissolution. This is done 5 times.   
22. The THF rinse is aspirated by the Primary Pump out of the bottom of the precipitation 
chamber (bypassing the silica gel column). The solution is delivered to the collection 
tube.   
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CHAPTER 3 
DEVELOPMENT OF AN AUTOMATED DEPROTECTION PLATFORM 
 
Steven G. Ballmer, Eric P. Gillis, and Martin D. Burke 
 
 This chapter describes the development of an automated deprotection platform for MIDA 
boronates including the construction of a fully automated deprotection module. Critical to the 
successful implementation of this automated deprotection platform was the discovery that MIDA 
boronates universally undergo deprotection under general mild conditions. Specifically, upon 
treatment with aqueous sodium hydroxide at room temperature for 20 minutes, MIDA boronates 
are universally and cleanly hydrolyzed to their corresponding boronic acids. Additionally, a 
simple predictable algorithm for both the aqueous volumes produced in these deprotections and 
the evaporation rates of the resulting organic solutions have enable the development of a fully 
automated MIDA boronate deprotection module that operates on a single set of general 
conditions. For specific details on the hardware and software control of this automated 
deprotection platform please see Chapter 5. 
Eric P. Gillis contributed to the design, construction, development, and implementation 
of the earlier configurations of the automated deprotection platform as summarized in Figure 3.1. 
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3-1 HYDROLYSIS OF BORONATES 
In the course of our laboratory’s development of iterative cross-coupling (ICC) and 
MIDA boronates in general it has been found that anhydrous conditions are essential for 
successful ICC sequences. That is, MIDA boronates are susceptible to hydrolysis in the presence 
of aqueous base and performing a cross-coupling reaction under any of the commonly used 
biphasic aqueous conditions provides a source of aqueous base. The resulting system, then, 
provides conditions for in situ hydrolysis of the bifunctional MIDA boronate coupling partner 
which leads to competitive random oligomerization over productive coupling. This can even 
occur as a result of the inclusion of protic solvents like methanol and isopropanol. 
Given this necessity of anhydrous conditions, at the conception of the automated MIDA 
boronate deprotection platform it was understood that there was really only one starting 
requirement: the boronic acid resulting from the deprotection of the corresponding MIDA 
boronate had to be in an anhydrous form. This “anhydrous form” did not necessarily mean 
having the boronic acid as the dehydrated boroxine, but rather simply as the free acid without 
exogenous water. The most logical and practical source of the anhydrous form of boronic acid 
would be simply a solution of the boronic acid is dry solvent. This simple goal (a boronic acid in 
dry solvent), however, presented a significant challenge for an automated platform at the time 
for. Specifically, the most common method for deprotecting a MIDA boronate is treatment with 
aqueous sodium hydroxide (NaOH). A dry solution of the resulting boronic acid is easily 
obtainable by standard manual methods (e.g. phase separation followed by drying over 
anhydrous drying agents like magnesium or sodium sulfate), but it was unclear at the time how 
the bulk and resulting residue water could be removed automatically. Furthermore, the partition 
coefficient of boronic acids between the organic and aqueous layers is not general and it was 
unclear how the boronic acid could be extracted effectively and generally in an automated 
fashion. Additionally, at the time there was not a simple and efficient method for the automatic 
concentration of the boronic acid solution.    
With these challenges in mind we targeted new methods for MIDA boronate deprotection 
that excluded, or at least minimized, the use of bulk water thereby making the method more 
amenable to automation.
1
 The standard aqueous basic deprotection condition is 0.1 M THF and 3 
equivalents NaOH as 1 M aqueous NaOH (3.3:1 organic:aqueous). Initial experiments attempted 
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to minimize the water content by simply using a smaller volume of more concentrated aqueous 
NaOH. Deprotections run at 5:1, 10:1, and 20:1 organic:aqueous were effective in forming the 
boronic acid in full conversion, but all remained too wet for further consideration. Specifically, 
the organic phase was dried over a series of anhydrous drying agents including magnesium 
sulfate (MgSO4), sodium sulfate (Na2SO4), calcium sulfate (CaSO4), potassium carbonate 
(K2CO3), and molecular sieves and the efficiency of the drying was determined by Karl-Fischer 
titration. Molecular sieves were found to be the only effective drying agent, but the large amount 
of sieves required (in excess of 8-10 grams of sieves to reach < 100 µg/mL water content) caused 
significant loss of boronic acids via adsorption. It should be noted here that the water content 
data for the Karl-Fischer titrations were collected on mock deprotections where the MIDA 
boronate was left out, because Karl-Fischer experiments are not compatible with boronic acids. 
Furthermore, it should be noted that the activation method for the molecular sieves was found to 
be crucial. The only acceptable method for activation was heating the sieves to 300 °C under 
ambient atmosphere and pressure for 24 hours and then cooling to room temperature under dry 
nitrogen or argon.
2
 Any other method led to incomplete activation or in some cases (e.g. flame 
drying under vacuum) destruction of the zeolite matrix.  
With the goal of continuing to minimize the bulk water content in the deprotection, three 
relatively anhydrous methods were investigated (Figure 3.1).
1
 In a limiting case of using smaller 
volumes of concentrated aqueous base as described above, 4-tolyl MIDA boronate (3.1) was 
deprotected in the presence of potassium hydroxide (KOH) and 99:1 THF:water (Figure 3.1, A). 
These conditions resulted in the formation of a large amount of colorless precipitate. This 
precipitation is consistent with the formation of the trihydroxy borate salt 3.2.
3
 While the 
dipotassium salt of MIDA (3.3) was not isolated or characterized it was the predicted byproduct 
and was likely a part of the precipitate. Treatment of the crude deprotection reaction with HCl in 
dioxanes caused the dissolution of some of the precipitate and afforded free 4-tolylboronic acid 
(3.4) upon isolation. Although the 3.4 was successfully isolated with a minimum of bulk water, 
the remaining precipitate was a sticky residue that was not ideal for the intended automated 
process (any remaining solids, especially sticky residues could cause clogs). Furthermore, when 
this method was applied to other MIDA boronates, incomplete conversion in the deprotection 
was observed due to the precipitate preventing efficient phase mixing.   
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Figure 3.1. Initial conditions explored for automated MIDA boronate deprotection. Minimally wet conditions with 
KOH afforded an insoluble borate salt 3.2 (A). Use of NaOMe afforded borate 3.6 as part of a thick slurry gel (B). 
Use of dried basic resin (Amberlyst A26) afforded an immobilized borate 3.2 that required acidification (C).  
 
 In an attempt to avoid the organic/aqueous phase separation problem entirely, sodium 
methoxide (NaOMe) was investigated as a source of base (Figure 3.1, B). Here, 3.1 in THF was 
treated with NaOMe. This afforded a very thick slurry/gel, assumedly containing trimethyl 
borate salt 3.6, that actually stopped the stirring process and stalled the conversion of the 
reaction. It should be noted here that the structure of 3.6 was not confirmed. Although it excludes 
water, the lack of conversion in this method combined with the formation of potential clog-
causing solids made it particularly unattractive for pursuing as an automatable deprotection 
method. 
 A final, and ultimately tractable, method for MIDA boronate deprotection under 
minimized water conditions was the use of hydroxide in the form of an immobilized base source 
(Figure 3.1, C). Specifically, a THF solution of 3.1 was treated with dried Amberlyst A26 (OH), 
which is a macroporous resin that is functionalized with ammonium residues with hydroxide 
counter ions. Although the structure was not confirmed, it is assumed that deprotection 
proceeded via 3.2 as an immobilized trihydroxy salt. Regardless of the structure, the deprotection 
proceeded in full conversion of 3.1 and afforded 3.4 after acidification with HCl in dioxanes. 
Because it utilized only residual water, proceeded in good conversion and yield, and had the 
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added benefit of being agitated by simple air bubbling of the resin this method stood out as a 
particularly attractive method to pursue for an automated MIDA boronate deprotection platform. 
Eric P. Gillis contributed heavily to the development of this method and to further extensive 
investigations of Amberlyst A26 (OH) in MIDA boronate deprotections.
1
   
 Both HCl in dioxanes and anhydrous acetic acid in THF were examined as acidification 
reagents and both were found to be effective in the isolation of boronic acids. It should be noted 
that the developed method for these MIDA boronate deprotections included an acid 
neutralization step, but residual acid had the potential to be included in downstream 
manipulations. Quite surprisingly, though, it was observed that nether acid adversely affected 
downstream chemistry in the presence of acid-sensitive functional groups. Specifically, when 
using HCl as an acidification reagent in the deprotection of an E,E-dienyl MIDA boronate, no 
isomerization of the corresponding E,E-dienyl boronic acid was observed. Furthermore, MOM 
protecting groups were also observed to be stable to treatment with HCl. This method was used 
effectively on a fully automated system similar to the one described below. However, after 
prolonged use of HCl in dioxanes, which is an aggressively corrosive reagent, as an acidification 
reagent considerable damage to the metal and plastic components was observed. All of the metal 
components that had contact with the HCl began developing corrosion and pitting while the 
plastic components, including PTFE components, became brittle and developed cracks. 
Additionally, it was found that even minor changes in the preparation of the Amberlyst resin had 
significant effects on the yield of the boronic acids.  
As an effect of what was likely a combination of the problems discussed above, including 
unforeseen acid sensitivity with downstream chemistry (although the actual source was never 
implicitly identified), significant irreproducibility in both the automated formation of boronic 
acids and their subsequent cross-couplings was observed. It was at this point that we questioned 
whether the standard basic aqueous conditions for MIDA boronate deprotection (THF and 
aqueous NaOH) would in fact be a tractable solution even though they were previously deemed 
to be unattractive for the automated platform.  
Our laboratory’s collective data suggested more and more that our standard aqueous 
conditions for MIDA boronate deprotections were not only mild but also surprisingly general, 
particularly when compared to other boronic acid derivatives. For instance, Suginome’s 1,8-
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diaminonaphthelene (DAN) ligand for boronic acid masking
4
 requires treatment with aqueous 
HCl or H2SO4 for cleavage. While these conditions are sufficient for the iterative synthesis of 
oligoarenes, they are not generally amenable to small molecule synthesis. Furthermore, pinacol 
boronate esters, which are sufficient coupling partners themselves, often require relatively harsh 
oxidative conditions for deprotection
5
, conditions that, similar to those for the DAN ligand, are 
not generally amenable to small molecule synthesis. For pinacol boronate esters in particular, 
significantly milder cleavage conditions utilizing a transesterification procedure with 
diethanolamine, followed by mild hydrolysis have been reported.
6,7 
These mild conditions, 
though, while certainly more amenable to small molecule synthesis in general are less attractive 
for automation due to the multiple transformations required. A facile process for the conversion 
of pinacol boronate esters to their corresponding boronic acids via the intermediacy of potassium 
trifluoroborates is also know.
8
 This process, similar to the pinacol boronate ester 
transesterification process discussed above is less than ideal for automation simply due to its 
multiple transformations. Furthermore, while good yields are observed with this process for aryl 
pinacol boronate esters, Lloyd-Jones has shown that the aqueous hydrolysis rate of 
trifluoroborates is highly dependent on the identity of the carbon unit attached to boron (Figure 
3.2).
9
  
Specifically, treatment of trifluoroborate 3.7 with three equivalents of cesium carbonate 
(Cs2CO3) in THF:water (10:1) at 55 °C affords its corresponding boronic acid 3.8. The 
hydrolytic half lives, however, vary drastically depending on the identity of 3.7. These half lives 
are reported to be as short as 1 minute in the case of cyclopropyl trifluoroborate (3.7d) or as long 
as 77,760 minutes (54 days) in the case of 3,5-di(trifluoromethyl)phenyl trifluoroborate (3.7s). 
Even relatively minor electronic perturbations effect significant changes as is the case when 
comparing 4-tolyl trifluoroborate (3.7m) with a hydrolytic half life of 51 minutes and phenyl 
trifluoroborate (3.7n) with a hydrolytic half life of 100 minutes.  
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Figure 3.2. Hydrolysis of trifluoroborates 3.7 to boronic acids 3.8 under basic aqueous conditions. The half life (t1/2) 
for each trifluoroborate is shown in parentheses.
9 
 
In stark contrast to these varying trifluoroborate hydrolytic half lives, the rates of 
hydrolysis of MIDA boronates under the standard basic aqueous conditions have been observed 
to be exceptionally similar, regardless of the identity of the carbon unit attached to boron. 
Specifically, upon treatment with three equivalents of 1 M aqueous NaOH at room temperature, 
full deprotection is achieved in less than 20 minutes for all MIDA boronates examined in our 
laboratory to date. The single exception to this general deprotection condition is aryl MIDA 
boronate 3.9 (Scheme 3.1), which requires 30 minutes to reach full conversion. We currently 
hypothesize that this retardation in hydrolysis rate is strictly a result of the sterically encumbered 
environment around the boron center.   
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Scheme 3.1. Aryl MIDA boronate 3.9 has been observed to take up to 30 minutes to reach full conversion under the 
standard aqueous basic deprotection conditions. This is currently thought to be due to the sterically encumbered 
environment of the boron center.  
 
In addition to demonstrating remarkable generality in hydrolysis rate
10,11 
the standard 
aqueous basic MIDA boronate deprotection conditions have also proved to be generally free of 
side reactions; the corresponding boronic acids are easily isolated as pure compounds after the 
water-soluble MIDA ligand is separated from the organic-soluble boronic acid. With all of the 
inherent benefits of the aqueous basic conditions we therefore sought to develop the automated 
MIDA boronate deprotection platform based directly on these general and mild conditions. 
Confident that the deprotection chemistry would operate generally, our initial concerns (as 
discussed previously) of 1) how to predict the potentially varying aqueous volumes during the 
workup for the deprotection reaction, 2) how to deal with unknown and potentially varying 
partition coefficients during the workup of the deprotection reaction, and 3) how to eliminate 
bulk and residual water became our primary objectives in the context of automation.    
 
3-2 DESIGN OF THE DEPROTECTION MODULE 
Based on the aqueous deprotection platform for MIDA boronates discussed above, we 
have designed, developed, and constructed a fully automated deprotection module for MIDA 
boronates in an iterative cross-coupling (ICC) cycle (Figure 3.3, please see Chapter 5 for specific 
details of the hardware and software control of this module.). As can be seen, the module 
consists of four major components: the deprotection tube, the pre-drying tube, the drying tube, 
and the deoxygenation/concentration tube. The module’s base is a custom-made anodized 
aluminum table that supports a series of luer ports which hold the tubes.  
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Figure 3.3. Picture of the automated MIDA boronate deprotection module showing the deprotection tube, the pre-
drying tube, the drying tube, and the deoxygenation/concentration tube.  
 
The automated platform pictured in Figure 3.3 is represented schematically in Figure 3.4 
below. The luer ports mentioned previously are connected to two automated syringe pumps 
through a series of automated valves and the entire module is controlled remotely by a computer. 
Collectively, the syringe pumps are connected to: 1) a source of tetrahydrofuran (THF), which is 
the organic solvent used for the deprotection reaction, 2) a source of diethyl ether (Et2O), which 
is the organic solvent used in the separation after the deprotection reaction, 3) a source of 0.5 M 
aqueous (pH = 6) potassium phosphate buffer, which is the quenching reagent used for the 
deprotection reaction, 4) a source of water (H2O), which is the aqueous solvent used for the 
deprotection reaction, 5) a source of 50% saturated aqueous sodium chloride (NaCl), which is the 
aqueous solvent used in the separation after the deprotection reaction, and 6) a waste container 
for disposing of unwanted solutions. Additionally, the bottom of each of the four tubes is 
connected to one of the automated syringe pumps.  
Deprotection 
Tube 
Deoxygenation/ 
Concentration 
Tube 
Drying 
Tube 
Pre-Drying 
Tube 
54 
 
The deprotection tube is a 25-mL polypropylene tube with a fiber frit (20 μm porosity) 
filled with the starting MIDA boronate and solid sodium hydroxide (NaOH) and topped with a 5-
mL polypropylene syringe barrel. This barrel acts as an overflow reservoir in the scenario that 
the deprotection tube is overfilled or bubbles out of the tube during agitation. With this current 
system now optimized, we have found that overflowing the deprotection tube is highly unlikely. 
However, should any malfunction lead to an overflowing situation, the syringe barrel prevents 
both the loss of potentially value-added building blocks as well as chemical spills and/or 
contamination of the deprotection module hardware. The bottom of the deprotection tube, as 
mentioned, is connected to one of the syringe pumps, but is also connected to the other syringe 
pump via a tee connector between the two pumps. Also as discussed earlier, three equivalents of 
NaOH (with respect to the MIDA boronate) are always used as a general condition for the 
deprotection. In the course of our experimentation we have found that this configuration of the 
module can accommodate deprotections on scales as large as 1.5 mmol of MIDA boronate (4.5 
mmol of NaOH) and as small as 0.040 mmol of MIDA boronate (0.121 mmol of NaOH).  
The pre-drying tube is a 25-mL polypropylene tube with a fiber frit (20 μm porosity) 
filled with a mixture of 2.1 g of anhydrous magnesium sulfate (MgSO4) and 800 mg of Celite
®
 
filter aid and topped with a small aluminum foil cap. This foil cap simply minimizes the contact 
that the anhydrous MgSO4 has with room atmosphere (and atmospheric moisture), thereby 
maintaining its anhydrous state as long as possible. Initial designs of the deprotection module 
actually used only anhydrous MgSO4 in this tube. We found, however, that the drying agent 
alone would form hard chunky clathrates upon exposure to water which not only trapped the 
desired boronic acids but also rendered it a less efficient drying agent. We hypothesized that 
adding a filter aid like Celite
®
 would prevent the formation of the chunky solids by thinning out 
the heterogeneous drying agent. Extensive experimental screening of the ratio of anhydrous 
MgSO4 to Celite
®
, as well as the total quantity of drying agent used showed that the 2.1 g of 
MgSO4/800 mg of Celite
®
 mixture provided the best balance between maximized yield of the 
boronic acid (as determined by mass recovery) and minimized water content (as determined by 
Karl-Fischer titration).     
The drying tube is a 25-mL polypropylene tube with a fiber frit (20 μm porosity) filled 
with 3.6 g of activated 4 Å powdered molecular sieves layered over 300 mg of Celite
®
 filter aid 
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and topped with a connection to a source of dry nitrogen. This helps to maintain the drying tube 
under inert atmosphere which provides a starting point for the deoxygenation process. Similar to 
the pre-drying tube, initial designs of the deprotection module actually used only the molecular 
sieves in this tube. We found, however, that the drying agent alone formed a thick slurry upon 
exposure to the wet organic solvent and this caused clogs in the drying tube. We hypothesized 
that again utilizing Celite
®
 as a filter aid would prevent the thick slurry of molecular sieves from 
clogging the tube. Like the pre-drying tube, extensive experimental screening of the ratio of 
molecular sieves to Celite
®
, as well as the total quantity of drying agent used showed that the 3.6 
g of  MgSO4/800 mg of Celite
®
 layering provided the best balance between maximized yield of 
the boronic acid (as determined by mass recovery) and minimized water content (as determined 
by Karl-Fischer titration).     
The deoxygenation/concentration tube is an empty 25-mL polypropylene tube with a 
fiber frit (20 μm porosity) topped with a three-way connection to a source of dry nitrogen and 
room atmosphere. This provides a dual mechanism whereby the deoxygenation process can be 
maintained under inert atmosphere while the concentration process still has a vent to room 
atmosphere. The bottom of the deoxygenation/concentration tube is also connected to a source of 
dry argon via a tee connector between the argon and the syringe pump. The argon, when sparged 
through the bottom of the tube, provides a method for deoxygenation of the organic solution and, 
over time, concentrates the solution by evaporating the organic solvent. The delivery of the argon 
to this tube is controlled by an automated solenoid valve. Please see Chapter 5 for more details of 
the manual setup and connectivity of the automated MIDA boronate deprotection module.      
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Figure 3.4. Schematic representation of the automated MIDA boronate deprotection platform showing its 
connectivity to the automated syringe pump system.  
 
The intended process for the fully automated MIDA boronate deprotection based on the 
platform and strategies described above is shown schematically in Figure 3.5. For a hypothetical 
deprotection of MIDA boronate 3.10 in the presence of THF and aqueous NaOH at room 
temperature, boronic acid 3.11 is afforded. Specifically, to the deprotection tube at room 
temperature and containing one equivalent of MIDA boronate and three equivalents of NaOH, is 
added 10 mL of THF and 3 mL of water. Through our experimentation, it was found that 10 mL 
of THF and 3 mL of water were generally effective for the deprotection transformation 
independent of the reaction scale. The THF dissolves the MIDA boronate and the water dissolves 
the NaOH affording a biphasic reaction system. The deprotection reaction is then agitated with 
argon sparging from the bottom of the deprotection tube. Similar to the 
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deoxygenation/concentration tube, the delivery of argon here is controlled by an automated 
solenoid valve. Empirically, it was found that argon at a delivery pressure of 4.5-5.5 psig 
provided the best results for the deprotection module as a whole. Additionally, in order to avoid 
overflowing the deprotection tube (into the 5-mL syringe barrel) with overly aggressive argon 
sparging, delivery of the argon in increasingly long pulses was found to be critical. Specifically, 
a pattern of 0.5-second pulses (with 1.5-second breaks) for a total of 20 seconds followed by 1-
second pulses (with 1-second breaks) for an additional 20 seconds and completed with 2-second 
pulses (with 2-second breaks) for the final 19 minutes and 20 seconds provides aggressive 
agitation for 20 minutes without overflowing the tube. 
This agitation affords a monophasic crude deprotection reaction containing MIDA ligand 
(likely as the sodium salt under the basic conditions) and boronic acid 3.11 (likely as the tri-
hydroxy borate under the basic conditions). Then 3 mL of 0.5 M  aqueous (pH = 6) potassium 
phosphate buffer is added to quench the reaction followed by 5 mL of Et2O. This affords a 
biphasic mixture with free 3.11 in solution in the ethereal organic layer and the water-soluble 
free MIDA ligand in solution in the aqueous layer. In practice, TLC’s of both layers indicate 
insignificant loss of 3.11 to the aqueous layer for all MIDA boronates examined to date. The 
aqueous layer is disposed of leaving behind the wet ethereal solution of 3.11 in the deprotection 
tube. This wet solution is then washed with 3 mL of 50% saturated aqueous NaCl which extracts 
a portion of the bulk water. The aqueous layer is again disposed of leaving behind a drier but still 
wet solution of 3.11 in the deprotection tube. 
This solution is then transferred to the pre-drying tube where the anhydrous MgSO4 
removes the remainder of the bulk water. The resulting drier solution of 3.11 is then transferred 
to the drying tube where the molecular sieves remove any remaining residual water affording a 
dry ethereal solution of 3.11. It was found that initially wetting the drying agents with 4 mL of 
neat THF before adding the boronic acid solution prevented any loss of volume of the organic 
solvent. The dry solution of 3.11 is then transferred to the deoxygenation/concentration tube 
where argon sparging removes dissolved oxygen and evaporates the organic solvent. Like the 
deprotection tube, it was found that delivery of the argon in increasingly long pulses was critical 
to prevent the overflow of the deoxygenation/concentration tube. Specifically, starting at 0.5-
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pulses with 1.5-second breaks and ramping up to continuous flow provided the best protocol for 
this process.  
Initial experiments investigating the deprotection of 3.1, afforded 3.4 in only 64% yield 
after the automated process just described. It was found, after manual flushing, that an additional 
14% of the theoretical mass of 3.4 remained in the pre-drying and drying tubes collectively. 
Adding two washes of the drying agents with 6 mL of neat THF (12 mL total) afforded 3.4 in a 
76% yield total. This washing protocol was incorporated as a general process for quantitative 
transfer and maximized yield of 3.11. This entire deprotection sequence described occurs in a 
fully automated fashion and the resulting dry and deoxygenated THF solution of freshly prepared 
3.11 is poised to undergo cross-coupling (see Chapter 4 for details) or isolation. Please see 
Chapter 5 for more details on the automated deprotection process specific to the automated 
operations. 
 
Figure 3.5. Schematic representation of the automated MIDA boronate deprotection process, including the aqueous 
deprotection, the two-stage drying process, and the deoxygenation/concentration process.  
 
 A particularly noteworthy aspect of this platform and module is that the fully automated 
MIDA boronate deprotection procedure is highly dependent on reproducible, if not predictable 
volumes. That is, the volume of both aqueous layers during the workup of the deprotection 
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reaction, as well as the total volume of solution finally transferred to the 
deoxygenation/concentration tube has to be predictable. The automated module currently has no 
method with which to measure the volumes in real time and adjust its liquid handling 
accordingly, so the volume values have to be preset in the software control by the operator. That 
means that these values have to be at least reproducible and ideally predictable through some sort 
of functional algorithm. 
 In the case of the aqueous separations and extractions after the deprotection reaction, if 
the volume of the aqueous layer intended to be disposed of is underestimated, then not all of the 
layer is disposed of. The resulting excess aqueous layer is then transferred to the drying process 
along with the organic layer. If the there is too much excess water, then the drying agents will be 
ineffective. On the other hand, if the volume of the aqueous layer is overestimated, then a portion 
of the organic layer will also be disposed of. This will not only result in a loss of the desired 
boronic acid, but also decrease the volume of the organic layer in downstream manipulations. In 
order to gain a better understanding of the aqueous volumes produced during the deprotection 
process a series of MIDA boronates including 3.1, 4-bromophenyl MIDA boronate, and trans-
propenyl MIDA boronate were subjected to the fully automated deprotection at varying reaction 
scales and the aqueous volumes both after the reaction quench and after the brine wash were 
measured (Table 3.1). For this small collection of MIDA boronates, the aqueous volumes 
reproduced over multiple runs of each experiment and in all cases the error was never more than 
200 μL. This reproducibility of the volumes was encouraging, but what was particularly 
surprising was that the aqueous volumes seemed to be independent of the MIDA boronate 
identity and correlated only to reaction scale. Specifically, for instance, when the deprotections 
were run on 1.0 mmol scale, the aqueous volume after the reaction quench was 4.0 ± 0.2 mL and 
the aqueous volume after the brine wash was 6.4 ± 0.2 mL (Table 3.1, entry 1), regardless of the 
MIDA boronate being deprotected. We were initially concerned that this small data set would 
not be applicable to a wider range of MIDA boronates. Encouragingly, though, we have found in 
the course of our experimentation that these scale-dependent aqueous volumes are reproducible 
over every MIDA boronate we have examined. Moreover, because these volumes are now 
predictable, the volume values can easily be adjusted in the software control based simply on the 
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scale of the deprotection being preformed and the fully automated procedure can be run with 
confidence that the aqueous layers will be disposed of with maximum efficiency.        
 
Table 3.1. Reproducible aqueous volumes, after reaction quench and brine wash, during the automated MIDA 
boronate deprotection process. The aqueous volume is correlated to the scale of the deprotection and not the identity 
of the group attached to boron.  
Entry Deprotection  
Scale (mmol) 
Aqueous Volume  
After Quench (mL) 
Aqueous Volume  
After Brine Wash (mL) 
1 1.0 4.0 ± 0.2 6.4 ± 0.2 
2 0.333 3.8 ± 0.2 6.0 ± 0.2 
3 0.111 3.0 ± 0.2 6.4 ± 0.2 
4 0.067 3.0 ± 0.2 6.4 ± 0.2 
 
 Similar volume reproducibility and predictability was required for the concentration 
process in the deoxygenation/concentration tube. If the total volume of boronic acid solution is 
underestimated, then the concentration time will not be sufficient to reach the desired volume 
and the subsequent cross-coupling reaction will then be run at a more dilute concentration than 
intended. If, however, the total volume of the solution is overestimated, then the concentration 
time will be too long and the boronic acid solution will be over-concentrated. We observed, 
encouragingly, that the total volume of ethereal solution finally transferred to the 
deoxygenation/concentration tube was reproducible over multiple experiments with varying 
MIDA boronates (20 mL total, please see Chapter 5 for experimental details). In most cases the 
targeted final volume of the boronic acid solution 9 mL. In order to accurately predict the 
appropriate concentration time to reach this volume we needed to have a better understanding of 
the concentration rate with our specific argon sparging system. Furthermore, Et2O is used as an 
extraction solvent and ends up, with THF, in the deoxygenation/concentration tube, but it is not 
the desired solvent for subsequent cross-coupling reactions. We understood from the beginning 
that the concentration process would evaporate the lower boiling Et2O before the THF, leaving 
the boronic acid as a solution in just THF eventually. We did not, however, know how long the 
concentration process would need to be in order to evaporate all of the Et2O.  
A simple experiment wherein we performed the fully automated deprotection process 
without a MIDA boronate present allowed us to cleanly probe both the overall concentration rate 
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and the rate of selective evaporation of Et2O over THF (Table 3.2). Specifically, upon the first 
full transfer of dried organic solvent to the deoxygenation/concentration tube (before any of the 
THF washes for quantitative transfer) there are a total of 12.0 mL of solvent (Table 3.2, entry 1). 
This solvent mixture is theoretically a 2:1 THF:Et2O mixture, or 33% Et2O. 
1
H NMR analysis of 
the solution showed it to be 27% Et2O, well within the expected error of the experiment 
considering that 8 mL of THF had been used to wet the drying agents and some of the Et2O was 
expected to have already evaporated during liquid handling operations. Once the argon sparging 
concentration process was initiated, the total volume was measure every 10 minutes and the Et2O 
content was determined periodically. After a total of 70 minutes of concentration the total 
volume had been reduced to 5.25 mL with a 8% Et2O content (Table 3.2, entry 8). An additional 
40 minutes of concentration (110 minutes total) reduced the total volume to 3.0 mL with a 2% 
Et2O content (Table 3.2, entry 12).  
With the addition of the two 6-mL THF washes described previously the Et2O content 
was able to be reduced to significantly less than 1% and the total averaged concentration rate was 
determined to be 0.1 mL/min (1 mL/10 min). This concentration rate has proved to be generally 
reproducible over all automated MIDA boronate deprotections examined to date and only slight 
variations, as expected, have been observed with a dependence on the ambient temperature. To 
temporarily minimize this temperature dependency, the ambient temperature of the laboratory in 
which the deprotection module is housed is often kept constantly below 23 °C (approximately 18 
°C). This provides much more reproducible concentration results and still averages a 0.1 mL/min 
concentration rate. Like the aqueous volumes discussed earlier, because the concentration rates 
are now predictable and reproducible, the concentration times can easily be adjusted in the 
software control based simply on the known starting volume and the desired final volume of the 
boronic acid solution.  
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Table 3.2. Reproducible concentration rates during the automated MIDA boronate deprotection process. 
Concentration is performed at room temperature (23 °C) with dry argon sparging from the bottom of the 
deoxygenation/concentration tube. The approximate total volume (starting at 12.0 mL) is measured in 10 minute 
intervals. The percent diethyl ether (Et2O) in tetrahydrofuran (THF), as determined by 
1
H NMR, is measured at 
various time points. Average concentration rate over entire process, including THF washes is 0.1 mL/min (1 mL/10 
min) 
Entry Concentration 
Time (min) 
Approximate Total 
Volume (mL) 
Percent Diethyl  
Ether in THF (%) 
1 0 12.0 27 
2 10 10.0 ---- 
3 20 9.0 ---- 
4 30 8.25 ---- 
5 40 7.5 ---- 
6 50 6.8 12 
7 60 6.0 ---- 
8 70 5.25 8 
9 80 ---- ---- 
10 90 4.0 5 
11 100 ---- ---- 
12 110 3.0 2 
 
3-3 SUMMARY 
 In summary, we have designed, developed, and constructed a fully automated MIDA 
boronate deprotection module based on a general MIDA boronate deprotection platform. This 
module utilizes a series of automated valves and syringe pumps to deprotect MIDA boronates, 
affording their corresponding boronic acids in a fully automated fashion. More importantly, the 
platform operates on remarkably general aqueous deprotection conditions (THF, aqueous NaOH, 
room temperature, 20 minutes) to hydrolyze the MIDA boronates. After reaction quenching, 
aqueous extraction, and drying the boronic acids are isolated as freshly prepared THF solutions. 
Additionally, the boronic acid solutions are deoxygenated and concentrated to the appropriate 
volume to prepare them for use in a subsequent cross-coupling reaction (see Chapter 4 for 
details).      
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CHAPTER 4 
DEVELOPMENT OF AN AUTOMATED CROSS-COUPLING PLATFORM 
 
Steven G. Ballmer, Eric P. Gillis, and Martin D. Burke 
 
 This chapter describes and details the development and construction of a fully automated 
MIDA boronate cross-coupling platform amenable to use in automated iterative cross-coupling 
(ICC) sequences. Specifically, the platform is designed to fully automate the Suzuki-Miyaura 
cross-coupling reaction of boronic acids, as prepared from MIDA boronates (see Chapter 3 for 
details), to bifunctional halo-MIDA boronates or other halides. Critical to the successful 
implementation of this automated platform is ready access to large quantities and numbers of 
building blocks suitable for cross-coupling. Access to these building blocks has been aided by 
the development of methods for the multi-gram synthesis of MIDA boronates. For specific 
details on the hardware and software control of this automated cross-coupling platform please 
see Chapter 5. 
 Eric P. Gillis contributed to the design and construction of early configurations of the 
automated cross-coupling platform and to the conceptual development of methods for multi-
gram MIDA boronate syntheses.  
 
 
 
 
 
Adapted in part from Ballmer, S. G.; Gillis, E. P.; Burke, M. D. Org. Synth. 2009, 86, 344-359. 
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4-1 MULTI-GRAM MIDA BORONATE SYNTHESIS
1
 
 In order for the fully automated cross-coupling module, or the fully functional small 
molecule synthesizer, in general, to be maximally efficient, ready access to large quantities of 
MIDA boronate building blocks is necessary. That is, the increased speed and efficiency of small 
molecule synthesis offered by the fully automated platform is only obtainable if there is already a 
stock of a large number and quantity of building blocks available to funnel into the automated 
synthesis platform. In this vein, we sought to translate our laboratory’s existing methods for 
MIDA boronate building block synthesis
2,3 
to the decagram scale (Figure 4.1). 
 
 
Figure 4.1. Multi-gram synthesis of: A) N-methyliminodiacetic acid, B) 4-bromophenyl MIDA boronate as a 
product of complexation of MIDA to a boronic acid, C) 4-(p-tolyl)phenyl MIDA boronate as a product of cross-
coupling a bifunctional MIDA boronate, and D) 4-(p-tolyl)phenyl boronic acid as a product of MIDA boronate 
hydrolysis. 
 
A previously reported synthesis of N-methyliminodiacetic acid (MIDA, 4.2) proceeds in 
only moderate yield from the reaction of methylamine and chloroacetic acid.
4
 A more effective 
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preparation, however, utilizes formalin and formic acid to reductively methylate (the Eschweiler-
Clarke conditions) iminodiacetic acid (4.1) in good yield.
5,6
 This particular synthetic route 
represents a significant improvement because not only is the use of toxic chloroacetic acid 
avoided, but all of the starting materials and reagents are readily available and inexpensive. 
Specifically, formalin and formic acid are commodity chemicals and tens of thousands of metric 
tons of 4.1 are produced annually as a starting material for the synthesis of herbicides, 
surfactants, and chelating agents.
7
 Furthermore, both 4.1 and MIDA (4.2) are environmentally 
benign and are both biodegradable.
8
 
We found that we were able to further optimize this method to be even more effective. 
Specifically, on a hundred-gram scale, 4.1 was methylated to afford MIDA (4.2) in 90% yield 
(Figure 4.1, A). Even this method has since been improved upon in our laboratory with 
contributions from Brice Uno and Jenna Klubnick. By switching the order of addition of reagents 
(now adding formalin dropwise to a pot of 4.1 in formic acid), running the reaction at a higher 
concentration (3 M), and using acetone rather than ethanol to crash out the product, we are able 
to synthesize MIDA (4.2) in nearly quantitative yield on a kilogram scale at an estimated cost, 
including all chemicals and solvents, of only $0.05/g to $0.10/g.    
The first synthesis of MIDA boronates was reported by Mancilla and coworkers.
9,10
 In 
order to obtain larger quantities of the desired MIDA boronate building blocks, though we 
sought to optimize their synthesis. Specifically, using a standard Dean-Stark apparatus, the 
complexation between 4-bromophenylboronic acid (4.3) and MIDA (4.2) proceeded in excellent 
yield (92%) to afford 4-bromophenyl MIDA boronate (4.4) on 40-gram scale (Figure 4.1, B). 
While benzene can be used as the azeotroping solvent in these complexations, and has been 
shown to be equally effective, here toluene was used to mitigate any toxicity concerns. Also, we 
have since further optimized this method, where the volume ratio of DMSO:toluene used in the 
complexation is significantly reduced (1:10 from 1:1). This enables more facile isolation of the 
resulting MIDA boronate. Furthermore, 4.4 was isolated without the need for column 
chromatography; simple precipitation from acetone and diethyl ether was sufficient for 
purification. Subsequently, the selective Suzuki-Miyaura cross-coupling between 4-tolylboronic 
acid and 4.4 proceeded in good yield (85%), affording 4-(4-tolyl)phenyl MIDA boronate (4.5) on 
20-gram scale (Figure 4.1, C). It is worth noting that this cross-coupling was performed without 
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the use of a glove box. In order to avoid MIDA boronate hydrolysis during the course of the 
reaction, though, it is critical to utilize rigorous Schlenk techniques and avoid the introduction of 
water. Freshly grinding anhydrous K3PO4 using a hot mortar and pestle (recently removed from a 
60 °C oven) is a convenient way to maintain anhydrous conditions during the reaction setup. In a 
final step, demonstrating that the hydrolysis of the MIDA ligand can conveniently be performed 
on scale, 4.5 was treated with aqueous sodium hydroxide in tetrahydrofuran and after a standard 
separation of the organic and aqueous layers, 4-(4-tolyl)phenyl boronic acid (4.6) was afforded 
in nearly quantitative yield (98%) on 6-gram scale (Figure 4.1, D). Throughout this sequence, all 
purifications/isolations were performed using only standard recrystallization or extraction 
techniques. Combined with the fact, as mentioned, that the cross-coupling may be performed 
without the use of a glovebox, there is no clear indication that these manipulations could not be 
performed on even greater scale, to provide larger quantities of MIDA boronate building blocks. 
In addition to their capacity for iterative cross-coupling (ICC), there are numerous 
enabling features that make MIDA boronate building blocks highly attractive intermediates for 
organic synthesis. In contrast to their boronic acid counterparts
11
, MIDA boronates are invariably 
monomeric and highly crystalline free-flowing solids. They have also proven to be extremely 
stable to benchtop storage and universally compatible with silica gel chromatography. These 
highly attractive qualities, combined with the methods for multi-gram scale synthesis of MIDA 
boronate building blocks detailed here and the further developments of MIDA boronate 
chemistry in our laboratory
12,13,14,15,16,17,18,19
 have collectively led to the commercialization of 
more than 140 MIDA boronate building blocks
20
, a number that is actively growing.  
 
4-2 DESIGN OF THE CROSS-COUPLING MODULE 
 With the methodology in place to readily access sufficient quantities of MIDA boronate 
building blocks as described above and based on the fully automated MIDA boronate 
purification and deprotection platforms (see Chapters 2 and 3, respectively) we have developed 
and constructed a fully automated cross-coupling module for use in iterative cross-coupling 
(ICC) sequences of MIDA boronates (Figure 4.2, see Chapter 5 for specific details on the 
hardware and software control of this automated module). 
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 This module consists of, basically, three heating stir plates each with its own aluminum 
heating block capable of holding a series of reaction vessels or tubes. A single cross-coupling 
reaction utilizes a reaction tube and a reaction filtration tube connected by a reaction transfer 
tube. The reaction tube section of the cross-coupling module is shown in greater detail in Figure 
4.3. The reaction tube is topped with an air condenser which condenses the reaction solvent in 
cases where a cross-coupling reaction is run at elevated temperatures. The reaction tube, seated 
in a heating block is surrounded by stir-bar-containing empty reaction tubes. In practice we 
found that a single reaction tube, by itself, struggled to maintain constant stirring because the 
magnetic stir bar often lost magnetic connection with the stir plate. This problem is avoided by 
using place holding (“dummy”) tubes that contain only a stir bar to fill the rest of the heating 
block. Here, the matrix of stir bars creates a stabilizing force of its own magnetic field and the 
individual stir bars collectively maintain contact with the magnetic stir plate. 
  
 
Figure 4.2. Picture of the automated MIDA boronate cross-coupling platform showing the cross-coupling reaction 
vessel and the reaction transfer system which consists of the reaction transfer tube and the reaction filtration tube. 
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Figure 4.3. Close-up picture of the automated MIDA boronate cross-coupling platform showing the cross-coupling 
reaction vessel, the placeholder (“dummy”) tubes, and the reaction transfer tube. 
 
The automated cross-coupling module pictured in Figures 4.2 and 4.3 is represented 
schematically below in Figure 4.4. As discussed, each section of the module is seated on a 
magnetic stir plate and each magnetic stir plate has its own custom-milled aluminum heating 
block. The entire module is connected to an automated syringe pump through a series of 
automated valves and is controlled remotely by a computer. The syringe pump is connected to: 
1) the THF solution of boronic acid (see Chapter 3 for details), 2) the top and the bottom of the 
reaction tube, and 3) the bottom of the reaction filtration tube. The reaction tube is a 25-mL 
polypropylene tube with a glass frit (20 μm porosity), a magnetic stir bar, a source of palladium, 
ligand, inorganic base, and the halide cross-coupling partner. This tube, as mentioned, is topped 
with an air condenser, which is simply a 10-mL polypropylene tube. The top of this condenser 
tube is connected to an oil bubbler which helps to maintain an oxygen-free atmosphere during 
cross-coupling reactions. The reaction filtration tube is another 25-mL polypropylene tube, but 
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with a fiber frit (20 μm porosity), a magnetic stir bar, Celite® filter aid, and Florisil®. The 
reaction and reaction filtration tubes are connected by a length of tubing, the reaction transfer 
tube. This tubing specifically connects the bottom interior of the reaction tube to the top of the 
reaction filtration tube. We knew from the beginning that at the completion of a cross-coupling 
reaction, the insoluble inorganic base (e.g. K3PO4, K2CO3, Cs2CO3) needed to be removed by 
some style of automated filtration before submitting in crude reaction solution to automated 
purification (see Chapter 2 for details). Initially, the automated cross-coupling platform was 
designed without the reaction transfer or reaction filtration tube and where the reaction tube had 
only a fiber frit. In theory, at the completion of a cross-coupling reaction, the automated syringe 
would aspirate the crude reaction solution through the bottom of the reaction tube, thereby 
filtering out the inorganic base on the fiber frit. In practice, however, we found that the 
prolonged aggressive stirring of the stir bar on the fiber frit caused significant damage to the 
frit’s surface, which resulted in severe clogs during filtration. We hypothesized that a more 
durable glass frit would hold up to the stir bar’s repeated impact, thereby retaining its pore 
integrity and preventing any clogs. While the implementation of the glass frit did help prevent 
any surface damage from the stir bar, we subsequently found that many cross-coupling reactions 
produced a crude mixture so fine and with such a high propensity to clog that the integrity of the 
frit was irrelevant and severe clogging was observed anyway. At this point we hypothesized that 
utilizing a filter aid to filter out the insoluble components of the crude cross-coupling reaction 
was the only general solution to the clogging problem. Specifically, we designed the reaction 
transfer tube to transfer, under reduced pressure supplied by the automated syringe pump, the 
heterogeneous crude reaction mixture from the reaction tube to the reaction filtration tube. 
Empirically, we found that a mixture of Celite
®
 and Florisil
®
 (2.5 g:1.25 g) provided the best 
filter aid. Once the heterogeneous crude reaction mixture is stirred with the filter aid, the crude 
reaction solution can be automatically aspirated, without clogging, from the bottom of the 
reaction filtration tube and can then be submitted to an automated purification. Please see 
Chapter 5 for more details on the connectivity of the cross-coupling module.     
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Figure 4.4. Schematic representation of the automated MIDA boronate cross-coupling platform showing its 
connectivity to the automated syringe pump system. 
 
The intended process for the fully automated Suzuki-Miyaura cross-coupling of a boronic 
acid with a bifunctional halo-MIDA boronate based on the platform and strategies described 
above is shown schematically in Figure 4.5. For a hypothetical cross-coupling of boronic acid 
4.7 to bifunctional halo-MIDA boronate 4.8 in the presence of a palladium catalyst, base, and 
solvent, the resulting cross-coupled MIDA boronate product 4.9 is formed (Figure 4.5, top).  
Just like in manual synthesis, we understood that ad hoc optimization of the reaction 
conditions (i.e. palladium source, ligand, base, solvent, temperature, and time) would likely be 
necessary to obtain optimized yields on automated cross-coupling reactions as well. We also 
understood, though, that a set of general cross-coupling conditions that would work for all 
Suzuki-Miyaura cross-couplings would be highly enabling and particularly beneficial to the 
efficiency of this automated cross-coupling platform. Clearly, an all-encompassing set of general 
cross-coupling conditions, while theoretically ideal, is an impractically aggressive goal given the 
total scope of the Suzuki-Miyaura transformation. We questioned, however, whether there might 
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be a set of generalized conditions that would be effective across at least a small subset of cross-
couplings. This would provide, then, at least a small boost in the efficiency of the automated 
platform.  
Tetrahydrofuran (THF) is commonly used as a solvent in the Suzuki-Miyaura cross-
coupling reaction. In addition, we had already found it to be effective in the automated MIDA 
boronate deprotection (see Chapter 3) and purification (see Chapter 2) platforms. Committed to 
maintaining efficient connectivity of the automated modules, we locked in THF as the primary 
reaction solvent for automated cross-couplings. Furthermore, in the course of investigating cross-
coupling conditions with manual experiments, we found that anhydrous K3PO4 demonstrated 
some generality as an effective base. Additionally, the collective work of our laboratory showed, 
serendipitously, that Buchwald’s biarylphoshine ligands, particularly XPhos21 and SPhos22 were 
somewhat generally effective ligands in cross-couplings of halo-MIDA boronates. This was 
especially encouraging because the well known air-stability of these ligands makes them easy to 
handle on the bench top without the need for a glovebox or inert-atmosphere equipment.
23
 This is 
a highly attractive property for maximizing the efficiency of the automated cross-coupling 
module. While we had initially considered maximizing the generality of the conditions by 
mixing XPhos and SPhos in a multiligand-based approach
24
 we fortuitously found that 
Buchwald’s second generation XPhos palladacycle25 provided an easily handleable and 
surprisingly generally effective catalyst system.  
These conditions (THF as solvent, anhydrous K3PO4 as base, and PdXPhos as catalyst) 
provided some generality in productive cross-coupling, but they still failed to provide good 
yields in some cases. We hypothesized that boronic acid decomposition, both before and during 
the cross-coupling reaction, was a major cause. To address the problem of boronic acid 
decomposition before the cross-coupling reaction we took advantage of inherent MIDA boronate 
properties. Specifically, MIDA boronates are very stable, and thus their clean hydrolysis 
immediately prior to a cross-coupling reaction ensures that every reaction starts with a pure 
boronic acid (see Chapter 3). To mitigate the problem of in situ boronic acid decomposition, we 
took advantage of slow addition cross-coupling (SACC). Our laboratory had found that in situ 
slow release (slow release cross-coupling, SRCC) of boronic acids from their corresponding 
MIDA boronates at a rate approaching or slower than productive cross-coupling maintains a low 
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concentration of boronic acid which minimizes competitive boronic acid decomposition 
pathways. This results in significantly increased yields in some case.
26
  This same study found 
that simple slow addition of the boronic acid into the cross-coupling (SACC) provided similar 
boosts in yield. This slow-addition technique was directly amenable to the automated syringe 
pump system and was used in conjunction with fresh preparation of the boronic acid in the 
design and execution of the automated cross-coupling platform.  
 
 
Figure 4.5. Schematic representation of the automated MIDA boronate cross-coupling process, including the slow-
addition of boronic acid. 
 
As a final step in maximizing the generality of the automated cross-coupling module, the 
boronic acid (4.7) is always used in excess with respect to the halide coupling partner (4.8). This 
biases the cross-coupling reaction toward full conversion to 4.9 and also typically results in the 
presence of excess unreacted 4.7 at the end of the reaction (Figure 4.5, bottom). In the automated 
event, the reaction tube contains 4.8, second generation XPhos palladacycle, and anhydrous 
K3PO4. The reaction tube, reaction transfer tube, and reaction filtration tube are purged with 
argon to remove oxygen. The reaction tube is stirred and heated to the desired temperature in the 
heating block, and then the syringe pump adds 3 mL of neat THF from the bottom to activate the 
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catalyst system. Then, the THF solution of 4.7 (9 mL of solution) is added slowly to the reaction 
tube from the top. Once fully added the cross-coupling reaction is allowed to stir for an 
additional time period to reach full conversion. The resulting crude reaction mixture containing 
insoluble K3PO4 and PdXPhos, excess 4.7 (and its associated decomposition products), and 4.9 
in THF is transferred to the reaction filtration tube as described above. Here the base is filtered 
away from the THF solution and the reaction tube, reaction transfer tube, and reaction filtration 
tube are all subsequently washed with neat THF for quantitative transfer. This entire sequence 
occurs in a fully automated fashion and the resulting THF solution of the crude MIDA boronate 
(4.9) is poised to undergo purification in the automated purification module (see Chapter 2). 
Please see Chapter 5 for more details on the automated cross-coupling process specific to the 
automated operations. 
It is important to note that the stir plate for the reaction filtration tube, like the syringe 
pump and valves, is also controlled remotely by the same computer and software. As detailed 
above, the reaction filtration tube contains a magnetic stir bar and filter aid. Specifically, the stir 
bar is at the bottom of the tube and is covered with the filter aid (Figure 4.6, A). In an early 
configuration of the automated cross-coupling module, this stir plate was operated only 
manually. That is, the stir plate was manually turned on at the beginning of the reaction and left 
on for the duration. This meant that the reaction filtration tube was being agitated for the entire 
time the cross-coupling reaction was going (up to 24 hours in some cases). By the time the 
reaction filtration tube was utilized, the stir bar had moved to the top of the filter aid layer and 
was too far from the stir plate to maintain a magnetic connection (Figure 4.6, B). Because it had 
lost magnetic connection, the stir bar could not mix the crude reaction mixture with the filter aid, 
which invariably resulted in a clog at the interface. This movement of the stir bar was a result of 
the phenomenon of granular convection (also referred to as the “Brazil nut 
effect”).27,28,29,30,31,32,33,34,35,36,37 Specifically, the continuous motion of the stir bar created a 
vibration in the reaction filtration tube which allowed the relatively smaller, although less dense 
particles of the filter aid, a small amount at a time, to settle underneath the stir bar. Over a 
prolonged time, the stir bar literally climbed to the top of the filter aid layer. Conceptually, the 
granular convection problem would be mitigated by simply stirring the reaction filtration tube 
only when it was needed. This would maintain magnetic connection between the stir plate and 
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stir bar thereby enable mixing of the filter aid and crude reaction mixture which prevents clogs 
(Figure 4.6, C). Not wanting to compromise the fully automated nature of the cross-coupling 
platform by manually turning on the stir plate during an experiment, we connected the reaction 
filtration stir plate to the cross-coupling module via a solid-state relay. This enables remote 
control of the power and therefore stirring of the plate.     
 
 
Figure 4.6. Schematic representation of granular convection (the “Brazil nut effect”) in the reaction filtration tube 
used in the automated cross-coupling module. A) The unstirred reaction filtration tube before the addition of the 
crude reaction mixture. The stir bar remains on the bottom of the tube, covered with the Celite/Florisil mixture. B) 
The continuously-stirred reaction filtration tube after the addition of the crude reaction mixture. The stir bar, under 
granular convection, has moved to the top of the Celite/Florisil mixture, lost magnetic contact with the stir plate, and 
will not stir the filter aid which causes clogs. C) The automatically stirred reaction filtration tube after the addition 
of the crude reaction mixture. The stir bar, not susceptible to granular convection, has stayed at the bottom of the 
tube and mixes the filter aid with the crude reaction mixture which prevents clogs.   
 
While all liquid handling manipulations and operations in the cross-coupling module are 
performed in a fully automated fashion, as is the stirring control of the reaction filtration tube as 
just discussed, the heating stir plate for the reaction tube is still controlled manually. That is, the 
temperature and stir rate are set and turned on and off manually by the operator. In practice the 
temperature and stir rate are preset and the plate is turned on at the beginning of an experiment. 
This way, no manual intervention is required after the initiation of the sequence.   
 
4-3 SUMMARY 
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 In summary, we have designed, developed, and constructed a fully automated cross-
coupling platform and module amenable to automated iterative cross-coupling (ICC) sequences 
of MIDA boronates. Specifically, the module can fully automate the Suzuki-Miyaura cross-
coupling reaction of boronic acids to bifunctional halo-MIDA boronates or other halide coupling 
partners. This platform was made possible by the development of methods for multi-gram 
synthesis of MIDA boronates as well as the development of somewhat general cross-coupling 
conditions.  
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CHAPTER 4: EXPERIMENTAL SECTION 
 
General methods and materials. Commercial reagents were purchased from Sigma-
Aldrich, EMD Millipore, Fisher Scientific, Alfa Aesar, Frontier Scientific, Inc., Oakwood 
Products, Inc., or Strem and were used without further purification unless otherwise noted. 
Manual syntheses were carried out in oven or flame-dried glassware and performed under a dry 
inert atmosphere unless otherwise noted. Unless otherwise noted, Celite™ refers to Celite™ 545 
filter aid (not acid washed). Solvents were purified via passage through packed columns as 
described by Pangborn and coworkers
1
 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; 
hexanes, benzene, toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated 
molecular sieves. Water was deionized. Triethylamine, diisopropylamine, diethylamine, 
pyridine, and 2,6-lutidine were freshly distilled under an atmosphere of dry nitrogen from CaH2. 
Thin layer chromatography (TLC) was performed using the indicated eluent on E. Merck 
silica gel 60 F254 plates (0.25 mm). Compounds were visualized by exposure to a UV lamp (λ = 
254 and/or 366 nm) and/or a basic solution of KMnO4 followed by brief heating with a 
Varitemp
®
 heat gun. Flash chromatography was performed as described by Still and coworkers
2
 
using EM Merck silica gel 60 (230-400 mesh). 
1
H NMR spectra were recorded at room 
temperature on one of the following instruments: Varian Unity 500, Varian VXR 500, or Varian 
Unity Inova 500NB. Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (CDCl3, δ = 7.26; 
CD3CN, δ = 1.94, center line; (CD3)2CO, δ = 2.05, center line; CD2Cl2, δ = 5.32, center line; 
(CD3)2SO, δ = 2.50, center line) or to add tetramethylsilane (δ = 0.00). Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, sept = septet, 
m = multiplet, br = broad, app = apparent, dd = doublet of doublets, dt = doublet of triplets, dq = 
doublet of quartets), coupling constant (J) in Hertz (Hz), and integration. 
13
C NMR spectra were 
recorded at room temperature on one of the following instruments: Varian Unity 500 or Varian 
VXR 500. Chemical shifts (δ) are reported in ppm downfield from tetramethylsilane and 
referenced to carbon resonances in the NMR solvent (CDCl3, δ = 77.16, center line; CD3CN, δ = 
1.32, center line;  (CD3)2CO, δ = 29.84, center line; CD2Cl2, δ = 53.84; (CD3)2SO, δ = 39.52, 
center line) or to add tetramethylsilane (δ = 0.00). Carbons bearing boron substituents were not 
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observed due to quadrupolar relaxation. 
11
B NMR were recorded using a General Electric 
GN300WB instrument and referenced to an external standard of BF3•Et2O. Low resolution mass 
spectra (LRMS) and high resolution mass spectra (HRMS) were performed by Furong Sun, 
Steve Mullen, and Elizabeth Eves at the University of Illinois School of Chemical Sciences Mass 
Spectrometry Laboratory. 
 
 
 
N-methyliminodiacetic acid (4.2). The glassware for this reaction was not dried and the 
procedure was performed under ambient atmosphere. A 1000-mL, single-necked, round-bottom 
flask, equipped with a magnetic stir bar is charged with iminodiacetic acid (4.1) (91.74 g, 689.2 
mmol, 1 equiv) and formalin (82.0 mL, 89.4 g, 1.04 mol, 1.51 equiv) to give an off-white 
suspension. The flask is then fitted with a water-cooled Allihn condenser (50 cm) topped with a 
125-mL pressure-equalizing addition funnel filled with formic acid (78.0 mL, 95.2 g, 2.07 mol, 
3.00 equiv). Use of a shorter Allihn condenser results in loss of the volatile formaldehyde 
reagent. Failure to condense the formaldehyde also results in significant formation of 
paraformaldehyde on the condenser and addition funnel. Paraformaldehyde can be easily 
removed with an alcoholic sodium hydroxide solution. All ground glass joints are sealed with 
Apiezon H high temperature vacuum grease and secured with Keck clips.   
The stirred reaction mixture is brought to reflux using a heating mantle, and then the 
formic acid is added dropwise over 20 minutes (approx. 4 mL/min). Addition of formic acid 
results in effervescence of CO2, which can become quite vigorous if the addition is performed 
too quickly. During this time, the reaction mixture becomes clear and orange. The addition 
funnel is then removed and the solution is allowed to reflux for 2 hours. At the end of 2 hours the 
heat source is removed and the solution is allowed to cool to 23 ºC over 20 minutes. The Allihn 
condenser is then removed and deionized water (50.0 mL) is added. The reaction mixture is then 
poured into a 2000-mL Erlenmeyer flask equipped with a large magnetic stir bar. Deionized 
water (2 X 50 mL) is used to quantitatively transfer the contents of the reaction mixture to the 
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Erlenmeyer flask. To the vigorously stirred reaction mixture is then added 1500-mL of absolute 
ethanol in six 250-mL portions leading to the precipitation of large white crystals. The 
precipitate is then collected by vacuum filtration. The 2000-mL Erlenmeyer flask is then rinsed 
with three 100-mL portions of absolute ethanol, with each washing being poured over the 
collected precipitate. The precipitate is allowed to air dry on the frit for 5 minutes. The frit is 
then placed into a large vacuum desiccator and residual solvent is removed under reduced 
pressure (23 ºC, 1 Torr) for 12 hours to give the title compound (4.2) as a free-flowing, air-
stable, white powder (91.37 g, 621.0 mmol, 90.1% yield).  
 
 
 
mp (uncorrected) 
 216 °C dec. 
 
1
H NMR (500 MHz, D2O) 
 δ 3.94 (s, 4H), 2.97 (s, 3H).  
 
13
C NMR (125 MHz, 95:5 DMSO-d6:D2O w/ TMS) 
 δ 168.3, 57.6, 43.0.  
 
IR (Nujol mull, cm
-1
) 
679, 691, 721, 886, 905, 959, 980, 1018, 1064, 1129, 1170, 1225, 1277, 1334, 1377, 
1417, 1462, 1694, 2853, 2923, 2953 3421. 
 
LRMS (ESI+) m/z (rel. intensity)  
 149 (6), 148 (M
+
, 74), 142 (8), 130 (10), 126 (18), 123 (19), 103 (6), 102 (100), 98 (5). 
 
HRMS (ESI+) 
 Calculated for C5H10NO4 [M+H
+
]: 148.0610 
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Found:     148.0616 
 
Elemental Analysis 
 Calculated: C, 40.82 H, 6.17 N, 9.52 
Found:  C, 40.81  H, 6.22 N, 9.37 
 
 
 
4-bromophenylboronic acid MIDA ester (4.4). The glassware for this reaction was not 
dried and the procedure was performed under ambient atmosphere. A 250-mL, single-necked, 
round-bottom flask, equipped with a magnetic stir bar is charged with 4-bromophenylboronic 
acid (4.3) (25.049 g, 124.73 mmol, 1 equiv) and N-methyliminodiacetic acid (4.2) (20.176 g, 
137.13 mmol, 1.10 equiv). To the flask is then added 50 mL of a mixture of dimethyl 
sulfoxide:toluene 1:1 to afford a light orange heterogeneous reaction mixture. The flask is then 
fitted with a toluene-filled Dean-Stark trap topped with a water-cooled Graham condenser. All 
ground glass joints are sealed with Apiezon H high temperature vacuum grease and secured with 
Keck clips. The arm of the Dean-Stark trap is wrapped with aluminum foil to facilitate heat 
transfer.   
The stirred reaction mixture is brought to reflux using a heating mantle. The reaction 
mixture is allowed to reflux for 3 hours, during which time the reaction darkens in color and 
becomes homogenous, giving a clear, brown solution. The heating mantle is removed, and the 
reaction is allowed to cool to 23 °C with stirring for 1 hour yielding a chunky, tan precipitate. At 
this point there is more solid than solvent and as such the reaction appears completely solid. The 
Dean-Stark trap and magnetic stir bar are removed and the reaction mixture is concentrated on a 
rotary evaporator (50 °C, 15 Torr and then 100 °C, 1 Torr) to afford the crude product as a dark 
tan, chunky solid. 
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The product is quantitatively transferred, using 500 mL of ethyl acetate in several 
portions, to a 4000-mL separatory funnel containing 600 mL of a saturated aqueous sodium 
chloride solution. To the separatory funnel is added another 1500 mL of ethyl acetate (2000 mL 
total) and 50 mL of deionized water to redissolve precipitated salt. The layers are separated, and 
the organic layer is dried over anhydrous MgSO4, filtered through Celite™, and concentrated on 
a rotary evaporator (35 °C, 80 Torr) to afford a yellow-orange solid. To this solid is added 100 
mL of hot (55 °C) acetone and the flask is swirled to give a suspension of white precipitate in a 
clear yellow-orange solution. While the majority of the product dissolves in acetone the 
suspended white crystals are undissolved product and should not be removed. In one portion, 100 
mL of diethyl ether is gently layered over the acetone suspension resulting in the formation of 
more white precipitate. The flask is sealed with a polyethylene cap and Parafilm
®
 and placed 
gently into a refrigerator and maintained at 3 °C for 12 hours. The resulting solid product is 
collected via vacuum filtration and washed with diethyl ether (8 X 25 mL). Residual solvent is 
removed under reduced pressure (23 °C, 1 Torr) for 6 hours to give the title compound (4.4) as a 
free-flowing, air stable, white solid (35.802 g, 114.78 mmol, 92.0% yield). 
 
 
 
mp (uncorrected) 
 244-245 °C 
 
1
H NMR (500 MHz, CD3CN)  
δ 7.55 (dt, J = 8.5, 2 Hz, 2H), 7.42 (dt, J = 8.5, 2 Hz, 2H), 4.07 (d, J = 17 Hz, 2H), 3.89 
(d, J = 17 Hz, 2H), 2.50 (s, 3H). 
 
13
C NMR (125 MHz, CD3CN)  
 δ 169.4, 135.5, 131.9, 124.4, 62.8, 48.5. 
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11
B NMR (100 MHz, CD3CN)  
 δ 12.0. 
 
IR (thin film, acetone, cm
-1
) 
645, 706, 813, 867, 962, 977, 997, 1038, 1060, 1088, 1106, 1155, 1181, 1220, 1238, 
1266, 1297, 1339, 1384, 1421, 1445, 1459, 1751, 2951, 2997. 
 
LRMS (EI
+
) m/z (rel. intensity)  
313.9 (9.6), 312.9 (74.4), 311.9 (27.1), 310.9 (M
+
, 76.7), 309.9 (18.8), 284.9 (32.8), 
282.9 (33.6), 256.9 (24.8), 255.9 (99.9), 254.9 (48.7), 253.9 (100.0), 252.9 (24.0), 128.0 
(41.5), 100.0 (78.5), 72.0 (21.6), 56.9 (77.6). 
 
HRMS (EI+) 
 Calculated for C11H11BBrNO4 [M
+
]: 310.99645 
Found:     310.99634 
 
Elemental Analysis 
 Calculated: C, 42.36  H, 3.55 N, 4.49 
Found:  C, 42.20  H, 3.48  N, 4.50 
 
 
 
4-(p-tolyl)-phenylboronic acid MIDA ester (4.5). An oven-dried 500-mL Schlenk flask 
equipped with a magnetic stir bar is charged with palladium (II) acetate (361 mg, 1.61 mmol, 
0.02005 equiv) and (2-biphenyl)-dicyclohexylphosphine (1.159 g, 3.307 mmol, 0.04124 equiv) 
and then quickly sealed with a rubber septum and placed under an inert atmosphere through five 
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cycles of evacuation (1000 mTorr) and purging with dry argon. Although it is possible to 
perform this type of selective cross-coupling reaction without the use of a glovebox, it is very 
important that rigorous Schlenk techniques are utilized to exclude water. Failure to exclude water 
can result in hydrolysis of the MIDA boronate ester. 
Tetrahydrofuran (400 mL) is then cannulated into the 500-mL Schlenk flask resulting in a 
clear, pale yellow-orange solution. Under positive argon pressure the rubber septum is removed 
and replaced with an oven-dried water-cooled Graham condenser topped with a rubber septum 
pierced with a 20G (1.5 inch) needle. Argon is allowed to flow through the system for 60 
seconds at which point the vent needle is replaced with an argon inlet needle and the Schlenk 
valve is closed. The reaction vessel is lowered into an oil bath preheated to 65 °C and the 
solution is allowed to reflux with stirring for 20 minutes, during which time the catalyst solution 
turns colorless. The heating bath is then removed and the catalyst solution is allowed to cool to 
23 °C over 10 minutes. The Schlenk valve is reopened and under a positive argon pressure the 
Graham condenser is replaced with a rubber septum and the head space is purged for 60 seconds 
through a 20G (1.5 inch) vent needle. 
In parallel with the catalyst preparation, an oven-dried 2000-mL three-neck round bottom 
flask equipped with a magnetic stir bar and fitted with an oven-dried water-cooled Graham 
condenser topped with a hose-barb adapter in the center neck and a rubber septa on each side 
neck is charged with 4.4 (25.000 g, 80.148 mmol, 1 equiv), p-tolylboronic acid (16.391 g, 120.56 
mmol, 1.50 equiv), and freshly-ground, anhydrous potassium phosphate (51.043 g, 240.46 mmol, 
3.00 equiv). It is very important that the potassium phosphate is finely ground and that it remains 
anhydrous throughout this process. This is achieved without the use of a glovebox. The reaction 
flask is then quickly placed under inert atmosphere (through the condenser top) through five 
cycles of evacuation (1000 mTorr) and purging with dry argon. Tetrahydrofuran (400 mL) is 
then added into the 2000-mL flask through one of the side necks resulting in a white suspension. 
The catalyst solution is then cannulated into the 2000-mL reaction flask with stirring 
resulting in a yellow suspension. The reaction flask is lowered into an oil bath preheated to 70 °C 
and allowed to reflux with stirring for 6 hours. The heat source is then removed and the reaction 
mixture is allowed to cool for 20 minutes. The Graham condenser and septa are removed from 
the flask necks and the reaction is quenched with 800 mL saturated ammonium chloride giving a 
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biphasic mixture comprised of a clear colorless bottom layer and a clear yellow-orange top layer.  
This mixture is poured into a 4000-mL separatory funnel. The reaction mixture is quantitatively 
transferred to the separatory funnel with 2 X 200-mL of THF:diethyl ether 1:1. The layers are 
separated, and the aqueous layer is extracted with 400 mL of THF:diethyl ether 1:1. The 
combined organic layers are washed with 100 mL saturated aqueous sodium chloride, dried over 
anhydrous MgSO4, and filtered through Celite™. The solvent is removed via rotary evaporation 
(35 °C, 20 Torr). Residual solvent is removed at reduced pressure (23 °C, 1 Torr) to afford the 
crude product as a yellow solid. Ethyl acetate (75 mL) is added to the crude mixture in three 
equal portions and the resulting mixture is swirled vigorously to give a yellow slurry. Diethyl 
ether (400 mL) is then added in 4 equal portions with swirling to give a white precipitate in a 
clear yellow solution. The precipitate is collected via vacuum filtration and allowed to air dry 
under suction for 5 minutes. The frit is then transferred to a large vacuum desiccator and residual 
solvent is removed at reduced pressure (23 °C, 1 Torr) to give the title compound as a free-
flowing, air stable, off-white powder (22.008 g, 68.104 mmol, 85.0% yield).  
 
 
 
mp (uncorrected) 
 211 °C dec. 
 
1
H NMR (500 MHz, CD3CN) 
δ 7.65 (d, J = 8 Hz, 2H), 7.56 (app d, J = 7.5 Hz, 4H), 7.28 (d, J = 7.5 Hz, 2H), 4.08 (d, J 
= 17 Hz, 2H), 3.92 (d, J = 17 Hz, 2H), 2.55 (s, 3H), 2.38 (s, 3H).  
 
13
C NMR (125 MHz, CD3CN)  
 δ 169.6, 142.5, 138.6, 138.4, 134.0, 130.5, 127.7, 127.1, 62.8, 48.5, 21.1.  
 
11
B NMR (100 MHz, CD3CN)  
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 δ 12.4. 
 
IR (thin film, acetone, cm
-1
) 
708, 745, 804, 835, 866, 887, 993, 1029, 1042, 1197, 1225, 1287, 1334, 1762, 2858, 
2951, 3013.   
 
LRMS (EI
+
) m/z (rel. intensity) 
324.1 (20.3), 323.1 (M
+
, 100.0), 322.1 (25.0), 313.0 (12.4), 311.0 (12.5), 285.0 (5.4), 
283.0 (5.6), 256.0 (16.5), 254.0 (16.7), 223.1 (16.4), 208.1 (25.9), 194.1 (28.6), 181.1 
(11.0), 168.1 (16.9), 141.1 (15.9), 128.1 (17.6), 115.1 (13.5), 101.0 (48.0), 100.1 (21.9), 
77.1 (25.2), 57.0 (37.1). 
 
HRMS (EI+) 
Calculated for C18H18BNO4 [M
+
]: 323.13289 
Found:     323.13287 
 
Elemental Analysis 
 Calculated: C, 66.90  H, 5.61  N, 4.33 
Found:  C, 65.35  H, 5.55  N, 4.21 
 
 
 
4-(p-tolyl)-phenylboronic acid (4.6). A 1000-mL, single-necked, round-bottom flask 
equipped with a magnetic stir bar is charged with 4.5 (9.975 g, 30.87 mmol, 1 equiv), 
tetrahydrofuran (200 mL), and an aqueous solution of 1 M sodium hydroxide (92.6 mL, 92.6 
mmol, 3.00 equiv) to give a biphasic system consisting of a clear colorless bottom layer and a 
cloudy white top layer. The flask is covered with a polypropylene cap and the reaction is stirred 
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vigorously at 23 °C for 10 min to give a biphasic system consisting of a clear colorless bottom 
layer and a clear yellow top layer. A saturated aqueous solution of ammonium chloride (250 mL) 
is then added. The resulting mixture is poured into a 1000-mL separatory funnel and the reaction 
vessel is rinsed with four 50-mL portions of diethyl ether, each washing being poured into the 
separatory funnel. The layers are separated and the aqueous layer is extracted with 
tetrahydrofuran:diethyl ether 1:1 (400-mL). The combined organic layers are dried over 
anhydrous MgSO4, filtered through Celite™, and concentrated via rotary evaporation (35 °C, 20 
Torr). The residual solvent is removed via three azeotropic cycles with acetonitrile on a rotary 
evaporator (3 X 50 mL, 35 °C, 20 Torr) and then at reduced pressure (23 °C, 1 Torr) for 6 hours 
to afford the title compound as a fine, off-white powder (6.43 g, 30.3 mmol, 98.2% yield). 
 
 
 
mp (uncorrected) 
130 °C dec.  
 
1
H NMR (500 MHz, 95:5 DMSO-d6:D2O w/ TMS) 
δ 7.87 (d, J = 8 Hz, 2H), 7.62 (d, J = 8 Hz, 2H), 7.59 (d, J = 8 Hz, 2H), 7.28 (2, J = 8 Hz, 
2H), 2.35 (s, 3H). 
 
13
C NMR (125 MHz, 95:5 DMSO-d6:D2O w/ TMS) 
δ 141.5, 137.1, 136.9, 134.7, 129.5, 126.4, 125.3, 20.6. 
 
11
B NMR (95:5 DMSO-d6:D2O w/ TMS) 
δ 36.3. 
 
IR (thin film, acetone, cm
-1
) 
807, 1003, 1024, 1091, 1158, 1340, 1380, 1653, 3406. 
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LRMS (EI
+
) m/z (rel. intensity) 
213.1 (14.3), 212.1 (M
+
, 100.0), 211.1 (25.5), 193.1 (10.4), 184.1 (16.8), 169.1 (7.6), 
168.1 (50.4), 167.1 (54.3), 166.1 (26.2), 165.1 (9.76), 153.1 (14.0), 152.1 (22.4), 115.1 
(9.2), 91.1 (10.2), 57.0 (7.3). 
 
HRMS (EI+)  
Calculated for C13H13BO2 [M
+
]: 212.10087 
Found:     212.10095 
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CHAPTER 5 
A SMALL MOLECULE SYNTHESIZER 
 
Steven G. Ballmer, Seiko Fujii, Junqi Li, Eric P. Gillis, Gregory F. Morehouse, Matthew J. 
Clark, and Martin D. Burke 
 
 This chapter describes the construction of a fully automated small molecule synthesizer 
that utilizes the iterative cross-coupling (ICC) platform with MIDA boronates. The full 
synthesizer consists of three distinct modules (deprotection, cross-coupling, and purification) and 
has the capacity to run up eight syntheses in parallel, with each synthesis capable of coupling up 
to four building blocks together using three sequential cycles of ICC. This chapter also describes 
the use of the small molecule synthesizer to synthesize, in a fully automated fashion, a series of 
materials, pharmaceuticals, natural products, and natural product derivatives. Critical to the 
success of the synthesizer was the discovery of general purification, deprotection, and cross-
coupling conditions for MIDA boronates as detailed in Chapters 2-4. 
Seiko Fujii, Junqi Li, and Gregory F. Morehouse contributed to the synthesis of many of 
the non-commercial building blocks and performed many of the manual experiments used 
determine and optimize reaction conditions used for automation. Junqi Li performed many of the 
post-automation manual deprotections. Eric P. Gillis contributed to the development and 
implementation of the software and to early configurations of the synthesizer. Matthew J. Clark 
contributed building block 5.37, based on Seiko Fujii’s synthetic route. 
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5-1 DESIGN OF THE SMALL MOLECULE SYNTHESIZER 
Based on the platforms developed for automated MIDA boronate deprotection, cross-
coupling, and purification discussed in Chapters 2-4 we constructed a fully automated small 
molecule synthesizer that operates on the automated iterative cross-coupling (ICC) platform for 
MIDA boronates (Figure 5.1).
1,2
 This section describes the hardware and software used to 
construct and control the synthesizer 
 
A. 
 
B. 
 
Figure 5.1. A. Picture of the full small molecule synthesizer. B. Picture of the small molecule synthesizer, cropping 
out the deprotection and purification equipment for Pumps 5-8 for clarity.  
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The full synthesizer is shown schematically in Figure 5.2. It consists of three distinct 
modules: the Purification Module (Figure 5.2, #1, see Chapter 2 for development details), the 
Deprotection Module (Figure 5.2, #2, see Chapter 3 for development details), and the Cross-
coupling Module (Figure 5.2, #3, see Chapter 4 for development details). This current 
configuration of the synthesizer is capable of running up to eight syntheses in parallel. Each one 
of the eight parallel synthesizers has its own dedicated syringe pump for fluid handling (Primary 
Pump). These eight Primary Pumps are built into a single housing unit (Figure 5.2, #4) that 
create the physical core of the synthesizer as well as form a support table for the Cross-coupling 
Module. In addition to the Primary Pumps, two separate syringe pumps are shared by all eight 
parallel synthesizers. The Auxiliary Pump (Figure 5.2, #5) is responsible for much of the fluid 
handling for the Purification Module while the Wet Pump (Figure 5.2, #6) handles all aqueous 
reagents and solutions utilized in the Deprotection Module.  
Each syringe pump uses a syringe (Figure 5.2, #11) to transfer fluid (either aqueous 
and/or organic liquid or gases) through a series of automated valves (Figure 5.2, #10) to its 
appropriate destination. Critical to the proper flow of all fluids and the maintenance of inert 
atmosphere throughout the synthesizer are series of automated solenoid valves connected to the 
inert gas manifold (Figure 5.2, #9) that control the flow of dry argon throughout the synthesizer. 
There are a total of eight solenoids, one dedicated to each of the Primary Pumps. Both the 
Purification and Cross-coupling Modules utilize heating magnetic stir plates (Figure 5.2, #7) for 
a source of agitation. The Cross-coupling Module also uses aluminum heating blocks (Figure 
5.2, #8) to maintain elevated reaction temperatures during cross-coupling. All of the necessary 
liquid reagents are stored in reagent containers connected to the synthesizer and are accessed, 
automatically, by the synthesizer when required. Any necessary solid reagents are manually 
added to the synthesizer before its use for a particular experiment.    
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Figure 5.2. Schematic representation of the full small molecule synthesizer showing the general layout of equipment 
and its identity.   
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Hardware control of the small molecule synthesizer   
Unless otherwise discussed, all commercial hardware components were purchased from 
J-KEM
®
 Scientific, Inc. (St. Louis, MO), Norgren
®
 Kloehn USA (Las Vegas, NV), Upchurch 
Scientific, Inc. (Oak Harbor, WA), or Luknova, Inc. (Mansfield, MA), or IKA
®
 Works, Inc. 
(Wilmington, NC). 
A number of small commercially-available hardware components were also used in the 
construction of the small molecule synthesizer. These are shown in Figure 5.3. 
 
 
Figure 5.3. Pictures of individual small hardware components used in the construction of the small molecule 
synthesizer and their respective product numbers from one of the following vendors: J-KEM
®
 Scientific, Inc. (St. 
Louis, MO), Norgren
®
 Kloehn USA (Las Vegas, NV), Upchurch Scientific, Inc. (Oak Harbor, WA), Luknova, Inc. 
(Mansfield, MA). 
 
Each of the ten syringe pumps on the small molecule synthesizer is fitted with a 10-mL 
glass and Teflon
®
 (polytetrafluoroethylene, PTFE) syringe (J-KEM
®
, SPGS-10000). As part of 
each syringe pump, each syringe is fitted into an eight-port addressable distribution valve (J-
KEM
®
, SPDV-8). These particular valves have eight addressable ports with an additional port 
for the syringe. This syringe port is the default inlet port, which then allows the syringe to 
connect to any one of the eight ports at a given time. This configuration means that each syringe 
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pump can aspirate/inject from any of eight separate ports or destinations. Critical to the leak-free 
and reproducible performance of theses syringes are the Teflon
®
 sealing washers (Kloehn, 
NC0024573) used to provide a tight seal between the glass tip of the syringe and the metal 
housing of the valve. All other valves used in the rest of the fluidic network are another style of 
eight-port addressable distribution valves (J-KEM
®
, SPDV-CS8). These valves have eight 
addressable ports with an additional front default inlet port. Similar to the syringe valves 
described above, this allows the inlet to connect to any one of the other eight ports at a given 
time and this configuration means that each inlet stream be distributed to any of eight separate 
ports or destinations.  
The final destination for any fluid on the synthesizer is a container in which either a 
chemical transformation (in the case of the Deprotection or Cross-Coupling Modules) or a work-
up/separation (in the case of the Deprotection or Purification Modules) takes place. In all cases, 
these containers, referred hereafter as “cartridges” are empty 12-g columns (Luknova, 
FC003012). These cartridges are fitted with medium-porosity fiber frits and have standard luer 
tips on the bottom and standard luer ports on the top. In the event of an experiment, each 
cartridge is pre-filled with its appropriate contents (see Chapter 5: Experiment Section for 
details). Every cartridge is connected to the synthesizer via a friction-sealed luer port/tip 
connection. Specifically, the bottom luer tips of all cartridges are plugged into a female luer to 
¼-28 female red polyether ether ketone (PEEK) adaptor (Upchurch, P-658). If connected to the 
synthesizer, the tops of cartridges are connected to a male luer with natural PP locking hub to ¼-
28 female red ethylene tetrafluoroethylene (ETFE) adaptor (Upchurch, P-675) or to a male luer 
to ¼-28 male natural ETFE adaptor (Upchurch, P-625) as part of a natural PEEK “Y”-connector 
(Upchurch, P-513).  
The inert gas manifold, which supplies dry argon and nitrogen to the synthesizer, is 
constructed from a series of natural PEEK tees (Upchurch, P-714) and 9-port black PEEK 
manifold (Upchurch, P-191). The manifold also uses flat bottomed perfluoroalkoxy (PFA) 
polymer resin plugs (Upchurch, P-316) to plug unused ports on each manifold. Each one of the 
eight Primary Pumps has its own dedicated tee and manifold. 
All of the tubing used in the fluidic network is either natural 1/16’’ O.D., 0.030’’ I.D. 
fluorinated ethylene propylene (FEP) tubing (Upchurch, 1520) or green 1/8’’ O.D., 0.062’’ I.D. 
95 
 
FEP tubing (Upchurch, 1521GL). All of the connections in the fluidic network are made with the 
appropriate female adaptor, a  blue ETFE flangeless ferrule (Upchurch, P-200), and one of the 
following male nuts: a red Delrin
®
 (polyoxymethylene, POM) flangeless nut (Upchurch, P-202), 
a black Delrin
®
 flangeless nut (Upchurch, P-201), a black Delrin
®
 short flangeless nut 
(Upchurch, P-208), a stainless steel flush nut (Upchurch, XF-358), or a custom-milled red 
Delrin
®
 flushnut. 
The Deprotection Module consists of two V6 programmable syringe pumps (J-KEM
®
, 
SYR-1400PC) which are connected to the controlling computer via a RS485 to USB connection. 
Each syringe pump aspirates and injects from 0.0 mL/min to 70.0 mL/min with a step of 0.0029 
mL. One pump (the Primary Pump) is utilized as the organic liquid handling pump and the other 
(the Wet Pump) is used exclusively as the aqueous liquid handling pump. The module utilizes an 
additional five eight-port distribution valves (J-KEM
®
, SPDV-CS8) housed in four separate quad 
stack KEM select distribution modules (J-KEM
®
, SYR-CS4) for liquid handling. A source of dry 
nitrogen and dry argon are used for liquid handling and deoxygenation/concentration processes.  
The Cross-coupling Module consists of one V6 programmable syringe pump (J-KEM
®
, 
SYR-1400PC), the Primary Pump described above. The module utilizes one additional eight-port 
distribution valve (J-KEM
®
, SPDV-CS8) housed in one separate quad stack KEM select 
distribution module (J-KEM
®
, SYR-CS4) for liquid handling (shared with the Deprotection 
Module). A source of dry nitrogen and dry argon are used for liquid handling and deoxygenation 
processes (shared with the Deprotection Module). Two RET control visc IKAMAG
®
 safety 
control heating stir plates (IKA
®
, 3364001) and one RCT basic IKAMAG
®
 safety control 
heating stir plate (IKA
®
, 3810001) are used for reaction stirring and temperature control.  
The Purification Module consists of two V6 programmable syringe pumps (J-KEM
®
, 
SYR-1400PC). One is the Primary Pump described above. The other pump (the Auxiliary Pump) 
is used exclusively as the column eluent and waste handling pump. The module utilizes an 
additional six eight-port distribution valves (J-KEM
®
, SPDV-CS8) housed in three separate quad 
stack KEM select distribution modules (J-KEM
®
, SYR-CS4) for liquid handling. Five of these 
distribution valves are shared with the Deprotection and Cross-coupling Modules. Two RET 
control visc IKAMAG
®
 safety control heating stir plates (IKA
®
, 3364001), shared with the 
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Cross-coupling module, and one RCT basic IKAMAG
®
 safety control heating stir plate (IKA
®
, 
3810001) are used. 
The heating blocks and support table used by the Cross-coupling Module and the 
cartridge support tables used by the Deprotection and Purification Modules are all custom-
designed and milled or constructed from aluminum by the University of Illinois at Urbana-
Champaign School of Chemical Sciences Machine Shop.  
 
Hardware connectivity of the small molecule synthesizer   
 As a completed unit, this fully automated small molecule synthesizer is comprised of a 
total of ten syringe pumps, 42 eight-port distribution valves, and over 300 additional outlet ports 
all connected in a complex fluidic network. As discussed above, some of this equipment, such as 
the Primary Pumps and their valves, is dedicated to one of the eight individual parallel 
synthesizers while other equipment, such as the Wet and Auxiliary Pumps and their valves, is 
shared among all eight of the parallel synthesizer units. In order to maximize the organization of 
the fluidic network for the operator and to clarify the identity of the equipment for the controlling 
software (see “Software control of the small molecule synthesizer” below for details) each major 
piece of equipment (a valve or syringe pump) is assigned a name or number. This identification 
and assignment system is shown schematically in Figure 5.4.  
 Each of the eight Primary Pumps in the Primary Pump housing is assigned a number 1-8 
from left to right. This number assignment is also used as the identification number for that 
entire individual synthesizer unit. That is, the leftmost Primary Pump in the Primary Pump 
housing is assigned the number 1 and is referred to as Pump 1 and any equipment dedicated to 
that pump is called Pump 1’s equipment. Under this assignment system, each of the eight 
Primary Pumps (Pumps 1-8) has its own dedicated fluidic system comprised of four valves 
(Valves 1-4). This dedicated fluidic system is used only by the controlling pump; it cannot 
physically access (or cross-contaminate) another dedicated fluidic system without using shared 
equipment. 
 The shared equipment, as discussed above, is shared among all eight of the parallel 
synthesizer units. Because this equipment is not dedicated to one of the eight individual parallel 
synthesizer units, it cannot be assigned a name connected to an individual Primary Pump. 
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Instead, the shared equipment is simply assigned a name or number of its own. Specifically, the 
shared syringe pumps are assigned the name Wet and Auxiliary (Aux.) Pumps and their valves 
are assigned the numbers 11 and 0, respectively. The shared valve equipment is numbered in 
sequential order starting from the last dedicated valve number. That is, the highest numbered 
dedicated valve is Pump 1-8’s Valve 4, so the shared valves are numbered starting with 5 (5-10 
and 12-13). These name and number assignments are how the operator refers to the equipment 
and, more importantly, how the software recognizes the equipment.    
 
 
Figure 5.4. Schematic representation of the full small molecule synthesizer showing the syringe pump and valve 
equipment assignments.  
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 The fluidic network, built from the hardware and assigned an identity as discussed above 
is shown schematically in Figure 5.5. Here, for clarity, only the distribution valves are shown; 
the syringes are omitted. As detailed above, Valves 1, 0, and 11 belong to the Primary Pump, 
Auxiliary Pump, and Wet Pump, respectively. All dedicated equipment is contained within the 
dashed box as indicated. That is, every Primary Pump has its own fluidic system as shown inside 
the dashed box. This figure is a specific example for Pump 1 and its first purification, but can be 
extrapolated for any of the other seven pumps.  
Each valve has eight ports (ports A-H) and each port is connected to a general 
destination. The general destination can be a resource (e.g. a reagent bottle or gas source), a 
cartridge location (e.g. deprotection cartridge #1), or another valve. In Figure 5.5, the label next 
to each port indicates what that specific port is connected to. Destinations not specifically shown 
in the schematic (e.g. reagent bottles and cartridges) are simply labeled with text boxes. 
Connections made between valves or another piece of equipment are shown as black lines. In the 
case where a specific valve port is either not used or left open to be used only to access ambient 
atmosphere, its label is left blank.  
Specifically, for the dedicated equipment fluidic network, Valve 1 is connected to the 
argon source via an automated solenoid and a tee connector through Port A. Valve 1 is also 
connected to the nitrogen source, all three reaction cartridge tops, and Valve 4. Valve 4 in turn is 
connected to all three predrying cartridges as well as the Purification Module top and sides for 
both purifications. Valve 2 is connected to Valve 1’s Port A through the tee connector and is also 
connected to all three degassing cartridges, all three reaction cartridge bottoms, and Valve 3. 
Valve 3 in turn is connected to all three deprotection cartridges and all three drying cartridges. 
Valve 2’s Port H is connected to shared equipment Valve 12, the valve from which all eight 
dedicated fluidic networks divert. That is, each of Valve 12’s eight ports is connected to an exact 
replica of the dedicated equipment fluidic network shown, one for each Primary Pump. 
For the shared equipment, Valve 12 is connected to Valve 6. Valve 6 is a reagent 
resource valve. It is connected to THF, dry nitrogen gas, waste, diethyl ether, and 1.5% methanol 
in diethyl ether. Separately, Valve 11 (the Wet Pump’s valve) is connected to Valve 13 as well as 
its reagents (water, THF, 50% saturated aqueous sodium chloride, waste, acetone, and pH = 6 
potassium phosphate buffer). Valve 13 in turn is connected to all three deprotection cartridges. It  
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Figure 5.5. Schematic representation of the valve connectivity on the small molecule synthesizer including shared 
and dedicated equipment.  
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should be noted, as discussed above, that Valve 3 is also connected to these cartridges. The two 
respective matching ports on the two valves are joined with a tee connector to form one line 
before connecting to the deprotection cartridge. Valve 0 (the Auxiliary Pump’s valve) is 
connected to its reagents (hexanes, waste, and THF) as well as Valve 5 and 7. These valves are 
the diverting distribution valves for all of the silica gel plugs in the Purification Module. 
Specifically, Valve 5 is connected to the silica gel plugs for both purifications for Pumps 1-4 and 
Valve 7 is used for Pumps 5-8.  
 The deprotection, predrying, drying, and degassing cartridge connections to Valves 2, 3, 
4, and 13 as described above all lead to the Deprotection Module. Specifically, they lead to the 
Deprotection Module table (see Figure 5.2), a custom-made aluminum table which secures a 
matrix of luer ports into which the appropriate cartridges are plugged in. There are two of these 
tables, one on the left hand side of the Primary Pump housing (for Pumps 1-4) and one on the 
right hand side of the Primary Pump housing (for Pumps 5-8). The top views of these two tables 
are represented schematically in Figures 5.6 (for Pumps 1-4) and Figures 5.7 (for Pump 5-8). 
These figures act as maps of the Deprotection Module, where each circle is a luer port into which 
a luer tip can be plugged in. Using Figure 5.6 as an example, there is a 10 X 8 matrix of luer 
ports. Those with an “X” through them are unused luer port place holders; these luer ports are 
not connected to any valve and should not be used for any experiment. Every two rows is a 
repeating pattern of luer tips for a different Primary Pump. That is, the first two (front/bottom) 
rows are dedicated to Pump 1, the second two rows are dedicated to Pump 2, and so on. In each 
pump’s set of luer ports there are three each of deprotection, predrying, drying, and degassing 
ports, one for each cycle of ICC. These are labeled accordingly and are connected to their 
respective matching valve ports as shown in Figure 5.5. There are also six additional luer ports 
labeled as “inert gas”. These ports lead directly to the inert gas manifold and, when connected to 
their associated drying or degassing ports (as indicated with a wavy line) with a short length of 
tubing, provide maintenance of inert atmosphere in those cartridges. The Deprotection Module 
table for Pumps 5-8 (Figure 5.7) follows the same layout as discussed here.              
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Figure 5.6. Schematic representation of the top view of the Deprotection Module table for Pumps 1-4 (left hand side 
of synthesizer). Each circle is a luer port, labeled with its usage.  
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Figure 5.7. Schematic representation of the top view of the Deprotection Module table for Pumps 5-8 (right hand 
side of synthesizer). Each circle is a luer port, labeled with its usage.  
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The reaction cartridge top and reaction cartridge bottom connections to Valves 1 and 2 as 
described above all lead to the Cross-coupling Module. Specifically, they lead to the Cross-
coupling Module table (see Figure 5.2), a custom-made aluminum table which secures a matrix 
of luer ports into which the appropriate cartridges are plugged in. This table sits directly one the 
Primary Pump housing and acts both as a cover for the inert gas manifold connections and the 
eight automated solenoids and as a table for the three heating stir plates used by the Cross-
coupling Module. The top view of this table is represented schematically in Figure 5.8. Similar to 
Figures 5.6 and 5.7 for the Deprotection Module, this figure act as a map of the Cross-coupling 
Module, where each circle is a luer port into which a luer tip can be plugged in. Unlike the 
Deprotection Module, cartridges are never plugged directly into these luer ports. Rather, each 
luer port is fitted with a length of tubing, the end of which is fitted with another luer port. It is 
this, now flexible and movable luer port that is then connected to the appropriate cartridge. As 
seen in Figure 5.8, the Cross-coupling Module table is a 8 X 9 matrix of luer ports. Each of the 
eight columns of luer ports is dedicated to a different Primary Pump. Specifically, the leftmost 
column is for Pump 1, the second leftmost column is for Pump 2, and so on. The nine rows of 
luer ports are broken down into three sets of three. Each set of three rows is dedicated to a 
different function and each of the three rows within a set is dedicated to a different cycle of ICC. 
That is, there are three functions that can be used in a sequence of up to three ICC cycles. 
Specifically, the front/bottom row is the connection for the first reaction cartridge’s top, the next 
row is the connection for the second reaction cartridge’s top, and the third row is the connection 
for the third reaction cartridge’s top. The second set of three rows is the connections for the 
reaction cartridges’ bottoms. The third (back/top) set of three rows is the connections for the 
reaction cartridges’ inert gas/vent sources. Similar to the “inert gas” ports of the Deprotection 
Module, these ports lead directly to the inert gas manifold and, when connected to their 
associated reaction cartridge, provide maintenance of inert atmosphere for that reaction. These 
are labeled accordingly and are connected to their respective matching valve ports as shown in 
Figure 5.5.  
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Figure 5.8. Schematic representation of the top view of the Cross-coupling Module table for Pumps 1-8 (center of 
synthesizer). Each circle is a luer port, labeled with its usage.  
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Software control of the small molecule synthesizer
3
 
 All synthesizer equipment, except for the three IKA
®
 RCT basic heating stir plates and 
the first IKA
®
 RET control-visc heating stir plate, is controlled by a custom software program 
which was written in VB.NET and is run on a Window’s based computer. As described above, 
the synthesizer has the capability of running up to eight syntheses in parallel simultaneously. 
Each synthesis is executed from the software environment using an independent virtual 
synthesizer and each virtual synthesizer can be scripted and started/stopped without regard to the 
state of the other virtual synthesizers. The custom software program ensures that resources are 
queued appropriately. Additionally, the software program is designed to interpret instructions to 
the synthesizer written in a simple custom scripting language. This enables the operator to write 
very general instructions to the synthesizer that are read by the software and then mapped and 
communicated to the appropriate hardware. The commands used in this scripting language are 
described and discussed in detail in Appendix A and B. The interface of the software program at 
rest is shown in Figure 5.9. The buttons across the top of the window labeled “Pump 1”, “Pump 
2”, etc. select the virtual synthesizer that is to be modified by the operator. The large text box 
provides an area in which the scripting commands are typed, copied, and edited. When the “Run” 
button is pressed the software proof-reads all of the scripting commands entered into the virtual 
synthesizer. If the syntax of the commands is correct then the virtual synthesizer begins 
operation of the actual synthesizer equipment. If there is a syntax error, the operator is alerted to 
the line of code that raised the error and the synthesizer does not begin operation until the error is 
corrected. Figure 5.10 illustrates the interface of the software program while it is running a script 
on the synthesizer. The active line of code is highlighted in blue while the lines of code that have 
been run are indicated in gray and the remaining lines are indicated in black. The “Break” button 
stops execution of the code and the “Pump Status” label alerts the operator to the current 
operation of the virtual synthesizer. If the virtual synthesizer is queued for use of shared 
equipment, then the status is updated in the “Pump Status” label. 
 An important aspect of the software is that scripts which are written for one virtual 
synthesizer are applicable to all the virtual synthesizers. That is, the script files are portable even 
though the actual valves that are operated by the script differ depending on which virtual 
synthesizer the code is executed from. One mechanism by which the software ensures portability 
106 
 
of the scripts is through the use of a “header” section (Figure 5.11). The header is a set of 
scripting commands that is specific to each virtual synthesizer and contains instructions on how 
to operate pieces of equipment that are unique to a particular virtual synthesizer. For example, 
each virtual synthesizer is mapped to a different port on valve #12 (Figure 5.5). Therefore, 
scripts that are written to be portable across all virtual synthesizers typically use a placeholder 
variable to refer to valve #12. The header of each virtual synthesizer includes code which 
specifies the value that will be used to replace the placeholder variable if the code is executed on 
that specific virtual synthesizer. The header section is typically hidden from the operator but is 
run as the first portion of code whenever the virtual synthesizer executes script.  
  
 
Figure 5.9. The software interface while the virtual synthesizer is not operating. This is the screen from which the 
virtual synthesizer is scripted. 
 
Buttons select the  
current virtual  
synthesizer 
Area where scripting 
commands are edited  
Begins execution of 
the script on the 
synthesizer   
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Figure 5.10. The software interface while the synthesizer is operating. This is the screen where the operator 
monitors the status of the synthesizer and script. 
 
 
Figure 5.11. The software interface used to change the “header” section of the script. 
Completed lines  
Current line   
Uncompleted lines  
Button interrupts the 
execution of the script  
“header” section  
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 From a technical standpoint, the software is built from a collection of programming 
objects (classes). The most broadly defined object is the virtual synthesizer object, which serves 
as a container for equipment objects. An equipment object comprises all of the software 
functions necessary to operate a single valve or syringe pump. Specifically, the equipment object 
translates relatively simple software instructions into the complex arrangement of ones and zeros 
that are understood by the hardware. The equipment also stores information on the exact 
hardware address of the equipment, as well as the route by which commands must be sent to the 
equipment. The most elementary object is the command object, which interprets a single line of 
code to determine if the syntax of the code is correct. If the syntax is correct, the command 
object stores the parameters necessary to perform the requested action. Specifically, the 
command object stores the name of the virtual synthesizer object and the name of the equipment 
object that will be required for the requested action, as well as the names of the functions that 
will be performed by the equipment object. When an operator presses the “Run” button in the 
software program, each line of the script is sent to its own unique command object which 
interprets the code. The command objects are then organized in a list and the software program 
sequentially instructs each command object in the list to execute its action.  
Finally, a series of prewritten and confirmed script programs has been prepared. These 
script programs were written to execute a number of distinct and often-used operations. These 
include first, second, and third-round deprotections, cross-coupling, and purifications as well as 
several routine maintenance operations, like washing. Each individual prewritten script program 
can be loaded using a simple drag and drop method and then the experiment is initiated by 
pressing “Run”. This enable operators who are not well-versed in the script writing to run 
experiments by simply loading the appropriate scripts for their intended experiment.         
 
5-2 SINGLE CYCLE OF AUTOMATED DEPROTECTION, CROSS-COUPLING, AND 
PURIFICATION 
Having constructed the fully automated synthesizer as described above based on the 
results discussed in Chapters 2-4 we sought to test its ability to perform a single cycle of MIDA 
boronate deprotection ([D]), cross-coupling ([C]), and purification ([P]) in a fully automated 
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fashion. Encouraged by the generality observed with the conditions discussed for automated 
purification, deprotection, and cross-coupling in Chapters 2, 3, and 4, respectively, we 
additionally sought to maximize the generality of the automated process by using these 
conditions. This process is represented schematically in Figure 5.12. Specifically, the 
deprotection module adds THF and water to a cartridge containing the starting MIDA boronate 
and solid NaOH (Figure 5.12, top). This system is agitated using pulses of argon gas at room 
temperature for 20 minutes. This is followed by a reaction quench with pH = 6 potassium 
phosphate buffer and diethyl ether and the resulting ethereal solution of the freshly prepared 
boronic acid is separated from the water-soluble MIDA ligand. The organic layer is dried over a 
series of drying agents (anhydrous MgSO4 and molecular sieves) mixed with Celite™ and then 
concentrated and deoxygenated (via argon sparging) to afford a dry deoxygentated THF solution 
of freshly prepared boronic acid (the argon sparging/concentration is carried out long enough to 
completely remove the more volatile diethyl ether, leaving only THF as the solvent). The cross-
coupling module then heats and stirs a reaction cartridge containing a coupling partner, 
PdXPhos, K3PO4, THF, and a magnetic stir bar (Figure 5.12, middle). The solution of boronic 
acid in THF, freshly prepared by the deprotection module, is then slowly added to the cross-
coupling reaction. Once fully added, the reaction is allowed to stir. Finally, the purification 
module executes catch-and-release chromatography on the crude reaction mixture using a series 
of eluents (Figure 5.12, bottom), starting with a 4:1 mixture of hexanes:THF, then using 1.5% 
(v/v) methanol in diethyl ether, then straight diethyl ether. This series of eluent removes non-
MIDA boronate containing impurities including unreacted boronic acid, decomposition 
byproducts associated with protodeborylation, and catalyst components. Finally THF is used to 
release the purified MIDA boronate. The ability to use THF as the release solvent enables 
transfer of the resulting concentrated solution of purified MIDA boronate product directly into 
the deprotection module to start the next ICC cycle. 
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Figure 5.12. Schematic representations of fully automated modules for the deprotection ([D]), cross-coupling ([C]), 
and purification ([P]) steps of ICC. 
 
We first tested the capacity of this automated platform to execute one full cycle of ICC 
with a wide range of structurally diverse MIDA boronates, using the same general conditions for 
each module (Figure 5.13). Specifically, we subjected a series of commercially available aryl 
(5.1a-5.1c, Figure 5.13, entries 1-3), heteroaryl (5.1d-5.1f, Figure 5.13, entries 4-6), and vinyl 
MIDA boronates (5.1g-5.1i, Figure 5.13, entries 7-9) to this process and quantified the 
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conversion at each step as well as yield and purity of the final MIDA boronate products (see 
Chapter 5: Experiment Section for details). Without any modifications of any of the general 
conditions (General condition for deprotection: MIDA boronate 5.1 (1 mmol, 3 equiv.), NaOH (9 
equiv.), THF (0.1 M), rt, 20 minutes. General condition for cross-coupling: MIDA boronate 5.3 
(1 equiv.), PdXPhos (5 mol%), K3PO4 (9 equiv.), THF (0.028 M), 55 °C, 16 hours. General 
condition for catch-and-release purification: SiO2, MeOH:Et2O (1.5:98.5, 36 mL), Et2O (36 mL), 
THF (12 mL)) we observed excellent conversions of all MIDA boronates 5.1 to the 
corresponding boronic acids 5.2 (97-99% conversion), and excellent conversions of MIDA-
protected haloboronic acid building block 5.3 (86-99% conversion) to provide good isolated 
yields of all of the desired cross-coupling products 5.4. Most importantly, all of the final MIDA 
boronate products 5.4a-i were isolated in good yield and excellent purity (with the exception of 
5.4c, all were at least >90% pure). 
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Figure 5.13. A range of structurally diverse MIDA boronate building blocks were subjected to one fully automated 
cycle of deprotection ([D]), cross-coupling ([C]), and purification ([P]) using the same set of general conditions in 
each module. General condition for deprotection: MIDA boronate 5.1 (1 mmol, 3 equiv.), NaOH (9 equiv.), THF 
(0.1 M), rt, 20 minutes. General condition for cross-coupling: MIDA boronate 5.3 (1 equiv.), PdXPhos (5 mol%), 
K3PO4 (9 equiv.), THF (0.028 M), 55 °C, 16 hours. General condition for catch-and-release purification: SiO2, 
MeOH:Et2O (1.5:98.5, 36 mL), Et2O (36 mL), THF (12 mL). % Conversions and % purity were determined via 
1
H 
NMR. 
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5-3 MULTIPLE CYCLES OF AUTOMATED DEPROTECTION, CROSS-COUPLING, AND 
PURIFICATION 
We next tested whether the synthesizer could prepare a wide range of structurally and 
functionally diverse materials, pharmaceuticals, and natural products via multiple ICC cycles 
(Figures 5.14 and 5.15). This section describes these experiments. Remarkably, a single 
automated run successfully delivered each of the targeted compounds in milligram quantities, 
fulfilling the requirements of most functional discovery assays. Moreover, similar to automated 
peptide, oligonucleotide, and oligosaccharide syntheses, all of the synthesizer-generated products 
were readily purified using standard chromatographic techniques, and any protecting groups 
other than MIDA were successfully removed in a separate step. In addition, most of the building 
blocks required for these syntheses are commercially available. Importantly, while at least 3-4 
days of full time commitment by a highly trained specialist would be required to manually 
synthesize each of these targets from the same building blocks, specialists and non-specialists 
alike can load the reaction cartridges and start the synthesizer in approximately 1 hour. This 
difference represents 3-4 days of time that could be committed to many other aspects of the small 
molecule discovery process. 
 
Materials targets  
We first targeted a set of organic materials components that are comprised of repeating 
heteroaryl or phenylene units (Figure 5.14, entries 1 and 2). Quaterthiophene 5.10
4
 represents an 
important motif found in organic solar cells.
5
 Using the same set of previously described general 
conditions for the automated deprotection, cross-coupling, and purification modules, building 
blocks 5.5, 5.6, and 5.9 were readily assembled to generate 7.5 mg of quaterthiophene 5.10 
(Figure 5.14, entry 1). As a second example, oligophenylenevinylenes (OPVs) such as 5.16 
represent important components of organic light-emitting diodes (OLEDs).
 6,7 
These OPV motifs 
suffer from notoriously limited solubility in many organic solvents and a common strategy used 
to improve their solubility is alkylating the aryl rings. In that vein, and to avoid potential 
solubility challenges, we  targeted OPV 5.16
8
, a tert-buytlated OPV target known to have 
favorable solubility properties. Encouragingly, and still using the same general conditions, the 
ethyl ester 5.15 was successfully synthesized  in a fully automated fashion from building blocks 
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5.11, 5.12, and 5.14 in good yield (84%, Figure 5.14, entry 2). A final manual hydrolysis 
afforded the targeted free acid OPV 5.16 (see Chapter 5: Experimental Section for details). 
 
Pharmaceutical targets 
 We next questioned whether the synthesizer could also prepare important pharmaceutical 
compounds representing increased structural complexity and diversity (Figure 5.14, entries 3-4). 
The phosphodiesterase inhibitor (PDE472) 5.21
9
, a small molecule currently under investigation 
for treating asthma, was readily prepared from building blocks 5.17, 5.18, and 5.20 (6.6 mg, 
Figure 5.14, entry 3.) without modification to the previously described general conditions for 
automated deprotection, cross-coupling, and purification. Because carbon–heteroatom bonds, 
which are very common in pharmaceuticals, can also be formed via cross-coupling
10
, we further 
targeted the anticancer B-Raf kinase inhibitor 5.26
11
. Remarkably, the same general conditions 
that were being used for C-C bond formation also enabled efficient C–N bond formation between 
building blocks 5.22 and 5.23. Another automated iteration of deprotection and cross-coupling 
with building block 5.25 completed the sequence to afford 12.9 mg of 5.26 (Figure 5.14, entry 
4). 
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Figure 5.14. Fully automated syntheses of a range of structurally and functionally diverse materials (entries 1-3) and 
pharmaceuticals (entries 4 and 5) were accomplished via multiple cycles of deprotection ([D]), cross-coupling ([C]), 
and purification ([P]). Yields reflect the quantity of each small molecule target that was generated with a single run 
on the synthesizer. All % yields are based on one equivalent of the final halide building block. Any protecting 
groups other than MIDA were removed in a separate step.  
 
Natural product targets 
Natural products represent the most structurally complex and diverse class of small 
molecules and are thus the most challenging targets for a general and automated synthesis 
platform. Similar to the changes in reaction conditions often employed in the automated 
synthesis of more complex peptides, minor modifications in some cases to the phosphine ligand, 
base, and/or reaction temperature and time (see Chapter 5: Experiment Section for details) 
enabled us to successfully expand the scope of the small molecule synthesizer to include a 
diverse range of complex natural product targets (Figure 5.15). Importantly, this collection of 
targets represents all four of the most common small molecule biosynthetic pathways; 
polyketide, fatty acid, polyterpene, and polyphenylpropanoid.  
 
116 
 
 
Figure 5.15. Fully automated syntheses of a range of structurally and functionally diverse natural products were 
accomplished via multiple cycles of deprotection ([D]), cross-coupling ([C]), and purification ([P]). Yields reflect 
the quantity of each small molecule target that was generated with a single run on the synthesizer. All % yields are 
based on one equivalent of the final halide building block. Any protecting groups other than MIDA were removed in 
a separate step.  
 
The crocacins represent a recently discovered series of antifungal natural products derived from 
both polyketide and non-ribosomal peptide biosynthesis machinery. Preliminary studies have 
suggested that these natural products inhibit the mitochondrial cytochrome bc1 segment of 
complex III in the respiratory transport chain, and thus represent excellent targets for further 
study. One such member of this family of natural products, (+)-crocacin C
12,13,14,15,16 
(5.31), has 
been previously synthesized in our laboratory via an ICC route.
17
 Due to its interesting 
structurally complexity we targeted 5.31 as our first natural product for automated synthesis. In a 
preliminary experiment, examining just the first fully automated cycle of ICC with building 
blocks 5.27 and 5.28, vinyl MIDA boronate intermediate 5.29 was successfully prepared in good 
yield (71%) and purity (>90%) (Scheme 5.1).     
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Scheme 5.1. First automated ICC cycle towards (+)-crocacin C (5.31). 
 
In a separate fully automated experiment, a subsequent cycle of deprotection and cross-
coupling with building block 5.30 afforded (+)-crocacin C (5.31) in 61% isolated yield after 
chromatographic purification (Figure 5.15, entry 1). Importantly, all of the functional groups and 
stereochemistry found in this natural product was pre-installed into the building blocks and more 
than 14 mg of this natural product was routinely prepared via a single run on the synthesizer, 
which is more than enough compound to support extensive biological investigations. 
We further targeted the synthesis of two natural products containing stereodefined 
polyene frameworks: the fatty acid β-parinaric acid (5.36)18,19 and the polyterpene all-trans-
retinal (5.42)
20,21,22
. Both targets have been successfully synthesized via an ICC route previously 
in our laboratory.
23
 The central challenge in constructing polyene frameworks like those 
contained in 5.36 and 5.42 involves controlling the stereochemistry of each double bond. A key 
feature of ICC is that stereochemistry is pre-installed in the building blocks and then faithfully 
translated into the targeted products during the assembly process. However, it was unclear 
whether isomerizations would occur during deprotection, cross-coupling and/or purification in 
this automated format. 
β-Parinaric acid, a widely used fluorescent probe of lipid biophysics, has been used for 
more than three decades in structural and functional studies of lipid bilayer membranes. In a 
preliminary experiment, examining just the first fully automated cycle of ICC with building 
blocks 5.32 and 5.33, trienyl MIDA boronate intermediate 5.34 was successfully prepared in 
good yield (71%) and purity (>90%) (Scheme 5.2), and more importantly, with no observable 
isomerization of the triene. 
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Scheme 5.2. First automated ICC cycle towards β-parinaric acid (5.36). 
 
In a separate fully automated experiment, a subsequent cycle of deprotection and cross-
coupling with building block 5.35 afforded β-parinaric acid (5.36) in 56% isolated yield after 
chromatographic purification (Figure 5.15, entry 2). As seen in the first cycle of ICC, the pre-
installed olefin stereochemistry was faithfully transferred to the target. Additionally, more than 
18 mg of the fatty acid was synthesized in one automated experiment; more than enough 
compound to support extensive biological investigations. 
As the chromophore for vision in all vertebrates, the light-harvesting cofactor in the 
energy transducing bacteriorhodopsin complex, and a key substrate for an oxidation process now 
linked to age-related macular degeneration in humans, the polyterpene derived natural product 
all-trans-retinal (5.42) has been and remains one of the most important small molecules in all of 
chemistry, biology, and medicine. Extensive research has focused on the development of 
efficient syntheses of this natural product and its structural and/or isotopic derivatives to 
powerfully enable fundamental studies of its function. Fully-automated synthetic access to such 
compounds from readily available building blocks stands to have a pervasive enabling impact on 
life science research. Similar to 5.36, in a preliminary experiment, examining just the first fully 
automated cycle of ICC with building blocks 5.37 and 5.38, trienyl MIDA boronate intermediate 
5.39 was successfully prepared in good yield (79%) and purity (>90%) (Scheme 5.3), and more 
importantly, with no observable isomerization of the triene. 
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Scheme 5.3. First automated ICC cycle towards all-trans-retinal ketal (5.41). 
 
In a separate fully automated experiment, a subsequent cycle of deprotection and cross-
coupling with building block 5.40 afforded all-trans-retinal ketal (5.41) in 74% isolated yield 
after chromatographic purification (Figure 5.15, entry 3). Again, as seen in the first cycle of ICC, 
the pre-installed olefin stereochemistry was faithfully transferred to the target. A separate manual 
deprotection afforded all-trans-retinal (5.42) as the free aldehyde (see Chapter 5: Experiment 
Section for details).  As with 5.31 and 5.36, quantities commensurate with biological assays were 
synthesized in a single automated experiment.  
Emboldened by these successes, we further targeted the automated synthesis of protected 
form (5.49) of the polyphenolpropanoid ratanhine (5.50), the largest and most complex natural 
product isolated from the medicinal plant Ratanhiae radix.
24,25
 What made this target particularly 
challenging was the presence of several difficult cross-couplings, the intermediacy of some very 
unstable boronic acids, and more so the additional third cycle of ICC required to form the 
tetramer. With exception of quaterthiophene target 5.10 discussed above, we had yet to test the 
capability of the synthesizer to complete complex three-step ICC sequences. A set of preliminary 
experiments, examining either just the first or second automated cycles of ICC were run. In the 
first case, one fully automated cycle with building blocks 5.43 and 5.44, afforded aryl MIDA 
boronate intermediate 5.45 in good yield (78%) and purity (>90%) (Scheme 5.4). Subsequently, 
one fully automated cycle with building blocks 5.45 and 5.46 afforded aryl MIDA boronate 
intermediate 5.47 in good yield (80%) and purity (>90%) (Scheme 5.5).   
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Scheme 5.4. First automated ICC cycle towards protected ratanhine (5.49). 
 
 
Scheme 5.5. Second automated ICC cycle towards protected ratanhine (5.49). 
 
Despite requiring several challenging cross-couplings and the intermediacy of some very 
unstable boronic acids, building blocks 5.43, 5.44, 5.46, and 5.48 were successfully cross-
coupled in a fully automated ICC experiment to afford protected ratanhine (5.49) in 36% yield 
(Figure 5.15, entry 4). A separate manual deprotection afforded free ratanhine (5.50) (see 
Chapter 5: Experiment Section for details). 
 
5-4 AUTOMATED SYNTHESIS OF A NATURAL PRODUCT LIBRARY 
Finally, the development of new medicines, biological probes, and materials with 
optimized functional properties often requires access to many structural derivatives of a specific 
small molecule of interest. Due to its modular nature, the ICC approach is well suited for 
enabling such access, especially if the required syntheses can be performed automatically. Thus, 
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as a final test for the small molecule synthesizer, we targeted the automated preparation of many 
derivatives of our most complex prior target, ratanhine (5.50). Furthermore, in this experiment, 
we did not permit any optimizations of any of the conditions used to construct protected 
ratanhine 5.49.  
We specifically input four sets of building blocks representing common substructural 
elements found throughout the neolignan family of medicinal natural products and/or other 
pharmaceutically relevant motifs (Figure 5.16 A). These building blocks include variations in 
oxidation states, methylation patterns, fluorine content, aromatic ring identity, and size. They 
also represent pre-programmed oligomer lengths of 3-4 units based on whether the third building 
block is a bifunctional halo-MIDA boronate or a capping halide. In the event, the small molecule 
synthesizer successfully generated 20 out of 20 of the targeted derivatives, collectively 
representing all possible combinations of this four-component matrix of building blocks (Figure 
5.16 B). Additionally, all 20 out of 20 targets were successfully deprotected in a separate manual 
step (see Chapter 5: Experimental Section for details) to afford the corresponding deprotected, 
free alcohol targets. Included in the collection of targets are two additional known natural 
products. Ratanhiaphenol III (5.56), another isolate from Ratanhiae radix, shows promising 
activity in the inhibition of protein tyrosine phosphate 1B (PTP1B)
26
. Target 5.58 (CAS # 
143001-80-3) is a known isolate from both Krameria grayi
27
 as well as Krameria interior
28
, a 
genus of plants used medicinally in tropical and subtropical America to fight eye infections and 
body weakness. It is worth noting that if performed independently in a manual fashion, these 20 
syntheses would require at least 2-3 months of full time commitment by a specialist. In contrast, 
executing all 20 of the automated syntheses required a total of only ~20 hours of person time. 
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Figure 5.16. A. A collection of natural product- and pharmaceutical-inspired building blocks for library synthesis. 
B. 20/20 targeted library members were successfully synthesized in a fully automated fashion using the same series 
of deprotection, cross-coupling, and purification conditions. The products include protected versions of the natural 
products ratanhine (5.49) and ratanhiaphenol III (5.56) - isolates from the same medicinal plant Ratanhiae radix – as 
well as many of their derivatives. Unless otherwise noted, the quantity of material indicated below each product 
represents the yield from a single run on the synthesizer. All percent yields are based on one equivalent of the final 
halide building block. All protecting groups other than MIDA (R = TIPS, TBDPSE, TMSE, or Bz) were 
successfully removed in a separate step.  
 
5-5 SUMMARY 
In summary, we have created a fully automated platform for small molecule synthesis. At 
present, this platform is best able to prepare targets that contain an abundance of sp
2
-hybridized 
atoms and can be retrosynthesized into four or fewer building blocks. However, within the 
bounds of this limitation, this small molecule synthesizer can already prepare compounds of 
diverse structure and function, including materials, pharmaceuticals, complex natural products, 
and derivatives. This breakthrough enables specialists to more efficiently make such compounds 
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and thereby accelerate the small molecule discovery process. It also delivers the power of small 
molecule synthesis to non-specialists and thereby will stimulate a dramatic expansion in small 
molecule discovery research. Increases in the scope of this automated platform will continue to 
be driven by new methods for making and cross-coupling suitable building blocks
29,30,31,32
, 
including those containing new types of heterocycles
29,33,34
, heteroatoms
10
, and even Csp
3
-
hybridized carbon atoms
35,36,37,38,39
. Harnessing these collective advances in concert with further 
improvements in the speed and generality of this small molecule synthesizer will ultimately help 
shift the rate-limiting step in small molecule science from synthesis to function study. 
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CHAPTER 5: EXPERIMENTAL SECTION 
 
General materials and methods 
Commercial reagents were purchased from Sigma-Aldrich, EMD Millipore, Fisher 
Scientific, Alfa Aesar, Frontier Scientific, Oakwood Products, or Strem and were used without 
further purification unless otherwise noted. Most of the building blocks used in these studies are 
available from Sigma-Aldrich
®
 [5.1a (730335), 5.1b (699853), 5.1c (699160), 5.1d (708828), 
5.1e (701017), 5.1f (701106), 5.1g (733539), 5.1h (697443), 5.1i (710024), 5.1j (699292), 5.1k 
(703710), 5.1l (707252), 5.3 (698083), 5.5 (MIDA080), 5.6 (701092), 5.12 (MIDA084), 5.14 
(B58407), 5.16 (MIDA083), 5.18 (363774), 5.17 (723711), 5.18 (MIDA081), 5.20 (C70223), 
5.23 (MIDA085), 5.27 (698032), 5.32 (MIDA034), 5.38 (MIDA013), 5.43 (701831), 5.44 
(MIDA014), 5.46 (MIDA017), 5.51 (MIDA039), 5.52 (MIDA015)], Frontier Scientific, Inc. [5.9 
(B1644), 5.25 (B10713), 5.53 (B1851)], or Aurora Fine Chemicals LLC [5.22 (A00.242.706)]. 
Manual syntheses were carried out in oven or flame-dried glassware and performed under a dry 
inert atmosphere unless otherwise noted. Unless otherwise noted: Celite™ refers to Celite™ 545 
filter aid (not acid washed); Darco
®
 refers to activated carbon, Darco
®
 G-60, -100 mesh, powder; 
and K3PO4 and K2CO3 were both anhydrous and were freshly and finely ground in a 120 °C 
mortar and pestle. XPhos 2
nd
 generation palladacycle refers to chloro(2-dicyclohexylphosphino-
2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II) (741825, Sigma-
Aldrich) (21). Solvents were purified via passage through packed columns as described by 
Pangborn and coworkers
1
 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexanes, benzene, 
toluene: dry neutral alumina and Q5 reactant; DMSO, DMF: activated molecular sieves. Water 
was deionized. Triethylamine, diisopropylamine, diethylamine, pyridine, and 2,6-lutidine were 
freshly distilled under an atmosphere of dry nitrogen from CaH2. 
Thin layer chromatography (TLC) was performed using the indicated eluent on E. Merck 
silica gel 60 F254 plates (0.25 mm). Compounds were visualized by exposure to a UV lamp (λ = 
254 and/or 366 nm) and/or a basic solution of KMnO4 followed by brief heating with a 
Varitemp
®
 heat gun. Flash chromatography was performed as described by Still and coworkers
2
 
using EM Merck silica gel 60 (230-400 mesh). 
1
H NMR spectra were recorded at room 
temperature on one of the following instruments: Varian Unity 500, Varian VXR 500, or Varian 
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Unity Inova 500NB. Chemical shifts (δ) are reported in parts per million (ppm) downfield from 
tetramethylsilane and referenced to residual protium in the NMR solvent (CDCl3, δ = 7.26; 
(CD3)2CO, δ = 2.05, center line; CD2Cl2, δ = 5.32, center line; (CD3)2SO, δ = 2.50, center line). 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, sept = septet, m = multiplet, br = broad, app = apparent, dd = doublet of doublets, dt = 
doublet of triplets, dq = doublet of quartets), coupling constant (J) in Hertz (Hz), and integration. 
13
C NMR spectra were recorded at room temperature on one of the following instruments: 
Varian Unity 500 or Varian VXR 500. Chemical shifts (δ) are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (CDCl3, δ = 77.16, 
center line; (CD3)2CO, δ = 29.84, center line; CD2Cl2, δ = 53.84; (CD3)2SO, δ = 39.52, center 
line). Carbons bearing boron substituents were not observed due to quadrupolar relaxation. High 
resolution mass spectra (HRMS) were performed by Furong Sun and Elizabeth Eves at the 
University of Illinois School of Chemical Sciences Mass Spectrometry Laboratory. 
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Design of the deprotection module  
 
 
 
The deprotection module consists of two J-KEM
®
 Scientific, Inc.  V6 programmable 
syringe pumps (part # SYR-1400PC) and are connected to the controlling computer via a RS485 
to USB connection. Both are fitted with a 10-mL glass/PTFE syringe (part # SPGS-10000) and 
an 8-port distribution valve (part # SPDV-8). Each syringe pump aspirates and injects from 0.0 
mL/min to 70.0 mL/min with a step of 0.0029 mL. One pump (the Primary Pump) is utilized as 
the organic liquid handling pump and the other (the Wet Pump) is used exclusively as the 
aqueous liquid handling pump. The module utilizes an additional five 8-port distribution valves 
(part # SPDV-CS8) housed in four separate quad stack KEM select distribution modules (part # 
SYR-CS4) for liquid handling. A source of dry nitrogen and dry argon are used for liquid 
handling and deoxygenation/concentration processes. Connections between valves are made with 
FEP tubing (1/16’’ OD, 0.030’’ ID).  
To the Deprotection Cartridge, the Primary Pump adds THF and the Wet Pump adds 
water. The reaction is then agitated with pulses of argon gas. The Wet Pump then adds aqueous 
potassium phosphate buffer (pH = 6) and the Primary Pump adds Et2O. The resulting biphasic 
system is agitated with pulses of nitrogen gas and the aqueous layer is drawn off and disposed of 
by the Wet Pump. The Wet Pump adds 50% saturated aqueous NaCl. The resulting biphasic 
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system is agitated with pulses of nitrogen and the aqueous layer is drawn off and disposed of by 
the Wet Pump. The Primary Pump transfers the wet organic solution to a Predrying, and 
subsequently Drying Cartridge, containing drying agents and agitates the mixture by repeatedly 
withdrawing/injecting the solution. The Primary Pump transfers the dried organic solution to a 
Concentration/Deoxygenation Cartridge and concentrates/deoxygenates the solution with pulses 
of argon gas.   
 
Design of the cross-coupling module 
 
 
 
The cross-coupling module consists of one J-KEM
®
 Scientific, Inc. V6 programmable 
syringe pump (part # SYR-1400PC), the Primary Pump described above. The module utilizes 
one additional 8-port distribution valve (part # SPDV-CS8) housed in one separate quad stack 
KEM select distribution module (part # SYR-CS4) for liquid handling (shared with the 
deprotection module). A source of dry nitrogen and dry argon are used for liquid handling and 
deoxygenation processes (shared with the deprotection module). Two IKA
®
 RET control visc 
IKAMAG
®
 safety control heating stir plates (part # 3364001) and one IKA
®
 RCT basic 
IKAMAG
®
 safety control heating stir plate (part # 3810001) are used for reaction stirring and 
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temperature control. Connections between valves are made with FEP tubing (1/16’’ OD, 0.030’’ 
ID).  
The Reaction Cartridge, agitated with a magnetic stir bar, is deoxygenated with pulses of 
argon gas. The Primary Pump adds THF to the reaction cartridge and then slowly adds the 
dried/deoxygenated THF solution of boronic acid. After the addition, the reaction is allowed to 
agitate.  
 
Design of the purification module 
 
 
 
The purification module consists of two J-KEM
®
 Scientific, Inc. V6 programmable 
syringe pumps (part # SYR-1400PC). One is the Primary Pump described above. The other 
pump (the Auxiliary Pump) is used exclusively as the column eluent and waste handling pump 
and is connected to the controlling computer via a RS485 to USB connection. The module 
utilizes an additional six 8-port distribution valves (part # SPDV-CS8) housed in three separate 
quad stack KEM select distribution modules (part # SYR-CS4) for liquid handling. Five of these 
distribution valves are shared with the deprotection and cross-coupling modules. Two IKA
®
 RET 
control visc IKAMAG
®
 safety control heating stir plates (part # 3364001), shared with the cross-
coupling module, and one IKA
®
 RCT basic IKAMAG
®
 safety control heating stir plate (part # 
131 
 
3810001) are used. Connections between valves are made with FEP tubing (1/16’’ OD, 0.030’’ 
ID).  
The Auxiliary Pump adds hexanes to the Precipitation Cartridge, agitated with a magnetic 
stir bar. The Primary Pump adds portions of the crude reaction solution to the Precipitation 
Cartridge. The Auxiliary Pump then withdraws the solvent through the Silica Gel Plug. This 
process is repeated until the Reaction Cartridge is empty. The Primary Pump then adds 1.5% 
MeOH in Et2O to the Precipitation Cartridge and then the Auxiliary Pump withdraws the solvent 
through the Silica Gel Plug. The Primary Pump then adds Et2O to the Precipitation Cartridge and 
then the Auxiliary Pump withdraws the solvent through the Silica Gel Plug. The Auxiliary Pump 
then adds THF to the Precipitation Cartridge and the Primary Pump removes the resulting 
solution and transfers it to the next Deprotection Cartridge.   
 
General procedure for setting up an automated synthesis 
The following cartridges are prepared (unless otherwise noted, cartridge refers to a 12-g 
Luknova column capped with a 12-g Luknova column screw cap). Once prepared the cartridges 
are connected to the synthesizer. 
 
First Deprotection Cartridges contain solid NaOH and the starting MIDA boronate. 
Second and Third Deprotection Cartridges contain solid NaOH. 
Predrying Cartridges contain Celite™ (800 mg) and anhydrous MgSO4 (2.1 g). These solids 
are mixed thoroughly and a plastic 5-mL syringe plunger is placed on top of the mixed solids. 
This is topped with an aluminum foil cover. 
Drying Cartridges contain Celite™ (300 mg) with 4 Å molecular sieves (activated, powder, -
325 mesh) (3.6 g) layered on top. A plastic 5-mL syringe plunger is placed on top of the layered 
solids.  
Concentration/Deoxygenation Cartridges are empty.  
First Reaction Cartridges contain a PTFE-coated magnetic stir bar, coupling partner, catalyst 
and ligand, and base. For this cartridge, the factory-supplied fiber frit has been removed and a 
medium porosity glass frit installed. The cap is pierced with a 1.5-inch 18 G needle and topped 
with an empty 4-g Luknova column (capped with a 4-g Luknova column screw cap). This cap is 
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tethered to another cap PTFE tubing (1/16-inch I.D., 1/8-inch O.D.). This additional cap, pierced 
with a 1.5-inch 18 G needle, is attached to the Reaction Filtration Cartridge. The PTFE tubing is 
adjusted to place the end of the tubing approximately 5 mm above the frit of the First Reaction 
Cartridge and approximately 20 mm below the screw cap of the Reaction Filtration Cartridge. 
The luer ports of both screw caps are packed with a small ball of rolled Kimberly-Clark
®
 
Kimwipes™. 
Reaction Filtration Cartridges contain a PTFE-coated magnetic stir bar and a mixture of 
Celite™ (2.5 g) and Florisil® (1.25 g). This is tethered to the First Reaction Cartridge as 
described above. 
Second and Third Reaction Cartridges contain a PTFE-coated magnetic stir bar, coupling 
partner, catalyst and ligand, and base. 
Precipitation Cartridges contain a PTFE-coated magnetic stir bar, Celite™ (150 mg), and 3-
aminopropyl functionalized silica gel (250 mg). Hexanes (10 mL) is added and the cartridge is 
swirled vigorously to suspend and homogenize the mixture of solids. The stir bar and solids are 
allowed to settle over 30 seconds and the supernatant hexanes is pushed out of the cartridge with 
an overhead pressure of air. The stir bar is now embedded in the mixture of solids wet with 
hexanes. 
Silica Gel Plugs contain silica gel, tightly packed, topped with a 4-g Luknova column frit. This 
is capped with a 4-g Luknova column screw cap, using four layers of PTFE tape on the sealing 
insert to ensure a leak-free seal. 
 
 
 
General automated procedure for one ICC cycle 
In the deprotection module, to a Deprotection Cartridge containing starting MIDA 
boronates 5.1 (1.0 mmol) and NaOH (3.0 mmol, 120 mg) is added 12 mL THF followed by 3 mL 
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water. After 20 minutes agitation at 23 °C, 3 mL aqueous potassium phosphate buffer (pH = 6) 
and 5 mL Et2O are added and the layers are separated. Then 3 mL 50% saturated aqueous NaCl 
are added and the layers are separated. The THF/Et2O solution of boronic acid is dried using a 
Predrying and Drying Cartridge. The resulting dry THF/Et2O solution is transferred to a 
Concentration/Deoxygenation Cartridge. The drying agents are washed with 6 mL THF, which is 
added to the Concentration/Deoxygenation Cartridge. The organic solution is concentrated to 10 
mL (evaporating most of the Et2O) and the drying agents are washed with an additional 6 mL 
THF, which is added to the Concentration/Deoxygenation Cartridge. The organic solution (now 
only THF) is concentrated to 9 mL. An empty Second Deprotection Cartridge is used to receive 
purified cross-coupling product 5.4. 
In the cross-coupling module, to a deoxygenated First Reaction Cartridge agitated  and 
heated at 55 °C and containing bifunctional MIDA boronate 5.3 (0.33 mmol, 104 mg), XPhos 2
nd
 
generation palladacycle (0.017 mmol, 13.1 mg, 5 mol%), and K3PO4 (3.0 mmol, 637 mg), is 
added 3 mL THF. The THF solution of boronic acid is added over 4 hours (0.0375 mL/min). At 
the end of the addition the reaction is stirred for an additional 12 hours.   
In the purification module, to a Reaction Filtration Cartridge is added the crude cross-
coupling solution and to a Precipitation Cartridge/Silica Gel Plug is added 12 mL hexanes. Then 
3 mL of the crude cross-coupling solution (filtered through the Reaction Filtration Cartridge) is 
added and the solvent is removed. This process is performed ten times, using 3 mL THF to wash 
the Reaction Cartridge and Reaction Filtration Cartridge for each cycle. Then 12 mL 1.5% 
MeOH in Et2O are added and the solvent is removed a total of three times (36 mL total). Then 12 
mL Et2O are added and the solvent is removed a total of three times (36 mL total). Finally, 12 
mL THF are added and the resulting purified solution of 5.4 is added to the Second Deprotection 
Cartridge.  
In the event, all cartridges are connected to the synthesizer and the synthesis is initiated. 
From this point forward, no human intervention is required throughout the completion of the 
synthesis and purification of targeted product 5.4.  
In order to characterize the progress of the automated reaction sequences (as shown in 
Fig. 2), the following analysis was performed. At the end of the deprotection quench, a 500-µL 
aliquot of the organic layer is removed manually from the First Deprotection Cartridge. The 
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sample is concentrated, a 
1
H NMR sample is prepared and a spectrum is acquired immediately. 
The percent conversion for the deprotection step is determined via integration of the resonances 
corresponding to the boronic acid product and any remaining MIDA boronate starting material. 
At the end of the synthesis, the final THF solution of purified 5.4 (in the empty Second 
Deprotection Cartridge) is concentrated and a 
1
H NMR spectrum acquired. The percent 
conversion for the cross-coupling is determined via integration of the resonances corresponding 
to the cross-coupling product 5.4 and any remaining halo MIDA boronate starting material 5.4. 
The purity of cross-coupling product 5.4 is determined via integration of the resonances 
corresponding to the cross-coupling product 5.4 and any impurities observed in the spectrum. 
Because the primary goal of the small molecule synthesizer is to easily prepare and purify the 
targeted compound, the general conditions were developed to maximize the % conversions for 
the deprotection and cross-coupling reactions as well as the % purity of the MIDA boronate 
product of each cycle, rather than the % yield. 
 
Automated synthesis of 5.4a 
The general procedure was followed using 251.7 mg (1.02 mmol) aryl MIDA boronate 
5.1a and 104.0 mg (0.333 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 99% and the conversion for the cross-coupling step was 98%. The desired 
aryl MIDA boronate 5.4a was obtained as a colorless solid of >95% purity (65.3 mg, 0.202 
mmol, 61% yield).  
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Figure 5.S1. 
1
H NMRs for automated synthesis of 5.4a. 
 
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.37, visualized by UV and KMnO4 stain. 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.64 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 8.5 Hz, 2H), 7.48 (s, 1H), 7.45 (dd, J = 7.5, 0.5 
Hz, 1H), 7.34 (t, J = 7.5 Hz, 1H), 7.17 (dd, J = 7.5, 0.5 Hz, 1H), 4.34 (d, J = 17.5 Hz, 
2H), 4.13 (d, J = 17 Hz, 2H), 2.54 (s, 3H), 2.37 (s, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
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δ 169.1, 140.7, 140.1, 138.0, 132.9, 128.7, 128.0, 127.2, 125.9, 123.7, 61.8, 47.6, 21.0. 
HRMS (EI+) 
 Calculated for C18H18BNO4:  323.13289    
 Found:     323.13253 
 
Automated synthesis of 5.4b 
The general procedure was followed using 284.5 mg (1.00 mmol) aryl MIDA boronate 
5.1b and 104.3 mg (0.334 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 99% and the conversion for the cross-coupling step was 99%. The desired 
aryl MIDA boronate 5.4b was obtained as an off-white solid of >90% purity (77.7 mg, 0.216 
mmol, 65% yield). 
 
 
Figure 5.S2. 
1
H NMRs for automated synthesis of 5.4b. 
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TLC (20% MeCN in Et2O) 
Rf = 0.28, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 8.23 (d, J = 1 Hz, 1H), 7.99 (d, J = 8 Hz, 2H), 7.92 (dd, J = 7.5, 1.5 Hz, 1H), 7.85 (dd, J 
= 9.0, 2 Hz, 1H), 7.82 (d, J = 8 Hz, 2H), 7.59 (d, J = 8 Hz, 2H), 7.56-7.49 (m, 2H), 4.38 
(d, J = 17 Hz, 2H), 4.16 (d, J = 17 Hz, 2H), 2.57 (s, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.6, 140.5, 137.6, 133.5, 133.3, 132.4, 128.7, 128.4, 127.6, 126.6, 126.4, 126.3, 
125.3, 125.2, 62.0, 47.8. 
 
HRMS (EI+) 
 Calculated for C21H18BNO4:  359.13289   
 Found:     359.13333 
 
Automated synthesis of 5.4c 
The general procedure was followed using 263.5 mg (1.00 mmol) aryl MIDA boronate 
5.1c and 104.4 mg (0.335 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 97% and the conversion for the cross-coupling step was 86%. The desired 
aryl MIDA boronate 5.4c was obtained as a colorless solid of >80% purity (69.2 mg, 0.204 
mmol, 61% yield).   
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Figure 5.S3. 
1
H NMRs for automated synthesis of 5.4c. 
 
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.31, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.66 (d, J = 8 Hz, 2H), 7.52 (d, J = 7.5 Hz, 2H), 7.37 (t, J = 7.5 Hz, 1H), 7.23 (d, J = 
7.5 Hz, 1H), 7.18 (s, 1H), 6.93 (dd, J = 8, 2.5 Hz, 1H), 4.35 (d, J = 17.5 Hz, 2H), 4.13 (d, 
J = 17 Hz, 2H), 3.80 (s, 3H), 2.54 (s, 3H). 
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13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.7, 160.0, 141.8, 140.7, 133.3, 130.3, 126.3, 119.2, 113.3, 112.3, 62.0, 55.3, 47.8. 
 
HRMS (EI+) 
 Calculated for C18H18BNO5:  339.12780   
 Found:     339.12732 
 
Automated synthesis of 5.4d 
The general procedure was followed using 242.1 mg (1.01 mmol) aryl MIDA boronate 
5.1d and 104.1 mg (0.3334 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 98% and the conversion for the cross-coupling step was 98%. The desired 
aryl MIDA boronate 5.4d was obtained as an off-white solid of >95% purity (78.7 mg, 0.250 
mmol, 75% yield). 
 
 
Figure 5.S4. 
1
H NMRs for automated synthesis of 5.4d. 
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TLC (20% MeCN in Et2O) 
Rf = 0.38, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.64 (d, J = 8.5 Hz, 2H), 7.52 (m, 2H), 7.47 (d, J = 8 Hz, 2H), 7.13 (dd, J = 4.5, 4 Hz, 
1H), 4.34 (d, J = 17 Hz, 2H), 4.12 (d, J = 17 Hz, 2H), 2.53 (s, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.7, 143.6, 134.4, 133.4, 128.8, 125.9, 124.9, 124.0, 62.0, 47.8. 
 
HRMS (EI+) 
 Calculated for C15H14BNO4S:  315.07366   
 Found:     315.07412 
 
Automated synthesis of 5.4e 
The general procedure was followed using 225.5 mg (1.01 mmol) aryl MIDA boronate 
5.1e and 104.4 mg (0.335 mmol) bifunctional MIDA boronate 5.3 The conversion for the 
deprotection step was 97% and the conversion for the cross-coupling step was 93%. The desired 
aryl MIDA boronate 5.4e was obtained as an off-white solid of >90% purity (72.4 mg, 0.242 
mmol, 72% yield).  
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Figure 5.S5. 
1
H NMRs for automated synthesis of 5.4e. 
 
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.33, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.73 (d, J = 2 Hz, 1H), 7.68 (d, J = 8.5 Hz, 2H), 7.48 (d, J = 8 Hz, 2H), 6.95 (d, J = 3 
Hz, 1H), 6.58 (dd, J = 3.5, 2 Hz, 1H), 4.34 (d, J = 17 Hz, 2H), 4.12 (d, J = 17.5 Hz, 2H), 
2.51 (s, 3H). 
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13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.7, 153.3, 143.2, 133.2, 131.0, 123.0, 112.4, 106.3, 62.0, 47.8. 
 
HRMS (EI+) 
 Calculated for C15H14BNO5:  299.09650     
 Found:     299.09715 
 
Automated synthesis of 5.4f 
The general procedure was followed using 325.4 mg (1.01 mmol) aryl MIDA boronate 
5.1f and 104.4 mg (0.335 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 99% and the conversion for the cross-coupling step was 99%. The desired 
aryl MIDA boronate 5.4f was obtained as an off-white solid of >95% purity (110.9 mg, 0.278 
mmol, 83% yield).  
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Figure 5.S6.  
1
H NMRs for automated synthesis of 5.4f. 
 
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.46, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.43 (d, J = 8 Hz, 2H), 7.33 (dd, J = 3, 1.5 Hz, 1H), 7.30 (d, J = 8.5 Hz, 2H), 6.26 (t, J 
= 3.5 Hz, 1H), 6.23 (dd, J = 3, 1.5 Hz, 1H), 4.34 (d, J = 17 Hz, 2H), 4.13 (d, J = 17 Hz, 
2H), 2.54 (s, 3H), 1.28 (s, 9H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.7, 149.1, 134.7, 134.4, 132.0, 128.2, 123.0, 114.7, 111.2, 83.9, 62.1, 47.9, 27.3. 
 
HRMS (ESI+) 
 Calculated for C20H24BN2O6:  399.1727   
 Found:     399.1723 
 
Automated synthesis of 5.4g 
The general procedure was followed using 261.1 mg (1.01 mmol) aryl MIDA boronate 
5.1g and 105.1 mg (0.337 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 98% and the conversion for the cross-coupling step was 95%. The desired 
aryl MIDA boronate 5.4g was obtained as a colorless solid of >90% purity (75.7 mg, 0.226 
mmol, 67% yield).  
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Figure 5.S7. 
1
H NMRs for automated synthesis of 5.4g. 
  
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.36, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.44 (d, J = 8.5 Hz, 2H), 7.38-7.32 (m, 3H), 7.28 (app dd, J = 8 Hz, 4H), 5.50 (s, 1H), 
5.47 (s, 1H), 4.34 (d, J = 17 Hz, 2H), 4.12 (d, J = 17 Hz, 2H), 2.54 (s, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.7, 149.4, 141.4, 140.9, 132.7, 128.6, 128.2, 128.1, 127.4, 115.0, 62.0, 47.8. 
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HRMS (EI+) 
 Calculated for C19H18BNO4:  335.13289   
 Found:     335.13356 
 
Automated synthesis of 5.4h 
The general procedure was followed using 265.9 mg (1.00 mmol) aryl MIDA boronate 
5.1h and 105.6 mg (0.339 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 98% and the conversion for the cross-coupling step was 99%. The desired 
aryl MIDA boronate 5.4h was obtained as an off-white solid of >95% purity (77.7 mg, 0.228 
mmol, 67% yield).  
 
 
Figure 5.S8  
1
H NMRs for automated synthesis of 5.4h. 
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TLC (20% MeCN in Et2O) 
Rf = 0.44, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.35 (s, 4H), 6.34 (d, J = 16.5 Hz, 1H), 6.25 (dd, J = 16.5, 7 Hz, 1H), 4.31 (d, J = 17 
Hz, 2H), 4.08 (d, J = 17 Hz, 2H), 2.47 (s, 3H), 2.13-2.06 (m, 1H), 1.74-1.68 (m, 4H), 
1.63-1.60 (m, 1H), 1.31-1.23 (m, 2H), 1.18-1.11 (m, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
δ 169.6, 138.1, 136.8, 132.7, 127.3, 125.4, 61.9, 47.7, 40.6, 32.6, 25.8, 25.6. 
 
HRMS (EI+) 
 Calculated for C19H24BNO4:  341.17984   
 Found:     341.18030 
 
Automated synthesis of 5.4i 
The general procedure was followed using 199.4 mg (1.01 mmol) aryl MIDA boronate 
5.1i and 104.2 mg (0.334 mmol) bifunctional MIDA boronate 5.3. The conversion for the 
deprotection step was 99% and the conversion for the cross-coupling step was 98%. The desired 
aryl MIDA boronate 5.4i was obtained as a colorless solid of >90% purity (64.9 mg, 0.238 
mmol, 71% yield).  
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Figure 5.S9. 
1
H NMRs for automated synthesis of 5.4i. 
 
 
 
TLC (20% MeCN in Et2O) 
Rf = 0.36, visualized by UV and KMnO4 stain. 
 
1
H-NMR (500 MHz, DMSO-d6:D2O, 95:5) 
δ 7.49 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8 Hz, 2H), 5.45 (s, 1H), 5.10 (t, J = 1.5 Hz, 1H), 
4.33 (d, J = 17 Hz, 2H), 4.10 (d, J = 17 Hz, 2H), 2.50 (s, 3H), 2.10 (s, 3H). 
 
13
C-NMR (125 MHz, DMSO-d6:D2O, 95:5) 
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δ 169.7, 142.7, 141.0, 132.7, 124.8, 112.9, 61.9, 47.8, 21.6. 
 
HRMS (EI+) 
 Calculated for C14H16BNO4:  273.11724   
 Found:     273.11679 
 
General automated procedure for multiple ICC cycles 
The general procedure for one ICC cycle is followed with these additions: 
If three building blocks are being assembled, the Second Deprotection Cartridge contains 
NaOH (1.0 mmol, 40 mg) and the Second Reaction Cartridge contains the second bifunctional 
MIDA boronate (0.11 mmol), XPhos 2
nd
 generation palladacycle (0.0056 mmol, 4.4 mg, 5 
mol%), and K3PO4 (1.0 mmol, 212 mg). This cartridge is identical to a First Reaction Cartridge, 
but is not tethered to a Reaction Filtration Cartridge.  
If four building blocks are being assembled, the Third Deprotection Cartridge contains 
NaOH (0.33 mmol, 13.3 mg) and no Drying Cartridge is used for the third reaction. The Third 
Reaction Cartridge is a 7-mL glass vial containing a PTFE-coated magnetic stir, the capping 
building block (0.037 mmol), XPhos 2
nd
 generation palladacycle (0.00185 mmol, 1.5 mg, 5 
mol%), and K3PO4 (0.33 mmol, 71 mg). The vial is sealed under argon with a septum-top screw 
cap.   
At the end of the synthesis, the crude reaction is purified by silica gel chromatography or 
preparative HPLC. 
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Automated synthesis of 5.10 
The general procedure was followed using 255.7 mg (1.01 mmol) thiophenyl MIDA 
boronate 5.5, 108.3 mg (0.34 mmol) thiophenyl MIDA boronate 5.6, 36.0 mg (0.11 mmol) 
thiophenyl MIDA boronate 5.6, and 7.9 mg (0.0385 mmol) bromothiophene 5.9. The crude 
residue was purified via silica gel chromatography (100% hexanes to 20% EtOAc in hexanes) to 
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afford quaterthiophene 5.10 as a red/orange solid (5.7 mg, 0.0147 mmol, 38% yield). The mixed 
fractions were combined and repurified via silica gel chromatography (100% hexanes to 10% 
EtOAc in hexanes) to afford an additional 1.8 mg of 5.10 as a red/orange solid (combined total 
of 7.5 mg, 0.0194 mmol, 50% yield). 
 
 
 
TLC (20% EtOAc in hexanes) 
Rf = 0.29, visualized by longwave UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 9.81 (s, 1H), 7.54 (s, 1H), 7.24 (d, J = 3.5 Hz, 1H), 7.17 (m, 3H), 7.06 (d, J = 3.5 Hz, 
1H), 6.90 (d, J = 5.0 Hz, 1H), 2.48 (s, 3H), 2.43 (s, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 182.6, 141.6, 140.6, 139.7, 139.2, 136.7, 135.8, 134.8, 134.5, 134.2, 131.7, 130.7, 
128.2, 126.2, 124.8, 124.2, 123.8, 16.1, 15.7. 
 
HRMS (EI+) 
 Calculated for C19H14OS4:  385.99277 
 Found:  385.99217 
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Automated synthesis of 5.19 
The general procedure was followed with the following modifications: In the second 
cross-coupling reaction, the concentration was 0.03 M with respect to 5.18 and addition of the 
boronic acid was performed over 1 minute. 
This procedure was followed using 372.0 mg (1.00 mmol) vinyl MIDA boronate 5.16, 
114.1 mg (0.34 mmol) bifunctional vinyl MIDA boronate 5.12, and 25.8 mg (0.113 mmol) ethyl 
ester 5.18. Oligophenylenevinylene 5.19 was afforded as a yellow solid (44.1 mg, 0.0945 mmol, 
84% yield).    
 
 
 
TLC (40% DCM in hexanes) 
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Rf = 0.31, visualized by UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.06 (d, J = 8 Hz, 2H), 7.59-7.54 (m, 6H), 7.41-7.39 (m, 3H), 7.23 (d, J = 16.5 Hz, 1H), 
7.22 (d, J = 16 Hz, 1H), 7.15 (d, J = 15.5 Hz, 1H), 7.12 (d, J = 16 Hz, 1H), 4.40 (q, J = 7 
Hz, 2H), 1.42 (t, J = 7.5 Hz, 3H), 1.40 (s, 18H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 166.5, 151.2, 141.9, 137.8, 136.5, 136.0, 130.9, 130.2, 130.1, 129.3, 127.5, 127.4, 
127.3, 127.0, 126.4, 122.4, 121.0, 61.0, 35.0, 31.6, 14.5. 
 
HRMS (ESI+) 
 Calculated for C33H39O2:  467.2950     
 Found:  467.2943  
 
 
Manual deprotection of 5.19 
To a solution of ethyl ester 5.19 (44.1 mg, 0.0945 mmol) in MeOH/THF 1:1 (2 mL) was 
added LiOH solution (18 mg, 0.752 mmol in 0.4 mL H2O) in one portion. The mixture was 
stirred vigorously at 45 C for 3.5 hours. The reaction was cooled briefly in an ice-water bath 
and 0.2 mL of 2 N HCl was added. The mixture was diluted with 5 mL H2O and extracted with 
EtOAc (10 mL, then 2 × 5 mL). The combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated. The crude product was purified by 
recrystallization from hot toluene. A second crop was obtained by precipitation from 
toluene/hexanes and combined with the first crop to afford oligophenylenevinylene 5.20 as a 
bright yellow solid (20.5 mg, 0.047 mmol, 50% yield). 
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1
H-NMR (500 MHz, DMSO-d6) 
δ 12.88 (s, 1H), 7.92 (d, J = 8 Hz, 2H), 7.70 (d, J = 8.5 Hz, 2H), 7.64 (s, 3H), 7.43 (d, J = 
1.5 Hz, 2H), 7.40 (d, J = 16.5 Hz, 1H), 7.34 (d, J = 16.5 Hz, 1H), 7.32 (d, J = 17 Hz, 1H), 
7.30 (s, 2H), 7.26 (d, J = 16.5 Hz, 1H), 1.31 (s, 18 H). 
 
13
C-NMR (125 MHz, DMSO-d6) 
δ 167.0, 150.5, 141.5, 137.2, 136.2, 135.7, 130.6, 129.7 (2C), 129.4, 127.2, 127.1, 126.8, 
126.4, 121.6, 120.8, 34.5, 31.2. 
 
HRMS (EI+) 
 Calculated for C31H34O2:   438.25588      
Found:     438.25538 
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Automated synthesis of 5.21 
The general procedure was followed with the following modifications: In the second 
cross-coupling reaction, the concentration was 0.03 M with respect to 5.20, 1.11 mmol of K3PO4 
were used, and addition of the boronic acid was performed over 1 minute. 
This procedure was followed using 277.1 mg (1.01 mmol) benzofurazanyl MIDA 
boronate 5.17, 114.7 mg (0.34 mmol) bifunctional aryl MIDA boronate 5.18, and 16.7 mg (0.111 
mmol) chloropyridine hydrochloride salt 5.20. The resulting crude residue was put into 1.5 mL 
dimethylformamide and purified via HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product 
number: 413910-302), 25 mL/min, gradient: A = water, B = acetonitrile, 0 min: 95% A, 5% B; 
20 min: 5% A, 95% B) to afford PDE472 (5.21) as an off-white solid (6.6 mg, 0.0218 mmol, 
20% yield). 
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TLC (EtOAc) 
Rf = 0.30, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
 δ 8.63 (br s, 2H), 8.12 (t, J = 1 Hz, 1H), 7.97 (dd, J = 9.5, 1 Hz, 1H), 7.96 (d, J = 2.5 Hz, 
1H), 7.93 (dd, J = 9, 2.5 Hz, 1H), 7.87 (dd, J = 9.5, 1.5 Hz, 1H), 7.74 (app d, J = 6 Hz, 2H), 7.35 
(d, J = 9 Hz, 1H), 3.98 (s, 3H). 
  
13
C-NMR (125 MHz, DMSO-d6) 
δ 157.3, 150.1, 149.3, 148.1, 146.1, 142.2, 135.8, 129.8, 129.1, 129.0, 128.2, 120.9, 114.9 
(2C), 112.7, 56.1. 
 
HRMS (ESI+) 
 Calculated for C18H14N3O2:  304.1086     
Found:     304.1081 
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Automated synthesis of 5.26 
The general procedure was followed using 149.8 mg (0.99 mmol) pyrimidine 5.22, 106.7 
mg (0.33 mmol) chloroisoquinoline 5.23, and 23.7 mg (0.114 mmol) bromoisoquinoline 5.25. 
The crude residue was purified via silica gel chromatography (50% hexanes in EtOAc to 100% 
EtOAc) to afford 5.26 as an orange/tan solid (12.9 mg, 0.0318 mmol, 28% yield). 
 
 
 
TLC (EtOAc) 
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Rf = 0.25, visualized by UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 9.31 (br s, 1H), 9.19 (s, 2H), 8.58 (d, J = 5 Hz, 1H), 8.16 (d, J = 8 Hz, 1H), 8.10 (s, 
1H), 8.05 (s, 1H), 7.95 (d, J = 8.5 Hz, 1H), 7.87-7.81 (m, 2H), 7.74 (d, J = 5.5 Hz, 1H), 
7.68-7.60 (m, 2H), 7.56 (br s, 1H), 1.44 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 171.2, 152.5, 151.6, 148.5, 143.2, 140.9, 136.9, 135.9, 135.2, 133.2, 132.7, 130.8, 
128.9, 128.6, 127.2, 126.8, 126.3, 125.6, 121.9, 120.6, 118.2, 39.0, 29.9. 
 
HRMS (ESI+) 
 Calculated for C26H24N5:   406.2032  
Found:     406.2031 
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Automated synthesis of 5.31 
The general procedure was followed with the following modifications: The First Reaction 
Cartridge did not have a medium porosity glass frit installed; it had only the factory-supplied 
fiber frit with a 4-g Luknova column fiber frit secured on top of it. The Reaction Filtration 
Cartridge and PTFE tether were not used. In the first cross-coupling reaction, 5 mol% (2.2 mg, 
0.01 mmol) Pd(OAc)2 and 20 mol% (12.2 mg, 0.04 mmol) P(o-tol)3 were used as palladium 
source and ligand, respectively, and 166 mg (1.2 mmol) anhydrous K2CO3 and 139 mg (0.6 
mmol) Ag2O were used as the base and the reaction was run for 8 hours and in order to fill the 
space around the 4-g Luknova column fiber frit an additional 800 mg K2CO3 was added. Both 
deprotection reactions were run for 10 minutes. The second cross-coupling reaction was run for 
18 hours in a 7-mL glass vial, 7.5 mol% (3.9 mg, 0.0050 mmol) 2
nd
 generation Buchwald XPhos 
palladacycle was used as catalyst, and 128 mg (0.6 mmol) K3PO4 was used as base.  
This procedure was followed using 140.0 mg (0.60 mmol) phenyl MIDA boronate 5.27, 
96.0 mg (0.20 mmol) bifunctional MIDA boronate 5.28, and 14.1 mg (0.0668 mmol) vinyl 
iodide 5.30. 
At the end of the synthesis, the crude reaction was filtered through a pad of Celite™. The 
filter pad was washed with copious THF (approximately 50 mL). The filtrate was then 
concentrated via rotary evaporation and the resulting residue was azeotroped with DCM (20 
mL). The resulting crude residue was purified via silica gel chromatography (40% EtOAc in 
hexanes to 50% EtOAc in hexanes) to afford (+)-crocacin C (5.31) as an off-white solid (14.5 
mg, 0.0406 mmol, 61% yield).  
 
 
 
TLC (20% EtOAc in hexanes) 
Rf = 0.08, visualized by UV. 
 
1
H-NMR (500 MHz, CDCl3) 
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δ 7.39 (d, J = 7.5 Hz, 2H), 7.32 (t, J = 7 Hz, 2H), 7.23 (t, J = 7 Hz, 1H), 6.56 (d, J = 16.5 
Hz, 1H), 6.17-6.01 (m, 3H), 5.63 (s, 1H), 5.38 (br s, 2H), 4.08 (dd, J = 7.5, 1 Hz, 1H), 
3.54 (s, 3H), 3.32 (s, 3H), 3.19 (dd, J = 10, 2 Hz, 1H), 2.56-2.53 (m, 1H), 2.25 (d, J = 1 
Hz, 3H), 1.56-1.52 (m, 1H), 1.19 (d, J = 7 Hz, 3H), 0.84 (d, J = 7 Hz, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 169.4, 149.7, 137.2, 136.8, 134.1, 132.1, 129.3, 128.7, 127.7, 126.5, 119.7, 86.5, 81.1, 
61.6, 56.6, 42.7, 40.2, 18.9, 13.9, 9.8. 
 
HRMS (ESI+) 
 Calculated for C22H32NO3:   358.2382  
Found:     358.2392 
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Automated synthesis of 5.36  
The general procedure was followed with the following modifications:  In the first cross-
coupling reaction, the reaction was run at room temperature for 24 hours and 5 mol% (3.7 mg, 
0.017 mmol) Pd(OAc)2 and 10 mol% (15.9 mg, 0.033 mmol) XPhos were used for palladium 
source and ligand, respectively, and 637 mg (3 mmol) anhydrous K3PO4 was used for base. The 
second deprotection reaction was run for 10 minutes, and the second cross-coupling reaction was 
run in a 20-mL glass vial at room temperature for 40 minutes using 4 mol% (1.1 mg, 0.0049 
mmol) Pd(OAc)2 and 8 mol% (4.6 mg, 0.0096 mmol) XPhos as the palladium source and ligand, 
respectively, and 14.0 mg (0.35 mmol) NaOH with 0.5 mL water was a source of aqueous base. 
The procedure was also conducted under subdued light conditions to protect against 
isomerization of the polyene framework. 
This procedure was followed using 283.2 (1.34 mmol) butenyl MIDA boronate 5.32, 81.9 
mg (0.34 mmol) dienyl MIDA boronate 5.33, and 35.2 mg (0.119 mmol) vinyl iodide 5.35.  
At the end of the synthesis, the crude reaction was transferred to a 125-mL separatory 
funnel and quenched with 50 mL saturated aqueous NH4Cl. It was then diluted with 40 mL Et2O. 
The layers were separated and the aqueous layer was washed with 50 mL Et2O. The combined 
organic layers were dried over anhydrous Na2SO4 and filtered through Celite™, washing with 
copious Et2O (approximately 100 mL). The filtrate was then concentrated via rotary evaporation 
and the resulting residue was put into 1.5 mL dimethylformamide and purified via HPLC 
(Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, gradient: A 
= water, B = acetonitrile, 0 min: 95% A, 5% B; 2 min: 95% A, 5% B; 15 min: 0% A, 100% B; 
30 min: 0% A, 100% B) to afford β-parinaric acid (5.36) as a fluorescent solid (18.3 mg, 0.0662 
mmol, 56% yield). 
1H NMR indicated a 10:1 mixture of the desired β-parinaric acid (5.36):9-(Z)-
parinaric acid (arising from 10:1 E:Z mixture of starting material vinyl iodide 5.35. 
1
H NMR and 
13
C NMR analysis of automatically synthesized 5.36 was fully consistent with the data 
previously reported for β-parinaric acid3. 
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TLC (50% Et2O in hexanes) 
Rf = 0.13, visualized by UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.21-6.05 (m, 6H), 5.76-5.63 (m, 2H), 2.34 (t, J = 7 Hz, 2H), 2.15-2.07 (m, 4H), 1.66-
1.60 (m, 2H), 1.43-1.26 (m, 8H), 1.01 (t, J = 7.5 Hz, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 179.2, 136.7, 135.1, 132.6, 132.6, 131.0, 131.0, 130.8, 129.8, 34.0, 33.0, 29.4, 29.2, 
29.1, 29.1, 26.0, 24.8, 13.7. 
 
HRMS (ESI+) 
 Calculated for C18H29O2:   277.2168   
Found:     277.2175 
 
Previously reported β-parinaric acid 
(300 MHz, CDCl3)
3 
Automatically synthesized β-parinaric acid 
(500 MHz, CDCl3) 
6.08 (m, 6H) 6.21-6.05 (m, 6H) 
5.75 (m, 2H) 5.76-5.65 (m, 2H) 
2.32 (t, J = 7.5, 2H) 2.34 (t, J = 7 Hz, 2H) 
2.1 (m, 2H), 2.11 (dq, J = 7.5, 7.2 Hz, 2H) 2.15-2.07 (m, 4H) 
1.60 (m, 2H) 1.66-1.60 (m, 2H) 
1.29 (m, 8H) 1.43-1.26 (m, 8H) 
1.08 (t, J = 7.5 Hz, 3H) 1.01 (t, J = 7.5 Hz, 3H) 
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Previously reported -parinaric acid 
(125 MHz, CDCl3)
3 
Automatically synthesized -parinaric acid 
(125 MHz, CDCl3) 
178.96 179.20 
136.98 136.73 
135.39 135.15 
132.90 132.64 
132.81 132.57 
131.29 131.03 
131.26 131.00 
131.05 130.79 
130.04 129.78 
34.16 34.00 
33.21 32.96 
29.63 29.38 
29.47 29.22 
29.42 29.12 
29.35 29.10 
26.27 26.02 
25.05 24.80 
13.94 13.69 
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Automated synthesis of 5.41 
The general procedure was followed with the following modifications: The First Reaction 
Cartridge did not have a medium porosity glass frit installed; it had only the factory-supplied 
fiber frit with a 4-g Luknova column fiber frit secured on top of it. The Reaction Filtration 
Cartridge and PTFE tether were not used. In the first cross-coupling reaction was run for 14 
hours at room temperature, 2.5 mol% (1.1 mg, 0.005 mmol) Pd(OAc)2 and 5 mol% (4.1 mg, 0.01 
mmol) SPhos were used a palladium source and ligand, respectively, 382 mg (1.8 mmol) K3PO4 
was used as base, and in order to fill the space around the 4-g Luknova column fiber frit an 
additional 750 mg K3PO4 was added. Both deprotection reactions were run for 10 minutes. The 
second cross-coupling reaction was run in a 7-mL glass vial at 40 °C for 6 hours, 5 mol% (2.6 
mg, 0.0033 mmol) 2
nd
 generation Buchwald XPhos palladacycle was used as catalyst and 195 
mg (0.6 mmol) Cs2CO3 was used as base. The procedure was also conducted under subdued light 
conditions to protect against isomerization of the polyene framework. 
This procedure was followed using 207.0 mg (0.60 mmol) vinyl MIDA boronate 5.37 
61.8 mg (0.20 mmol) vinyl MIDA boronate 5.38, 18.8 mg (0.0667 mmol) vinyl iodide ketal 
5.40. 
At the end of the synthesis, the crude reaction was filtered through a pad of Celite™. The 
filter pad was washed with copious THF (approximately 50 mL). The filtrate was then 
concentrated via rotary evaporation and the resulting residue was azeotroped with DCM (20 
mL). The resulting crude residue was purified via silica gel chromatography (100% hexanes to 
30% EtOAc in hexanes) to afford all-trans-retinal ketal 5.41 as a yellow oil (18.2 mg, 0.0491 
mmol, 74% yield).  
 
 
 
TLC (petroleum ether:ether 4:1)  
Rf = 0.86, stained by KMnO4. 
 
1
H-NMR (500 MHz, CDCl3) 
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δ 6.66 (dd, J = 14.8, 11.2 Hz, 1H), 6.27 (d, J = 15.2 Hz, 1H), 6.19-6.08 (m, 3H), 5.54 (d, 
J = 6 Hz, 1H), 5.21 (d, J = 6.4 Hz, 1H), 3.66 (d, J = 11.2 Hz, 2H), 3.53 (d, J = 10.8 Hz, 
2H), 2.01 (t, J = 6.4 Hz, 2H), 1.95 (s, 3H), 1.91 (s, 3H), 1.70 (s, 3H), 1.62-1.59 (m, 2H), 
1.47-1.44 (m, 2H), 1.23 (s, 3H), 1.01 (s, 6H), 0.75 (s, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 139.3, 137.8, 137.6, 136.6, 135.8, 130.0, 129.3, 127.2, 127.0, 126.2, 109.8, 98.8, 39.6, 
34.2, 33.0, 30.0, 28.9, 23.0, 22.0, 21.7, 19.2, 13.4, 12.7.  
  
HRMS (ESI+) 
 Calculated for C25H39O2: 371.2950 
 Found:    371.2950 
 
 
 
Manual deprotection of 5.41 
A 7-mL vial charged with 5.41 (18.2 mg, 0.049 mmol, 1.0 equiv.) was sealed with a 
PTFE-lined cap and purged with N2 and THF (1.0 mL, 0.05M) was added to afford a clear 
yellow solution. The vial was cooled to 0 
°
C in an ice bath for 5 minutes. Aqueous HCl (1M, 0.5 
mL) was added dropwise to the reaction vial and the reaction mixture was allowed to warm to 23 
°
C with stirring over 30 minutes. After 30 minutes, the reaction mixture was transferred to a 
separatory funnel containing aqueous saturated NaHCO3 (5 mL), rinsing with diethyl ether (10 
mL) and the phases were separated. The aqueous layer was back-extracted with diethyl ether (5 
mL) and the combined organic layers were dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo to afford a yellow-orange oil. The resulting crude material (4:1 ratio of all-
trans retinal (5.42):13-cis-retinal) was adsorbed onto Celite™ from an acetone solution and 
purified by silica gel chromatography (32:1 hexanes:EtOAc) to afford all-trans retinal (5.42) as 
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an orange solid (8.9 mg, 0.0313 mmol, 64% yield). Characterization matches what is reported in 
the literature.
4
 
 
 
 
 
1
H-NMR (500 MHz, CDCl3) 
δ 10.11 (d, J = 8 Hz, 1H), 7.14 (dd, J = 15, 11.5 Hz, 1H), 6.37 (d, J =15 Hz, 1H), 6.34 (d, 
J = 15 Hz, 1H), 6.19 (d, J = 9.5 Hz, 1H), 6.16 (d, J = 16 Hz, 1H), 5.97 (d, J = 8.5 Hz, 
1H), 2.33 (d, J = 1 Hz, 3H), 2.04-2.02 (m, 2H), 2.03 (s, 3H), 1.72 (s, 3H), 1.63-1.60 (m, 
2H), 1.49-1.46 (m, 2H), 1.03 (s, 6H). 
 
Natural all-trans-retinal
4 
Synthetic all-trans-retinal 
10.12 (1H) 10.11 (1H) 
7.15 (1H) 7.14 (1H) 
6.37 (1H) 6.37 (1H) 
6.36 (1H) 6.34 (1H) 
6.20 (1H) 6.19 (1H) 
6.18 (1H) 6.16 (1H) 
5.98 (1H) 5.97 (1H) 
2.33 (3H) 2.33 (3H) 
2.03 (3H) 2.03 (3H) 
1.72 (3H) 1.72 (3H) 
1.04 (6H) 1.03 (6H) 
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Automated synthesis of 5.49 
The general procedure was followed with the following modifications: The first cross-
coupling reaction was performed using SPhos as the ligand and K2CO3 as the base. The second 
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and third deprotection reactions were run for 10 and 30 minutes, respectively. The second cross-
coupling reaction was run for 14 hours and the third cross-coupling reaction was run for 24 hours 
using SPhos as the ligand.  
This procedure was followed using 297.1 mg (1.51 mmol) trans-1-propenyl MIDA 
boronate (5.43), 119.8 mg (0.34 mmol) 5-bromo-2-benzofuranyl MIDA boronate (5.44), 42.6 mg 
(0.068 mmol) bifunctional aryl MIDA boronate 5.46, and 6.4 mg (0.0139 mmol) capping vinyl 
bromide 5.48. 
Protected ratanhine 5.49 was isolated as a colorless oil (4.7 mg, 36% yield), the 
1
H NMR 
of which contained small amounts of hydrocarbon impurities presumed to represent some 
leaching from the HPLC column.  
 
 
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 13.4 min 
 
1
H-NMR (500 MHz, acetone-d6)  
δ 7.67 (s, 1H), 7.64-7.62 (m, 4H), 7.54 (d, J = 9 Hz, 2H), 7.50 (s, 1H), 7.45-7.43 (m, 8H), 
7.25 (d, J = 2 Hz, 1H), 7.21 (d, J = 8.5 Hz, 1H), 7.10 (d, J = 8.5 Hz, 1H), 6.95 (d, J = 1 
Hz, 1H), 6.56 (dd, J = 16, 2 Hz, 1H), 6.51-6.46 (m, 3H), 6.38 (dq, J = 15.5, 6.5 Hz, 1H), 
6.35 (s, 1H), 6.26 (dq, J = 15.5, 6.5 Hz, 1H), 5.46 (s, 2H), 3.86-3.83 (m, 2H), 3.81 (s, 
3H), 3.57-3.54 (m, 2H), 1.91 (dd, J = 6.5, 1.5 Hz, 3H), 1.88 (dd, J = 5, 1.5 Hz, 3H), 1.20-
1.17 (m, 2H), 0.99 (s, 9H), 0.89-0.86 (m, 2H), 0.02 (s, 9H). 
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HRMS (ESI+) 
 Calculated for C59H65O6Si2:  925.4320   
Found:     925.4316 
 
 
 
Manual deprotection of 5.50 
To a 1-mL Reacti-vial
™
 containing 5.49 and a PTFE-coated magnetic stir bar was added 
CsF (8.2 mg, 0.054 mmol) and 18-crown-6 (1.1 mg, 0.00416) followed by DMSO (0.15 mL) in a 
glovebox. The vial was sealed with a cap and stirred at 50 C for 14 hours. The reaction was then 
cooled to room temperature, diluted with 8 mL EtOAc and washed with a solution of 1:1 
saturated aqueous NH4Cl/H2O (8 mL). The aqueous layer was extracted with 4 mL EtOAc. The 
combined organic layers were washed with H2O (2 × 4 mL), then with brine (8 mL). The organic 
phase was dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude product 
was purified by silica gel chromatography (30% to 40% EtOAc/pentane) to afford ratanhine 
(5.50) as an off-white solid (0.2 mg, 0.00036 mmol, 7% yield). 
 
 
 
TLC (40% EtOAc/pentane) 
Rf = 0.44, visualized by shortwave UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 7.83 (dt, J = 9.0, 2.0 H, 2H), 7.77 (s, 1H), 7.53 (s, 1H), 7.43 (dd, J = 8.5, 2.0 Hz, 1H), 
7.37 (d, J = 8.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 1H), 7.28 (d, J = 8.0, 1.0 Hz, 1H), 7.17 (d, J 
= 8.5 Hz, 1H), 7.14 (s, 1H), 6.83 (dt, J = 8.5, 2.0 Hz, 2H), 6.55 (s, 1H), 6.50 (dd, J = 
15.5, 1.5 Hz, 1H), 6.44 (dd, J = 16.0, 1.5 Hz, 1H), 6.31-6.21 (m, 2H), 5.61 (d, J = 1.5 Hz, 
1H), 5.57 (d, J = 2.0 Hz, 1H), 3.96 (s, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 1.84 (dd, J = 
6.5, 1.5 Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C36H31O6:   559.2121 
Found:     559.2128 
 
General Scheme for Automated Synthesis of Library Members 5.56-5.67 
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TLC (50% DCM in hexanes) 
Rf = 0.51, stained by KMnO4. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.82 (d, J = 8.5 Hz, 1H), 7.74-7.71 (m, 4H), 7.53 (d, J = 1.5 Hz, 1H), 7.47-7.42 (m, 
6H), 7.39 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 1.5 Hz, 1H), 7.17 (d, J = 1 Hz, 1H), 6.52-
6.46 (m, 3H), 6.24 (dq, J = 15.5, 6.5 Hz, 1H), 4.14-4.11 (m, 2H), 3.93 (s, 3H), 1.88-1.84 
(m, 5H), 1.09 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 161.3, 158.8, 153.8 (2C), 136.7, 134.8, 134.0, 132.2, 131.2, 130.3, 128.7, 128.3, 124.5, 
122.8, 118.7, 112.8, 111.2, 106.6, 105.0, 100.0, 66.2, 55.9, 28.1, 18.6, 18.5, 12.6.  
 
HRMS (ESI+) 
 Calculated for C36H39O3Si:  547.2668   
 Found:     547.2673    
 
 
 
TLC (50% DCM in hexanes) 
Rf = 0.23, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.84 (dd, J = 8, 0.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.47-7.43 (m, 6H), 7.14 (s, 1H), 7.10 
(d, J = 1.5 Hz, 1H), 6.93 (d, J = 1.5 Hz, 1H), 6.50-6.45 (m, 3H), 6.24 (dq, J = 15.5, 6.5 
Hz, 1H), 4.14-4.10 (m, 2H), 4.01 (s, 3H), 3.93 (s, 3H), 1.87-1.84 (m, 5H), 1.09 (s, 9H). 
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13
C-NMR (125 MHz, acetone-d6) 
δ 161.3, 158.7, 153.7, 145.9, 143.0, 136.7, 135.0, 134.8, 132.6, 132.5, 130.3, 128.7, 
128.3, 124.6, 112.8, 111.6, 106.6, 105.2 (2C), 100.0, 66.2, 56.3, 56.0, 28.1, 18.5 (2C) 
12.6. 
 
HRMS (ESI+) 
 Calculated for C37H41O4Si:  577.2774  
 Found:     577.2767 
 
 
 
TLC (50% DCM in hexanes) 
Rf = 0.49, stained by KMnO4. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.83 (d, J = 8.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.61 (d, J = 1.5 Hz, 1H), 7.47-7.42 (m, 
7H), 7.35 (dd, J = 8.5, 2 Hz, 1H), 7.19 (d, J = 0.5 Hz, 1H), 6.77 (dt, J = 16, 1.5 Hz, 1H), 
6.51-6.47 (m, 2H), 6.35 (dt, J = 15.5, 5 Hz, 1H), 4.47 (dd, J = 4.5, 1.5 Hz, 2H), 4.14-4.11 
(m, 2H), 3.94 (s, 3H), 1.88-1.84 (m, 2H), 1.22-1.08 (m, 30H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 161.4, 158.8, 154.1, 154.0, 136.7, 134.8, 133.2, 131.3, 130.3, 130.2, 128.8, 128.7, 
128.3, 123.3, 119.3, 112.8, 111.3, 106.7, 105.0, 100.0, 66.2, 64.8, 56.0, 28.1, 18.6, 18.4, 
12.8, 12.6. 
 
HRMS (ESI+) 
 Calculated for C45H59O4Si2:  719.3952   
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 Found:     719.3925 
 
 
 
TLC (50% DCM in hexanes) 
Rf = 0.40, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.84 (app d, J = 9 Hz, 1H), 7.74-7.71 (m, 4H), 7.48-7.43 (m, 6H), 7.17 (d, J = 1 Hz, 
1H), 7.16 (s, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.73 (dt, J = 15.5, 1.5 Hz, 1H), 6.50 (s, 1H), 
6.50--6.48 (m, 1H), 6.36 (dt, J = 16, 4.5 Hz, 1H), 4.47 (dd, J = 5, 1.5 Hz, 2H), 4.14-4.11 
(m, 2H), 4.02 (s, 3H), 3.93 (s, 3H), 1.88-1.84 (m, 2H), 1.20-1.09 (m, 30H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 161.3, 158.7, 153.8, 146.0, 143.2, 136.7, 143.7, 134.2, 132.7, 130.5, 130.3, 128.8, 
128.7, 128.3, 112.8, 112.3, 106.6, 105.5, 105.2, 100.0, 66.2, 64.8, 56.3, 55.9, 28.1, 18.6, 
18.4, 12.8, 12.6. 
 
HRMS (ESI+) 
 Calculated for C46H61O5Si2:  749.4058   
Found:     749.4056   
 
 
 
TLC (20% EtOAc in hexanes) 
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Rf = 0.28, stained by KMnO4. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.37 (dd, J = 3, 0.5 Hz, 1H), 7.89 (dd, J = 8.5, 0.5 Hz, 1H), 7.63 (dd, J = 2 Hz, 1H), 
7.50 – 7.48 (m, 2H), 7.39 (dd, J = 8.5, 2 Hz, 1H), 7.31 (d, J = 1 Hz, 1H), 6.53 (dd, J = 16, 
1.5 Hz, 1H), 6.29 (dq, 15.5, 6.5 Hz, 1H), 3.95 (s, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 157.0, 156.6, 155.2, 142.5, 139.2, 134.5, 132.0, 130.4, 125.1, 123.7, 121.2, 120.9, 
119.3, 111.9, 103.6, 56.2, 18.6. 
 
HRMS (ESI+) 
 Calculated for C17H16NO2:  266.1181 
 Found:   266.1180 
 
 
  
TLC (20% EtOAc in hexanes) 
Rf = 0.23, stained by KMnO4. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.36 (dd, J = 3, 0.5 Hz, 1H), 7.89 (dd, J = 8.5, 0.5 Hz, 1H), 7.49 (dd, J = 8.5, 3.0 Hz, 
1H), 7.28 (s, 1H), 7.19 (d, J = 1.5 Hz, 1H), 7.01 (d, J = 1.5 Hz, 1H), 6.50 (d, J = 15.5, 1.5 
Hz, 1H), 6.29 (dq, J = 16, 6.5 Hz, 1H), 4.05 (s, 3H), 3.95 (s, 3H), 1.87 (dd, J = 6.5, 1.5 
Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
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δ 156.9, 156.6, 146.3, 144.5, 142.5, 139.2, 135.5, 132.3, 131.8, 125.1, 121.2, 120.8, 
112.0, 105.8, 103.9, 56.3, 56.2, 18.5. 
 
HRMS (ESI+) 
 Calculated for C18H18NO3:  296.1287 
 Found:   296.1282 
 
 
 
 Library member 5.62 was isolated as an off-white solid containing 5.62 (5.6 mg, 19% 
yield) and a small amount of cross-coupling byproduct and was carried on to the manual 
deprotection without further purification. 
  
TLC (20% EtOAc in hexanes) 
Rf = 0.33, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.37 (dd, J = 3, 1 Hz, 1H), 7.89 (dd, J = 9, 1 Hz, 1H), 7.71 (d, J = 1.5 Hz, 1H), 7.52 (d, 
J = 8.5, 1H), 7.49 (dd, J = 8.5, 3 Hz, 1H), 7.46 (dd, J = 8.5, 1H), 7.34 (d, J = 1 Hz, 1H), 
6.80 (dt, J = 15.5, 2 Hz, 1H), 6.40 (dt, J = 15.5, 5 Hz, 1H), 4.50 (dd, J = 4.5, 2 Hz, 2H), 
3.96 (s, 3H), 1.22-1.10 (m, 21H). 
 
HRMS (ESI+) 
 Calculated for C26H36NO3Si:  438.2464   
 Found:     438.2468 
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TLC (20% EtOAc in hexanes) 
Rf = 0.26, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.36 (dd, J= 3, 0.5 Hz, 1H), 7.90 (dd, J = 9, 0.5 Hz, 1H), 7.49 (dd, J = 8.5, 3 Hz, 1H), 
7.30 (s, 1H), 7.26 (d, J = 1.5 Hz, 1H), 7.08 (d, J = 1.5 Hz, 1H), 6.76 (dt, J = 15.5, 2 Hz, 
1H), 6.41 (dt, J = 16, 4.5 Hz, 1H), 4.49 (dd, J = 5, 2 Hz, 2H), 4.06 (s, 3H), 3.95 (s, 3H), 
1.21-1.11 (m, 21H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 157.0, 156.6, 146.4, 144.7, 142.5, 139.2, 134.8, 131.9, 130.2, 129.3, 121.2, 120.8, 
112.8, 106.0, 103.9, 64.7, 56.4, 56.2, 18.4, 12.8. 
 
HRMS (ESI+) 
 Calculated for C27H38NO4Si:  468.2570   
 Found:     468.2572 
 
 
 
TLC (20% DCM in hexanes) 
Rf = 0.27, visualized by UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 7.94 (d, J = 9 Hz, 1H), 7.74-7.72 (m, 4H), 7.62 (d, J = 1.5 Hz, 1H), 7.48-7.42 (m, 7H), 
7.37 (dd, J = 8.5, 1.5 Hz, 1H), 7.10 (d, J = 0.5 Hz, 1H), 6.91 (dd, J = 9, 2.5 Hz, 1H), 6.82 
(quint, J = 1.5 Hz, 1H), 6.51 (dd, J = 16, 2 Hz, 1H), 6.27 (dq, J = 16, 7 Hz, 1H), 4.17-
4.14 (m, 2H), 1.90-1.87 (m, 2H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H), 1.10 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.7, 154.2, 151.7, 147.0, 136.7, 134.6, 134.5, 132.0, 130.4, 130.3, 129.8, 128.7, 
125.1, 123.8, 121.5 (JC-F = 257 Hz), 119.2, 116.8, 114.2, 111.6, 109.0, 105.7, 67.0, 28.1, 
18.6 (2C), 12.4. 
 
HRMS (ESI+) 
 Calculated for C36H36F3O3Si:  601.2386   
 Found:     601.2386 
   
 
 
TLC (20% DCM in hexanes) 
Rf = 0.09, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.94 (d, J = 9 Hz, 1H), 7.74-7.72 (m, 4H), 7.48-7.42 (m, 6H), 7.18 (d, J = 1.5 Hz, 1H), 
7.07 (s, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.92 (dd, J = 9, 2.5 Hz, 1H), 6.81 (quint, J = 2 Hz, 
1H), 6.48 (dd, J = 16, 2 Hz, 1H), 6.27 (dq, J = 16, 6.5 Hz, 1H), 4.17-4.14 (m, 2H), 4.03 
(s, 3H), 1.90-1.86 (m, 2H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H), 1.09 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
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δ 160.7, 151.5, 146.9, 146.1, 143.6, 136.7, 135.5, 134.6, 132.3, 131.9, 130.3, 129.7, 
128.7, 125.1, 121.5 (JC-F = 257 Hz), 116.8, 114.2, 111.8, 109.0, 105.9 (2C), 67.0, 56.4, 
28.1, 18.6, 18.5, 12.4. 
 
HRMS (ESI+) 
 Calculated for C37H38O4F3Si:  631.2491   
 Found:     631.2488 
 
 
 
Library member 5.66 was isolated as a colorless oil containing 5.66 (21.6 mg, 42% yield) 
and a small amount of a cross-coupling byproduct and was carried on to the manual deprotection 
without further purification. 
 
TLC (10% DCM in hexanes) 
Rf = 0.11, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.95 (d, J = 9 Hz, 1H), 7.74-7.70 (m, 5H), 7.50-7.41 (m, 8H), 7.13 (d, J = 0.5 Hz, 1H), 
6.92 (dd, J = 9, 2.5 Hz, 1H), 6.82 (quint, J = 1.5 Hz, 1H), 6.79 (dt, J = 16, 1.5 Hz, 1H), 
6.39 (dt, J = 16, 4.5 Hz, 1H), 4.48 (dd, J = 5, 2 Hz, 2H), 4.18-4.14 (m, 2H), 1.90-1.87 (m, 
2H), 1.21-1.08 (m, 30H). 
 
HRMS (ESI+) 
 Calculated for C45H54F3O4Si2:  771.3513   
 Found:     771.3550 
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TLC (20% DCM in hexanes) 
Rf = 0.11, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.95 (d, J = 8.5 Hz, 1H), 7.74-7.72 (m, 4H), 7.46-7.42 (m, 6H), 7.26 (d, J = 1.5 Hz, 
1H), 7.09 (s, 1H), 7.06 (d, J = 1 Hz, 1H), 6.93 (dd, J = 8.5, 2.5 Hz, 1H), 6.81 (quint, J = 
1.5 Hz, 1H), 6.79 (dt, J = 15.5, 2 Hz, 1H), 6.39 (dq, J = 16, 4.5 Hz, 1H), 4.47 (dd, J = 4.5, 
1.5 Hz, 2H), 4.17-4.14 (m, 2H), 4.04 (s, 3H), 1.90-1.86 (m, 2H), 1.20-1.09 (m, 30H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.7, 151.6, 146.9, 146.2, 143.8, 136.7, 134.8, 134.6, 132.0, 130.3, 130.2, 129.8, 
129.3, 128.7, 121.5 (JC-F = 257 Hz), 116.8, 114.2, 112.6, 109.0, 106.2, 106.0, 67.0, 64.7, 
56.4, 28.1, 18.5, 18.4, 12.8, 12.4. 
 
HRMS (ESI+) 
 Calculated for C46H57F3O5Si2Na:  825.3594   
 Found:     825.3600 
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General Scheme for Automated Synthesis of Library Members 5.69-5.75 
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HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 17.1 min 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.71 (s, 1H), 7.68-7.61 (m, 6H), 7.60 (d, J = 2.5 Hz, 1H), 7.50 (d, J = 1.5 Hz, 1H), 7.47-
7.41 (m, 7H), 7.36 (d, J = 8.5 Hz, 1H), 7.29 (dd, J = 8.5, 1.5 Hz, 1H), 7.17-7.13 (m, 2H), 
7.10-7.06 (m, 2H), 6.95 (d, J = 1 Hz, 1H), 6.56 (dd, J = 16, 2 Hz, 1H), 6.51 (dd, J = 16, 
1.5 Hz, 1H), 6.38 (dq, J = 16, 6.5 Hz, 1H), 6.34 (s, 1H), 6.25 (dq, J = 15.5, 7 Hz, 1H), 
5.50 (d, J = 1.5 Hz, 1H), 5.49 (d, J = 2 Hz, 1H), 3.88-3.86 (m, 2H), 3.79 (s, 3H), 1.90 (dd, 
J = 6.5, 1.5 Hz, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 1.27-1.23 (m, 2H), 0.99 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C54H53O5Si:  809.3662   
Found:     809.3658 
 
 
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
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 14.3 min 
 
TLC (70% DCM in hexanes) 
Rf = 0.5, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.75 (s, 1H), 7.68-7.63 (m, 6H), 7.59 (d, J = 2.5 Hz, 1H), 7.47-7.41 (m, 8H), 7.17-7.14 
(m, 2H), 7.10-7.07 (m, 3H), 6.93 (s, 1H), 6.55 (dd, J = 16, 1.5 Hz, 1H), 6.48 (dd, J = 16, 
1.5 Hz, 1H), 6.38 (dq, J = 16, 6.5 Hz, 1H), 6.34 (s, 1H), 6.26 (dq, J = 15.5, 6.5 Hz, 1H), 
5.51 (d, J = 2 Hz, 1H), 5.50 (d, J = 2 Hz, 1H), 4.00 (s, 3H), 3.88-3.85 (m, 2H), 3.78 (s, 
3H), 1.90 (dd, J = 6.5, 1.5 Hz, 3H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H), 1.27-1.23 (m, 2H), 
0.99 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C55H55O6Si:  839.3768  
Found:     839.3772 
 
 
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 48.3 min 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.71 (s, 1H), 7.67-7.58 (m, 7H), 7.47-7.37 (m, 10H), 7.16-7.14 (m, 2H), 7.10-7.07 (m, 
2H), 6.97 (s, 1H), 6.78 (app d, J = 16 Hz, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.41-6.36 
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(m, 2H), 6.35 (s, 1H), 5.51 (d, J = 1.5 Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 4.50 (dd, J = 5, 2 
Hz, 2H), 3.88-3.85 (m, 2H), 3.79 (s, 3H), 1.91 (dd, J = 6.5, 1.5 Hz, 3H), 1.29-1.07 (m, 
23H), 0.94 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C63H73O6Si2:  981.4946   
Found:     981.4949 
 
 
 
Library member 5.72 was isolated as a colorless oil (3.0 mg), the 
1
H NMR of which 
contained small amounts of hydrocarbon impurities presumed to represent some leaching from 
the HPLC column.    
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 10% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 33.4 min 
 
TLC (50% DCM in hexanes) 
Rf = 0.18, visualized by UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.75 (s, 1H), 7.69-7.62 (m, 6H), 7.60 (d, J = 2.5 Hz, 1H), 7.47-7.40 (m, 7H), 7.17-7.13 
(m, 3H), 7.10-7.06 (m, 2H), 7.00 (d, J = 1.5 Hz, 1H), 6.95 (s, 1H), 6.76 (dt, J = 15.5, 1.5 
Hz, 1H), 6.56 (dd, J = 15.5, 1.5 Hz, 1H), 6.40-6.35 (m, 2H), 6.34 (s, 1H), 5.52 (d, J = 1.5 
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Hz, 1H), 5.50 (d, J = 1.5 Hz, 1H), 4.49 (dd, J = 5, 2 Hz, 2H), 4.02 (s, 3H), 3.88-3.85 (m, 
2H), 3.78 (s, 3H), 1.90 (dd, J = 6.5, 2.5 Hz, 3H), 1.29-1.23 (m, 2H), 1.23-1.08 (m, 21H), 
0.99 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C64H74O7Si2Na:  1033.4871   
Found:     1033.4895 
 
 
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 12.2 min 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.71 (s, 1H), 7.64-7.62 (m, 4H), 7.56-7.53 (m, 2H), 7.46-7.41 (m, 8H), 7.10 (d, J = 8 
Hz, 1H), 7.08 (d, J = 1 Hz, 1H), 6.94 (d, J = 1.5 Hz, 1H), 6.93 (s, 1H), 6.56 (dd, J = 15.5, 
1.5 Hz, 1H), 6.51-6.47 (m, 3H), 6.38 (dq, J = 15.5, 6.5 Hz, 1H), 6.34 (s, 1H), 6.27 (dq, J 
= 15.5, 6.5 Hz, 1H), 5.46 (s, 2H), 4.02 (s, 3H), 3.87-3.84 (m, 2H), 3.80 (s, 3H), 3.56 (app 
t, J = 8 Hz, 2H), 1.90 (dd, J = 6.5, 1.5 Hz, 3H), 1.88 (dd, J = 6.5, 1.5 Hz, 3H), 1.23-1.20 
(m, 2H), 0.98 (s, 9H), 0.91-0.88 (m, 2H), 0.03 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C60H67O7Si2:  955.4425   
Found:     955.4437 
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HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 26.8 min 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.69 (s, 1H), 7.64-7.61 (m, 5H), 7.57 (s, 1H), 7.55 (d, J = 9 Hz, 2H), 7.46-7.34 (m, 9H), 
7.10 (d, J = 8.5 Hz, 1H), 6.97 (s, 1H), 6.80 (dt, J = 16, 1.5 Hz, 1H), 6.56 (dd, J = 15.5, 
1.5 Hz, 1H), 6.49 (d, J = 7 Hz, 2H), 6.41-6.34 (m, 3H), 5.46 (s, 2H), 4.51 (dd, J = 5, 2 
Hz, 2H), 3.90-3.85 (m, 2H), 3.81 (s, 3H), 3.58 (app t, J = 8 Hz, 2H), 1.91 (dd, J = 6.5, 1 
Hz, 3H), 1.24-1.17 (m, 5H), 1.15-1.12 (m, 18H), 0.99 (s, 9H), 0.88 (m, 2H), 0.03 (s, 9H). 
 
HRMS (ESI+) 
 Calculated for C68H85O7Si3:  1097.5603   
Found:     1097.5591 
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Library member 5.75 was isolated as a colorless oil (4.0 mg), the 
1
H NMR of which 
contained small amounts of hydrocarbon impurities presumed to represent some leaching from 
the HPLC column.  
 
HPLC (Agilent Prep-C18, 10 µm, 30 x 150 mm (product number: 413910-302), 25 mL/min, 
gradient: A = water, B = 20% THF in MeCN, 0 min: 80% A, 20% B; 5 min: 0% A, 100% B; 50 
min: 0% A, 100% B) 
 22.3 min 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.72 (s, 1H), 7.64-7.62 (m, 5H), 7.55 (d, J = 8.5 Hz, 2H), 7.46-7.41 (m, 7H), 7.14 (d, J 
= 1 Hz, 1H), 7.10 (d, J = 8 Hz, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.95 (s, 1H), 6.76 (dt, J = 
15.5, 1.5 Hz, 1H), 6.56 (dd, J = 16, 2 Hz, 1H), 6.49 (d, J = 8.5 Hz, 2H), 6.42-6.34 (m, 
3H), 5.44 (d, J = 2 Hz, 1H), 5.43 (d, J = 2 Hz, 1H), 4.50 (dd, J = 5, 2 Hz, 2H), 4.03 (s, 
3H), 3.88-3.82 (m, 2H), 3.80 (s, 3H), 3.59 (app t, J = 8 Hz, 2H), 1.91 (dd, J = 6.5, 1.5 Hz, 
3H), 1.24-1.17 (m, 5H), 1.15-1.13 (m, 18H), 0.99 (s, 9H), 0.91-0.88 (m, 2H), 0.03 (s, 
9H). 
 
HRMS (ESI+) 
 Calculated for C69H86O8Si3Na:  1149.5528   
Found:     1149.5552 
 
Deprotection of Library Members 
 
Deprotection condition 1 (for library members 5.56-5.59 and 5.62-5.67) 
To a 7-mL vial containing the protected library member and a PTFE-coated magnetic stir 
bar was added TBAF•3H2O (2.2–15 equiv) followed by 1:1 DMSO/DMPU under ambient 
atmosphere. The vial was sealed with a Teflon-lined cap and stirred at 50 C for 30 minutes–6 
hours. The reaction was then cooled to room temperature and diluted with a solution of 1:1 
saturated NH4Cl/H2O (1.5–2 mL). The layers were mixed and the aqueous layer was removed. 
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The organic layer was washed with H2O (2 × 1.5 mL). The combined aqueous phase was 
extracted with EtOAc (3 mL). The organic phase was dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo. The crude product was purified by silica gel chromatography to give the 
pure product as a white or off-white solid. 
 
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.14, visualized by shortwave UV.  
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.77 (br s, 1H), 7.83 (d, J = 8.5 Hz, 1H), 7.54 (d, J = 2.0 Hz, 1H), 7.41 (d, J = 8.5 Hz, 
1H), 7.29 (dd, J = 8.5, 2.0 Hz, 1H), 7.16 (d, J = 1.0 Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 
6.60 (dd, J = 8.0, 2.0 Hz, 1H), 6.51 (d, J = 16, 1.5 Hz, 1H), 6.25 (dq, J = 15.5, 7 Hz, 1H), 
3.99 (s, 3H), 1.86 (dd, J = 7.0, 2.0 Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.2, 154.2, 153.8, 134.0, 132.3, 131.3, 128.5, 124.5, 122.7, 118.7, 111.9, 
111.2, 108.5, 104.6, 100.2, 55.9, 18.6. 
 
HRMS (ESI+) 
 Calculated for C18H17O3:  281.1178 
 Found:   281.1181  
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TLC (30% EtOAc/hexanes) 
Rf = 0.3, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.73 (br s, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.13 (s, 1H), 7.11 (d, J = 1.0 Hz, 1H), 6.93 (d, 
J = 1.0 Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 6.60 (dd, J = 8.5, 2.0 Hz, 1H), 6.48 (dd, J = 16, 
1.5 Hz, 1H), 6.25 (dq, J = 16, 6.5 Hz, 1H), 4.03 (s, 3H), 3.98 (s, 3H), 1.86 (dd, J = 6.5, 
1.5 Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.1, 154.0, 145.9, 142.9, 135.0, 132.7, 132.6, 128.5, 124.6, 111.9, 111.6, 
108.5, 105.1, 104.8, 100.2, 56.4, 55.9, 18.6. 
 
HRMS (ESI+) 
 Calculated for C19H19O4:   311.1283 
Found:     311.1277 
 
 
 
TLC (50% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 8.78 (br s, 1H), 7.83 (d, J = 8.5 Hz, 1H), 7.61 (d, J = 1.5 Hz, 1H), 7.43 (d, J = 8.5 Hz, 
1H), 7.36 (dd, J = 9.0, 2.0 Hz, 1H), 7.18 (d, J = 0.5 Hz, 1H), 6.70 (d, J = 16.0 Hz, 1H), 
6.64 (d, J = 2.5 Hz, 1H), 6.60 (dd, J = 8.5, 2.5 Hz, 1H), 6.38 (dt, J = 16, 5.5 Hz, 1H), 4.25 
(t, J = 5.5 Hz, 2H), 3.99 (s, 3H), 3.84 (t, J = 5.5 Hz, 1H).  
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.1, 154.2, 153.9, 133.3, 131.3, 130.5, 129.6, 128.5, 123.0, 119.2, 111.8, 
111.2, 108.4, 104.5, 100.2, 63.4, 55.8. 
 
HRMS (ESI+) 
 Calculated for C18H17O4:   297.1127 
Found:     297.1128  
 
 
 
TLC (60% EtOAc/hexanes) 
Rf = 0.22, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6)   
δ 8.75 (br s, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.18 (d, J = 1.5 Hz, 1H), 7.15 (s, 1H), 6.99 (d, 
J = 1.0 Hz, 1H), 6.66 (dt, J = 17, 1.5 Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 6.60 (dd, J = 8.5, 
2.5 Hz, 1H), 6.38 (dt, J = 16, 5.5 Hz, 1H), 4.25 – 4.24 (m, 2H), 4.04 (s, 3H), 3.99 (s, 3H), 
3.84 (br s, 1H). 
 
13
C-NMR (125 MHz, acetone-d6) 
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δ 160.2, 159.1, 154.2, 146.0, 143.2, 134.4, 132.8, 130.9, 129.7, 128.5, 112.3, 111.9, 
108.5, 105.4, 104.8, 100.2, 63.4, 56.4, 55.9. 
 
HRMS (ESI+) 
 Calculated for C19H19O5:  327.1232 
 Found:   327.1223  
 
 
 
TLC (60% EtOAc/hexanes) 
Rf = 0.36, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.37 (dd, J = 2.5, 0.5 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 1.5 Hz, 1H), 7.52 
(d, J = 8.5 Hz, 1H), 7.50 (dd, J = 9.0, 3.0 Hz, 1H), 7.45 (dd, J = 8.5, 1.5 Hz, 1H), 7.33 (d, 
J = 1 Hz, 1H), 6.72 (dt, J = 15.5, 1.5 Hz, 1H), 6.41 (dt, J = 16.0, 5.5 Hz, 1H), 4.26 (t, J = 
8.0 Hz, 2H), 3.96 (s, 3H), 3.87 (br t, J = 5.0 Hz, 1H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 157.1, 156.6, 155.4, 142.4, 139.2, 133.8, 130.4, 130.2, 130.1, 124.1, 121.2, 120.9, 
119.8, 111.9, 103.5, 63.3, 56.2. 
 
HRMS (ESI+) 
 Calculated for C17H16NO3:  282.1130 
 Found:  282.1132 
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TLC (60% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 8.36 (dd, J = 2.5, 0.5 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.49 (dd, J = 9.0, 3.0 Hz, 1H), 
7.30 (s, 1H), 7.25 (d, J = 1.0 Hz, 1H), 7.08 (d, J = 1.5 Hz, 1H), 6.68 (app d, J = 15.5 Hz, 
1H), 6.41 (dt, J = 16, 5.5 Hz, 1H), 4.25 (t, J = 5.5 Hz, 2H), 4.06 (s, 3H), 3.95 (s, 3H), 
3.86 (br t, J = 5.5 Hz, 1H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 159.9, 156.5, 146.3, 144.6, 142.4, 139.2, 134.8, 131.8, 130.4, 130.2, 121.2, 120.8, 
112.6, 105.9, 103.8, 63.3, 56.3, 56.2. 
 
HRMS (ESI+) 
 Calculated for C18H18NO4:  312.1236 
 Found:  312.1239  
  
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.36, visualized by shortwave UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.96 (d, J = 8.5 Hz, 1H), 7.63 (d, J = 1.0 Hz, 1H), 7.47 (d, J = 8.5 Hz, 
1H), 7.38 (dd, J = 8.5, 1.5 Hz, 1H), 7.10 (s, 1H), 7.03 (dd, J = 8.5, 2.0 Hz, 1H), 6.98 (m, 
1H), 6.52 (dd, J = 15.5, 1.5 Hz, 1H), 6.28 (dq, J = 15.5, 6.5 Hz, 1H), 1.87 (dd, J = 6.5, 
1.5 Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 159.7, 154.2, 152.0, 147.2, 134.4, 131.9, 130.5, 130.0, 125.0, 123.7, 121.5 (JC-F = 257 
Hz), 119.1, 115.9, 115.7, 111.5, 109.3, 105.3, 18.5. 
 
HRMS (ESI+) 
 Calculated for C18H14O3F3: 335.0895  
 Found:  335.0889 
 
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 9.33 (br s, 1H), 7.96 (d, J = 9.0 Hz, 1H), 7.19 (d, J = 0.5 Hz, 1H), 7.07 (s, 1H), 7.03 
(dd, J = 8.5, 2.0 Hz, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.97 (m, 1H), 6.49 (dd, J = 15.5, 1.5 
Hz, 1H), 6.28 (dq, J = 16.0, 6.5 Hz, 1H), 4.04 (s, 3H), 1.86 (dd, J = 6.5, 3.0 Hz, 3H). 
 
13
C-NMR (125 MHz, acetone-d6) 
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δ 159.7, 151.7, 147.1, 146.0, 143.5, 135.4, 132.2, 131.9, 129.9, 125.0, 121.5 (JC-F = 256 
Hz), 115.9, 115.7, 111.8, 109.2, 105.8, 105.6, 56.3, 18.5. 
 
HRMS (ESI+) 
 Calculated for C19H16O4F3: 365.1001 
 Found:  365.0997 
 
 
 
TLC (40% EtOAc/hexanes) 
Rf = 0.21, visualized by shortwave UV.  
 
1
H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.97 (d, J = 8.5 Hz, 1H), 7.10 (d, J = 1.5 Hz, 1H), 7.50 (d, J = 8.5 Hz, 
1H), 7.44 (dd, J = 8.5, 2.0 Hz, 1H), 7.12 (d, J = 0.5 Hz, 1H), 7.04 (dd, J = 8.5, 2.5 Hz, 
1H), 6.98 (quint, J = 2 Hz, 1H), 6.72 (d, J = 16 Hz, 1H), 6.41 (dt, J = 16.0, 5.0 Hz, 1H), 
4.26 (d, J = 5.0 Hz, 2H), 3.84 (br s, 1H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 159.8, 154.4, 152.1, 147.2, 133.8, 130.6, 130.1, 130.0 (2C), 124.0, 121.5 (JC-F = 256 
Hz), 119.7, 115.9, 115.7, 111.6, 109.3, 105.3, 63.3. 
 
HRMS (ESI+) 
 Calculated for C18H14O4F3: 351.0844 
 Found:  351.0849 
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TLC (40% EtOAc/hexanes) 
Rf = 0.13, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.97 (d, J = 8.5 Hz, 1H), 7.26 (d, J = 0.5 Hz, 1H), 7.09 (s, 1H), 7.06 (d, 
J = 1.0 Hz, 1H), 7.04 (dd, J = 8.5, 2.5 Hz, 1H), 6.97 (m, 1H), 6.68 (d, J = 15.5 Hz, 1H), 
6.41 (dt, J = 16.0, 5.0 Hz, 1H), 4.26 (d, J = 5.0 Hz, 2H), 4.06 (s, 3H), 3.85 (br s, 1H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 159.7, 151.8, 147.1, 146.1, 143.7, 134.8, 131.9, 130.4, 130.1, 129.9, 121.5 (JC-F = 256 
Hz), 115.9, 115.7, 112.4, 109.2, 106.0, 105.6, 63.3, 56.4. 
 
HRMS (ESI+) 
 Calculated for C19H16O5F3: 381.0950 
 Found:  381.0946 
 
Deprotection condition 2 (for library members 5.69-5.72) 
To a 1-mL Reacti-vial
™
 containing the protected tetramer library member and a PTFE-
coated magnetic stir bar was added TBAF•3H2O (15-20 equiv) followed by DMSO under 
ambient atmosphere. The vial was sealed with a cap and stirred at 50 C for 5 hours. The reaction 
was then cooled to room temperature, diluted with 8 mL Et2O and washed with a solution of 1:1 
saturated NH4Cl/H2O (4 mL). The aqueous layer was extracted with 4 mL Et2O. The combined 
organic layers were washed with H2O (2 × 4 mL), then with brine (4 mL). The organic phase was 
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dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude product was 
purified by silica gel chromatography. 
 
 
 
TLC (40% EtOAc/pentane) 
Rf = 0.49, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.77 (s, 1H), 7.53 (d, J = 1.5 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.27 (dd, J = 8.5, 2.0 
Hz, 1H), 7.18-7.17 (m, 3H), 6.82 (dd, J = 6.5, 3.0 Hz, 1H), 6.68 (s, 1H), 6.50 (dd, J = 
16.0, 1.5 Hz, 1H), 6.31 (dd, J = 15.5, 1.5 Hz, 1H), 6.24 (dq, J = 16.0, 6.5 Hz, 1H), 6.05 
(dq, J = 15.5, 7.0 Hz, 1H), 5.69 (d, J = 2.5 Hz, 1H), 5.66 (d, J = 2.5 Hz, 1H), 3.99 (s, 3H), 
1.85 (dd, J = 6.5, 1.5 Hz, 1H), 1.78 (dd, J = 6.5, 1.5 Hz, 1H). 
 
HRMS (ESI+) 
 Calculated for C29H27O4:  439.1909 
 Found:   439.1904 
 
 
 
TLC (40% EtOAc/pentane) 
Rf = 0.46, visualized by shortwave UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 7.81 (s, 1H), 7.18-7.14 (m, 3H), 7.10 (d, J = 1.0 Hz, 1H), 6.90 (d, J = 1.0 Hz, 1H), 6.82 
(dd, J = 7.5, 1.5 Hz, 1H), 6.67 (s, 1H), 6.46 (dd, J = 16, 1.5 Hz, 1H), 6.30 (dd, J = 15.5, 
1.0 Hz, 1H), 6.24 (dq, J = 15.5, 6.5 Hz, 1H), 6.04 (dq, J = 15.5, 6.5 Hz, 1H), 5.70 (d, J = 
1.5 Hz, 1H), 5.67 (d, J = 2.0 Hz, 1H), 3.98 (s, 3H), 3.96 (s, 3H), 1.85 (dd, J = 7.0. 2.0 Hz, 
3H), 1.78 (dd, J = 6.5, 1.5 Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C30H29O5:  469.2015 
 Found:  469.2014 
 
 
 
The yield of the deprotection of 5.71 was determined by 
1
H-NMR using an internal 
standard. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.78 (s, 1H), 7.60 (d, J = 1 Hz, 1H), 7.40 (d, J = 8 Hz, 1H), 7.33 (dd, J = 8.5, 1.5 Hz, 
1H), 7.19-7.17 (m, 3H), 6.82 (d, J = 9 Hz, 1H), 6.70-6.68 (m, 2H), 6.37 (dt, J = 16, 5.5 
Hz, 1H), 6.31 (dd, J = 15.5, 1 Hz, 1H), 6.05 (dq, J = 15.5, 6.5 Hz, 1H), 5.69 (d, J = 2 Hz, 
1H), 5.66 (d, J = 2 Hz, 1H), 4.24 (dd, J = 5, 2 Hz, 2H), 3.99 (s, 3H), 1.78 (dd, J = 6.5, 1.5 
Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C29H27O5:  455.1858 
 Found:   455.1866 
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TLC (40% EtOAc/pentane) 
Rf = 0.48, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.81 (s, 1H), 7.18 – 7.14 (m, 4H), 6.97 (d, J = 1.0 Hz, 1H), 6.82 (dd, J = 7.0, 1.5 Hz, 
1H), 6.67 – 6.63 (m, 2H), 6.37 (dt, J = 16, 5.5 Hz, 1H), 6.30 (dd, J = 15.5, 1.5 Hz, 1H), 
6.04 (dq, J = 16.0, 7.0 Hz, 1H), 5.69 (d, J = 2.0 Hz, 1H), 5.66 (d, J = 2.0 Hz, 1H), 4.23 
(d, J = 4.5 Hz, 2H), 3.98 (s, 3H), 3.98 (s, 3H), 1.78 (dd, J = 6.5, 2.0 Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C30H29O6:  485.1964 
 Found:   485.1952 
 
Deprotection condition 3 (for library members 5.73-5.75) 
To a 1-mL Reacti-vial
™
 containing the protected library member and a PTFE-coated 
magnetic stir bar was added CsF (25-30 equiv) and 18-crown-6 (2 equiv) followed by DMSO in 
a glovebox. The vial was sealed with a cap and stirred at 50 C for 14 hours. The reaction was 
then cooled to room temperature, diluted with 8 mL EtOAc and washed with a solution of 1:1 
saturated NH4Cl/H2O (8 mL). The aqueous layer was extracted with 4 mL EtOAc. The combined 
organic layers were washed with H2O (2 × 4 mL), then with brine (8 mL). The organic phase was 
dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude product was 
purified by silica gel chromatography. 
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TLC (40% EtOAc/pentane) 
Rf = 0.39, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.85 (app d, J = 9.0 Hz, 2H), 7.81 (s, 1H), 7.43 (dd, J = 8.5, 2.5 Hz, 1H), 7.33 (d, J = 
2.5 Hz, 1H), 7.18 (d, J = 8.5 Hz, 1H), 7.12 – 7.10 (m, 2H), 6.92 (d, J = 1.5 Hz, 1H), 6.84 
(app d, J = 9.0 Hz, 2H), 6.55 (s, 1H), 6.49 – 6.42 (m, 2H), 6.30 – 6.21 (m, 2H), 5.62 (d, J 
= 2.0 Hz, 1H), 5.58 (d, J = 1.5 Hz, 1H), 3.97 (s, 3H), 3.96 (s, 3H), 1.86 (dd, J = 6.5, 1.5 
Hz, 3H), 1.83 (dd, J = 7.0, 2.0 Hz, 3H). 
 
HRMS (ESI+) 
 Calculated for C37H33O7:   589.2226 
Found:     589.2224 
 
 
 
TLC (60% EtOAc/pentane) 
Rf = 0.24, visualized by shortwave UV. 
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1
H-NMR (500 MHz, acetone-d6) 
δ 7.82 (app d, J = 8.5 Hz, 2H), 7.77 (s, 1H), 7.60 (d, J = 1.5 Hz, 1H), 7.43 (dd, J = 8.0, 
2.0 Hz, 1H), 7.40 (d, J = 8.0 Hz, 1H), 7.35-7.33 (m, 2H), 7.17 (d, J = 8.5 Hz, 1H), 7.15 
(d, J = 1.0 Hz, 1H), 6.83 (app d, J = 9.0 Hz, 2H), 6.69 (app d, J = 16.0 Hz, 1H), 6.56 (s, 
1H), 6.44 (d, J = 16 Hz, 1H), 6.38 (dt, J = 16.0, 5.5 Hz, 1H), 6.27 (dq, J = 16, 6.5 Hz, 
1H), 5.61 (d, J = 1.5 Hz, 1H), 5.58 (d, J = 2.0 Hz, 1H), 4.25-4.24 (m, 2H), 3.97 (s, 3H), 
1.84 (dd, J = 6.5, 1.5 Hz, 3H).  
 
HRMS (ESI+) 
 Calculated for C36H31O7:   575.2070 
Found:     575.2070 
 
 
 
TLC (60% EtOAc/pentane) 
Rf = 0.23, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.85 (dt, J = 8.5, 2.0 Hz, 2H), 7.81 (s, 1H), 7.43 (dd, J = 8.0, 2.0 Hz, 1H), 7.33 (d, J = 
2.0 Hz, 1H), 7.18-7.17 (m, 2H), 7.13 (s, 1H), 6.98 (s, 1H), 6.84 (dt, J = 9.0, 2.0 Hz, 2H), 
6.66 (app d, J = 16.0 Hz, 1H), 6.55 (s, 1H), 6.44 (dd, J = 16.5, 1.5 Hz, 1H), 6.37 (dt, J = 
16.0, 5.5 Hz, 1H), 6.27 (dq, J = 16.0, 6.5 Hz, 1H), 5.62 (d, J = 1.5 Hz, 1H), 5.58 (d, J = 
1.5 Hz, 1H), 4.25-4.24 (m, 2H), 3.99 (s, 3H), 3.96 (s, 3H), 1.83 (dd, J = 6.5, 1.5 Hz, 3H).  
 
HRMS (ESI+) 
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 Calculated for C37H33O8:   605.2175 
Found:     605.2167 
 
Manual synthesis of building blocks for (+)-crocacin C (5.31) 
  
 
Conditions: (a) 3-(trimethylsilyl)propiolaldehyde, Sn(OTf)2, NEt3, CH2Cl2, -78 
o
C, 2 h; (b) Me4NBH(OAc)3, 
MeCN/AcOH 2:1, -25 
o
C, 16 h; (c) Me3OBF4, proton sponge, CH2Cl2, 23 
o
C, 2.5 h; (d) (NH4)2Ce(NO3)6, 
MeCN/H2O, 10:1, 23 
o
C, 1 h; (e) Dess-Martin periodinane, CH2Cl2, 0 
o
C to 23 
o
C, 1.5 h; (f) CHI3, CrCl2, THF, 0 
o
C 
to 23 
o
C, 3 h. (g) n-BuLi, THF, B(OMe)3, -78 
o
C; 1N HCl; (h) N-methyliminodiacetic acid, benzene/DMSO 10:1, 80 
o
C, 2 h; (i) AgNO3, 2,6-lutidine, acetone/H2O 1:1, 0 
o
C, 2.5 h; (j) HSnBu3, Pd2dba3, RuPhos, CH2Cl2, 23 
o
C; (k) I2, 
CH2Cl2, 23 
o
C. 
 
 
 
Manual synthesis of β-hydroxyketone 5.77  
To a 500-mL Schlenk flask charged with Sn(OTf)2 (112.5 mmol, 46.9 g) was added 
CH2Cl2 (500 mL) and triethylamine (120 mmol, 16.7 mL) dropwise. The resulting orange-brown 
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suspension was cooled to -78 °C. To the stirred mixture was added (S)-1-(p-methoxybenzyloxy)-
2-methylpentan-3-one (5.76)
5
 (75.0 mmol, 17.8 g, 2.00 mL) as a neat liquid over 15 minutes. 
The mixture was stirred for 2 hours at -78 °C. To the mixture was added 3-
(trimethylsilyl)propiolaldehyde
6
 (112.5 mmol, 14.2 g) as a neat liquid over 20 minutes. The 
mixture was stirred for an additional 3 hours at -78 °C. The reaction was quenched by pouring 
the mixture slowly into saturated aqueous NH4Cl (300 mL) cooled in an ice bath, rinsing with 
additional CH2Cl2. The mixture was stirred vigorously for 10 minutes and then filtered through 
Celite™ to remove the tin(II) salts. The filtrate was transferred to a 2-L separatory funnel and the 
phases separated. The organic phase was washed with saturated aqueous NH4Cl (200 mL). The 
combined aqueous phases were extracted with CH2Cl2 (200 mL). The combined organic phases 
were washed with H2O (200 mL), dried over anhydrous MgSO4, filtered and concentrated in 
vacuo to afford a yellow-brown oil. This residue was subjected to flash chromatography on silica 
gel (EtOAc:hexanes 8:100 → 20:100) to afford 5.77 as a colorless oil (36.71 g, 73%). 
 
 
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.22, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.5 (app d, J = 8.5 Hz, 2H), 6.87 (app d, J = 8.5 Hz, 2H), 4.78 (d, J = 3.5 Hz, 1H), 4.43 
(d, J = 11.5 Hz, 1H), 4.36 (d, J = 11.5 Hz, 1H), 3.79, (s, 3H), 3.58 (app t, J = 9 Hz, 1H), 
3.41 (dd, J = 9, 5 Hz, 1H), 3.14 (m, 1H), 2.92, (dq, J = 7.5, 3 Hz, 1H), 1.26 (d, J = 7.5 
Hz, 3H), 1.01 (d, J = 7 Hz, 3H), 0.17 (s, 9H) 
 
13
C-NMR (125 MHz, CDCl3) 
δ 216.1, 159.3, 129.5, 129.3, 113.8, 104.0, 90.2, 73.1, 63.3, 55.2, 51.7, 44.7, 13.5, 10.5, -
0.2 
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HRMS (ESI+) 
 Calculated for C20H30O4NaSi: 385.1811 
 Found:   385.1808 
 
 
 
Manual synthesis of diol 5.78 
To a 1-L, 3-neck, round-bottom flask charged with tetramethylammonium 
triacetoxyborohydride (298 mmol, 78.30 g) was added dry acetic acid (240 mL) and MeCN (400 
mL). The resulting homogeneous solution was cooled to -30 °C and stirred for 30 minutes. To 
the stirred solution was added β-hydroxyketone 5.77 (71.6 mmol, 25.95 g), dropwise over 1 
minute, as a solution in MeCN (50 mL + 50 mL rinse). The solution was stirred and allowed to 
slowly warm to 0 °C over 13 hours. The reaction was then poured into aqueous dibasic sodium 
tartrate solution (0.5 M, 400 mL) and stirred for 1 hour. The solution was transferred into a 
separatory funnel, and Et2O was added. After mixing and phase separation, the aqueous layer 
was extracted with Et2O. The combined organic phase was washed with saturated aqueous 
NaHCO3 (2 × 200 mL), then brine (20 mL). The organic phase was dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo. Toluene was added to azeotrope most of the 
remaining acetic acid prior to silica gel purification. The residue obtained after concentration was 
subjected to flash chromatography on silica gel (EtOAc:hexanes:AcOH 10:90:2 → 20:80:2) to 
afford 5.78 as a pale yellow oil (18.51 g, 71%).  Chromatographic purification was carried out 
again to obtain an analytically pure sample (colorless oil). 
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TLC (30% EtOAc/hexanes) 
Rf = 0.39, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 7.22 (app d, J = 8.5 Hz, 2H), 6.87 (app d, J = 8.5 Hz, 2H), 4.65 (d, J = 2.5 Hz, 1H), 
4.46 (d, J = 11 Hz, 1H), 4.45 (d, J = 11.5 Hz, 1H), 3.80, (s, 3H), 3.73-3.68 (m, 2H), 3.45 
(dd, J = 9.5, 5.5 Hz, 1H), 2.00-1.94, (m, 2H), 1.03 (t, J = 7 Hz, 6H), 0.17 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 159.4, 129.4, 129.3, 113.9, 105.6, 89.6, 80.1, 73.6, 73.4, 66.0, 55.2, 40.6, 34.9, 14.8, 
12.8, -0.1. 
 
HRMS (ESI+) 
 Calculated for C20H33O4Si: 365.2148 
 Found:   365.2152 
 
 
 
Manual synthesis of per-methylated diol 5.79 
To a 1-L Schlenk flask charged with diol 5.78 (25.8 mmol, 9.40 g) was added CH2Cl2 
(450 mL). To the stirred solution was added Proton Sponge (141.9 mmol, 38.70 g) as a solid in 
one portion, then trimethyloxonium tetrafluoroborate (180.6 mmol, 38.70 g) as a solid in one 
portion. The mixture was stirred at 23 °C for 16 hours. The orange mixture was filtered and the 
solid was rinsed with additional CH2Cl2 (100 mL). The filtrate was concentrated in vacuo to ~50 
mL, during which a solid precipitated. To this suspension was added Et2O (300 mL), mixed and 
filtered, rinsing with 150 mL Et2O. The filtrate was transferred to a 1-L separatory funnel and 
washed with 0.5 M HCl (2 × 250 mL). The aqueous phase was extracted with 100 mL Et2O. The 
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combined organics were neutralized with saturated aqueous NaHCO3 (200 mL) and washed with 
brine, dried over anhydrous MgSO4, filtered and concentrated to give a yellow oil.  The oil was 
subjected to flash chromatography on silica gel (EtOAc:hexanes 1:20 → 1:10) to afford 5.79 as a 
colorless oil (5.37 g, 53%). 
 
 
 
TLC (10% EtOAc/hexanes) 
Rf = 0.33, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3)  
δ 7.25 (app d, J = 8.5 Hz, 2H), 6.89 (app d, J = 8.5 Hz, 2H), 4.44 (d, J = 11.5 Hz, 1H), 
4.38 (d, J = 11.5 Hz, 1H), 4.21 (d, J = 3 Hz, 1H), 3.80, (s, 3H), 3.57 (dd, J = 9.5, 5 Hz, 
1H), 3.41 (s, 3H), 3.39, (s, 3H), 3.27 (dd, J = 9.0, 8.0 H, 1H), 3.13 (dd, J = 10.0, 2.5 Hz, 
1H), 2.10 – 2.04, (m, 1H), 1.94 – 1.88 (m, 1H), 1.09 (d, J = 7.0 Hz, 3H), 1.01 (d, J = 7.5 
Hz, 3H), 0.18 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 160.0, 130.8, 129.0, 113.7, 104.7, 90.9, 85.1, 72.7, 72.0, 71.3, 61.2, 56.5 (2C), 55.2, 
41.7, 35.7, 16.4, 11.3, 0.0. 
 
HRMS (ESI+) 
 Calculated for C22H36O4NaSi: 415.2281 
 Found:   415.2272 
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Manual synthesis of alcohol 5.80 
To a stirred solution of 5.79 in MeCN and H2O was added ceric ammonium nitrate (1.844 
mmol, 1.011 g) portion wise over 15 minutes under ambient atmosphere and temperature. The 
solution was stirred for 60 minutes. at 23 °C, then diluted with Et2O (100 mL) and washed H2O 
(150 mL) and saturated NaHSO3 (2 × 150 mL). The combined aqueous layer was extracted with 
Et2O (100 mL). The organic phase was dried over anhydrous MgSO4, filtered and concentrated. 
The resulting oil was subjected to flash chromatography on silica gel (EtOAc:CH2Cl2 0:100 → 
20:100) to afford 5.80 as a colorless oil (202 mg, 77%). 
 
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.37, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 4.23 (d, J = 3 Hz, 1H), 3.86 (d, J = 11, 3 Hz, 1H), 3.53 (dd, J = 11.5, 4.5 Hz, 1H), 3.46, 
(s, 3H), 3.40 (s, 3H), 3.24 (dd, J = 10, 2 Hz, 1H), 2.01-1.95 (m, 1H), 1.88-1.82, (m, 1H), 
1.18 (d, J = 7.5 Hz, 3H), 0.99 (d, J = 7 Hz, 3H), 0.18 (s, 9H) 
 
13
C-NMR (125 MHz, CDCl3) 
 δ 104.3, 91.4, 87.7, 71.8, 64.4, 61.4, 56.4, 42.1, 35.6, 16.1, 11.2, -0.1 
 
HRMS (ESI+) 
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 Calculated for C14H28O3NaSi: 295.1705 
 Found:   295.1708 
 
 
 
Manual synthesis of aldehyde 5.81 
To a solution of alcohol 5.80 (15.15 mmol, 4.13 g) in CH2Cl2 (150 mL) in a 300-mL 
round-bottom flask cooled to 0 °C was added Dess-Martin periodinane (30.3 mmol, 12.86 g) 
portionwise over 5 minutes, under ambient atmosphere. The reaction was stirred for 10 minutes 
after the addition was complete, then the ice/water bath was removed. The reaction was stirred 
for another 75 minutes, and then transferred to a separatory funnel. The mixture was extracted 
with 1:1 saturated NaHCO3/1.5 M Na2S2O3 (6 × 50 mL) until TLC indicated that all byproducts 
have been removed. The aqueous phase was then extracted with CH2Cl2 (100 mL), and the 
combined organic phases were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated at 27 °C. The resulting oil (5.81) was dried briefly under high vacuum (~15 
minutes), then used immediately for the next reaction. 
 
 
 
Manual synthesis of iodide 5.82  
To a 500-mL Schlenk flask charged with anhydrous CrCl2 (242.4 mmol, 29.81 g) was 
added THF (250 mL) and cooled to 10 °C in an ice/water bath. With the exclusion of light, to the 
stirred suspension was added slowly over 15 minutes via cannula a solution of aldehyde 5.81 
(assumed 15.15 mmol) and CHI3 (75.75 mmol, 29.83 g) in THF (80 mL). The resulting red 
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mixture was stirred at 23 °C for 2 hours. The mixture was filtered through Celite™ and washed 
with Et2O (300 mL). The dark-colored solution was transferred to a separatory funnel and 
washed with H2O (2 x 200 mL), brine, then dried over anhydrous MgSO4, filtered and 
concentrated to give a black residue. The residue was absorbed onto Celite™ in vacuo from an 
acetone solution. The resulting powder was subjected to flash chromatography on silica gel 
(hexanes:EtOAc 100:0 → 20:100). The product obtained after chromatography was stirred with 
saturated Na2SO3 and passed through a pad of Darco® to remove residual iodine to afford 5.82 
as a pale yellow oil (4.06 g, 68% over 2 steps). 
 
 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.52, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.55 (dd, J = 15, 9.5 Hz, 1H), 6.02 (dd, J = 15, 1 Hz, 1H), 4.23 (d, J = 2 Hz, 1H), 3.43, 
(s, 3H), 3.39 (s, 3H), 3.04 (dd, J = 10, 2 Hz, 1H), 2.49-2.43 (m, 1H), 1.72-1.65 (m, 1H), 
1.13 (d, J = 6.5 Hz, 3H), 0.94 (d, J = 7 Hz, 3H), 0.19 (s, 9H) 
 
13
C-NMR (125 MHz, CDCl3) 
 δ 147.3, 104.3, 91.3, 85.1, 75.1, 71.8, 61.3, 56.4, 43.2, 42.1, 18.1, 10.8, -0.0 
 
HRMS (ESI+) 
 Calculated for C15H27O2NaISi: 417.0723 
 Found:   417.0741 
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Manual synthesis of boronic acid  5.83 
In an unoptimized procedure, a dry 200-mL Schlenk flask was charged with THF (46 
mL) and iodide 5.82 in 10 mL THF. The solution was cooled to -78 °C and n-BuLi (1.6 M in 
hexanes, 12.3 mmol, 7.7 mL) was added dropwise via cannula over 15 minutes, during which the 
reaction turned yellow. The reaction was stirred at -78 °C for 25 minutes, then trimethylborate 
(13.45 mmol, 1.5 mL) was added neat in one portion. Stirring was continued at -78 °C for 20 
minutes and then the cooling bath was removed. The reaction was slowly warmed to 23 °C over 
2 hours. The reaction was poured into a 1 N HCl solution (200 mL) pre-cooled to 0 °C and 
stirred for 15 minutes. The mixture was transferred to a separatory funnel, rinsing with 100 mL 
Et2O. The mixture was shaken and the phases were separated. The aqueous phase was extracted 
with Et2O (2 × 50 mL). The combined organics were washed with H2O (50 mL), brine, dried 
over anhydrous MgSO4, filtered and concentrated to give a yellow oil (5.83), which was diluted 
with toluene (30 mL) and used directly in the next step. 
 
 
 
Manual synthesis of vinyl MIDA boronate 5.84 
To a solution of the boronic acid 5.83 in toluene (50 mL) and DMSO (5 mL) was added 
N-methyliminodiacetic acid (1.45 g, 9.84 mmol). The round-bottom flask was fitted with a 
Dean-Stark trap and a reflux condenser and refluxed for 4 hours. The reaction was cooled to 23 
°C and transferred into 1:1 saturated NaCl/H2O (50 mL). The organic phase was washed with 
another 50 mL 1:1 saturated NaCl/H2O. The combined aqueous phase was washed with Et2O (2 
× 50 mL), and the organic layer was dried over anhydrous MgSO4, filtered, and concentrated. 
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The residue was purified by flash column chromatography on silica gel (Et2O:acetone 100:0 → 
1:2) to give 5.84 as a white solid (1.74 g, 50% over 2 steps). 
 
 
 
TLC (acetone/hexane 1:1) 
Rf = 0.47, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.24 (dd, J = 18, 8 Hz, 1H), 5.41 (dd, J = 18, 1 Hz, 1H), 4.21 (d, J = 3 Hz, 1H), 3.82 
(d, J = 16.5 Hz, 2H), 3.66 (dd, J = 16.5, 3 Hz, 2H), 3.40 (s, 3H), 3.38 (s, 3H), 3.08 (dd, J 
= 10, 2 Hz, 1H), 2.80, (s, 3H), 2.52-2.49 (m, 1H), 1.68-1.61 (m, 1H), 1.13 (d, J = 7 Hz, 
3H), 0.95 (d, J = 7 Hz, 3H), 0.17 (s, 9H) 
 
13
C-NMR (125 MHz, CDCl3) 
δ 167.6, 167.5, 148.9, 104.8, 91.3, 85.6, 72.1, 61.6, 61.2, 56.8, 46.9, 42.8, 42.1, 18.2, 
11.2, 0.2 
 
HRMS (ESI+) 
 Calculated for C20H35BNO6Si: 424.2327 
 Found:   424.2329  
 
 
 
Manual synthesis of vinyl MIDA boronate 5.85 
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To a solution of alkyne 5.84 in acetone/H2O/lutidine (10:10:1, 84 mL) at 0 °C was added 
AgNO3 in one portion. The reaction was gradually allowed to warm to 23 °C over 2.5 hours. The 
reaction was quenched by transferring the mixture into saturated aqueous NH4Cl (100 mL) and 
diluted with EtOAc (50 mL). The mixture was filtered to remove the insoluble salts. The filtrate 
was transferred to a separatory funnel and the phases were separated. The organic phase was 
washed with 0.5 M HCl (2 × 50 mL) and the aqueous phase extracted with EtOAc (50 mL). The 
organic layer was washed with brine, dried over anhydrous MgSO4, filtered and concentrated to 
afford a white foam. The foam was dissolved in Et2O (~10 mL), then 20% Et2O/hexane (30 mL) 
was added and the suspension was filtered, washing with additional 20% Et2O/hexane (20 mL). 
The filtrate was concentrated in vacuo to give 5.85 as a white solid (1.22 g, 87%) 
 
 
 
TLC (acetone/hexane 1:1) 
Rf = 0.34, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.24 (dd, J = 17.5, 8 Hz, 1H), 5.41 (dd, J = 17.5, 1 Hz, 1H), 4.23 (t, J = 2 Hz, 1H), 
3.79 (d, J = 16 Hz, 2H), 3.66 (dd, J = 16, 1.5 Hz, 2H), 3.42 (s, 3H), 3.40 (s, 3H), 3.09 
(dd, J = 10, 2.5 Hz, 1H), 2.81, (s, 3H), 2.55-2.47 (m, 1H), 2.40 (d, J = 2 Hz, 1H), 1.69-
1.61 (m, 1H), 1.14 (d, J = 7 Hz, 3H), 0.96 (d, J = 7 Hz, 3H) 
 
13
C-NMR (125 MHz, CDCl3) 
δ 168.1, 168.0, 148.1, 85.3, 82.6, 74.3, 71.2, 61.4, 61.0, 56.6, 46.9, 42.5, 41.9, 18.0, 10.7 
 
HRMS (ESI+) 
 Calculated for C17H27BNO6: 352.1931 
 Found:   352.1933 
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Manual synthesis of vinyl MIDA boronate 5.86 
Preparation of catalyst stock solution. A dry 7-mL vial equipped with a PTFE-coated 
magnetic stir bar was charged with RuPhos
7
 (9.3 mg, 0.02 mmol). The vial was brought into the 
glovebox, and Pd2dba3 (4.6 mg, 0.005 mmol) was added. CH2Cl2 (3 mL) was added, and the 
mixture was stirred at 23
 
°C for 25 minutes. 
The freshly prepared catalyst stock solution was used immediately for the preparation of 
5.86: A dry 20-mL vial equipped with a PTFE-coated magnetic stir bar was charged with alkyne 
5.85 (176 mg, 0.5 mmol). The vial was evacuated and filled with argon (x 3), then CH2Cl2 (5 
mL) was then added, followed by the catalyst stock solution, rinsing with CH2Cl2 (2 mL). 
Tributyltin hydride (0.27 mL, 1.00 mmol) was added neat dropwise to the reaction under argon 
at 23 °C, over 1 hour 25 minutes. The reaction was stirred at 23 °C for 2 hours after the addition 
was complete. The reaction was concentrated in vacuo and purified by silica gel chromatography 
(10% to 50% acetone/hexanes). The yellow solid obtained after concentration was dissolved in 
10% acetone/hexanes and passed through a pad of Darco® and Celite™ to give a colorless 
solution. The solution was concentrated in vacuo to give 5.86 as an off-white solid (255 mg, 
79%). 
 
 
 
TLC (acetone/hexane 1:1) 
Rf = 0.47, stained by KMnO4 
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1
H-NMR (500 MHz, CDCl3) 
δ 6.27 (dd, J = 18, 7.5 Hz, 1H), 6.12, (d, J = 19 Hz, 1H), 5.84, (dd, J = 19, 6 Hz, 1H), 
5.38 (d, J = 18 Hz, 1H), 3.83-3.82 (m, 1H), 3.79 (dd, J = 16.5, 3 Hz, 2H), 3.65 (d, J = 
16.5 Hz, 2H), 3.46-3.44 (m, 1H), 3.44 (s, 3H), 3.26 (s, 3H), 3.11 (dd, J = 9.5, 2.5 Hz, 
1H), 2.78, (s, 3H), 2.55-2.47 (m, 1H), 1.53-1.47 (m, 6H), 1.31 (sext, J = 7.5 Hz, 6H), 
1.13 (d, J = 6.5 Hz, 3H), 0.91-0.87 (m, 15H), 0.77 (d, J = 7.5 Hz, 3H) 
 
13
C-NMR (125 MHz, CDCl3) 
δ 167.4, 149.1, 147.5, 130.4, 86.1, 84.0, 61.4, 60.8, 56.4, 46.6, 42.0, 41.7, 29.1, 27.2, 
18.1, 13.7, 9.8, 9.4. 
 
LRMS (ESI+) 
 Calculated for C29H55BNO6Sn: 644.3 
 Found:   644.3 
 
 
 
Manual synthesis of MIDA boronate 5.28 
To a solution of stannane 5.86 (1.387 g, 2.16 mmol) in CH2Cl2 (20 mL) in a 50-mL 
round-bottom flask was added dropwise a solution of I2 (0.576 g, 2.27 mmol) in CH2Cl2 (30 mL) 
via a pressure-equalizing funnel at 0 °C under ambient atmosphere over 1 hour. The funnel was 
rinsed with CH2Cl2 (10 mL) and the solution added portion wise to the reaction. The ice bath was 
removed and the reaction was allowed to gradually warm to 23 °C over 1 hour. The reaction was 
transferred into a 250-mL separatory funnel, rinsing with additional CH2Cl2. The organic layer 
was washed with 2 × 30 mL 1 M Na2S2O5 solution, then with 2 × 25 mL 3 M KF solution. The 
combined aqueous layer was extracted with 25 mL CH2Cl2. The organic phase was dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (1:6 to 2:3 acetone/hexanes) to give 5.28 as a white solid (0.827 g, 80%). 
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TLC (acetone/hexane 1:1) 
Rf = 0.32, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 6.46 (dd, J = 14.5, 7 Hz, 1H), 6.26, (d, J = 14.5 Hz, 1H), 6.19, (dd, J = 17.5, 7.5 Hz, 
1H), 5.39 (d, J = 17.5 Hz, 1H), 3.94 (d, J = 16.5 Hz, 2H), 3.88-3.87 (m, 1H), 3.68 (dd, J 
= 16.5, 4.5 Hz, 2H), 3.42 (s, 3H), 3.26 (s, 3H), 3.07 (dd, J = 9.5, 1.5 Hz, 1H), 2.80, (s, 
3H), 2.55-2.47 (m, 1H), 1.12 (d, J = 7.0 Hz, 3H), 1.50-1.45 (m, 1H), 0.76 (d, J = 7.0 Hz, 
3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 167.7, 167.6, 148.5, 145.8, 85.8, 82.8, 61.4, 61.0, 56.7, 46.8, 41.8, 41.6, 18.0, 9.8. 
 
HRMS (ESI+) 
 Calculated for C17H28BNO6I: 480.1054 
 Found:   480.1053 
 
Manual synthesis of building blocks for all-trans-retinal ketal (5.41) 
 
 
 
Manual synthesis of  MIDA boronate 5.37 
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The following reaction was run in duplicate. In a glovebox, to a 40-mL vial charged with 
vinyl iodide 5.87
8
 (914 mg, 3.66 mmol, 1.2 equiv.) and bisborylated diene 5.88
9
 (1064 mg, 3.05 
mmol, 1.0 equiv.) was added PdCl2(dppf)•CH2Cl2 (125 mg, 0.153 mmol, 5 mol%), finely ground 
anhydrous K3PO4 (3884 mg, 18.3 mmol, 6.0 equiv.), and DMSO (20 mL, 0.15 M). The vial was 
sealed with a PTFE-lined cap and removed from the glovebox. The vial was placed in a 45 °C 
aluminum heat block and maintained at that temperature with stirring for 24 hours. The reaction 
was cooled to 23 °C and transferred to a separatory funnel, diluting with EtOAc (50 mL). The 
organic layer was washed with brine:H2O (1:1, 2 x 50 mL) to remove DMSO, dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo. The crude material was adsorbed onto 
Celite™ from an acetone solution and purified by silica gel chromatography (hexanes:EtOAc 1:1 
→ EtOAc) to afford trienyl MIDA boronate 5.37 as a pale yellow solid (1.0 g, 48%). 
 
 
 
TLC (EtOAc) 
 Rf = 0.45, stained by KMnO4 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 6.17 (d, J = 16.5 Hz, 1H), 6.11 (d, J = 16.5 Hz, 1H), 5.34 (s, 1H), 4.21 (d, J = 16.5 
Hz, 2H), 4.04 (d, J = 17.0 Hz, 2H), 3.03 (s, 3H), 1.98 (s, 3H), 1.98-2.01 (m, 2H), 1.67 
(s, 3H), 1.58-1.62 (m, 2H), 1.45-1.47 (m, 2H), 1.00 (s, 6H). 
 
11
B-NMR (128 MHz, acetone-d6) 
 δ 15.8. 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 169.0, 148.7, 141.2, 138.3, 129.3, 127.1, 62.3, 47.3, 40.2, 34.7, 33.4, 29.2, 21.8, 19.8, 
15.4. 
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HRMS (ESI+) 
 Calculated for C19H29O4NB:  346.2190 
 Found:     346.2192 
 
 
 
 
 
Manual synthesis of aldehyde 5.90
10
   
Crotyl alcohol 5.89
11,12
 (1.08 g, 5.54 mmol, 1.0 equiv.) and activated MnO2 (14 g, 30 
equiv.) was charged in a 100-mL round-bottom flask equipped with a PTFE-coated magnetic stir 
bar and topped with a rubber septum and purged with N2. Dichloromethane (50 mL, 0.11 M) was 
added to the round-bottom flask and the resulting reaction mixture was stirred at 23 °C for 45 
minutes. After 45 minutes, the reaction mixture was filtered through a plug of silica gel and 
Celite™ and concentrated in vacuo to afford aldehyde 5.90 as a yellow oil (500 mg, 46% yield). 
 
 
 
TLC (petroleum ether:diethyl ether 4:1) 
 Rf = 0.51, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
 δ 9.79 (d, J = 6.5 Hz, 1H), 6.84-6.86 (m, 1H), 3.00 (s, 3H). 
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13
C-NMR (125 MHz, CDCl3) 
 δ 185.9, 141.8, 126.1, 29.9 
 
HRMS (ESI+) 
Calculated for C4H6OI: 196.9463 
Found:    196.9468 
  
 
 
Manual synthesis of vinyl iodide 5.40  
Aldehyde 5.90 (150 mg, 0.77 mmol, 1.0 equiv.), neopentyl glycol (797 mg, 7.7 mmol, 
10.0 equiv.), and p-toluene sulfonic acid (15 mg, 0.08 mmol, 0.1 equiv.) was charged in a 40-mL 
vial equipped with a PTFE-coated magnetic stir bar. The vial was sealed with a PTFE-lined cap 
and purged with N2. Dichloromethane (15 mL, 0.05 M) was added to the vial and the resulting 
mixture was stirred for 1 minutes until homogeneous. Activated 4 Å powdered molecular sieves 
(300 mg, 2:1 weight ratio to aldehyde) were added to the vial to afford a cloudy white solution. 
The resulting reaction mixture was stirred at 40 °C for 24 hours. After 24 hours, the reaction 
mixture was filtered through a filter funnel and concentrated in vacuo. The resulting white solid 
was adsorbed onto Celite™ from an acetone solution and purified by silica gel chromatography 
(4:1 petroleum ether:ether) to afford vinyl iodide 5.40 as a pale yellow oil (150 mg, 69%). 
 
 
 
TLC (petroleum ether:diethyl ether 4:1) 
 Rf = 0.71, stained by KMnO4 
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1
H-NMR (500 MHz, CDCl3) 
δ 6.27 (d, J = 6.0 Hz, 1H), 5.02 (d, J = 6.0 Hz, 1H), 3.64 (d, J = 11.5 Hz, 2H), 3.88 (d, J 
= 11.0 Hz, 2H), 2.51 (s, 3H), 1.20 (s, 3H), 0.74 (s, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
 δ 138.0, 102.0, 97.9, 30.0, 29.1, 22.9, 21.9. 
 
HRMS (ESI+) 
 Calculated for C9H16O2I: 283.0195 
 Found:    283.0200 
 
Manual synthesis of building blocks for protected ratanhine (5.49) and derivative library (5.56-
5.67, 5.69-5.75) 
 
 
 
 
 
Manual synthesis of aryl iodide 5.92 
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A 100-mL round-bottom flask charged with 4-bromo-3-methoxyphenol (5.91) (5000 mg, 
24.63 mmol, 1.0 equiv.) was sealed with a septum and purged with N2 and diethyl ether (25 mL, 
1.0 M) was added to afford a clear solution. The flask was cooled to 0 °C in an ice bath for 10 
minutes. Iodine monochloride (1.3 mL, 1.05 equiv.) was added dropwise to the reaction flask 
and the reaction mixture was allowed to warm to 23 °C with stirring over 1.5 hours. After 1.5 
hours, the reaction mixture was transferred to a separatory funnel containing aqueous saturated 
Na2S2O3 (50 mL), rinsing with diethyl ether (50 mL) and the phases were separated. The 
aqueous layer was back-extracted with diethyl ether (50 mL × 3) and the combined organic 
layers were dried over anhydrous MgSO4, filtered, and concentrated in vacuo to afford crude 
5.92 as a yellow-brown oil (7.86 g, 97% crude yield). This oil was used for the next step without 
further purification. 
 
 
 
TLC (hexanes:diethyl ether 2:3) 
Rf = 0.32, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 7.73 (s, 1H), 6.62 (s, 1H), 5.23 (s, 1H), 3.86 (s, 3H). 
 
HRMS (EI+) 
 Calculated for C7H6O2IBr: 327.85961 
 Found:    327.85939 
 
 
 
Manual synthesis of TBDPSE-protected phenol 5.94  
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Triphenylphosphine (PPh3, 5054 mg, 19.3 mmol, 1.8 equiv.) was charged in a 100-mL 
Schlenk flask equipped with a PTFE-coated magnetic stir bar and back-filled with N2. THF (57 
mL) was added and the reaction mixture was cooled to 0 °C for 10 minutes. Diisopropyl 
azodicarboxylate (DIAD, 3.8 mL, 1.8 equiv.) was added dropwise to the reaction flask affording 
a white precipitate. This heterogeneous mixture was stirred at 0 °C for 10 minutes. Alcohol 5.93 
(5482 mg, 19.3 mmol, 1.8 equiv.) was added to the reaction flask and THF (4 mL) was added to 
dissolve all reagents and the resulting mixture was stirred at 0 °C for 10 minutes. Separately, aryl 
iodide 5.92 (3511 mg, 10.7 mmol, 1.0 equiv.) was charged in a 20-mL vial, back-filled with N2, 
and THF (6 mL) was added. This solution was added to the reaction flask at 0 °C and stirred at 
that temperature for 10 minutes. After 10 minutes, the reaction mixture was warmed to 23 °C 
with stirring for 16 hours. After 16 hours, the reaction mixture was transferred to a 200-mL 
round-bottom flask, rinsing with diethyl ether (20 mL), and concentrated in vacuo to afford an 
orange oil. The crude material was adsorbed onto Celite™ from an acetone solution and purified 
by SiO2 chromatography (20% DCM:hexanes → 30% DCM:hexanes) to afford 5.94 as a white 
solid (5.23 g, 82%). 
 
 
 
TLC (hexanes:diethyl ether 2:3) 
Rf = 0.68, stained by KMnO4 
 
1
H-NMR (500 MHz, CDCl3) 
δ 7.81 (s, 1H), 7.65 (d, J = 7.0 Hz, 4H), 7.43 – 1.38 (m, 6H), 6.09 (s, 1H), 4.02 – 3.98 (m, 
2H), 3.68 (s, 3H), 1.86 – 1.83 (m, 2H), 1.07 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 157.8, 156.8, 141.2, 135.8, 133.5, 129.5, 127.9, 103.0, 98.0, 75.6, 67.6, 56.2, 27.6, 18.0, 
11.7.   
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HRMS (ESI+) 
 Calculated for C25H28O2SiBrINa: 616.9984 
 Found:     616.9979 
 
 
 
Manual synthesis of aryl MIDA boronate 5.46  
In a glove box, to a 100-mL round-bottom flask equipped with a PTFE-coated magnetic 
stir bar and containing aryl iodide 5.94 (3572 mg, 6.0 mmol, 1.0 equiv.) was added potassium 
acetate (1767 mg, 18.0 mmol, 3.0 equiv.), bis(neopentylglycolato)diboron (1355 mg, 6.0 mmol, 
1.0 equiv.) and PdCl2dppf•CH2Cl2 (147 mg, 0.18 mmol, 3 mol%). The flask was sealed with a 
septum cap and removed from the glove box. Outside the glovebox, DMSO (50 mL, 0.12 M) 
was added to the reaction flask under N2 atmosphere and the reaction mixture was placed in an 
80 °C oil bath and stirred at that temperature for 18 hours. After 18 hours, the reaction mixture 
was cooled to 23 °C and 1 M aqueous NaOH (18.0 mL, 3.0 equiv) was added dropwise and the 
resulting heterogeneous mixture was stirred vigorously for 30 minutes at 23 °C. The reaction 
mixture was transferred to a separatory funnel with EtOAc (100 mL) and water (100 mL). The 
layers were separated and the aqueous phase was extracted with water (3 x 100 mL). Combined 
organic layers were dried over anhydrous MgSO4, and concentrated in vacuo to afford a crude 
sample of boronic acid 5.95 as a brown oil. This crude boronic acid was concentrated in a 40-mL 
I-Chem vial and charged with N-methyliminodiacetic acid (MIDA) anhydride
13
 (3873 mg, 30 
mmol, 5.0 equiv.) and equipped with a PTFE-coated magnetic stir bar. The vial was flushed with 
N2 and THF (20 mL, 0.3 M) was added and the reaction mixture was placed in a 70 °C 
aluminum heat block and stirred at that temperature for 24 hours. After 24 hours, the reaction 
mixture was cooled to 23 °C and transferred to a separatory funnel with EtOAc (100 mL) 
followed by deionized water (100 mL). The phases were separated and the aqueous layer was 
extracted with EtOAc (50 mL x 3). The combined organic layers were washed with brine (100 
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mL), dried over anhydrous MgSO4, and concentrated in vacuo to afford an off-white solid. The 
crude material was adsorbed onto Celite™ from an acetone solution and purified by SiO2 
chromatography (hexanes:EtOAc 1:1 → EtOAc) and recrystallized from DCM/hexanes to afford 
5.46 as a white solid (1.707 g, 46% over three steps).  
 
 
 
TLC (EtOAc) 
 Rf = 0.66, stained by KMnO4 
 
1
H-NMR (500 MHz, acetone-d6) 
δ 7.70 (d, J = 8.0 Hz, 2H), 7.63 (s, 1H), 7.42-7.45 (m, 6H), 6.45 (s, 1H), 4.35 (d, J = 17.0 
Hz, 2H), 4.20 (d, J = 17.0 Hz, 2H), 4.11-4.14 (m, 2H), 3.72 (s, 3H), 2.84 (s, 3H), 1.91 – 
1.88 (m, 2H), 1.05 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 169.3, 163.1, 158.5, 138.9, 136.5, 134.5, 130.3, 128.7, 98.5, 70.1, 67.2, 64.5, 56.3, 48.2, 
27.9, 21.7, 18.5, 11.8. 
 
HRMS (ESI+) 
 Calculated for C30H36O6BNSiBr:  624.1588 
 Found:                   624.1602 
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Manual synthesis of aryl bromide 5.54 
To a stirred solution of triphenylphosphine (1.10 g, 4.2 mmol, 1.2 equiv) in THF (10 mL) 
at 0 °C was added dropwise diisopropylazodicarboxylate (DIAD; 830 μL, 4.2 mmol, 1.2 equiv) 
to generate a yellow suspension. In one portion, 4-bromo-3-methoxyphenol (5.91) (711 mg, 3.5 
mmol, 1 equiv) and silyl alcohol 5.93 (1.19 g, 4.2 mmol, 1.2 equiv) were added. The mixture 
was stirred for 15 minutes, after which the ice bath was then removed and the reaction warmed to 
ambient temperature. After stirring for 1 hour, the reaction was diluted with diethyl ether and 
adsorbed onto Celite™ in vacuo. The Celite™ pad was loaded onto a silica gel column and 
eluted with hexanes/DCM gradient (4:1 to 3:7).  Fractions containing a minor impurity were re-
adsorbed on Celite™ and eluted from a silica gel column using a hexanes/DCM gradient (4:1 to 
3:1).  Purified fractions were combined to afford 5.54 as a colorless amorphous solid (1.19g, 
72%). 
 
 
 
1
H-NMR (500 MHz, acetone-d6)  
δ 7.74 – 7.72 (m, 4H), 7.50 – 7.44 (m, 6H), 7.34 (d, J = 8.5 Hz, 1H), 6.43 (d, J = 2.5 Hz, 
1H), 6.27 (dd, J = 9.0, 3.0 Hz, 1H), 4.08 – 4.05 (m, 2H), 3.81 (s, 3H) 1.86 – 1.83 (m, 
2H), 1.11 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.5, 157.5, 136.6, 134.7, 133.8, 130.3, 128.7, 107.7, 102.4, 101.3, 66.3, 56.4, 28.1, 
18.5, 12.5. 
 
HRMS (EI+) 
 Calculated for C25H29O2SiBr: 468.11202 
 Found:   468.11118 
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Manual synthesis of aryl bromide 5.55 
To a stirred solution of triphenylphosphine (765 mg, 3.0 mmol, 1.5 equiv) in THF (7.5 
mL) at 0 °C was added dropwise diisopropylazodicarboxylate (DIAD; 570 μL, 3.0 mmol, 1.5 
equiv) to generate a yellow suspension. In one portion, 4-bromo-3-(trifluoromethoxy)phenol 
(5.96) (500 mg, 2.0 mmol, 1 equiv) and silyl alcohol 5.93 (830 mg, 3.0 mmol, 1.5 equiv) were 
added. The mixture was stirred for 15 minutes, after which the ice bath was then removed and 
the reaction warmed to ambient temperature. After stirring for 16 hours, the reaction was diluted 
with diethyl ether and adsorbed onto Celite™ in vacuo. The Celite™ pad was loaded onto a 
silica gel column and eluted with 4:1 hexanes/DCM.  The colorless oil from this column was re-
adsorbed onto Celite™, loaded onto silica gel, and eluted with a hexanes/DCM gradient (hexanes 
to 9:1 hexanes/DCM) to afford 5.55 as a colorless oil (785 mg, 77%). 
 
 
 
1
H-NMR (500 MHz, acetone-d6)  
δ 7.71 – 7.69 (m, 4H), 7.55 (d, J = 8.5 Hz, 1H), 7.47 – 7.41 (m, 6H), 6.82 – 6.81 (m, 1H), 
6.75 (dd, J = 8.5, 2.5 Hz, 1H), 4.11 – 4.07 (m, 2H), 1.86 – 1.83 (m, 2H), 1.08 (s, 9H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 160.5, 157.5, 136.6, 134.7, 133.8, 130.3, 128.7, 107.7, 102.4, 101.3, 66.3, 56.4, 28.1, 
18.5, 12.5. 
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Manual synthesis of TMSE-protected phenol 5.99 
Triphenylphosphine (PPh3, 7450 mg, 28.4 mmol, 1.8 equiv.) was charged in a 250-mL 
round-bottom flask equipped with a PTFE-coated magnetic stir bar and back-filled with N2. THF 
(70 mL) was added and the reaction mixture was cooled to 0 °C for 10 minutes. Diisopropyl 
azodicarboxylate (DIAD, 5.6 mL, 28.4 mmol, 1.8 equiv.) was added dropwise to the reaction 
flask affording a white precipitate. This heterogeneous mixture was stirred at 0 °C for 10 
minutes. TMS ethanol 5.98 (4.1 mL, 28.4 mmol, 1.8 equiv.) was added to the reaction flask and 
the resulting mixture was stirred at 0 °C for 10 minutes. Phenol 5.97 (2400 mg, 15.8 mmol, 1.0 
equiv.) was added to the flask in one portion followed by THF (10 mL) and the resulting reaction 
mixture was and stirred at 0 °C for 10 minutes. After 10 min, the reaction mixture was warmed 
to 23 °C with stirring for 16 hours. After 16 hours, the reaction mixture was concentrated in 
vacuo to afford a clear oil. This crude oil was dissolved in minimum amount of diethyl ether (5 
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mL). Hexanes (100 mL) were added and the solution was stirred at 23 °C for 5 minutes until 
white solid precipitated. The solid was filtered through a fritted filter funnel rinsing with 
hexanes. The filtrate was concentrated in vacuo to afford a clear oil, which was adsorbed onto 
Celite™ from an acetone solution and purified by SiO2 chromatography (20% DCM:hexanes → 
50% DCM:hexanes) to afford 5.99 as a clear oil (434 mg, 11%). 
 
 
 
TLC (dichloromethane:hexanes 1:1) 
Rf = 0.28, shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
δ 7.97 (d, J = 9.5 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 4.13 (t, J = 7.5 Hz, 2H), 3.88 (s, 
3H), 1.15 (t, J = 8.0 Hz, 2H), 0.09 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 216.4, 172.1, 163.5, 132.3, 121.4, 114.2, 65.8, 17.6, -1.35.   
 
HRMS (ESI+) 
 Calculated for C13H20O3SiNa: 275.1079 
 Found:     275.1084 
 
 
 
Manual synthesis of TMSE-protected phenol 5.100 
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  A 40-mL vial equipped with a PTFE-coated magnetic stir bar was charged with 
LiOH.H2O (722 mg, 17.2 mmol, 10 equiv.) and deionized H2O (4 mL). The vial was placed in a 
60 °C aluminum heating block and stirred at that temperature for 5 minutes until a clear solution 
was afforded. The vial was removed from the heating block and a solution of methyl ester 5.99 
(434 mg, 1.72 mmol, 1.0 equiv.) in THF (9 mL, 0.2 M) was added to the reaction vial. The vial 
was sealed with a PTFE-lined cap and placed in a 60 °C aluminum heating block and stirred at 
that temperature for 14 hours. The reaction mixture was cooled to 23 °C, then to 0 °C for 10 
minutes. 6 N HCl was added dropwise to the crude reaction mixture with stirring until pH ≤ 1. 
The reaction mixture was transferred to a separatory funnel with H2O (20 mL) and EtOAc (40 
mL). The phases were separated and the aqueous layer was extracted with EtOAc (40 mL x 2). 
The combined organic layers were washed with brine (50 mL), dried over anhydrous MgSO4, 
and concentrated in vacuo to afford a white solid. The crude solid was adsorbed onto Celite™ 
from an acetone solution and purified by SiO2 chromatography (1:4 EtOAc:hexanes → 2:1:7 
EtOAc:EtOH:hexanes) to afford 5.100 as a white solid (361 mg, 88%). 
 
 
 
TLC (EtOAc:hexanes 1:4) 
Rf = 0.22, shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.03 (d, J = 9.0 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 4.15 (t, J = 7.5 Hz, 2H), 1.16 (t, J = 
8.0 Hz, 2H), 0.09 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 172.2, 163.5, 132.3, 121.4, 114.2, 65.8, 17.6, -1.35.   
 
HRMS (ESI+) 
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 Calculated for C12H18O3SiNa: 261.0923 
 Found:     261.0934 
 
 
 
Manual synthesis of ester 5.102 
A 100-mL flask equipped with a PTFE-coated magnetic stir bar was charged with 
benzoic acid 5.100 (361 mg, 1.51 mmol, 1.0 equiv.) and back-filled with N2. Phenol 5.101 (447 
mg, 1.82 mmol, 1.2 equiv.), DMAP (222 mg, 1.82 mmol, 1.2 equiv.), and dichloromethane (20 
mL, 0.08 M) were added to the reaction flask. The clear, colorless solution was cooled to 0 °C 
and stirred at that temperature for 10 minutes. DCC (375 mg, 1.82 mmol, 1.2 equiv.) was added 
in one portion at 0 °C under N2 and stirred at that temperature for 10 minutes. The ice bath was 
removed after 10 minutes and the reaction flask was allowed to warm to 23 °C with stirring over 
15 hours. After 15 hours, the reaction mixture was concentrated in vacuo to afford a yellow 
sludge. The crude material was adsorbed onto Celite™ from an acetone solution and purified by 
SiO2 chromatography (30% DCM:hexanes → 40% DCM:hexanes) to afford 5.102 as a clear oil 
(575 mg, 81%). 
 
 
 
TLC (30% DCM:hexanes) 
Rf = 0.21, shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
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δ 8.14 (d, J = 8.5 Hz, 2H), 7.92 (s, 1H), 7.61 (d, J = 8.5 Hz, 1H), 6.96 (d, J = 9.0 Hz, 
2H), 6.92 (d, J = 8.5 Hz, 1H), 6.70 (dd, J = 11.0 Hz, J = 14.5 Hz, 1H), 5.78 (s, 1H), 5.74 
(s, 1H), 5.32 (d, J = 11.0 Hz, 1H), 4.17 (t, J = 8.0 Hz, 2H), 1.18 (t, J = 7.5 Hz, 2H), 0.10 
(s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 164.4, 163.6, 148.2, 137.5, 135.3, 132.8, 132.4, 129.2, 124.9, 120.8, 117.5, 114.4, 90.4, 
65.9,17.5, -1.33.   
 
HRMS (ESI+) 
 Calculated for C20H24O3SiI:  467.0540 
 Found:     467.0534 
 
 
 
Manual synthesis of vinyl bromide 5.104 
A 50-mL flask equipped with a PTFE-coated magnetic stir bar was charged with olefin 
5.102 (575 mg, 1.23 mmol, 1.0 equiv.), sealed with a septum, and back-filled with N2. 
Dichloromethane (12 mL, 0.1 M) was added to afford a clear, colorless solution. This solution 
was cooled to 0 °C and stirred at that temperature for 10 minutes. Bromine (0.14 mL, 2.71 mmol, 
2.2 equiv.) was added dropwise to the reaction mixture at 0 °C over the course of 20 minutes 
until a bright red color persisted. The crude reaction mixture was concentrated in vacuo and 
azeotroped with DCM (3 x 15 mL) to afford dibromide 5.103 as a yellow foamy solid (721 mg, 
93% crude yield). Dibromide 5.103 (721 mg, 1.15 mmol, 1.0 equiv.) was concentrated in a 50-
mL round-bottom flask. The flask was equipped with a PTFE-coated magnetic stir bar, sealed 
with a septum, and back-filled with N2. Acetonitrile (11.5 mL, 0.1 M) was added and the 
reaction mixture was stirred at 23 °C for 5 minutes. DBU (0.2 mL, 1.34 mmol, 1.2 equiv.) was 
added dropwise and the resulting mixture was stirred for 10 minutes. After 10 minutes, 
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incomplete conversion was observed by TLC analysis, so another 0.3 mL of DBU was added 
dropwise. After 20 minutes of stirring at 23 °C, the reaction mixture was cooled to 0 °C and 1 N 
HCl (10 mL) was added. The reaction mixture was transferred to a separatory funnel with EtOAc 
(15 mL) and H2O (15 mL) and the layers were separated. The phases were separated and the 
aqueous layer was extracted with EtOAc (10 mL x 2). The combined organic layers were dried 
over anhydrous MgSO4 and concentrated in vacuo to afford a clear oil. The crude material was 
adsorbed onto Celite™ from an acetone solution and purified by SiO2 chromatography (40% 
DCM:hexanes) to afford 5.104 as a pale yellow oil (503 mg, 75% over two steps). 
 
 
 
TLC (1:3 DCM:hexanes) 
Rf = 0.25, shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.13 (d, J = 9.0 Hz, 2H), 7.78 (s, 1H), 7.70 (d, J = 8.5 Hz, 1H), 6.98 (d, J = 8.5 Hz, 
1H), 6.96 (d, J = 9.0 Hz, 2H), 5.91 (d, J = 1.5 Hz, 1H), 5.84 (d, J = 2.0 Hz, 1H), 4.17 (t, 
J = 8.0 Hz, 2H), 1.17 (t, J = 8.0 Hz, 2H), 0.10 (s, 9H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 164.1, 163.6, 147.8, 138.9, 138.9, 135.4, 132.5, 125.3, 123.0, 122.7, 120.7, 114.4, 89.4, 
65.9, 17.5, -1.34.   
 
HRMS (ESI+) 
 Calculated for C20H23O3SiBrI: 544.9645 
 Found:     544.9646 
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Manual synthesis of TMSE-protected phenol 5.48 
In a glove box, to a 7-mL vial equipped with a PTFE-coated magnetic stir bar and 
containing aryl iodide 5.104 (20 mg, 0.037 mmol, 1.0 equiv.) and trans-propenyl boronic acid 
(5.105) (4.73 mg, 0.055 mmol, 1.5 equiv.) was added ground potassium phosphate (23 mg, 0.11 
mmol, 3.0 equiv.) and PdCl2dppf•CH2Cl2 (1.5 mg, 0.002 mmol, 5 mol%) followed by THF (0.7 
mL, 0.05 M). The vial was sealed with a cap and removed from the glove box. The vial was 
placed in a 45 °C aluminum heating block and stirred at that temperature for 24 hours. After 24 
hours, the reaction mixture was cooled to 23 °C, filtered through a pad of Celite™, and 
concentrated in vacuo. The crude material was adsorbed onto Celite™ from an acetone solution 
and purified by SiO2 chromatography (30% DCM;hexanes) to afford 5.48 as a pale yellow oil 
(13.5 mg, 80% yield).  
 
 
 
TLC (1:1 DCM:hexanes)  
Rf = 0.31, shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.15 (d, J = 8.5 Hz, 2H), 7.40 (s, 1H), 7.35 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 8.5 Hz, 
1H), 6.96 (d, J = 9.0 Hz, 2H), 6.39 (d, J = 16.0 Hz, 1H), (dq, J = 15.5 Hz, J = 6.5 Hz, 
1H),  5.89 (d, J = 1.5 Hz, 1H), 5.82 (d, J = 1.5 Hz, 1H), 4.17 (t, J = 8.0 Hz, 2H), 1.90 (d, 
J = 7.0 Hz, 3H), 1.17 (t, J = 8.0 Hz, 2H), 0.10 (s, 9H). 
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13
C-NMR (125 MHz, CDCl3) 
δ 164.6, 163.4, 146.4, 135.8, 133.2, 132.4, 129.6, 127.6, 127.2, 126.8, 124.6, 123.2, 
122.1, 121.2, 114.3, 65.9, 18.5, 17.5, -1.33.   
 
HRMS (ESI+) 
 Calculated for C23H28O3SiBr:  459.0991 
 Found:     459.0987 
 
 
Conditions: (a) Benzoyl chloride, iPr2NEt, DMAP, CH2Cl2, rt, 19 h; (b) Br2, CH2Cl2, 0 
o
C, 20 min; (c) 1,8-
Diazabicyclo[5.4.0]undec-7-ene (DBU), MeCN, rt, 30 min; (d), trans-propenylboronic acid, PdCl2dppf.CH2Cl2, 
K3PO4, THF, 65 
o
C 
 
  
 
Manual synthesis of benzoate ester 5.106 
A dry 25-mL Schlenk flask equipped with a PTFE-coated magnetic stir bar was charged 
with the phenol 5.101 (738 mg, 3 mmol) and DMAP (73.3 mg, 0.6 mmol) under N2. The flask 
was sealed with a rubber septum and CH2Cl2 (15 mL) was added via syringe. To this solution 
was added DIPEA (2.1 mL, 12.1 mmol) in one portion. Benzoyl chloride (0.7 mL, 6.03 mmol) 
was then added neat dropwise over 5 minutes. The reaction was stirred for another 19 hours at 
room temperature, then transferred into a separatory funnel containing 1 N HCl (10 mL). After 
mixing and phase separation, the organic layer was washed with another portion of 1 N HCl (10 
mL) and then with H2O (20 mL). The combined aqueous layer was extracted with CH2Cl2 (20 
mL). The organic phase was washed with brine (20 mL), dried over anhydrous MgSO4, filtered 
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and concentrated. The crude product was purified by silica gel chromatography (30 - 35% 
CH2Cl2/hexanes) to afford 5.106 as a colorless viscous oil (643 mg, 61%). 
 
 
 
TLC (50% DCM/hexanes) 
Rf = 0.44, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.21 (d, J = 7 Hz, 2H), 7.94 (d, J = 2 Hz, 1H), 7.66 (tt, J = 7.5, 1.5 Hz, 1H), 7.63 (dd, J 
= 8, 1.5 Hz, 1H), 7.56 (t, J = 7.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 1H), 6.71 (dd, J = 17.5, 11 
Hz, 1H), 5.77 (dd, J = 18, 1 Hz, 1H), 5.34 (d, J = 11 Hz, 1H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 164.6, 148.0, 137.5, 135.4, 133.9, 132.7, 130.2, 129.0, 128.9, 128.7, 124.7, 117.7, 90.6. 
 
HRMS (ESI+) 
 Calculated for C15H12O2I:  350.9882 
 Found:   350.9890 
 
 
 
Manual synthesis of vinyl bromide 5.108 
A solution of alkene 5.106 (3.37 g, 9.62 mmol) in CH2Cl2 (120 mL) in a 200-mL round-
bottom flask was cooled to 0 °C under N2. Bromine (0.49 mL, 9.62 mmol) was added neat 
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dropwise over 15 minutes. After the addition was complete, the reaction was stirred for a further 
5 minutes. The reaction was concentrated in vacuo to give an orange solid (5.107). Residual 
bromine was removed by azeotroping the residue with CH2Cl2 (15 mL × 2). The round bottom 
flask containing the crude product and equipped with a PTFE-coated magnetic stir bar was 
sealed with a rubber septum and back-filled with N2 twice. MeCN (120 mL) was added to 
dissolve most of the solid. DBU (1.4 mL, 9.5 mmol) was then added neat dropwise via syringe 
over 15 minutes. The reaction was stirred for 15 minutes before being charged with another 
portion of DBU (0.2 mL, 1.34 mmol) added neat dropwise into the reaction. After another 15 
minutes, another portion of DBU (0.2 mL, 1.34 mmol) was added. The reaction was poured 
slowly into 2 N HCl solution (100 mL) cooled to 0 °C with vigorous stirring. EtOAc (50 mL) 
was added and the mixture stirred. After phase separation, the aqueous layer was extracted with 
EtOAc (50 mL). The combined organic phase was washed with brine (100 mL), then dried over 
anhydrous MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (30-35% CH2Cl2/hexanes) to afford 5.108 as an off-white solid (2.67g, 66% 
over 2 steps). 
 
 
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.47, visualized by shortwave UV. 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.20 (d, J = 7.5 Hz, 2H), 7.79 (d, J = 2 Hz, 1H), 7.72 (dd, J = 8.5, 2 Hz, 1H), 7.66 (t, J 
= 7.5 Hz, 1H), 7.52 (tt, J = 8, 1.5 Hz, 2H), 6.99 (d, J = 8.5 Hz, 1H), 5.92 (d, J = 2 Hz, 
1H), 5.85 (d, J = 1.5 Hz, 1H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 164.4, 147.6, 138.9, 135.4, 133.9, 130.3, 128.8, 128.6, 125.1, 123.1, 122.5, 89.7. 
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HRMS (ESI+) 
 Calculated for C15H10O2BrINa : 450.8807  
 Found:   450.8809 
 
 
 
Manual synthesis of 5.68 
A dry 40-mL vial equipped with a PTFE-coated magnetic stir bar was charged with the 
aryl iodide 5.108 (858 mg, 2.0 mmol) and trans-propenyl boronic acid (5.105) (223 mg, 2.6 
mmol). The vial was brought into a glovebox and charged with K3PO4 (1.27 g, 3 equiv.), 
PdCl2dppf.CH2Cl2 (849 mg, 4 mmol) and THF (20 mL, 0.1 M). The vial was sealed with a 
Teflon-lined cap and stirred at 60 °C for 18 hours. The reaction was cooled to 23 °C and filtered 
through a pad of Celite™ and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (30-40% CH2Cl2/hexanes) to give 5.68 as an off-white solid (268 mg, 39%). 
 
 
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.43, visualized by shortwave UV 
 
1
H-NMR (500 MHz, CDCl3) 
δ 8.22 (dd, J = 8.0, 1.0 Hz, 2H), 7.65 (t, J = 7.5 Hz, 1H), 7.52 (app t, J = 8.0 Hz, 2H), 
7.41 (d, J = 2.0 Hz, 1H), 7.36 (dd, J = 8.5, 2.0 Hz, 1H), 7.15 (d, J = 8.5 Hz, 1H), 6.40 
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(dd, J = 16.0, 1.5 Hz, 1H), 6.26 (dq, J = 15.5, 6.5 Hz, 1H), 5.90 (d, J = 1.5 Hz, 1H), 5.83 
(d, J = 2.0 Hz, 1H), 1.90 (dd, J = 7.0, 1.5 Hz, 3H). 
 
13
C-NMR (125 MHz, CDCl3) 
δ 164.8, 146.2, 136.0, 133.6, 133.3, 130.3, 129.5, 129.3, 128.6, 127.6, 127.2, 127.0, 
124.5, 123.1, 122.2, 18.5. 
 
HRMS (ESI+) 
 Calculated for C18H16O2Br : 343.0334 
 Found:   343.0336 
 
 
 
 
Manual synthesis of 5.111 
A flame-dried single-necked 200mL round-bottomed flask containing a PTFE-coated stir 
bar was taken into the glove box, where dicyclohexylborane (464mg, 2.6mmol, 0.1eq) was 
added. This was capped with a rubber septum and taken out of the glove box, where THF was 
added (26mL). To this stirring suspension was added in portions alkyne 5.109 as a solution in 
DCM (0.992 M, 17 mL, 26.0 mmol, 1 equiv), which generated a colorless solution and evolved 
heat. To this solution was added neat catecholborane (5.110) (3.6 mL, 27 mmol, 1.05 equiv) in 
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portions. After the addition was complete, the reaction was stirred vigorously for 4 hours. The 
reaction was then opened to ambient atmosphere and 1 M aqueous NaOH (60 mL, 60 mmol, 2.3 
equiv) was added and stirred vigorously. The dark brown solution was then poured into 1:1 ethyl 
acetate:diethyl ether (900 mL), to which was added 1:1 saturated aqueous NH4Cl:H2O (150 mL). 
The mixture was shaken and the layers were separated. The organic layer was rinsed with brine 
(150 mL), dried over anhydrous MgSO4, and filtered over Celite™. The solution was 
concentrated to a blue oil, then dissolved in acetone and adsorbed onto Celite™, then subjected 
to flash chromatography (SiO2, 8:2:1 hexanes/diethyl ether/methanol). Fractions containing the 
product (5.111) were concentrated under reduced pressure, resulting in a yellow oil.  This oil was 
used directly without further purification. 
 
 
 
1
H-NMR (400 MHz, 95:5 DMSO-d6:D2O)  
δ 6.47 (dt, J = 17.9 Hz, 3.7 Hz, 1H), 5.59 (dt, J = 17.9 Hz, 1.8 Hz, 1H), 4.23 (m, 2H), 
1.11-0.94 (m, 19H) 
 
 
 
Manual synthesis of 5.51 
Boronic acid 5.111 was transferred with benzene (235 mL) to a 500-mL round-bottomed 
flask equipped with a PTFE-coated magnetic stir bar, and N-methyliminodiacetic acid (5.75 g, 
39.1 mmol, 1.5 equiv) and DMSO (26 mL) were added. This flask was fitted with a Dean-Stark 
trap and a reflux condenser and was heated to reflux under ambient atmosphere in an oil bath.  
The mixture was stirred for 2 hours, after which it was cooled to ambient temperature.  The 
mixture was concentrated to a residue which was partitioned between ethyl acetate (400 mL) and 
saturated aqueous NaHCO3 (300 mL). The layers were separated, and the aqueous layer was 
238 
 
rinsed with ethyl acetate (3 x 100 mL). The combined organic layers were then rinsed with 1:1 
brine:H2O (100 mL), 3:1 brine:H2O (100 mL), then brine (50 mL). The organic layers were then 
dried over anhydrous MgSO4, filtered over Celite™, then concentrated to a yellow oil. This oil 
was taken up in acetone and adsorbed onto Celite™, then subjected to flash chromatography 
(SiO2, diethyl ether3:2 diethyl ether/acetonitrile). Fractions containing the product (5.51) were 
concentrated to a colorless foam (6.10g, 63% over two steps). 
 
 
 
1
H-NMR (500 MHz, acetone-d6)  
δ 6.19 (dt, J = 17.6Hz, 3.9Hz, 1H), 5.83 (dt, J = 17.6Hz, 2.0Hz, 1H), 4.34 (m, 2H), 4.20 
(d, J = 16.9Hz, 2H), 4.00 (d, J = 16.9Hz, 2H), 3.00 (s, 3H), 1.21-1.03 (m, 19H). 
 
13
C-NMR (125 MHz, acetone-d6) 
δ 169.0, 144.7, 65.7, 62.3, 47.3, 18.4, 12.8. 
 
HRMS (ESI+) 
 Calculated for C17H33BNO5Si: 370.2221 
 Found:     370.2225 
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Manual synthesis of 5.113 
 To a 1000-mL single-necked round-bottom flask equipped with a PTFE-coated magnetic 
stir bar is added ethyl benzofuran-2-carboxylate 5.112 (29.916 g, 100.02 mmol, 1.00 equiv) and 
THF (200 mL).  To the resulting stirred clear yellow solution is added 1 M aqueous NaOH (120 
mL, 120 mmol, 1.20 equiv).  The resulting biphasic mixture was allowed to stir vigorously at 
room temperature for 2 hours.  The reaction is transferred to a 1000-mL separatory funnel and 
diluted with reagent grade (BHT-stabilized) diethyl ether (250 mL) and water (150 mL).  To the 
funnel is added concentrated HCl until the aqueous phase maintains a pH of approximately 2 by 
litmus paper.  The phases are separated and the organic phase is dried over anhydrous MgSO4, 
filtered through Celite™, and concentrated in vacuo (35 °C, 100 Torr) to give the crude 5.113 as 
an off white chunky powder. 
 The crude product was not purified further.         
 
 
 
TLC (hexanes:ethyl acetate 1:1) 
 Rf = 0.13, stained by KMnO4. 
 
1
H NMR (500 MHz, DMSO-d6)   
δ J = 2 Hz, 1H), 7.25 (d, J = 2 Hz, 1H), 3.98 (s, 3H), 3.33 (bs, 1H).  
 
13
C NMR (125 MHz, DMSO-d6) 
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 δ 159.6, 147.1, 146.0, 143.5, 129.7, 117.0, 116.2, 113.0, 112.3, 56.4. 
 
HRMS (EI+) 
 Calculated for C10H7BrO4:  269.95277 
 Found:     269.95341 
 
 
 
Manual synthesis of 5.114 
To a 1000-mL single-necked round-bottom flask equipped with a PTFE-coated magnetic 
stir bar is added benzofuran-2-carboxylic acid 5.113 (100 mmol, 1 equiv), quinoline (freshly 
distilled, 300 mL), and copper bronze (20.972 g, 115 mmol, 1.15 equiv).  The flask is fitted with 
a water-cooled Allihn condenser.  The reaction system is then vac/filled (1000 mTorr) with dry 
nitrogen and a nitrogen inlet is placed in the condenser, leaving the top of the condenser open to 
ambient atmosphere (This set-up allows the reaction to be maintained under oxygen-free 
conditions while venting lower-boiling residues to an appropriately vented fume hood).  The 
reaction is allowed to reflux with stirring in a heating mantle for 1 hour.  The reaction is then 
allowed to cool to room temperature with stirring over 1 hour and filtered through Celite.  The 
Celite pad is washed with copious amounts of reagent grade (BHT-stabilized) diethyl ether and 
the combined filtrates are transferred to a 2000-mL separatory funnel.  To the funnel is added, 
diethyl ether (500 mL), hexanes (250 mL), ice (~100 g), and 6 M aqueous HCl (500 mL).  The 
mixture is carefully swirled for several minutes and then shaken.  The phases are separated and 
the aqueous phase is extracted with diethyl ether:hexanes (1:1, 250 mL).  The combined organic 
layers are washed with 6 M aqueous HCl (100 mL), 1 M aqueous NaOH (50 mL), brine (50 mL), 
dried over anhydrous MgSO4, filtered through Celite™, and concentrated in vacuo (40 °C, 100 
Torr) to give the crude product as a dark red/brown liquid. 
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The crude product was purified via flash chromatography (SiO2, 8 x 16 cm, hexanes:ethyl 
acetate 1:0 → 9:1) to give 5.114 as a yellow oil (19.485 g, 85% yield)      
 
 
 
TLC (hexanes) 
 Rf = 0.09, stained by KMnO4. 
 
1
H NMR (500 MHz, CDCl3) 
δ 7.61 (d, J = 2 Hz, 1H), 7.33 (d, J = 2 Hz, 1H), 6.91 (d, J = 2 Hz, 1H), 6.70 (d, J = 2 Hz, 
1H), 3.99 (s, 3H).   
  
13
C NMR (125 MHz, DMSO-d6) 
 δ 147.0, 145.7, 142.6, 130.3, 115.8, 115.3, 109.8, 106.6, 56.2. 
 
HRMS (EI+) 
 Calculated for C9H7BrO2:  225.96294 
 Found:     225.96284 
 
 
 
Manual synthesis of 5.52 
To a 250-mL three-necked round-bottom flask equipped with a PTFE-coated stir bar, an 
internal thermometer in one side neck, an argon inlet in the center neck, and a rubber septum in 
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one side neck is added hexanes (40 mL) and n-BuLi (1.6 M in hexanes, 17.2 mL, 27.5 mmol, 
1.20 equiv).  This clear colorless solution is allowed to cool to -10 °C in a dry ice/brine bath with 
stirring for 10 minutes.  To the cooled stirred solution is added diisopropylamine (3.5 mL, 25.0 
mmol, 1.09 equiv) and the resulting solution is allowed to stir for 30 minutes, maintaining the 
dry ice/brine bath.   To this cooled stirred solution is added dry diethyl ether (40 mL) to quench 
excess n-BuLi.  This solution is allowed to stir for 20 minutes, maintaining the dry ice/brine 
bath.  To this cooled stirred solution is added benzofuran 5.114 (5.212 g, 22. 96 mmol, 1.00 
equiv) dropwise as a solution in dry diethyl ether (40 mL) from a 100-mL single-necked pear-
shaped flask via cannula (20G).  The cannula transfer is performed at such a rate that the internal 
reaction temperature does not rise above -10 °C.  Additional diethyl ether (16 mL) is used for 
quantitative transfer, again insuring that the internal reaction temperature does not rise above -10 
°C.  This reaction solution is stirred for 2 hours, maintaining the dry ice/brine bath.  To the 
cooled stirred solution is then added trimethylborate (5.2 mL, 46.6 mmol, 2.03 equiv) and then 
reaction is allowed to warm to room temperature with stirring over 30 minutes.   
 To the stirred reaction is added 5 M aqueous HCl (50 mL) and the reaction is stirred 
vigorously for 10 minutes during which time a white precipitate forms and then dissolves.  This 
mixture is transferred to a 1000-mL separatory funnel.  To the funnel is added water (125 mL) 
and reagent grade (BHT-stabilized) diethyl ether (62 mL).  The phases are separated and the 
aqueous phase is extracted with diethyl ether (62 mL).  The combined organic layers are washed 
with 5% w/v aqueous NaOH (125 mL).   This aqueous layer is then extracted with petroleum 
ether (82 mL) and is then adjusted to pH ~ 1.5 (by litmus paper) with concentrated HCl.  The 
acidified aqueous layers is extracted with diethyl ether (4 x 62 mL) and these combined organic 
layers are washed with water (62 mL), brine (62 mL), dried over anhydrous MgSO4, filtered 
through Celite™, and concentrated in vacuo (40 °C, 100 Torr) to give a sample of crude boronic 
acid 5.115 as a tan solid: TLC (diethyl ether), Rf = 0.46, stained by KMnO4; 
1
H NMR (500 MHz, 
DMSO-d6) δ 7.47 (d, J = 1.5 Hz, 1H), 7.40 (s, 1H), 7.08 (d, J = 1.5 Hz, 1H), 3.95 (s, 3H); 3.003 
g, 48% yield. 
To a 100-mL single-necked round-bottom flask equipped with a PTFE-coated magnetic 
stir bar is added the crude boronic acid, toluene (50 mL), DMSO (5 mL), and MIDA (2.435 g, 
16.55 mmol, 1.50 equiv based on starting boronic acid).  The flask is fitted with a toluene-filled 
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Dean-Stark trap topped with a water-cooled Dimroth condenser.  The reaction is allowed to 
reflux with stirring in a heating mantle for 12 hours during which time the reaction darkens from 
tan to brown.  The reaction is allowed to cool with stirring to room temperature and is then 
concentrated in vacuo (40 °C, 50 Torr).  The resulting residue is dissolved in ethyl acetate (250 
mL) and transferred to a 500-mL separatory funnel.  This organic layer is washed with water (6 x 
75 mL) (These successive water washes are crucial for the quantitative removal of DMSO.  If 
not effectively removed, DMSO may result in difficulties with purification), brine (75 mL), dried 
over anhydrous MgSO4, filtered through Celite™, and concentrated in vacuo (40 °C, 50 Torr) 
giving the crude product as a dark brown solid. 
The crude product is then dissolved in a minimum amount of acetone and precipitated 
with diethyl ether.  The precipitate is isolated by vacuum filtration and residual solvent is 
removed under vacuum (room temperature, 1000 mTorr) to give 5.52 as an off-white solid 
(3.873 g, 44% yield over the two steps).    
   
 
 
TLC (ethyl acetate) 
 Rf = 0.51, stained by KMnO4. 
 
1
H NMR (500 MHz, CD3CN) 
δ 7.38 (d, J = 1.5 Hz, 1H), 7.05 (s, 1H), 7.02 (d, J = 1.5 Hz, 1H), 4.13 (d, J = 17 Hz, 2H), 
3.96 (s, 3H), 3.96 (d, J = 17 Hz, 2H), 2.71 (s, 3H).     
 
13
C NMR (125 MHz, DMSO-d6) 
  δ 169.0, 145.6, 145.1, 130.9, 115.9, 115.0, 114.4, 109.8, 61.7, 56.1, 47.5. 
 
HRMS (EI+) 
 Calculated for C14H13BBrNO6: 381.00193 
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 Found:     381.00213 
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APPENDIX A 
SCRIPTING COMMANDS USED TO PROGRAM THE SYNTHESIZER 
 
This appendix describes the commands that are used in the custom scripting language 
that is interpreted by the software that runs the synthesizer. Each command described here is 
followed by an example of its usage. The scripting language is not case-sensitive. 
 
‘ (apostrophe)  
 Description: 
Used to designate a comment. The text following an apostrophe is not interpreted by the 
program as a command. 
 
Usage: 
„ enter comment text following the apostrophe 
 
Example: 
valve 1a 2b „ This is a comment on the same line as a command 
„ This is a comment on its own line 
 
[ ] (brackets) 
 Description: 
Used to designate a variable. A variable is a place-holder for a value that can be specified 
with a define command. Using variables allows the code to be more flexible. 
 
Usage: 
command [variableName] 
 
Executes a command, represented here generically as command, for which the variable 
variableName contains the instructions to be interpreted by the command. The value 
of variableName would be defined earlier in the code using the define command 
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Example: 
valve [Tube] 
pump 5 in= [THF] out=a rate=[StdRate] 
 
In the above code the variables are [Tube], [THF], and [StdRate]. Using the 
define command the values could be set at the beginning of the code and could be 
changed easily before the file is executed. For example: 
 
define Tube=4a THF=b StdRate=45 
 
valve [Tube] 
pump 5 in=[THF] out=a rate=[StdRate] 
pump 2 in=[THF] out=a 
valve 2b [Tube] 
 
In this way the code is more flexible. This same routine could be called for a number of 
different tube locations and using just one line or code the entire routine could be 
modified for a new tube location. Also, if the location of the THF bottle changed, it 
would be easy to specify a new location using just one line of code, even though the 
routine accesses the THF bottle on several lines. 
 
DEFINE 
 Description: 
Used to set the value of a variable within a script. NOTE: Due to current code limitations 
each variable should only be defined once in a procedure. 
 
Usage: 
define variable_name=variable_value 
 
variable_name represents the name of the variable to define 
variable_value is the data which will now stand in the place of all instances of the 
variable defined by variable_name 
248 
 
 
Example: 
define pumpnum=a 
valve 4[pumpnum] 
valve 5[pumpnum] 8[pumpnum] 
 
All instances of [pumpnum] (the variable) will be replaced with the valve a at runtime. 
That is, the program will interpret the script as follows: 
 
define pumpnum=a 
valve 4a 
valve 5a 8a 
 
Variables allow flexible code since with a few uses of the define command a general 
script can be mapped onto any number of equipment combinations. 
 
PAUSE 
 Description: 
 Pauses the script for a specified period of time before executing the next line. 
 
 Usage: 
 pause [number of seconds to pause] 
 
 Example: 
 pause 5 
 
 This pauses the script for five seconds. 
 
LOG 
 Description: 
Writes a user comment to the file “MachineLog.txt” with a time and date stamp. The 
comment is added to the end of the file without affecting the previous text in the log file. 
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The command is useful in logging the time and date when specified portions of code are 
executed or completed. 
 
 Usage: 
 log “text here” 
 
 Any text can be entered between the two quotation marks. 
 
 Example: 
 log “Program Start” 
 
Writes “5/28/13 1:00:00 PM: Program Start” to the file “MachineLog.txt” 
where the system date is 5/28/13 and the system time is 1:00:00 PM. 
 
SUB 
END SUB 
 Description: 
The sub and end sub commands enclose scripting commands that can be executed as 
a sub routine. That is, a particular sequence of code can be designated as a sub routine 
and given a unique identifying name. Rather than retyping the code each time the routine 
needs to be run, the code can be executed using the run command. Additionally, using 
the background command sub routines can be executed as background processes 
(although care needs to be taken in how the code is scripted). 
 
 Usage: 
 sub SubName 
  enter lines of code here 
 end sub 
 
Define a sub routine with the identifier SubName. The code contained within the sub 
and end sub lines can be executed by using the run command followed by the 
250 
 
identifier. NOTE: Every sub routine within a script must have a unique identifier. If two 
sub routines with the same identifier are used, then an error with result. 
 
 Example: 
 sub test 
  log “Start time” 
  pause 30 
  log “End time” 
 end sub 
 
Defines the sub routine test. At this point the synthesizer will not actually do anything. 
Rather, it has saved the instructions defined by the test routine for later use. To execute 
the test script the run command is used. 
 
run test „ Run the script once 
run test „ Run the script again 
 
The test sub routine is run twice. Each time the sub routine is run it writes the line 
“Start time” to the log file, waits 30 seconds, and writes the line “End time” to 
the log file. After the above script has executed, the log file will contain four new lines. 
 
RUN 
 Description: 
 Runs a sub routine that has been specified by the sub command structure. 
 
 Usage: 
 run SubName 
 
Executes the code contained within the sub routine represented by the identifier 
SubName. The identifier SubName can refer to any sub routine definded earlier in the 
script using the sub and end sub commands. 
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Example: 
see the above examples for the sub and end sub commands. 
 
BACKGROUND 
 Description: 
Begins the execution of a sub routine as a background process. After processing this 
initial event, the script will immediately read the next line of the main code as the 
background process continues. NOTE: There are important consequences to running a 
process in the background. It is the script writer’s responsibility to ensure that the 
background process will not conflict with the foreground process. Specifically, 
appropriate use of the lock and unlock commands is encouraged to make sure that the 
same equipment is not being accessed at the same time. Additionally, the program cannot 
display the progress of the background process, nor can it save the progress of the 
background process if the code is halted. Thus, the background command should 
be used sparingly. NOTE: Only one instance of a sub routine per pump is allowed to 
execute as a background process at any given time. 
 
Usage: 
background SubName 
 
Begins background execution of the sub routine with the identifier SubName. 
 
Example: 
sub TestPause 
 pause 15 
end sub 
 
background TestPause 
 
pause 10 
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The sub TestPause portion defines a sub routine that will have the synthesizer pause 
for 15 seconds. The background command then calls the TestPause routine to 
execute in the background while it then immediately processes the next command, 
pause 10. Thus, the total execution time for this script will be 15 seconds, since the 
synthesizer will simultaneously pause for both 15 and 10 seconds. 
 
WAIT 
 Description: 
Halts program execution until a condition is met. Specifically, the wait command 
allows other synthesizer processes to catch up to the script before executing the next 
command line. This is particularly useful in coordinating background-executed sub 
routines. 
 
Usage: 
wait SubRoutineName 
 
SubRoutineName is the identifier of a sub routine that was previously executed using 
the background command. The system will wait until the process for 
SubRoutineName is complete before proceeding to the next line. 
 
Example: 
sub TestPause 
 pause 15 
end sub 
 
background TestPause 
 
pause 5 
wait TestPause 
 
log “Script Complete” 
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Similar to the example of the background command, the sub TestPause portion 
defines a sub routine that will have the synthesizer pause 15 seconds. The background 
command then calls the TestPause routine to execute in the background while it then 
immediately processes the next command line, pause 5. After the pause 5 command 
completes the synthesizer pauses and waits for the TestPause sub routine that is 
running in the background to complete. Thus, the line “Script Complete” is not 
written to the log file until 15 seconds after the background TestPause command 
is executed. If the wait TestPause command was omitted, the log command would 
execute 5 seconds after the background TestPause command was executed. 
 
VALVE 
 Description: 
Used to change the port position of an 8-port valve. The command can also be used to 
turn a solenoid valve on or off. Multiple valves can be manipulated sequentially in a 
single valve command. 
 
Usage: 
valve command1 command2 command3 
 
command1, command2, command3, etc. describes the number of the valve being 
manipulated and the new state for the valve. Multiple valves can be manipulated using a 
single valve command. In fact, there is no limit to the number of manipulations that can 
be performed with a single valve command. Changes to the valves of the system are 
executed in the order command1, then command2, then command3, etc. 
 
Example: 
valve 1a 
 
This moves valve 1 to position a 
254 
 
 
valve 1a 2b 
 
This moves valve 1 to position a then moves valve 2 to position b 
 
valve xon 
 
This turns the solenoid on 
 
valve xoff 
 
This turns the solenoid off 
 
PUMP 
 Description: 
Used to control the syringe pump. This command is used to move specific volumes of 
fluid from one port to another at a rate specified by the operator. 
 
 Usage: 
pump volume in=PortIn out=PortOut rate=RateOfAspiration/Injection 
 rateIn=RateOfAspiration rateout=RateOfInjection 
 
volume specifies the amount of fluid that is to be moved by the syringe pump. The 
volume specified can be greater that the capacity of the syringe only if the syringe is both 
aspirating and injecting the fluid during the same command. The volume is expressed as 
a number representing mL. That is, do not include the unit when specifying the volume. 
PortIn (optional) specifies the port from which the reagent will be aspirated. If 
PortIn is not specified the program will use whatever port the syringe pump is already 
set to.  
PortOut (optional) specifies the port to which the fluid will be injected. If PortOut is 
not specified the program will use whatever port the syringe pump is already set to.  
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RateOfAspiration/Injection (optional) allows the operator to specify the rate 
at which the syringe pump will handle the fluid transfer. The rate is specified as a number 
representing mL/min. That is, do not include the unit when specifying the rate. 
RateOfAspiration (optional) (similar to above) allows the rate of aspiration of the 
syringe to be set independently of the rate of injection. 
RateOfInjection (optional) (same as RateOfAspiration) but specifies the rate 
of injection. NOTE: if the rate of aspiration is specified but the rate of injection is omitted 
the default rate in injection will be used. This applies vice-versa when only the rate on 
injection is specified. 
 
 Example: 
 pump 5 in=a out=b rate=5 
 
Pumps 5 mL of fluid from port a to port b at a rate of 5 mL/min for both aspiration and 
injection. 
 
 pump 3 in=a out=b ratein=10 rateout=2 
 
Pumps 3 mL of fluid from port a to port b at a rate of 10 mL/min for aspiration and 2 
mL/min for injection. 
 
 pump 5 in=b out=c 
 
 Pumps 5 mL of fluid from port b to port c at the default rate for aspiration and injection. 
 
 pump 4 in=a 
 
Aspirates 4 mL of fluid from port a in to the syringe and then waits for the next 
command. It is the operator’s responsibility to account for the fate of the fluid in the 
syringe. NOTE: No more than 10 mL of fluid can be aspirated into the syringe with this 
command (since the syringe has a capacity of 10 mL). 
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pump 2 out=b 
 
Injects 2 mL of syringe contents to port b. This command assumes that the syringe 
contains at least 2 mL of fluid that was aspirated with a previous command. 
 
pump out=b 
 
Injects the entire contents of the syringe to port b. This command assumes that the 
syringe contains fluid that was aspirated with a previous command. NOTE: This 
command can be used to ensure that the syringe is completely empty before executing 
additional code. 
 
pump out 
 
Similar to above, however a port is not specified. The syringe injects the entire contents 
to the currently selected port. 
 
pump 0.5 in out 
 
Aspirates 0.5 mL of fluid from the default port and then injects it back through this port. 
This command is useful for priming fluid lines or mixing a solution in the syringe. 
 
pump 1 in out=c rate=2 
 
Aspirates 1 mL of fluid from the currently selected port and then injects it through port c 
at a rate of 2 mL/min. 
 
AUX 
 Description: 
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This command follows the same structure as the pump command, but sends its 
instructions to the auxiliary pump. 
 
Usage: 
Same as the pump command 
 
Example: 
aux 3 in=b out=a ratein=10 rateout=2 
 
Uses the auxiliary pump to transfer 3 mL of fluid from port a to port b, aspirating at a rate 
of 10 mL/min and injecting at 2 mL/min. 
 
WETPUMP 
 Description: 
This command follows the same structure as the pump command, but sends its 
instructions to the wet pump. 
 
 Usage: 
 Same as the pump command. 
 
 Example: 
 wetpump 3 in=a out=b ratein=10 rateout=2 
 
Uses the wet pump to transfer 3 mL of fluid from port a to port b, aspirating at a rate of 
10 mL/min and injecting at 2 mL/min. 
 
LOCK 
 Description: 
Used to claim a pump or valve for exclusive access by a particular module. This 
command is used on synthesizers for which there are several autonomous processes that 
share a common resource (a common valve or pump). Other processes that try to access 
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the shared valve or pump while it is locked will get a busy signal and will wait until the 
resource becomes available. The resource is freed with the unlock command. 
 
 Usage: 
 lock # 
 lock aux 
 lock wetpump 
 
# indicates the number of the valve that should be locked. To use a single lock 
command to lock many valves, separate each valve name with a space. 
aux indicates that the auxiliary pump should be locked 
wetpump indicates that the wetpump should be locked 
 
Example: 
lock 3 5 aux 
 
Locks valve 3, valve 5, and the auxiliary pump for exclusive access by the calling 
module. 
 
UNLOCK 
 Description: 
Used to release a pump or valve from exclusive access by a particular module (see lock 
command). 
 
Usage: 
unlock # 
unlock aux 
unlock wetpump 
unlock all 
 
# indicates the number of the valve that should be unlocked. To use a single unlock 
command to unlock many valves, separate each valve number with a space. 
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aux indicates that the auxiliary pump should be unlocked 
wetpump indicates that the wet pump should be unlocked 
all indicates that all resources locked by the calling module should be unlocked 
 
Examples: 
unlock 3 5 aux 
 
Releases valve 3, valve 5, and the auxiliary pump from exclusive access by the calling 
module. 
 
unlock all 
 
Releases all resources from exclusive access by the calling module. 
 
STIRON 
 Description: 
Used to control the stirring of the reaction filtration cartridge. The IKA
®
 RET control-
visc heating stir plate used to stir the filtration cartridge is powered through a solid state 
relay. The default position of the relay is off; the stir plate has no power. When it is 
turned on, the stir plate is receives power and resumes is preset stir rate and temperature 
(preset by the operator). When combined with the stiroff command the stir plate can 
be turned on and off during a program. 
 
 Usage: 
 stiron 
 
 Example: 
 stiron 
 
 valve 1a 
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The solid state relay is turned on, providing power to the stir plate, which resumes its 
preset stir rate and temperature. The script will immediately read the next line of the main 
code (valve 1a) as the stir plate begins powering up. Once powered up, the stir plate 
will maintain its preset stir rate and temperature until the stiroff command is called. 
 
STIROFF 
 Description: 
 See description for stiron command above. 
 
 Usage: 
 stiroff 
 
 Example: 
valve 1a 
 
stiroff 
 
valve 1b 
 
After executing the valve 1a command the solid state relay is turned off, powering 
down the stir plate, stopping the stirring of the reaction filtration tube. The script will 
immediately read the next line of the main code (valve 1b) as the stir plate powers 
down. This command assumes that the stiron command has been called previously.  
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APPENDIX B 
SAMPLE PROGRAM SCRIPT USED ON THE SYNTHESIZER 
 
This appendix shows an example of a complete program script written with the 
commands described in Appendix A. Specifically, this program script was written to have the 
synthesizer execute one deprotection ([D]), cross-coupling ([C]), and purification ([P]) sequence 
as a single experiment (Scheme B.1). This is the program script exactly as the operator would 
enter it for the software to interpret it. 
 
 
Scheme B.1. General scheme for the experiment executed by the program script shown in Appedix B; a sequence of 
one deprotection ([D], cross-coupling ([C]), and purification ([P]).  
 
' =========== 
' Definitions 
' =========== 
 
„ Define experiment name 
define experiment=experiment_name 
 
„ Define addition rates (mL/min) 
define additionRate1=0.057 
define additionRate2=0.057 
define additionRate3=0.057 
 
' Define post-addition stir times(seconds) 
' Total reaction time is sum of slow-addition and post-addition stir times 
'  1h = 3600    2h = 7200    3h = 10800   4h = 14400 
'  5h = 18000   6h = 21600   7h = 25200   8h = 28800 
'  9h = 32400  10h = 36000  11h = 39600  12h = 43200  
' 13h = 46800  14h = 50400  15h = 54000  16h = 57600 
' 17h = 61200  18h = 64800  19h = 68400  20h = 72000 
' 21h = 75600  22h = 79200  23h = 82800  24h = 86400  
' 25h = 90000  26h = 93600  27h = 97200  28h = 100800 
' 29h = 104400 30h = 108000 31h = 111600 32h = 115200  
' 33h = 118800 34h = 122400 35h = 126000 36h = 129600 
' 37h = 133200 38h = 136800 39h = 140400 40h = 144000 
' 45 min = 2700 
 
define stirTime1=44100 
define stirTime2=46800 
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define stirTime3=57600 
 
log " start of [experiment] " 
 
valve 13h 
 
log " BEGIN: addition of THF " 
' ================================ 
' Add THF To 1st Deprotection Tube 
' ================================ 
' First portion of THF 
lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 5 in=a rate=[fastTHF] ' aspirate THF 
  pause 10 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate argon plug to clear lines 
  pause 10 
unlock 12 6 ' unlock common reagents 
 
valve [deprotect] 
valve 2g 
pump out=a rate=10 
pump 2 in=b out=a ratein=60 rateout=20 
 
' Second portion of THF 
lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 5 in=a rate=[fastTHF] ' aspirate THF 
  pause 10 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate argon plug to clear lines 
  pause 10 
unlock 12 6 ' unlock common reagents 
 
valve [deprotect] 
valve 2g 
pump out=a rate=10 
pump 2 in=b out=a ratein=60 rateout=20 
 
' There should now be 10 mL THF in 1st deprotection tube 
log " COMPLETE: addition of THF " 
 
valve 3h '  move valve 3 away from 1st deprotection tube 
pause 10 ' give some time for the MIDA boronate to dissolve 
 
' ================================== 
' Add Water To 1st Deprotection Tube 
' ================================== 
wetpump 3 in=a rate=5 
pause 3 
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valve 13a ' select 1st deprotection tube  
wetpump out=d rate=5 
wetpump 2 in=e out=d ratein=60 rateout=10 
wetpump 2 in=e out=d ratein=60 rateout=10 
 
log " water now added to 1st deprotection tube " 
 
valve 13h ' move valve 13 away from 1st deprotection tube 
  
' ================================== 
' Begin Agitation Via Argon Sparging 
' ================================== 
log " BEGIN: 1st deprotection aggitation " 
valve [deprotect] 
valve 2g 
valve 1h ' move valve 1 away from pressure of argon 
 
lock [gas] 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
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valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1  
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1  
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1  
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1  
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
265 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 1 min  
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
266 
 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 2 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
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valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 3 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
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valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 4 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
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valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 5 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
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valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 6 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
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valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 7 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
272 
 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 8 min 
 
273 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
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pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 9 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
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pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 10 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
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pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 11 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
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pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 12 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
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pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 13 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
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pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 14 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
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pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 15 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
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pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 16 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
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pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 17 min 
 
valve xon 
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pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
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valve xon 
pause 2 
valve xoff 
pause 2 ' 18 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
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valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 19 min 
 
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
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valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2  
valve xon 
pause 2 
valve xoff 
pause 2 ' 20 min 
 
unlock [gas] 
 
log " COMPLETE: 1st deprotection aggitation " 
 
' ==================================================== 
' Quench The Reaction With pH=6 0.5 M Phosphate Buffer 
' ==================================================== 
sub quench 
  wetpump 3 in=b rate=5 ' aspirate buffer 
  pause 5 
  valve 13a 
  wetpump out=d rate=5 ' inject buffer 
  wetpump 2 in=e out=d ratein=60 rateout=10 
  wetpump 2 in=e out=d ratein=60 rateout=10 
  valve 13h 
end sub 
 
background quench 
 
' ==================== 
' Prime The Ether Line 
' ==================== 
lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [ether] ' select ether 
  pump 5 in=a rate=5 ' aspirate ether 
  pause 10 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastEther] ' aspirate argon plug to clear lines 
  pause 3 
  pump out=d rate=20 ' inject ether to waste flask 
 
  valve [me]  
  valve 2h  
  valve [ether] 
  pump 5 in=a rate=5 
  pause 10 
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  valve [ar] 
  pump 2 in=a rate=[fastEther]  
  pause 3 
  pump out=d rate=20  
 
  valve [me]  
  valve 2h  
  valve [ether] 
  pump 5 in=a rate=5 
  pause 10 
  valve [ar]  
  pump 2 in=a rate=[fastEther]  
  pause 3 
  pump out=d rate=20  
 
  pump 2 in=b out=d ratein=60 rateout=20   
 
' ================= 
' Add Diethyl Ether 
' ================= 
  valve [me] 
  valve 2h  
  valve [ether] 
  pump 5 in=a rate=[fastEther] 
  pause 10 
  valve [ar]  
  pump 2 in=a rate=[fastEther]  
  pause 3 
unlock 12 6 ' unlock common reagents 
 
wait quench 
 
valve [deprotect] 
valve 2g 
pump out=a rate=10 
pump 2 in=b out=a ratein=60 rateout=10 
pump 2 in=b out=a ratein=60 rateout=10 
 
valve 3h  
valve 13a 
wetpump 10 in=e out=d ratein=60 rateout=20 
wetpump 10 in=e out=d ratein=60 rateout=20 
wetpump 10 in=e out=d ratein=60 rateout=20 
log " 1st deprotection fully quenched " 
 
' ================================= 
' Aspirate 1st Deprotection Mixture 
' ================================= 
wetpump 10 in=d rate=10 
pause 30 
wetpump 4.0 out=d rate=10  
pause 10 
wetpump out=f rate=10  
wetpump 2 in=e out=f ratein=60 rateout=20 
wetpump 2 in=e out=d ratein=60 rateout=20 
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wetpump 2 in=e out=d ratein=60 rateout=20 
 
' =========================== 
' Aspirate 50% Saturated NaCl 
' =========================== 
wetpump 3 in=g rate=5 
pause 5 
 
' ================================================== 
' Inject 50% Saturated NaCl To 1st Deprotection tube 
' ================================================== 
wetpump out=d rate=5 
wetpump 2 in=e out=d ratein=60 rateout=20 
wetpump 2 in=e out=d ratein=60 rateout=20 
 
valve 13h  
valve [deprotect] 
valve 2g 
valve 1h 
lock [gas] 
  valve xon 
  pause 1 
  valve xoff 
  pause 5 
  valve xon 
  pause 1 
  valve xoff 
unlock [gas] 
valve 3h  
valve 13a 
wetpump 10 in=e out=d ratein=60 rateout=20 
wetpump 10 in=e out=d ratein=60 rateout=20 
wetpump 10 in=e out=d ratein=60 rateout=20 
pause 10 
 
' ============================================= 
' Aspirate Salt-Washed 1st Deprotection Mixture 
' ============================================= 
wetpump 10 in=d rate=10 
pause 30  
wetpump 6.4 out=d rate=10  
pause 10 
wetpump out=f rate=10  
wetpump 2 in=e out=f ratein=60 rateout=20 
wetpump 2 in=e out=d ratein=60 rateout=20  
wetpump 2 in=e out=d ratein=60 rateout=20     
valve 13h 
 
' ============================ 
' PRE-DRYING OVER MgSO4:Celite 
' ============================ 
sub predryCycleStep1   
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
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  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 
  pump 2 in=b out=h ratein=60 rateout=45 
  pump 10 in=h out=h rate=15 ' ten times of agitation 
  pump 5 in=b out=h ratein=60 rateout=45 
end sub 
 
log " BEGIN: predrying " 
lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 4 in=a rate=10 ' aspirate THF 
  pause 10 
  valve [ar] ' select argon 
  pump 2 in=a rate=10 ' aspirate argon plug 
unlock 12 6 
valve 4a 
pump out=h rate=15 
pump 2 in=b out=h ratein=60 rateout=30 
 
'Transfer to predrying tube 
  valve [deprotect] 
  valve 2g 
  valve 4a 
  pump 9 in=a rate=15 
  pause 1 
  pump out=h rate=15 
  pump 9 in=a rate=15 
  pause 1 
  pump out=h rate=15 
  pump 5 in=b out=h ratein=60 rateout=45 
 
run predryCycleStep1  ' rep1 
run predryCycleStep1  ' rep2 
 
lock 12 6 ' lock common reagents 
   valve [me] ' select syringe pump 
   valve 2h ' select common reagents 
   valve [thf] ' select THF 
   pump 4 in=a rate=10 ' aspirate THF 
   pause 10 
   valve [ar] ' select argon 
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   pump 2 in=a rate=10 ' aspirate argon plug 
 unlock 12 6 
valve 2g 
valve [drying] 
pump out=a rate=15 
pump 2 in=b out=a ratein=60 rateout=30 
 
log " BEGIN: Transfer from predrying to drying tube " 
valve 4a 
valve 2g 
valve [drying] 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
' All solution should now be in the drying tube 
 
' ====================== 
' DRYING/DEGASING MODULE 
' ====================== 
sub dryingCycle1 
   valve [drying] 
   valve 2g 
   pump 8 in=a rate=5 
   valve 1b 
   pause 1 
   pump out=a rate=10 
   pump 3 in=b out=a ratein=60 rateout=45 
end sub 
 
log " BEGIN: drying " 
run dryingCycle1 ' Rep 1 
run dryingCycle1 ' Rep 2 
run dryingCycle1 ' Rep 3 
run dryingCycle1 ' Rep 4 
run dryingCycle1 ' Rep 5 
run dryingCycle1 ' Rep 6 
run dryingCycle1 ' Rep 7 
run dryingCycle1 ' Rep 8 
run dryingCycle1 ' Rep 9 
run dryingCycle1 ' Rep 10 
run dryingCycle1 ' Rep 11 
run dryingCycle1 ' Rep 12 
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log " BEGIN: transfer to degassing tube " 
' Rep 1 
valve [drying] 
valve 2g 
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas] 
pump out=a rate=20 
 
' Rep 2 
valve [drying] 
valve 2g   
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas]   
pump out=a rate=20 
 
' Rep 3 
valve [drying] 
valve 2g   
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas]   
pump out=a rate=20 
 
' Rep 4 
valve [drying] 
valve 2g   
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas]   
pump out=a rate=20 
 
' Air plug 
pump 2 in=b out=a ratein=60 rateout=20 
 
log " BEGIN: first wash of drying agents " 
 
' ============================= 
' First Wash Of Drying Reagents 
' ============================= 
 lock 12 6 ' lock common reagents 
   valve [me] ' select syringe pump 
   valve 2h ' select common reagents 
   valve [thf] ' select THF 
   pump 6 in=a rate=10 ' aspirate THF 
292 
 
   pause 10 
   valve [ar] ' select argon 
   pump 2 in=a rate=10 ' aspirate argon plug 
 unlock 12 6 
valve 4a 
pump out=h rate=15 
pump 2 in=b out=h ratein=60 rateout=20 
 
run predryCycleStep1  ' rep1 
 
valve 4a 
valve 2g 
valve [drying] 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
run dryingCycle1 ' Rep 1 
run dryingCycle1 ' Rep 2 
run dryingCycle1 ' Rep 3 
run dryingCycle1 ' Rep 4 
run dryingCycle1 ' Rep 5 
 
' Rep 1 
valve [drying] 
valve 2g  ' Select drying tube 
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas]  ' Select degassing tube 
pump out=a rate=20 
 
' Rep 2 
valve 2g 
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas] 
pump out=a rate=20 
 
' Air plug 
pump 2 in=b out=a ratein=60 rateout=35 
 
log " all solution (first and wash) should now be in degassing tube " 
 
' there are  mL in the tube 
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log " BEGIN: first concentration/deoxygenation " 
valve 2a  
pump 6 in=a rate=10 
pump 1 in=b out=a ratein=60 rateout=20 
valve 1h 
' there are  mL in the tube 
 
lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
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valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
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pause 2 
valve xoff 
pause 2 ' 1 min 
 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
unlock [gas] 
 
' there are  mL in the tube 
pump 2 out=a rate=20  
pump 2 in=b rate=60 
pause 1 
pump 1 out=a rate=20 
valve 1h  
' there are  mL in the tube 
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lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
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valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 ' 1 min 
 
valve xon 
pause 5 
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valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
unlock [gas] 
 
' there are  mL in the tube 
pump 3 out=a rate=20  
pump 2 in=b rate=60 
pause 1 
pump 1 out=a rate=20 
valve 1h  
' there are  mL in the tube 
 
lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
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pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
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valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 ' 1 min 
 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
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valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
unlock [gas] 
 
' there are  mL in the tube 
pump out=a rate=20   
pump 2 in=b out=a ratein=60 rateout=30 
valve 1h  
' there are  mL in the tube 
 
' ============================= 
' Second Wash Of Drying Reagents 
' ============================= 
log " BEGIN: second wash of drying agents " 
lock 12 6 ' lock common reagents 
   valve [me] ' select syringe pump 
   valve 2h ' select common reagents 
   valve [thf] ' select THF 
   pump 6 in=a rate=10 ' aspirate THF 
   pause 10 
   valve [ar] ' select argon 
   pump 2 in=a rate=10 ' aspirate argon plug 
 unlock 12 6 
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valve 4a 
pump out=h rate=15 
pump 2 in=b out=h ratein=60 rateout=20 
 
run predryCycleStep1  ' rep1 
 
valve 4a 
valve 2g 
valve [drying] 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
pump 10 in=h rate=15 
pause 10 
pump out=a rate=20 
pump 2 in=b out=a ratein=60 rateout=20 
 
run dryingCycle1 ' Rep 1 
run dryingCycle1 ' Rep 2 
run dryingCycle1 ' Rep 3 
run dryingCycle1 ' Rep 4 
run dryingCycle1 ' Rep 5 
 
' Rep 1 
valve [drying] 
valve 2g   
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas]   
pump out=a rate=20 
 
' Rep 2 
valve 2g 
pump 10 in=a rate=5 
pause 10 
valve 1b 
pause 1 
valve [degas] 
pump out=a rate=20 
 
' Air plug 
pump 2 in=b out=a ratein=60 rateout=35 
 
log " all solution should now be in degassing tube " 
 
' there are  mL in the tube 
log " BEGIN: second concentration/degassing " 
valve 2a  
pump 8 in=a rate=10 
pump 1 in=b out=a ratein=60 rateout=20 
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valve 1h 
' there are  mL in the tube 
 
lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
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valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 ' 1 min 
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valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
valve xon 
pause 600 
valve xoff ' 20 min 
 
valve xon 
pause 600 
valve xoff ' 30 min 
 
unlock [gas] 
 
' there are  mL in the tube 
pump 4.0 out=a rate=20  
pump 2 in=b rate=60 
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pause 1 
pump 1 out=a rate=20 
valve 1h  
' there are  mL in the tube 
 
lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
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valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
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pause 2 ' 1 min 
 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
valve xon 
pause 600 
valve xoff ' 20 min 
 
unlock [gas] 
 
' there are  mL in the tube 
pump out=a rate=20   
pump 2 in=b out=a ratein=60 rateout=30 
valve 1h  
' there are  mL in the tube 
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lock [gas] 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 10 sec 
 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 
valve xon 
pause 0.5 
valve xoff 
pause 1.5 ' 20 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
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valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 30 sec 
 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 
valve xon 
pause 1 
valve xoff 
pause 1 ' 40 sec 
 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 
valve xon 
pause 2 
valve xoff 
pause 2 ' 1 min 
 
valve xon 
pause 5 
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valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 
valve xon 
pause 5 
valve xoff 
pause 5 ' 2 min 
 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 
valve xon 
pause 10 
valve xoff 
pause 10 ' 3 min 
 
valve xon 
pause 420 
valve xoff ' 10 min 
 
unlock [gas] 
 
' there are  mL in the tube 
 
log " COMPLETE: Concentration/degassing " 
 
valve 8a  
 
lock [gas] 
  pump 5 in=b out=e ratein=60 rateout=20 
  pump 5 in=b out=e ratein=60 rateout=20 
  pump 5 in=b out=e ratein=60 rateout=20 
 
  pump 5 in=b out=g ratein=60 rateout=20 
  pump 5 in=b out=g ratein=60 rateout=20 
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  pump 5 in=b out=g ratein=60 rateout=20 
 
  valve [rxntube] 
  pump 8 in=b out=a ratein=60 rateout=20 
  pump 8 in=b out=a ratein=60 rateout=20 
  pump 8 in=b out=a ratein=60 rateout=20 
  
  log "Purge reaction tube with argon" 
  valve 1h 
  valve [rxntube3]  
  valve xon  
  pause 0.5 
  valve xoff 
  pause 0.5 
  valve xon  
  pause 1 
  valve xoff 
  pause 1 
  valve xon  
  pause 2 
  valve xoff 
  pause 2 
  valve xon  
  pause 5 
  valve xoff 
  pause 5 
  valve xon  
  pause 10 
  valve xoff 
  pause 10 
  valve xon  
  pause 600  
  valve xoff  
unlock [gas] 
 
valve 8b  
 
' =============== 
' REACTION MODULE 
' =============== 
lock 12 6 ' lock common reagents 
valve [me] ' select syringe pump 
valve 2h ' select common reagents 
valve [thf] ' select THF 
pump 3 in=a rate=10 ' aspirate THF 
pause 10 
valve [ar] ' select argon for plug 
pump 2 in=a rate=10 ' aspirate argon plug to clear the line 
pause 3 
unlock 12 6 
valve [rxntube] 
pump out=a rate=10 
pump 2 in=b out=a ratein=60 rateout=10 
pump 2 in=b out=a ratein=60 rateout=35 
valve 2h  
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pump 2.5 in=b out=g ratein=60 rateout=0.5  
 
valve [degas] 
pump 4.5 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
log "BEGIN: slow addition to reaction tube" 
pump 1.5 out=[rxntop] rate=3  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
  
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
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pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
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valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]  
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
valve [degas] 
pump 3 in=a rate=10 
pause 15 
pump 2 out=a rate=10 
pause 3 
 
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump 0.177 out=[rxntop] rate=[additionRate1]  
pump out=[rxntop] rate=[additionRate1]   
 
pump 2.5 in=b out=g ratein=60 rateout=0.5 
 
log " BEGIN: stirring [experiment] for [stirTime1]s " 
pause [stirTime1]  
log " COMPLETE: stirring [experiment] for [stirTime1]s " 
 
StirOn ' turn on stirring to filter aid tube 
 
sub addRxnSolution 
  valve 4e 
  pump out=h rate=15 ' Add the rxn solution to the ppt. chamber 
  pump 5 in=b rate=45 
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  pump out=h rate=20 ' Air plug to clear the line. 
  valve 4d 
  pump 10 in=b out=h ratein=30 rateout=50  
  pump 10 in=b out=h ratein=30 rateout=50  
end sub 
 
sub addHexane 
  lock aux [Column] ' Lock auxiliary pump and column selector 
  valve [PptValve1] ' select bottom of the column 
  ' Pump first 6 mL, total = 6 mL 
  aux 6 in=b rate=35  
  pause 3  
  aux out=[ColumnSelect] rate=10 
  ' Pump second 6 mL, total = 12 mL 
  aux 6 in=b rate=35  
  pause 3  
  aux out=[ColumnSelect] rate=10 
 
  aux 10 in=h out=[ColumnSelect] ratein=60 rateout=30 
  aux 10 in=h out=[ColumnSelect] ratein=60 rateout=30 
  unlock aux [Column] ' Unlock auxiliary pump and column selector 
end sub 
 
sub drainColumn 
  lock aux [Column] ' Lock auxiliary pump and column selector 
  valve [pptValve1] ' Select bottom of the column 
  ' -- rep1 
  aux 10 in=[ColumnSelect] rate=70   
  pause 45  
  valve 0h  
  aux out=g rate=70 
  ' -- rep2 
  aux 10 in=[ColumnSelect] rate=70 
  pause 45 
  valve 0h 
  aux out=g rate=70 
  ' -- rep3 
  aux 10 in=[ColumnSelect] rate=70 
  pause 45 
  valve 0h 
  aux out=g rate=70 
  ' -- rep4 
  aux 10 in=[ColumnSelect] rate=70 
  pause 45 
  valve 0h 
  aux out=g rate=70 
 
  aux 3 in=h out=[ColumnSelect] rate=45   
 
  pause 5 
  unlock aux [Column] ' Unlock auxiliary pump and column selector 
end sub 
 
sub drainColumn_addHexane 
317 
 
' This sub merges the two subroutines so that they can be run back-to-back as 
a background process 
 
  run drainColumn 
  run addHexane 
end sub 
 
background addHexane 
 
valve 8b  
pump 10 in=[rxntop3] out=d ratein=10 rateout=40  
pump 10 in=[rxntop3] out=d ratein=10 rateout=40  
pump 10 in=[rxntop3] out=d ratein=10 rateout=40 
valve 8a  
 
pause 600 'wait for stirring 
 
StirOff ' TURN OFF STIRRING for filter aid tube 
 
pause 60 ' wait for settling 
 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  pump 6 out=a rate=10 ' send back all but 3 mL 
  ' there are  mL aspirated into the syringe 
 
wait addHexane 
 
log "Begining product ppt. procedure" 
 
' Cycle #1 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
  
 
 
 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  pump 6 out=a rate=10 ' send back all but 3 mL, should have all THF removed 
from filter aid tube now 
   
wait draincolumn_addHexane 
 
' Cycle #2 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b  
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
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  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate argon plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a  
  valve [rxntube3]  
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  wait draincolumn_addHexane 
 
' Cycle #3 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b  
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #4 
run addRxnSolution ' Now add the rxn solution 
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background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #5 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
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  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #6 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #7 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
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  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #8 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #9 
run addRxnSolution ' Now add the rxn solution 
background draincolumn_addHexane ' Elute the column and send it to waste, 
then fill it back up with hexanes 
 
valve 8b ' close celite vent valve 
' -------- Add the THF to the rxn tube, then let stir for 2 minutes. 
   lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [thf] ' select THF 
  pump 3.0 in=a rate=[fastTHF] ' aspirate THF 
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  pause 3 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastTHF] ' aspirate Ar plug to clear lines 
  pause 3 
   unlock 12 6 
  pump out=[rxntop] rate=10 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pump 2 in=b out=[rxntop] ratein=45 rateout=30 
  pause 120 ' let the mixture stir for 2 minutes 
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40  
pump 10 in=[rxntop3] out=d ratein=20 rateout=40 
valve 8a ' open the celite tube vent valve 
  valve [rxntube3] ' select rxn tube 
  pump 9 in=a rate=1 ' Overfill the syringe w/ rxn solution. 
  pause 120 
  ' there are  mL aspirated into the syringe 
wait draincolumn_addHexane 
 
' Cycle #10 
run addRxnSolution ' Now add the rxn solution 
run draincolumn 
run draincolumn 
 
define addnrate=20   
 
sub addEtherMeOH 
  ' Add 12 mL of Ether w/ 1.5% v/v MeOH to the ppt. chamber 
   lock 12 6 ' lock common reagents 
    valve [me] ' select syringe pump 
    valve 2h ' select common reagents 
    ' ------------ Rep 1 
    valve [meoh] ' select Et2O w/ MeOH 
    pump 6.5 in=a rate=[fastEther]  
    pause 5 
    valve [ar] ' select Ar for plug 
    pump 2.5 in=a rate=[fastEther] 
    pause 3 
    valve 4e 
    pump out=h rate=15 ' Add the solution to the ppt. chamber 
    ' ------------ Rep 2 
    valve [meoh] 
    pump 6.5 in=a rate=[fastEther] 
    pause 5 
    valve [ar] ' select Ar for plug 
    pump 2.5 in=a rate=[fastEther] 
    pause 3 
    pump out=h rate=15 ' Add the solution to the ppt. chamber 
    pump 5 in=b rate=30 
    pump out=h rate=20 ' Air plug to clear the line. 
   unlock 12 6 
 
  valve 4d 
  pump 10 in=b out=h ratein=30 rateout=50  
  pump 10 in=b out=h ratein=30 rateout=50  
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end sub 
 
' ============================= 
' Prime The Ether/Methanol Line 
' ============================= 
lock 12 6 ' lock common reagents 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [meoh] ' select ether 
  pump 5 in=a rate=5 ' aspirate ether 
  pause 10 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastEther] ' aspirate argon plug to clear lines 
  pause 3 
 
  pump out=d rate=20 ' inject ether to waste flask 
 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [meoh] ' select ether 
  pump 5 in=a rate=5 ' aspirate ether 
  pause 10 
  valve [ar] ' select Ar for plug 
  pump 2 in=a rate=[fastEther] ' aspirate argon plug to clear lines 
  pause 3 
 
  pump out=d rate=20 ' inject ether to waste flask 
 
  valve [me] ' select syringe pump 
  valve 2h ' select common reagents 
  valve [meoh] ' select ether 
  pump 5 in=a rate=5 ' aspirate ether 
  pause 10 
  valve [ar] ' select argon for plug 
  pump 2 in=a rate=[fastEther] ' aspirate argon plug to clear lines 
  pause 3 
   
  pump out=d rate=20 ' inject ether to waste flask 
  pump 2 in=b out=d ratein=60 rateout=20  
 
' Rep #1 (12 mL total washing) 
run addEtherMeOH 
run drainColumn 
 
' Rep #2 (24 mL total washing) 
run addEtherMeOH 
run drainColumn 
 
' Rep #3 (36 mL total washing) 
run addEtherMeOH 
run drainColumn 
 
run drainColumn 
 
sub addEther 
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    lock 12 6 ' lock common reagents 
    valve [me] ' select syringe pump 
    valve 2h ' select common reagents 
    ' ------------ Rep 1 
    valve [ether] ' select Et2O 
    pump 6.5 in=a rate=[fastEther] 
    pause 5 
    valve [ar] ' select Ar for plug 
    pump 2.5 in=a rate=[fastEther] 
    pause 3 
    valve 4e 
    pump out=h rate=15 ' Add the solution to the ppt. chamber 
    ' ------------ Rep 2 
    valve [ether] ' select Et2O 
    pump 6.5 in=a rate=[fastEther] 
    pause 5 
    valve [ar] ' select Ar for plug 
    pump 2.5 in=a rate=[fastEther] 
    pause 3 
    pump out=h rate=15 ' Add the solution to the ppt. chamber 
    pump 5 in=b rate=30 
    pump out=h rate=20 ' Air plug to clear the line. 
   unlock 12 6 
 
  valve 4d 
  pump 10 in=b out=h ratein=30 rateout=50  
  pump 10 in=b out=h ratein=30 rateout=50  
end sub 
 
' Rep #1 (12 mL total washing) 
run addEther 
run drainColumn 
 
' Rep #2 (24 mL total washing) 
run addEther 
run drainColumn 
 
' Rep #3 (36 mL total washing) 
run addEther 
run drainColumn 
 
run drainColumn 
run drainColumn  
 
' PRODUCT ELUTION 
' Define sub routines: 
sub mixPPtx5 
  valve 4d 
  pause 50  
  pump 5 in=b out=h rate=45 ' bubble air through the ppt. chamber to help mix 
the mixture 
  ' --- 
  pause 50  
  pump 5 in=b out=h rate=45  
  ' --- 
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  pause 50  
  pump 5 in=b out=h rate=45  
  ' --- 
  pause 50  
  pump 5 in=b out=h rate=45  
  ' --- 
  pause 50  
  pump 5 in=b out=h rate=45  
end sub 
 
sub transfer 
  ' Send the product solution to 2nd deprotection tube  
  valve 4d 
  pump 10 in=h rate=10 
  pause 45 
 
  ' Relieve the vacuum via the nitrogen port.  
   
  valve 1b 
  pause 5 
  
  ' Send the MIDA boronate solution out to 2nd deprotection tube  
  valve 2g 
  valve 3b 
  pump out=a rate=20 
  pump 3 in=b out=a ratein=30 rateout=20 ' Air plugs to clear the line 
  pump 3 in=b out=a ratein=30 rateout=20 
end sub 
 
 lock 12 6 ' Lock common reagents to prevent two processes from using THF at 
the same time 
lock aux [Column] ' Lock auxiliary pump equipment 
  valve [pptValve1] 
  'Wash the syringe with THF (2 x 1 mL) to make sure there is no residual 
MeOH from the ether washes. 
  ' v---- Rep #1 
  aux 1 in=d rate=10 ' Aspirate 1 mL THF 
  pause 3 
  aux 9 in=h rate=20 
  aux out=g rate=70 
  ' v---- Rep #2 
  aux 1 in=d rate=10 ' Aspirate 1 mL THF 
  pause 3 
  aux 9 in=h rate=20 
  aux out=g rate=70 
 
  '-- 
  aux 6.5 in=d rate=10 ' Aspirate 6 mL THF 
  pause 10 
  valve [pptValve1] ' Select bottom of the column 
  aux out=[ColumnSelect] rate=2 ' Pass the THF slowly through the column to 
maximize its residence time 
  '-- 
  aux 6.5 in=d rate=10 ' Aspirate 6 mL THF 
  pause 10 
326 
 
  valve [pptValve1] ' Select bottom of the column 
  aux out=[ColumnSelect] rate=2 ' Pass the THF slowly through the column to 
maximize its residence time 
 
 aux 1 in=h out=[ColumnSelect] ratein=45 rateout=2  
 unlock 12 6 aux [Column] 
 
' Run through 40 reps of air aggitation of the ppt. chamber 
run mixPPtx5 '5 
run mixPPtx5 '10 
run mixPPtx5 '15 
run mixPPtx5 '20 
run mixPPtx5 '25 
run mixPPtx5 '30 
run mixPPtx5 '35 
run mixPPtx5 '40 
 
' Send the MIDA boronate solution to 2nd deprotection tube  
 
run transfer ' Rep #1 
run transfer ' Rep #2 
run transfer ' Rep #3 
run transfer ' Rep #4 
run transfer ' Rep #5 
run transfer ' Rep #6 
 
lock aux [Column] 
  valve [pptValve1] 
  aux 3 in=h out=[ColumnSelect] ratein=45 rateout=3   
  aux 5 in=h out=[ColumnSelect] ratein=45 rateout=25 
  aux 5 in=h out=[ColumnSelect] rate=45 
unlock aux [Column] 
 
run mixPPtx5 
 
' Transfer the wash solution 
run transfer 
 
' Purification procedure complete. 
log " COMPLETE: first purification of [experiment] " 
 
 
